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iv Abstract 
Towards the Development, Application and Understanding of Copper-
Catalysed Alkene Functionalisation Processes using Iodonium Salts 
This thesis comprises three projects focused on the use of the combination of catalytic copper and 
iodonium salts towards the functionalisation of alkenes.  
Chapter 2 details the development of an enantioselective and regiodivergent allylic amide arylation 
procedure using a specific copper(II)-bisoxazoline pre-catalyst and hexafluorophosphate diaryliodonium 
salts. The regioselectivity of the process was discovered to be controlled by the electronic properties of 
the iodane employed, allowing enamide production to be biased with electron-poor iodonium salts and 
oxazines to be produced with electron-rich analogues. An overall scope of 38 compounds was 
collaboratively elaborated, with 20 synthesised personally. All products were generated in useful yields 
and high levels of enantioselectivity.  
Chapter 3 describes efforts towards the application of a copper-catalysed oxy-alkenylation procedure to 
the production of the macrolidal natural product (–)-lyngbyaloside B. It is proposed that an elaborate 
homoallylic carbamate may be coupled with a complex polyoxygenated alkenyl(aryl)iodonium salt as a 
fragment coupling for polyketide synthesis. Following extensive investigations, it was discovered that the 
challenging vinyl-iodonium salt could be synthesised in good yields and then coupled with the desired 
homoallylic carbamate, albeit in limited yield and low d.r..  
Chapter 4 presents initial studies towards a computational understanding of the copper-catalysed 
arylation of alkenes with iodonium salts. Evidence is presented to suggest that two functionalisation 
modes are energetically accessible, allowing the production of regioisomeric arylated products. 
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1 Introduction – The Catalytic Generation and Reaction of Aryl and 
Alkenyl Cation Equivalents 
This introduction describes the development of catalytically-generated aromatic and vinyl electrophiles 
and their application in C–C bond-forming reactions. The success that has been achieved with the use 
of palladium(II) species as transient electrophilic equivalents is discussed before the argument is extended 
to copper(III). It is demonstrated that the combination of copper salts and iodonium salts provides a 
powerful platform for the functionalisation of nucleophiles, especially carbon-based functionalities. 
1.1 sp2-Hybridised Carbon Electrophiles 
Arenes and alkenes are two of the most fundamental functional groups in organic chemistry. The 
exploitation of these planar moieties has allowed for the development of classes of molecules crucial to 
modern life. Such compounds include materials, pharmaceuticals and agrochemicals (Figure 1).  
 
Figure 1 – Examples of commercially and societally important compounds bearing sp2-hybridised groups: 
KevlarTM 1, a synthetic fibre; LipitorTM 2, a statin; and λ-cyhalothrin 3, a pesticide  
One method for the generation of complex aromatic and vinylic species is to functionalise a simple arene 
or alkene core. Many such processes exploit the electronic properties of the π-systems of aromatic groups 
and olefins. An example of π-nucleophilicity can be seen in the Friedel-Crafts reaction (Scheme 1a) 
whilst π-electrophilicity is exemplified by addition-elimination (Scheme 1b).  
 
Scheme 1 – a) Friedel-Crafts π-nucleophilicity and b) addition-elimination π-electrophilicity 
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An alternative strategy to generate the same classes of product as above is through the reaction of some 
sp2-hybridised nucleophile or electrophile equivalent (Scheme 2).  
 
Scheme 2 – Conceptual description of a sp2-hybridised group a) nucleophile and b) electrophile  
A wide variety of nucleophilic sp2-equivalents are routinely used in organic synthesis. Such reactive 
species include, amongst many others, Grignards reagents and organolithiums (Figure 2a). 
Contrastingly, stoichiometric sp2-hybridised electrophiles are less widely used and are more limited in 
scope, largely being constrained to high-valent aryl- and alkenyl-main group compounds (Figure 2b).  
 
Figure 2 – Representative synthetic equivalents for a) an sp2-hybridised nuceleophile and b) an sp2-hybridised 
electrophile 
Lead(IV),1 bismuth(V)2 and iodine(III)3 species have all been employed towards the arylation and 
vinylation of numerous nucleophile classes. For example, phenyllead triacetate has been observed to 
arylate malonates, triphenylbismuth dichloride has been used to generate arylated napthols and 
diaryliodonium salts have been used to functionalise thiocarboxylates (Scheme 3).4–6  
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Scheme 3 – a) Kozyrod’s malonate arylation with lead(IV) reagent 14;4 b) Barton’s 2-napthol arylation with 
bismuth(V) reagent 17;5 c) You and Chen’s thiocarboxylate arylation with iodine (III) reagent 206 
Despite the operational simplicity of arylation reactions using high-valent main-group compounds, the 
use of these reagents is far from ideal. Lead is toxic, bismuth has a low abundance and the reaction of 
iodanes requires relatively forcing conditions with even strong nucleophiles. Attention has therefore been 
directed towards the development of catalytically-generated and highly reactive sp2-hybridised 
electrophile equivalents. This introduction discusses progress towards such intermediates, first addressed 
by an overview of palladium catalysis before the concept is extended to powerful copper-catalysed 
methods employing hypervalent iodine reagents such as 20 to functionalise even poor nucleophiles. 
1.2 Palladium-Catalysed Generation and Reactivity of sp2 Electrophile 
Equivalents 
1.2.1. Palladium-catalysed cross-coupling 
The development of cross-coupling has had an undeniably huge impact on modern chemistry. The 
importance of this work for allowing the development of new disconnections for chemical synthesis is 
highlighted by the awarding of the 2010 Nobel Prize to Richard Heck, Akira Suzuki and Ei-ichi Negishi 
for their contributions to the field. Despite the very broad uses of the reaction, the underlying principle 
of cross-coupling is very simple: a metal catalyst is employed to connect an aryl, alkenyl or even alkyl 
(pseudo)halide with a nucleophile (Scheme 4). Although a variety of elements have been observed to be 
competent coupling catalysts (including the first-row transition metals iron,7 copper,8 and nickel9,10), 
palladium is by far the most widely-used.11 
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Scheme 4 – Simplified cross-coupling procedure 
The broad use of palladium can be attributed to the well-defined organometallic behaviour of the metal 
centre, allowing the key mechanistic steps of cross-coupling to be characterised, understood, and 
manipulated (Scheme 5).12 At the simplest level, the active catalyst in palladium-catalysed cross-coupling 
is the 14-electron palladium (0) species 22, generated in situ by ligand dissociation or by a reduction 
process from an introduced palladium(II) source. Oxidative addition of complex 22 into an aryl/vinyl 
(pseudo)halide furnishes stable 16-electron palladium (II) adduct 23. 23 then undergoes transmetalation 
with a nucleophilic equivalent to give nucleophile-bound complex 24 before reductive elimination 
occurs to give the coupled product and to regenerate the Pd(0) catalyst.  
 
Scheme 5 – Simplified cross-coupling mechanism 
The consistency of the behaviour of palladium has allowed for the coupling of a broad range nucleophilic 
species to aryl and vinyl (pseudo)halides.11 Boronic acids,13 Grignard reagents,14 organozincs,15 
organotin species16 and copper acetylides17 are all commonly-employed coupling partners. As such, 
Palladium(II) intermediate 23 is often considered as a sp2-hybridised electrophile equivalent, able to 
undergo reaction with a nucleophilic equivalent (Scheme 6).  
 
Scheme 6 – Palladium(II) intermediates as sp2 electrophile equivalents 
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Significant interest has been invested in the use of heteroatomic nucleophiles to attack aryl/alkenyl-
palladium(II) intermediate 23. The first and most famous of these processes is the Buchwald-Hartwig 
reaction, which directly couples free amines to the in situ-formed sp2 electrophile equivalent (Scheme 
7).18,19 The reaction typically requires a strong base, sterically demanding ligands and elevated 
temperatures and has evolved to tolerate a wide range of nitrogen-bearing inter- and intramolecular 
coupling partners.20,21 The analogous use of oxygen,22 sulfur23 and phosphorous24 nucleophiles has also 
been reported.  
 
Scheme 7 – a) Hartwig’s,19 and b) Buchwald’s18 original amine coupling conditions 
Similarly, the reaction of carbon-based functional groups with aryl/alkenyl-palladium(II)-intermediates 
has also been widely exploited. One of the most important of such processes is the alkene-coupling 
Mizoroki-Heck reaction (Scheme 8), which proceeds by a distinct mechanism to the general cross-
coupling procedure described above.25–27 In this reaction, following oxidative addition, palladium 
complex 23 undergoes ligand exchange to give alkene-bound adduct 38. The aryl/alkenyl moiety inserts 
into the alkene to generate coordinatively-unsaturated alkyl palladium(II) intermediate 39, which then 
undergoes β-hydride elimination to give the coupled alkene-bound palladium hydride 40. Ligand 
exchange and reductive elimination then occur to furnish the functionalised alkene product, an 
equivalent of acid and the regenerated catalyst. 
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Scheme 8 – a) Heck reaction;25 b) Heck reaction mechanism (L = phosphine)27 
As there is substantial back-bonding from the palladium centre to the alkene in olefin-bound complex 
38,28,29 it cannot be claimed that the alkene component in the Mizoroki-Heck reaction acts as a true 
nucleophile. However, there is less ambiguity with the use of enolates to nucleophilically attack aryl- and 
alkenyl-palladium(II) intermediates.30–36 One such enolate arylation process, Hartwig’s α-arylation of 
methyl/phenyl ketone, is shown below (Scheme 9). 31 
 
Scheme 9 – Hartwig’s ketone α-arylation via enolate formation31 
1.2.2. Electrophilic metalation of arenes with aryl/alkenyl-palladium(II) species 
The use of carbon-based nucleophiles to attack in situ-generated sp2-electrophile equivalents has been 
extended to Friedel-Crafts chemistry, allowing the coupling of arenes to alkenyl/aryl-halides via a C–H 
functionalisation approach (Scheme 10). Such a procedure advantageously removes the need for pre-
functionalisation of the aryl group (by borylation, metalation, etc.).37 The use of electron-rich heterocycles 
has been particularly successful under this C–H activation manifold. Friedel-Crafts-selective 
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functionalisation is observed on the exposure of (benzo)thiophenes, (benzo)furans and nitrogenous 
heteroaromatics to the combination of aryl/vinyl halides and a palladium source (Scheme 11).38–41 
 
Scheme 10 – Direct electrophilic palladation via a Friedel-Crafts type process 
 
Scheme 11 – Representative palladium-catalysed Friedel-Crafts type reactions proceeding through a 
palladium(II)–aryl intermediate: a) Ohta’s thiophene arylation38 and b) Gevorgyan’s indolizine arylation40 
Interestingly, Sames first demonstrated that C-2 arylation results on the addition of indoles to reaction 
conditions that generate electrophilic aryl-palladium(II) intermediates (Scheme 12a).42 This unexpected 
selectivity derives from a Friedel-Crafts C-3 palladation followed by a 1,2-migration to give C-2 
palladated intermediate 57 for elimination then reductive elimination (Scheme 12b). The 
metalation/migration pathway was evidenced by the observation of a large secondary kinetic isotope 
effect at the indole C-3 position (kH/kD = 1.6) and by Hammett investigations varying the indole at the 
C-7 position. The C-2 selectivity can be overturned with free N–H indoles by using magnesium bases.43  
 
Scheme 12 – Sames’ C-2 indole arylation a) procedure42 and b) key palladation/migration mechanism43  
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The forcing conditions required to effect the electrophilic metalation reactions shown in Schemes 11 
and 12 is attributable to the strongly electron-donating ligand-field of the palladium–aryl adduct 55, 
reducing the electrophilicity of the metal centre. Larrosa sought to overcome the use of such extreme 
conditions for the palladium-catalysed arylation of indole 58 by removing phosphine ligands and adding 
a silver salt to the reaction mixture (Scheme 13a). According to Larrosa’s hypothesis, the absence of 
stabilising phosphines and the abstraction of iodide ligands by the silver salt would give formally cationic 
aryl-palladium(II) intermediate 61. The electron-deficiency of this complex was expected to promote 
electrophilic metalation, allowing the reaction to proceed at room temperature (Scheme 13b). 
 
Scheme 13 – Larrosa’s C-2 indole arylation a) procedure and b) conceptual mechanistic overview44  
Despite the clear efficacy of this process, it is not immediately clear how the palladium(II) source 
introduced at the start of the reaction is reduced to palladium(0). Such a reduction process is required 
for an initial oxidative addition step that furnishes 60. It is therefore possible that the reaction proceeds 
by a distinct mechanism to that proposed by Larrosa, likely by the pathway discussed in the next section. 
1.2.3. Direct electrophilic metalation of nucleophilic arenes 
An alternative strategy for the generation of palladium(II)-centred electrophilic arene equivalents 
requires no phosphine ligand or aryl/alkenyl(pseudo)halide. Reactivity proceeds via the direct 
electrophilic palladation of a nucleophilic arene with an unstabilised palladium(II) source, resulting in 
the generation of an electrophilic arene equivalent. Subsequent nucleophilic attack of the aryl-
palladium(II) species furnishes palladium complex 66 for reductive elimination (Scheme 14). 
 
Scheme 14 – Alternative electrophilic metalation approach employing palladium (II) salts as the electrophile  
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Fujiwara first explored such reactivity in his seminal 1967 work detailing the coupling of simple arenes 
with alkenes to form styrene derivatives (Scheme 15).45–49 The reaction is proposed to begin with the loss 
of an acetate ligand from palladium(II) acetate.49 An aryl group then undergoes electrophilic metalation 
with cationic palladium(II) complex 67 with the resulting complex then bound by an alkene to give 68. 
A Heck-type mechanism of alkene insertion and β-hydride elimination then follows to furnish product-
bound palladium hydride intermediate 70. Ligand exchange and reductive elimination processes then 
furnish the product and a Pd(0) complex. The low-valent palladium is then re-oxidised to palladium(II) 
acetate by copper(II) acetate under aerobic conditions. As can be seen from the use of benzene in the 
reaction, this Pd(II)/Pd(0) manifold is able to functionalise relatively non-nucleophilic arenes under 
milder conditions than many of the Pd(0)/Pd(II) procedures described above (Schemes 11 and 12). 
Fujiwara’s alkenylative Friedel-Crafts C–H activation procedure has been extended to substituted 
benzene rings and various heterocycles.50,51 
 
Scheme 15 – Fujiwara’s oxidative Heck a) process and b) mechanism45–47 
The palladium(II)-palladium(0) cycling approach has been modified by a number of groups towards the 
functionalisation of indoles using different nucleophile coupling strategies (Scheme 16). Gaunt’s indole 
alkenylation achieves selective C-2/C-3 functionalisation with a judicious choice of solvent and 
oxidant.52 Shi effected an oxidative Suzuki coupling, intercepting the aryl-palladium(II) intermediate 
with a boronic acid to furnish 2-arylated indoles.53 Finally, Fagnou employed concerted-metalation-
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deprotonation chemistry54–56 as a secondary C–H activation mode to transfer an additional 
unfunctionalised arene to the electrophilically-palladated palladium(II) intermediate.57 
 
Scheme 16 – a) Gaunt’s indole C-2/C-3 selective oxidative Heck reaction,52 b) Shi’s oxidative Suzuki coupling 
with indole,53 c) Fagnou’s dual C–H activation indole phenylation procedure57 
Sanford also employed the intrinsic electrophilicity of palladium(II) acetate in her 2006 indole arylation 
employing a diaryliodonium salt and using a palladium(II)-palladium(IV) redox manifold (Scheme 
17a).58 The reaction is proposed to proceed through the electrophilic metalation and 1,2-migration of 
indole 73 with palladium(II) acetate species 81 before the resulting adduct (82) undergoes oxidative 
addition with diaryliodonium salt 79. Reductive elimination of diarylated palladium(IV) intermediate 
83 gives the coupled product and re-generates the palladium(II) catalyst (Scheme 17b).  
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Scheme 17 – Sanford’s Pd(II)/Pd(IV) C-2 indole arylation a) process and b) mechanism58 
1.3 Generation of sp2 Electrophile Equivalents with Other Metals 
The generation and reactivity of electrophilic sp2 equivalents has also been described with metals other 
than palladium. Although the chemistry of such processes is generally less well-understood than the 
analogous palladium-catalysed methods, this area of research is expanding rapidly. Three examples are 
shown below (Scheme 18). 
The first of these processes (Scheme 18a) is a Nickel-catalysed Negishi reaction.59 Although the 
mechanism of this reaction is poorly described, it has been evidenced that the key electrophilic 
intermediate is nickel(III) radical cation 86.60 Transmetalation of 86 with alkyl zinc 87 and subsequent 
reductive elimination provides the alkyl-coupled product. Separately, Miqueu, Amgoune and Bourissou 
have demonstrated phenylmagnesium bromide 10 to react with gold(III) complex 89 to give the cationic 
aryl-gold(III) complex 90 (Scheme 18b).61 This species is observed to react with alkenes to give unusual 
gold(III)-arene adducts. Finally, Sames has demonstrated electrophilic aryl-rhodium(III) complexes to 
functionalise indoles at the C-2 position (Scheme 18c).62 Interestingly, in contrast with the behaviour 
observed under palladium catalysis (Scheme 12), the rhodium-catalysed procedure is evidenced to occur 
through a concerted metalation-deprotonation pathway to directly furnish the C-2 arylated product 76.  
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Scheme 18 – a) Knochel’s nickel-catalysed Negishi coupling with alkyl zinc reagent 87;59 b) Miqueu, Amgoune 
and Bourissou’s generation of gold(III) arene complex 90;61 c) Sames’ rhodium-catalysed indole C-2 arylation 
proceeding through a CMD process62 
Much attention has been directed towards the reactivity of aryl- and alkenyl copper(III) species as potent 
sp2-hybridised electrophile equivalents. The reason for this interest can be seen by comparing a 
copper(III) complex with its palladium(II) analogue (Figure 3). As d8 metal ions, both species would have 
16-electron configurations and a square-planar structure. However, the first-row d-block position of 
copper and the increased charge on the metal centre indicates that the Cu(III) species will be 
substantially more electrophilic than the Pd(II) complex. It was predicted that the copper(III) species 
would demonstrate functionalisation chemistry different to that observed with palladium. The following 
section discusses the generation and reactivity of copper(III) intermediates in catalysis. 
 
Figure 3 – Comparison of aryl/alkenyl-Pd(II) and aryl/alkenyl-Cu(III) species 
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1.4 The Generation and Reactivity of Copper(III) Species 
1.4.1. Copper(III) intermediates in synthetic chemistry 
Although copper(III) species were first proposed as early as 1974,63 the first unambiguous evidence for 
such adducts was not provided until the late 1980s, achieved by the crystallographic characterisation of 
a number of stabilised Cu(III) complexes (Figure 4).64–66 
 
Figure 4 – Examples of crystallographically characterised organo-copper (III) species64–66 
Copper(III) species are increasingly implicated in important methods in organic chemistry.67 Possibly 
the best known of such a reaction is the copper catalysed conjugate addition of Grignard reagents to 
α,β-unsaturated carbonyl compounds, first described by Kharasch in 1941. In this study, the addition 
of catalytic copper(I) chloride to the reaction between methylmagnesium bromide and isopherone was 
observed to overturn the natural 1,2-regioselectivity of the Grignard addition (Table 1).68 
 
Entry Additive 
Yield/ % 
99 100 101 
1 - 43 48 - 
2 1 mol% CuCl - 7 83 
Table 1 – Addition of methylmagnesium bromide to isopherone (98) in the presence and absence of copper 
chloride68 
The related addition of Gilman reagent 104 to cyclohexanone (Scheme 19a) has been investigated both 
with rapid-injection nuclear magnetic resonance (NMR) spectroscopy and computational methods.69,70 
These studies enabled the characterisation of the intermediate copper(I) and copper(III) species on-path 
towards the production of conjugate adduct 103 (Scheme 19b). It was determined that the mechanism 
initially proceeds by the coordination of Gilman reagent 104 to the enone to furnish adducts 105 and 
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106. Addition of trimethylsilylcyanide results in the oxidative attack of the copper(I) centre to the 
conjugate position of the Michael acceptor, thereby generating copper(III) adduct 107. The production 
of 107 is in line with previous computational studies that indicate trialkyl, square-planar, anionic Cu(III) 
species to be particularly stable.71,72 107 undergoes a formal reductive elimination on warming to give 
the coupled product 103.  
 
Scheme 19 – a) Overview of the addition of Gilman reagent 104 to cylohexenone and b) spectroscopically 
determined copper-centred intermediates on this pathway69 
Although these conjugate addition studies show the accessibility of copper(III) species, the chemistry 
observed more reflects the reducing ability of copper(I) species rather than the electrophilicity of Cu(III). 
However, the reactivity of catalytically-generated, copper-centred sp2-hybridised electrophile 
equivalents is implicated in another historically-important process: the Ullmann reaction. 
1.4.2. Generation of electrophilic Cu(III) intermediates in Ullmann-type reactions 
Ullmann’s investigations represent some of the earliest work carried out in cross-coupling. His studies 
focused on the use of copper to mediate ipso-reactivity with aryl-halides. The first of his developments 
was described in 1901 and details the homocoupling of ortho-nitrobromobenzene (Scheme 20a).73 An 
analogous amination procedure was described two years later, coupling aniline to ortho-chlorobenzoic 
acid 110 (Scheme 20b).74 This amination process was further developed in 1906 by Goldberg, 
demonstrating that catalytic loadings of copper could give high product yields on addition to a basified 
mixture of bromobenzene and ortho-aminobenzoic acid in refluxing nitrobenzene (Scheme 20c).75 
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Scheme 20 – a) Ullmann’s copper(0)-mediated biaryl formation;73 b) Ullmann’s copper(0)-mediated amination 
procedure;74 Goldberg’s copper(0)-catalysed amination procedure75 
The extreme conditions required for Ullmann and Goldberg’s processes meant that the use of copper 
catalysis for cross-coupling was comparatively under-researched for the next century.67,76 However, in 
2001 and 2002, the Taillefer and Buchwald groups concurrently patented Ullmann-type processes 
employing ligands to enhance reactivity.77–79 These studies prompted a revival in the area and led to the 
development of a large number of carbon-heteroatom bond-forming processes.80,81 One such example 
can be seen in Buchwald’s N-/O-selective arylation of aminoalcohols, where the selective coupling of 
either the alcohol or amine portion of 113 is controlled by the ligand employed (Scheme 21).82 Diketone 
ligand 114 gives amine functionalisation, whilst the use of phenanthroline 116 leads to reaction through 
the alcohol. Whilst the differing chemoselectivity can be explained based on the native ligand charge 
and pKa differences, the wider mechanism of the process is disputed. 
 
Scheme 21 – Buchwald’s N-/O-selective arylation of aminoalcohols82 
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There are two generally proposed pathways for Ullmann-type reactivity. One such proposal invokes a 
Cu(I)-Cu(II) cycling mechanism and radical behaviour, whilst the second focuses on a Cu(I)-Cu(III) 
redox loop and employs oxidative addition and reductive elimination steps. Extensive kinetic 
investigations have been carried out to either confirm or disprove either of these mechanisms, but have 
yielded few conclusive results. Studies employing radical traps and radical clocks have, with the 
exception of a photoinduced process,83 demonstrated free-radical activity to not be mechanistically 
viable.84–86 These results can be rationalised by any radical activity occurring in a closed-shell manner 
but can also be taken as evidence for a Cu(I)/Cu(III) cycle. Unfortunately, this latter manifold has also 
proved very difficult to experimentally support, largely due the identification of the aryl-halide activation 
step as the turnover-limiting step in Ullmann couplings. Computational evaluation has therefore become 
the method of choice for the investigation of the behaviour of copper-catalysed heteroatom arylation 
reactions using iodoarenes.  
Computational studies have been carried out on Buchwald’s N-/O-selective aminoalcohol arylation 
process (Scheme 21). In line with the disagreement regarding the behaviour of the copper catalyst, both 
Cu(I)-Cu(II) and Cu(I)-Cu(III) redox cycles have been investigated. Firstly, computing model systems 
with methanol and methylamine, Houk and Buchwald proposed distinct closed-shell radical 
mechanisms for N- and O-arylation (Scheme 22).87  
 
Scheme 22 – Houk and Buchwald’s a) SET and b) IAT mechanistic rationale;87 bold red/blue quantities denote 
the relative energy of the system at that stage of the mechanism (kcal mol-1) 
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N-arylation was computed to proceed through a single electron transfer (SET) process with the catalyst 
resting state the anionic ligand-bound copper(I) iodide adduct 118 (Scheme 22a). The first step of the 
reaction involves the displacement of the iodide with deprotonated amine, giving anionic copper(I) 
amide 119. This species then acts as a single-electron reductant, reducing iodobenzene to its 
corresponding radical anion and furnishing the copper(II) adduct 120. The radical anion then loses 
iodide to give a phenyl radical which rapidly attacks the copper-bound nitrogen to generate copper(I) 
amine complex 121. Displacement of the coupled amine with iodide regenerates the anionic adduct 
118.  
In contrast, O-arylation was determined to occur through an iodine atom transfer (IAT) mechanism 
(Scheme 22b). In this process, methanol displaces iodide from the neutral copper(I) species 123 and is 
concurrently deprotonated to give copper(I) methoxide 124. The intermediate then undergoes iodine 
atom transfer to give copper(II) intermediate 125 and phenyl radical. The radical then attacks the bound 
methoxide, formally reducing the copper centre to generate ether-bound copper(I) iodide 126. 
Dissociation of the product aryl ether regenerates the catalyst.  
Computing the reaction system employing the true substrate, the Fu group proposed alternative 
mechanisms for the observed N- and O-arylations (Scheme 23).88 Both of these processes proceed 
through a copper(I)/(III) redox manifold. 
 
Scheme 23 – Yu’s a) nitrogen arylation and b) oxygen arylation with a Cu(I)/Cu(III) mechanistic rational;.88 bold 
red/blue quantities denote the relative energy of the system at that stage of the mechanism (kcal mol-1) 
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In the case of nitrogen arylation (Scheme 23a), the catalytic cycle rests at the copper(I)-aryl iodide adduct 
128. Oxidative addition of 128 is observed to be relatively energetically favourable (ΔG‡ = +9.7 kcal 
mol-1), giving copper(III) intermediate 129. A rate-determining apical association of the aminoalcohol 
then gives nitrogen-bound adduct 130 (ΔG = +14.1 kcal mol-1). Subsequent elimination of iodide and 
concurrent deprotonation of the amine gives Cu(III) amide 131, which then undergoes reductive 
elimination to furnish the nitrogen-coupled adduct 132 and regenerate copper(I).  
Oxygen arylation (Scheme 23b) proceeds from copper(I) iodide complex 123. Ligand association with 
the hydroxylamine gives metastable intermediate 133, which rapidly loses iodide with deprotonation of 
the alcohol to form copper(I) alkoxide 134. The oxy-anion-bound intermediate then undergoes the rate-
limiting oxidative addition step (ΔG‡ = 22.7 kcal mol-1), giving apical-iodide bound Cu(III) adduct 135. 
Reductive elimination furnishes the coupled product 136 and reforms the Cu(I) iodide catalyst. 
Yu has also calculated the highest-energy points on Houk and Buchwald’s SET/IAT models when 
applied to the use of 5-amino-pentan-1-ol 113. It is shown that for nitrogen arylation, the highest point 
on the oxidative addition/reductive elimination energetic profile is substantially lower in energy than 
for the proposed SET pathway (ΔΔG‡ = 34.8 kcal mol-1). Similarly, the highest point on the 
Cu(I)/Cu(III) pathway towards oxygen arylation is lower in energy than that of the IAT mechanism 
(ΔΔG‡ > 16.2 kcal mol-1). These data indicate that a copper(I)-copper(III) cycling mechanism is generally 
more favourable than copper(I)-copper(II) radical processes. 
Further support for a copper(I)-copper(III) reaction manifold can be seen in Ribas’ work on the 
generation and reaction of crystallographically characterised aryl-copper(III) adducts.89 Ribas’ crucial 
work builds on results published in 2002 from a collaboration between Hedman, Hodgson, Llobet and 
Stack.90 These early studies detail the generation of copper(III)-aryl adducts via disproportionation from 
copper(II) salts in the presence of triazamacrocylic ligand 137 (Scheme 24a). The products were verified 
by X-ray crystallography and the oxidation state of the metal centre was confirmed by K-edge 
absorption spectroscopy. Using an engineered ligand backbone (140) and basic conditions, Ribas 
directly demonstrated oxidative addition of copper(I) salts into C–Br bonds to occur (Scheme 24b), 
allowing the production of stable copper(III) adducts (141). Interestingly, the reaction could be reversed 
on the addition of acid to the system. Furthermore, macrocylic aryl bromide 142 has been observed to 
undergo coupling with nucleophile 143 in the presence of catalytic copper hexafluorophosphate 
(Scheme 24c), firmly supporting the role of Cu(III) in the Ullmann reaction. This result was reinforced 
by the production of aryl ethers on the exposure of copper(III) species such as 138 and 141 to oxygen 
nucleophiles.91  
Introduction – The Catalytic Generation and Reaction of Aryl and Alkenyl Cation Equivalents 
 19 
 
Scheme 24 – a) Hedman, Hodgson, Llobet and Stack’s product of copper(III)-aryl species by copper(II) 
disproportionation;90 Ribas’ b) reversible Cu(I) oxidative addition into aryl bromide 140 and c) catalytic coupling 
of 142 to nucleophile 14389 
Whilst other mechanistic pathways cannot be discounted, clear evidence has been provided to indicate 
that copper(I)-copper(III) redox cycling is possible. The accessibility of Cu(III) under this reaction 
manifold has implications beyond the Ullmann reaction as other processes have also been proposed to 
proceed through high-valent copper intermediates. Examples include the Hurtley reaction,92–94 the 
Chan-Lam coupling,95 and the aromatic Finkelstein reaction.96 Finally, the mechanistic studies carried 
out on the reactivity of copper salts with aryl halides has allowed understanding of copper-catalysed 
reactions employing diaryliodonium salts, the focus of the remainder of this chapter. 
1.4.3. Generation and reactivity of electrophilic Cu(III) species with iodonium salts 
The ability of copper salts to catalyse reactions with iodonium salts was first described by Beringer in 
1956. It was noted that the addition of 0.1 mol% copper chloride to a solution of diphenyliodonium 
chloride 20 accelerated the maximum rate of iodane decomposition by a factor of 25 (Table 2).97 
Interestingly, although the maximal rate of decomposition was similar with both copper(I) and copper(II) 
salts (entries 2 and 3), copper(I) appears to be the active catalyst in the reaction as the use of copper(II) 
chloride demonstrates an induction period. This hypothesis was further supported by Lockhart’s 
observation of a significant rate inhibition on the addition of the Cu(I)-chelating ligand cuproin to an 
analogous reaction.98,99 
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Entry Additive k1 (max) / h-1 
1 - 0.021 
2 0.1 mol% CuCl2 0.49 
3 0.1 mol% CuCl 0.52 
Table 2 –Beringer’s observation of an increased demcomposition rate on the addition of copper salts to a 
solution of diaryliodonium salt 20 97 
Further investigating the reactivity of diaryliodonium salts with copper, Lockhart compared the 
behaviour of diazonium and diaryliodium salts on exposure to a copper(I) source in methanol solution. 
Whilst the decomposition of the diazonium salt was observed to dominantly furnish benzene, the 
analogous reaction with iodonium salt 147 gave majority anisole production (Scheme 25). These results 
imply the former reaction to proceed via free-radical chemistry and the latter to proceed through a 
distinct mechanistic pathway, disfavouring Roberts’ hypothesis of a radical process for the copper-
catalysed decomposition of diaryliodonium salts.100  
 
Scheme 25 – Comparison between the decomposition of a) diazonium salt 145 and b) diaryliodonium salt 147 
However, treatment of 147 with copper(I) benzoate in dichloromethane furnished a mixture of benzene, 
biphenyl and phenyl benzoate (149), behaviour more consistent with radical activity (Scheme 26). The 
relative amount of biphenyl produced was observed to be proportional to the copper loading, implying 
a bimolecular reaction in copper for the generation of this species. 
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Scheme 26 – Reaction of diphenyliodonium hexafluoroarsenate with catalytic copper in dichloromethane98 
Lockhart noted that all the observed products of the copper-catalysed decomposition of 147 could be 
rationalised through the intermediacy of copper(III) species 150 (Scheme 27). Anisole 146 and phenyl 
benzoate 149 can be generated by nucleophilic attack/reductive elimination of 150. Biphenyl 148 is 
proposed to result from reaction of the high-valent intermediate with a second equivalent of the 
copper(III) species. Finally, the production of benzene can be attributed to a minor radical 
decomposition process, abstracting a hydrogen atom from the reaction medium.  
 
Scheme 27 – Lockhart’s Cu(III) hypothesis rationalising all observed products98 
Canty and Sanford have recently demonstrated the mechanistic role of a copper(III) intermediate in 
their procedure for the generation of aryl fluorides from diaryliodonium salts and KF (Scheme 28).101 
Computational investigations on the fluorination of phenyl(mesityl)iodonium triflate (Scheme 29), 
revealed that the first step in the reaction was the association of anionic copper adduct 153 with free 
iodonium cation 154. The resulting copper-iodonium adduct 155 then rearranges to π-bound copper 
intermediate 157 before oxidative insertion occurs with a low energetic penalty via transition state 
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structure 158. κ2-Stabilised aryl-copper(III) species 159 then undergoes facile reductive elimination to 
furnish fluoroarene-bound copper(I) species 161. Dissociation of fluorobenzene and association of a 
fluoride allows for catalyst turnover. 
 
Scheme 28 – Canty and Sanford’s diaryliodonium fluorination procedure101 
 
Scheme 29 – Canty and Sanford’s computation investigation of their fluorination procedure; energies are given 
as ΔG relative to the starting system in kcal mol-1 101 
Canty and Sanford have since detailed three other possible oxidative addition transition states for their 
fluorination process (Figure 5).102 Difluorinated copper(I) adduct 163 appears to have to the lowest-
energy oxidative addition barrier.  
 
Figure 5 – Canty and Sanford’s further investigations into the oxidative addition of copper (I) species with 
diaryliodonium salts; transition state energies are given as ΔG relative to the starting system in kcal mol-1 101 
In analogy with palladium-catalysed methodologies, the combination of copper salts and iodonium salts 
has been employed to couple a wide variety of heteroatomic nucleophiles to aryl and alkenyl groups. 
Four examples of this reactivity are shown below (Scheme 30). Kim has demonstrated pyridiones to 
react very rapidly with diaryliodonium salts in the presence of copper(I) chloride (Scheme 30a).103 
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Nagorny has developed a dual copper and hydrogen-bond donor catalyst mixture to form phenolic 
esters from simple carboxylic acids and iodonium salts (Scheme 30b).104 Krief has developed 
methodology for the copper-catalysed generation of sulfonium salts from thioethers and iodonium salts 
(Scheme 30c).105 Finally, Gaunt has employed the chiral PyBOX ligand 175 to effect the arylative kinetic 
resolution of secondary phosphine oxides using copper-catalysis with symmetrical iodonium 
tetrafluoroborates (Scheme 30d).106 
 
Scheme 30 –a) Kim’s copper-catalysed pyridone arylation;103 b) Nagorny’s carboxylic acid arylation employing a 
synergistic copper hydrogen-bond door catalysis;104 c) Krief’s copper-catalysed thioether arylation giving 
sulfonium salts;105 d) Gaunt’s enantioselective secondary phosphine oxide arylation procedure106  
1.5 The Reactivity of Aryl and Alkenyl-Copper(III) Intermediates with Carbon 
Nucleophiles 
With the high electrophilicity of the putative aryl- and alkenyl-copper(III) intermediates generated on 
the combination of iodonium salts and copper, much attention has been directed towards the use of this 
reaction manifold for carbofunctionalisation. In contrast with the limited reactivity of comparable 
palladium(II) species, it was hypothesised that the greater charge density of the copper(III) centre will 
allow for increased activity under milder conditions (c.f. section 1.2). The reaction of carbon nucleophiles 
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with high-valent copper(III) species was first tested with indole functionalisation under a Friedel-Crafts 
manifold. 
1.5.1. Friedel-Crafts interception of Cu(III) electrophiles  
In line with Barton’s elegant work employing organobismuth reagents,107 Gaunt was able to generate 
C-3 arylated indoles using a combination of copper(II) triflate and diaryliodonium triflates (Scheme 
31a).108 In contrast to the majority of previous reports, this procedure gave C-3 arylated product rather 
than the C-2 substituted adduct, evidencing the reaction to occur through the expected electrophilic 
metalation pathway. To rationalise the observed reactivity, elements of Gaunt’s proposed mechanism 
can be combined with insight gained from Sanford’s work to form the following hybrid mechanism 
(Scheme 31b). In line with Sanford’s studies, the active catalytic species is proposed to be copper(I) anion 
178 and the cycle is proposed to begin on the association and oxidative addition of iodonium cation 179 
to the starting copper(I) adduct. From here, the resulting κ2-triflate-stabilised aryl-copper(III) 
intermediate 180 acts as a Friedel-Crafts electrophile, functionalising indole 73 at the C-3 position to 
give the cationic indole-copper(III) complex 181. The electron-deficient nature of the copper centre 
precludes C-3 to C-2 migration, with simple deprotonation preferred to furnish the neutral copper(III) 
species 182. A facile reductive elimination generates the C-3 arylated indole product 177. 
 
Scheme 31 – Gaunt’s copper-catalysed C-3 indole arylation a) procedure108 and b) proposed hybrid mechanism 
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This indole functionalisation process was exploited as the first step in Gaunt’s 2015 synthesis of 
dictyodendrin B. Starting from cheap and commercial 4-bromoindole, arylation could be carried-out 
on a 42 g scale to furnish the 3-subsituted anisole adduct in 68% yield. The product was converted to 
the desired indolic natural product in twelve further steps.109 Furthermore, You demonstrated the 
efficacy of the combination of copper and iodonium salts in the C-2 arylation and vinylation of 3-
substituted indoles.110 As an extension, Greaney has also shown that Gaunt’s method can be combined 
with Ullmann-type chemistry to give double indole arylation in a one-pot procedure by consuming both 
aryl groups from the diaryliodonium salt (Scheme 32).111  
 
Scheme 32 – Greaney’s double indole arylation111  
The MacMillan, Reisman and You groups noted that the copper-catalysed reaction of iodonium salts 
with indoles bearing a C-3 pendant nucleophilic groups would allow the synthesis of pyrroloindolines 
by intramolecular trapping of the C-2 localised carbocationic intermediate.112–115 MacMillan 
implemented this strategy by employing a chiral ligand backbone to give enantioenriched products 
(Scheme 33).  
 
Scheme 33 – MacMillan’s enantioselective pyrroloindoline synthesis employing copper catalysis and 
diaryliodonium salts112 
Reisman’s group was able to employ one of their methods in expedient syntheses of naseseazines A and 
B.115 The synthetic strategy involved the transfer of brominated anilide iodonium salt 191 to the pendant 
indole of proline/tryptophan dimer 190. C-2 cation trapping with the tryptophan amide yielded 
arylated polycycle 193 in 62% yield (Scheme 34a). Anilide 193 was then methonolysed and the product 
exposed to alkyne 194 in the presence of a palladium(0) source to undergo a Larock indolisation to give 
the desired pyrolloindoline product in 47% yield over two steps (Scheme 35b).116  
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Scheme 35 –Reisman’s synthesis of naseseazine B 195 by a) copper-catalysed pyrroloindoline generation with 
diaryliodonium salt 191 and b) a palladium-catalysed indole formation with alkyne 194115 
In addition to indole functionalisation, Glorius has demonstrated that other electron-rich heterocycles 
undergo copper-catalysed Friedel-Crafts reactivity with iodonium salts.117 Observed products include 
arylated furan, thiofuran and benzofuran species. Similarly, both Kumar and Wang have demonstrated 
that other nitrogenated heterocycles will react with iodonium salts in the presence of copper via an 
intermediate metalated species.118,119 Kumar’s approach employs lithiation whilst Wang’s method 
proceeds through organozinc adducts. To date, nine further heterocycles have been functionalised using 
the copper/iodonium salt manifold (Table 3).  
 
Table 3 – Heterocycles described to be functionalised using copper and iodonium salts with and without 
intermediate metalation117–119 
The Gaunt group next turned their attention towards the application of the copper and iodonium salt 
reagent combination to anilines and anisoles, allowing selective functionalisation at the para-position of 
the substrates (Scheme 36).120 The high para-selectivity observed contrasts with the majority of other 
metal-catalysed methods for the functionalisation of electron-rich benzene rings, generally observed to 
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provide mixtures of ortho-/meta-/para-substituted products.56,121–123 The highly selective reactivity 
observed under copper-catalysis provides further evidence that the reaction proceeds through 
electrophilic metalation rather than alternative C–H functionalisation mechanisms. Friedel-Crafts 
functionalisation of non-heteroaromatic arenes has been further extended by Hu and Wang to generate 
a broad suit of biphenyl species and to describe a general method for the ortho-arylation of para-
substituted phenols.124,125  
 
Scheme 36 – Gaunt’s para-functionalisation of aniline and anisole substrates120 
1.5.2. Non-classical aromatic functionalisation with Cu(III) electrophiles  
During the course of studies into indole arylation with copper and iodonium salts, Gaunt noted that the 
natural C-3 selectivity of the reaction could be overturned with the use of N-acetylated indole 209 
(Scheme 37).108 
 
Scheme 37 – Gaunt’s C-2 selective N-acyl indole arylation108 
The switch in regioselectivity is attributable to the steering ability of the pendant carbonyl moiety, 
mechanistically explainable in two ways. Firstly, it is possible that the indole reacts through the C-3 
position to generate Cu(III) adduct 211, in line with the observation of C-3 arylation in the absence of 
a coordinating group (Scheme 31). The carbonyl group of the acetylated indole can then induce a C-3 
to C-2 migration giving 213 via intermediate 212 (Scheme 38 – upper cycle). Reductive elimination 
would furnish the desired C-2 substituted product. Alternatively, the carbonyl group could directly bind 
aryl-copper(III) intermediate 214. A concerted metalation-deprotonation process at the C-2 position 
would then directly generate catalytic intermediate 213 through a transition state such as 215 (Scheme 
38 – lower cycle).  
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Scheme 38 – Proposed mechanistic origins of the Gaunt’s C-2 selective N-acyl indole arylation procedure 
Gaunt questioned whether the directing ability of carbonyl groups would allow for the non-natural 
functionalisation of other arene rings. Pursuing this strategy, he published in 2009 a highly meta-selective 
copper-catalysed pivanilide arylation (Scheme 39a).126 The observed behaviour is in direct contrast with 
Daugulis’ analogous palladium-catalysed ortho-arylation using the exact same substrate.127 Interestingly, 
the anti-Friedel-Crafts reactivity could be reproduced on the copper-catalysed arylation of other α-aryl 
carbonyl species such as 218, a structural analogue of pivanilide 216 (Scheme 39b).128  
 
Scheme 39 –Gaunt’s meta-selective arylation of a) pivanilides126 and b) other α-aryl carbonyl species128 
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The origins of the non-natural selectivity of Gaunt’s pivanilide arylation were computationally 
investigated by the Wu and Ding groups,129,130 both evaluating the mechanism of the reaction using a 
simplified acetylanilide substrate (Scheme 40). It is computed that the ground-state Cu(III)-amide 
intermediate 219 initially re-orientates with an energetic penalty of +14.4 kcal mol-1 to give the apical 
aryl-associated copper(III) adduct 220. This intermediate then undergoes a concerted carbocupration 
process, simultaneously ortho-cuprating and meta-arylating the anilide to give intermediate 222. The 
transition state 221 for the meta-arylation process is calculated to lie at an accessible +19.2 kcal mol-1 
above adduct 219. Elimination, releasing an equivalent of triflic acid, re-aromatises the anilide ring and 
furnishes the coupled-product-bound copper(I) species 223. Product dissociation and re-oxidation gives 
resting copper(III) intermediate 180 ready for amide association to regenerate the starting complex.  
 
Scheme 40 – Wu’s computational evaluation of Gaunt’s copper-catalysed meta-selective anilide arylation;129 bold 
quantities denote the relative energy of the system at that stage of the mechanism (kcal mol-1) 
The Wu and Ding groups have also calculated the energetic barrier to the formation of the Friedel-
Crafts-favoured ortho-arylated product. Both studies predict that the ortho-functionalisation would occur 
through a concerted metalation-deprotonation pathway with triflate acting as the base. Wu calculated 
an intermolecular carbonyl-directed CMD process whilst Ding computed an amide N–H directed bond 
formation/cleavage process. In both instances the energies of the transition states are calculated to be 
H
N
OCu
TfO
Me
OTf
220
NH
OCu
TfO
H
H
TfO
TfO
222
Me
H
N
OCu
TfO
Me
OTf
221
Cu OTfO
S O
O
F3C
224
HN
O
Me
Cu OTf
‡OTfCuTfO
NH
O Me 219
180 223
TfO
I
HN O
Me
HN O
Me
168
re-orientation concertedcarbocupration
eliminationamideassociation
ligand exchange
oxidative addition
TfOH
0.0
+14.4
+6.6
+19.2
Introduction – The Catalytic Generation and Reaction of Aryl and Alkenyl Cation Equivalents 
 30 
higher in energy than those leading to meta-functionalisation (ΔG‡ = +2–7 kcal mol-1). Interestingly, the 
relative energetic similarity of the ortho- and meta-arylation transitions states imply the accessibility of two 
potential processes for the functionalisation of arenes (carbocupration vs. CMD) under the investigated 
copper/iodonium salt manifold. The computed accessibility of a CMD process with a pivanilide 
substrate supports the second mechanistic proposal for the C-2 indole arylation described above (Scheme 
38, lower cycle). 
Gaunt’s modular synthesis of the indolocarbazole natural product staurosporinone 230 employs both 
meta- and ortho-selective copper-catalysed arylation procedures. These reactions are employed to 
introduce pendant phenyl groups to an aniline core, later constructed via five further C–H 
functionalisation processes into the desired product (Scheme 41).131 This strategy allowed the synthesis 
of staurosporinone in ten steps and in 12.7% overall yield. It was envisaged that the use of derivatised 
iodonium salts in the synthetic route would allow for the generation of a range of unsymmetrical 
staurosporinone analogues. 
 
Scheme 41 – Gaunt’s total synthesis of staurosporinone 230 employing two copper-catalysed arylations131 
Shi has further elaborated the concept of directing functionalisation to non-natural ring positions. His 
group has described a C-6 selective indole arylation/alkenylation procedure using copper and iodonium 
salts. Inspired by previous palladium-catalysed studies giving C-7-selective indole functionalisation,132 
the reaction uses a phosphinic amide to direct reactivity towards the desired position (Scheme 42).133  
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Scheme 42 – Shi’s C-6 selective indole arylation intramolecularly directed by a phosphinic amide moiety133 
It is proposed that the steric bulk of the tert-butyl groups of phosphinic amide 231 helps orientate the 
directing group towards the six-membered ring portion of the indole. From here, the mechanistic 
proposal is analogous to that described by Wu and Ding in their computational investigations into the 
meta-selective anilide arylation. Co-ordination of the phosphoryl moiety to the aryl-copper(III) 
intermediate 180 places the electrophilic metal centre under the indolic C-7 position and the aryl group 
under C-6. A concerted carbocupration process provides the desired carbon-carbon connectivity, 
generating formal alkyl copper intermediate 234. Elimination of this species would regenerate copper(I) 
and furnish the observed C-6 functionalised indole (Scheme 43). 
 
Scheme 43 – Proposed mechanism for Shi’s C-6 selective indole arylation 
1.5.3. α-Carbonyl functionalisation with Cu(III) electrophiles 
The earliest examples of non-aromatic carbofunctionalisation processes using copper and iodonium salts 
employed enolate equivalents as the nucleophilic coupling partners. The first report of this type was 
MacMillan’s procedure for the enantioselective α-arylation of aldehydes using iodonium salts using a 
synergistic catalyst system of a copper salt and organocatalyst 236 (Scheme 44a).134 The same process 
has also been performed with alkenyl(aryl)iodonium salts to give aldehyde α-vinylation.135 It is proposed 
that the reaction proceeds through coordination of pre-formed enamine 241 to copper(III) intermediate 
240. The bound enamine then attacks the copper centre to give alkyl-copper species 243. Reductive 
elimination and hydrolysis then provides the α-functionalised aldehyde (Scheme 44b). 
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Scheme 44 – a) MacMillan’s enantioselective aldehyde α-arylation and α-vinylation procedures;134,135 b) 
proposed mechanism and origin of enantioselectivity 
Applying similar reactivity to an achiral system, Pannecoucke, Gillaizeau and Kesavan have 
demonstrated that cyclic enamides may undergo copper-catalysed arylation and vinylation with 
iodonium salts to give a range of functionalised piperidines (Scheme 45).136,137 
 
Scheme 45 – Pannecouke and Gillaizeau’s enamide arylation136 
Both the Gaunt and MacMillan groups further applied the concept of copper-catalysed asymmetric 
electrophilic arylation to the reaction of silyl ketinimides. Publishing in 2011, the groups described 
analogous reactions controlled by the presence of a chiral bisoxzoline ligand around the copper centre. 
MacMillan used a TBS-protected ketinimide, hexafluorophosphate iodonium salts and a copper(I) 
catalyst to effect the transformation, whilst Gaunt used a TMS-protected substrate, triflate iodonium salt 
and copper(II) complex 248 (Scheme 46).138,139  
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Scheme 46 – Gaunt’s enantioselective silyl ketinimide arylation with copper-bisoxazoline complex 248138 
Finally, Zhang and co-workers have elaborated a one-pot conjugate addition and arylation reaction to 
functionalise enones at both α- and β- positions in high anti-diastereoselectivity. This procedure relies on 
the addition of Gilman reagent to a cyclic α,β-unsaturated ketone before trapping the resulting enolate 
with an iodonium salt in the presence of further catalytic quantities of copper (Scheme 47).140  
 
Scheme 47 – Zhang’s generation of α-aryl, β-alkyl ketones from simple enones140 
1.5.4. Alkyne functionalisation with Cu(III) electrophiles 
1.5.4.1 Terminal alkyne functionalisation 
The functionalisation of terminal alkynes with copper(I) species and iodonium salts was first described 
in Kang’s 1997 investigations into carbonylative Sonogoshira-type processes. Despite investigations 
initially focusing on the use of both palladium and copper, the reaction of alkyne 251 with 
diphenyliodonium tetrafluoroborate was observed to proceed with only the addition of copper as a 
catalyst (Scheme 48).141 
 
Scheme 48 – Kang’s copper-catalysed carbonylative Sonogoshira reaction with iodonium salts141 
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iodonium salt to give adduct 255 following carbon monoxide association. 1,1-Migratory insertion of the 
CO ligand into the Cu–aryl bond would provide acyl-bound copper(III) species 256. Reductive 
elimination would occur from this intermediate to furnish the product and re-generate copper(I) 
acetylide (Scheme 49). 
 
Scheme 49 – Proposed mechanism for Kang’s carbonylative Sonogoshira-type reaction 
Though Kang’s work has been more recently extended to a classical Sonogoshira process,142 there have 
been few further developments using solely copper as a catalyst for this coupling mode. The majority of 
systems for terminal alkyne coupling favour a mixed palladium/copper catalyst system.143 
1.5.4.2 Internal alkyne functionalisation 
Interested in the functionalisation of less intrinsically-nucleophilic carbon-based functional groups, the 
Gaunt group turned their attention towards the derivitisation of internal alkynes using copper catalysis 
and iodonium salts. Such a process was first described with the generation of vinyl triflates via a syn-
carbotriflation process, demonstrated to be particularly successful for the generation of dienyl triflates 
from alkynes and alkenyl iodonium salts (Scheme 50).144 
 
Scheme 50 – Gaunt’s Z-selective alkyne carbotriflation with alkenyl iodonium salts under copper catalysis144 
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The formation of the vinyl triflate product is proposed to occur through adduct 260, formed by the 
initial coordination of an alkyne to an in situ generated copper(III) species. The high Z-selectivity of the 
product indicates the functionalisation mechanism to proceed through a concerted carbocupration 
mechanism, giving alkenyl-copper(III) species 262 via a transition structure such as 261 (Scheme 51). 
Reductive elimination will furnish the triflate-coupled product.  
 
Scheme 51 – Concerted carbocupration mechanism towards syn-functionalisation of alkynes 
It was observed during Gaunt’s studies that the use of phenyl-substituted unsymmetrical alkynes led to 
the formation of the E-configured vinyl triflate. The reversal in stereoselectivity can be attributed to the 
formation of either a vinyl cation (265) or some vinyl-cation-like copper(III) intermediate (264). The 
highly electrophilic intermediate would be attacked by a free triflate ion approaching from the least 
sterically constrained trajectory to give the observed alkenyl triflate geometry (Scheme 52). 
 
Scheme 52 – Proposed E-selective vinyl triflate formation via a vinyl-cation like species 
The Liu and Gaunt groups both noted unsymmetrical propargylic alcohols to re-arrange on exposure 
to iodonium salts in the presence of a copper catalyst to furnish α,β-unsaturated ketones. This Meyer-
Schuster-type reactivity145 was exploited to generate 45 examples of α,β-unsaturated carbonyl 
compounds and their corresponding hydrates (Scheme 53).146,147 
 
Scheme 53 – Gaunt’s copper-catalysed arylative Meyer-Schuster reaction146 
The Liu group proposed the observed reactivity to result from a 4-endo-dig anti-oxy-cupration from alkyne 
co-ordinated Cu(III) intermediate 269. Reductive elimination of the resulting product would generate 
oxetene intermediate 271 which would rapidly undergo an electrocyclic ring opening to yield the desired 
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unsaturated ketone (Scheme 54).147 However, it should be noted that the same oxetene intermediate 
could be generated via the intermediacy of a vinyl-cation or some equivalent copper(III)-bound 
intermediate (c.f. Scheme 52 above, intermediates 264 and 265). In the place of the above triflate 
addition, anti-attack with the pendant alcohol would occur. 
 
Scheme 54 –Liu’s mechanistic proposal involving an anti-oxy-cupration and an electrocyclic ring-opening147 
Qu reported another alkyne anti-oxy-arylation process giving the formation of dihydrofurans and 
dihydropyrans from unsymmetrical aryl/alkyl-alkynes bearing pendant ether groups (e.g. 272).148 These 
substrates were treated with an iodonium salt and a copper catalyst to generate a range of 5- and 6-
membered cyclic vinyl ethers (Scheme 55). 
 
Scheme 55 – Qu’s copper-catalysed generation of dihydrofurans and dihydropyrans148 
Novák has also employed a tethered nucleophile strategy to generate both benzoxazines and oxazolines 
by the copper-catalysed arylation of two carefully-designed alkyne substrates using iodonium salts 
(Scheme 56).149,150 Interestingly, the products of the two reactions are formed with anti- and syn-oxy-
arylation respectively. Additionally, in contrast with previous examples, the formation of oxazoline 278 
occurs with arylation at the less intrinsically-nucleophilic alkyne position, implying its formation through 
a carbonyl-directed carbocupration/reductive elimination process (Scheme 57). 
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Scheme 56 – Novák’s a) benzooxazine formation149 and b) oxazoline formation150 
 
Scheme 57 – Proposed mechanistic origin of Novák’s unnatural alkyne arylation furnishing oxazolines 
The Gaunt group has demonstrated tethered arenes to act as nucleophiles in the carboarylation of 
alkynes (Scheme 58).151 The in situ-generated reactive species is thought to be quenched in a Friedel-
Crafts manner to generate a range of polycyclic hydrocarbons. Given the high electrophilicity required 
for such a process, the reaction is proposed to proceed via a vinyl-cation-like intermediate. The Chen 
group have used similar chemistry to successfully effect a carbocationic relay giving diyne bicylisation 
(Scheme 59).152 
 
Scheme 58 – Gaunt’s alkyne carboarylation to give polycyclic hydrocarbons151 
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Scheme 59 – Chen’s diyne bicyclisation via a carbocation relay152 
Finally, the Gaunt and Chen groups have both published migratory cyclisation reactions, induced by a 
copper-catalysed alkyne arylation process, appearing to proceed through insertion into a C–H bond 
(Scheme 60).153,154 Gaunt rationalised the observed reactivity through the occurrence of a 1,5-hydride 
to quench the putative vinyl-cation intermediate 289, transferring the positive charge to a secondary 
alkyl centre (290). The electron-rich alkene would then trap this transient electrophilic centre to give 
benzylic carbocation 291. Elimination from the most acidic proton would furnish the observed product 
(Scheme 61).  
 
Scheme 60 – Gaunt’s synthesis of pentenes via a C–H insertion/cyclisation strategy153 
 
Scheme 61 – Gaunt’s proposed cyclisation mode to furnish pentene 288 
However, Chen’s group computationally investigated the origins of the observed migration cascade and 
determined copper(III)-bound vinyl cation 292 to be lower in energy than the corresponding free vinyl 
cation 293 (Scheme 62a). Furthermore, no secondary carbocationic intermediate (as required for the 
stepwise mechanism above) could be computationally isolated. The computational evidence indicated 
the copper centre to be mechanistically important for the migration/cyclisation steps of the reaction. It 
was determined that the desired product could be accessed via a concerted migration and trapping 
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process with the participation of the copper catalyst. An energy profile for this process is shown below 
(Scheme 62b).154 
 
Scheme 62 – a) comparison of relative energies of copper(III) bound vinyl cation equivalent and free vinyl cation; 
b) energy profile for concerted C–H migration and secondary carbocation trapping (energies are given as ΔG 
relative to the starting system in kcal mol-1)154 
The reaction is computed to proceed by association of the alkyne to phenyl-copper(III) intermediate 
296, generated by oxidative addition of copper(I) triflate into a diphenyliodonium cation. There is 
observed to be little energetic penalty to the carbocupration process giving vinyl-cation-like species 292 
(ΔG‡ = +0.3 kcal mol-1). A transition state (299) with characteristics of 1,5-hydride transfer and 
simultaneous alkene attack was determined to be accessible (ΔG‡ = +5.4 kcal mol-1), allowing the 
generation of adduct 300 for simple elimination. 
1.5.5. Alkene functionalisation with Cu(III) electrophiles 
The copper-catalysed functionalisation of alkenes using iodonium salts was first described by the Gaunt 
group in 2012. Rather than providing products that would be expected for a Heck reaction mechanism, 
reactivity was observed to proceed with carbocation-like behaviour. A large number of reactions were 
performed to demonstrate the breadth of the reactivity.155 Examples include simple alkene arylation to 
give non-conjugated alkene products (Scheme 63a) and classical β-pinene and semipinacol-type 
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rearrangements (Schemes 63b and c). Interestingly, the scope of this latter semipinacol rearrangement 
has recently been expanded and the transformation made enantioselective.156 
 
Scheme 63 – Gaunt’s alkene simple alkene functionalisation displaying carbocation-like behaviour;155 a) simple 
alkene arylation to give a stepped alkene product; b) arylative fragmentation of β-pinene; c) arylative semi-
pinacol rearrangement; d) carbonyl-directed alkene arylation 
Distinctly, it was observed that carbonyl-bearing substrate 310 gave arylation to form only one product 
(Scheme 63d). This reactivity is attributable to the directing ability of the Weinreb amide (Scheme 64). 
Analogous to Chen’s computation of a vinyl-cation-like copper(III) intermediate, the exclusive formation 
of product 311 could imply the existence of a formally copper-bound species (e.g. 314) that behaves 
analogously to a carbocationic intermediate.  
 
Scheme 64 – Proposed alkene functionalisation by directed carbocupration  
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nucleophile. This concept was exploited to diastereoselectivity transform allylic amides and homoallylic 
carbamates into oxazines and homoallylic carbonates respectively (Scheme 65a and b).157,158 Similarly, 
Zhou, Li, Fun and Tang have employed Friedel-Crafts nucleophilicity to trap the carbocation-like 
intermediate formed on the treatment of N-aryl-acrylamides with copper and diaryliodonium salts 
(Scheme 65c).159–161  
 
Scheme 65 – a) Gaunt’s oxy-arylation strategy to generate oxazines;157 b) Gaunt’s oxy-alkenylation to generate 
homoallylic carbonates;158 c) Zhou and Li’s oxindole synthesis159 
Lastly, Gaunt and co-workers have developed a cascade arylation procedure to generate a series of 
tetralins from the copper-catalysed functionalisation of terminal alkenes with iodonium salts (Scheme 
66a). The reaction is proposed to proceed via the intermediacy of carbocation-like intermediate 324, 
formed by the arylation of 322. The electrophilic species then undergoes a 1,2-hydride shift cascade to 
give carbocation 325. Finally, this intermediate undergoes an intramolecular Friedel-Crafts reaction 
with the aryl group to give the desired tetralin (Scheme 66b). 
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Scheme 66 – a) Gaunt’s copper-catalysed tetralin synthesis;153 b) simplified mechanistic scheme for this process 
It can be seen from the above studies that a variety of alkenes can undergo functionalisation on treatment 
with copper and iodonium salts to provide a range of arylated and vinylated products, apparently formed 
through a variety of different mechanisms. Work is required to further extend and understand this 
observed reactivity. 
1.6 Summary 
The combination of copper salts and iodonium salts has been demonstrated to be a rich strategy for the 
functionalisation of nucleophilic groups. Compelling evidence suggests the intermediacy of aryl- and 
alkenyl-copper(III) species in these systems, with the copper(III) intermediates appearing to react as 
potent sp2-hybridised carbocation equivalents. Their highly electrophilic behaviour contrasts with 
analogous palladium(II) systems, allowing the development of reactions that proceed under mild 
conditions and by distinct functionalisation modes. Novel reactivity observed under this copper-
catalysed manifold includes non-classical carbofunctionalisation, enantioselective arylation/vinylation 
and the induction of carbocation-like reactivity on alkynes and alkenes. The combination of copper and 
iodonium salts requires significant further understanding to maximise its potential in organic chemistry. 
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2 Enantioselective and Regiodivergent Copper-Catalysed Arylation 
of Allylic Amides with Diaryliodonium Salts 
2.1 Project Overview 
This chapter describes the development of a novel copper-catalysed enantioselective alkene 
functionalisation strategy. Initial efforts focused on the reaction of allylic amide substrates with 
diaryliodonium salts to furnish diarylated enamides in high e.e.. Working from an initial result, 
optimisation studies were carried out on the enamide formation process. No significant improvements 
in yield or e.e. were observed throughout these investigations. However, investigating the scope of the 
enamide formation reaction revealed that the regioselectivity of the alkene arylation process was sensitive 
to the electronic nature of the iodonium salt. It was observed that electron-poor diaryliodonium salts 
would react with allylic amides to give enamide products whilst the use of electron-rich diaryliodonium 
salts would furnish oxazines (Scheme 67). A scope of twenty enamides and eighteen oxazines was 
elaborated, giving product formation in synthetically useful yields and in universally high e.e.. 
 
Scheme 67 – Overview of the electronically-controlled regiodivergent arylation of allylic amide 315 with 
diaryliodonium salt 324 
2.2 Project Background 
In 2012, Gaunt and co-workers described the reaction of allylic amides with diaryl- and 
alkenyl(aryl)iodonium triflates to furnish a range of oxazine products (Scheme 68).157 
 
Scheme 68 – Gaunt’s copper-catalysed oxazine formation from allylic amides with iodonium salts157 
During the development of this alkene oxy-arylation reaction, Elise Cahard noted that no reaction was 
observed between phenyl substrate 315 and meta-bromophenyl iodonium triflate 330 (Scheme 69a). 
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Interestingly, the same reaction performed in the presence of the sterically-congested base 2,6-di-tert-
butylpyridine (DTBP) led to the formation of a cis/trans mixture of enamide 332 (Scheme 69b).162 
 
Scheme 69 – Reactivity of allylic amide 315 with iodonium salt 330 in a) absence and b) presence of 2,6-di-tert-
butylpyridine (DTBP)162 
As was discussed in section 1.5.5, carbocation-like behaviour has been observed throughout Gaunt’s 
investigations into copper catalysed alkene functionalisation processes using iodonium salts. Consistent 
with such a picture, the formation of oxazine products can be rationalised through a benzylic 
carbocationic intermediate (Scheme 70a). However, the production of enamide product 332 
corresponds to a reversal in the expected regioselectivity of the alkene arylation, implying the preferential 
formation of a secondary carbocation-like intermediate (Scheme 70b). 
 
Scheme 70 – a) expected arylation pathway, proceeding via the most stabilised carbocation to give oxazine 
formation; b) unexpected arylation towards the enamide, by analogy proceeding via a secondary carbocation  
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meta-arylation of pivanilides (Scheme 39, introduction), the formation of the enamide product can be 
attributed to the directing ability of the carbonyl moiety. It was questioned whether this non-natural 
alkene functionalisation process could be made enantioselective, merging three distinct concepts in high-
valent copper catalysis (Scheme 71).  
 
Scheme 71 – a) Gaunt’s copper-catalysed arylation of alkenes;155 b) Gaunt’s meta-selective arylation of 
pivanilides;126 c) Gaunt’s enantioselective arylation of silylketinimides;138 d) conceptual union of copper-catalysed 
alkene functionalisation, non-natural regioselectivity and enantioselective arylation chemistry 
2.3 Initial Investigations 
Previous work conducted as a part III student provided proof of concept for the enantioselective 
arylation of allylic amide substrate 315. Conditions were identified to furnish diarylated enamide 
product 332 in 75% yield, high Z-selectivity and in 16% e.e. (Scheme 72).  
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Scheme 72 – Initial enantioselective conditions for the formation of enamide 332 (NMR yield with 1,3,5-
trimethoxybenzenetricarboxylate) 
Subsequently, Elise Cahard applied the reagent combination used in MacMillan’s silyl ketinimide 
arylation to the enamide formation process.139 Pleasingly, the use of hexafluorophosphate salt 338 with 
catalyst complex 248 was observed to generate enamide 332 in 65% yield and 93% e.e. (Scheme 73).  
 
Scheme 73 – Second-generation enantioselective conditions for the formation of enamide 332 (NMR yield with 
1,3,5-trimethoxybenzenetricarboxylate) – Elise Cahard 
Large variability in the yield of this enamide formation reaction was recorded. Subsequent investigations 
indicated that freshly prepared reagents were required in order to achieve reproducible results. 
Accordingly, the reaction was performed with fresh substrate, iodonium salt, catalyst complex and 
distilled di-tert-butylpyridine to give the product in a reliable 71% yield and 92% e.e. (Scheme 74).  
 
Scheme 74 – Enamide 332 formation under controlled conditions (NMR yield with 1,3,5-
trimethoxybenzenetricarboxylate) 
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2.4 Further Reaction Optimisation 
Following the observation of high enamide e.e. with the combination of allylic amide 315, 
hexafluorophosphate iodonium salt 338 and catalyst 248, Elise Cahard investigated other reaction 
parameters. Her studies included screens of bases and solvents, variation in the stoichiometries of the 
copper pre-catalyst solution, variation in the ratio of starting material to iodonium salt, and changes in 
the non-transferring aryl-group of the iodonium salt. No improvements were observed throughout these 
investigations. Further optimisation studies were then carried out on uninvestigated reaction parameters. 
2.4.1. Enamide stability and reaction time 
The effect of increasing the length of the reaction time was first probed (Table 4). No improvement in 
yield was achieved by quenching the reaction after 28 hours compared with a 24-hour reaction-time. 
Incomplete mass balance was observed with extended exposure.  
 
Entry Reaction time Yield / %a,b 
1 24 hours 70 (30) 
2 28 hours 70 (18) 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material. 
Table 4 – Investigation into the effect of increasing the reaction time  
1H NMR analysis of the crude enamide-formation reaction reveals the presence of thermal 
rearrangement product E–332 (<5%) and traces of what are thought to be alkene 339 and aldehyde 
340 (Figure 6). It is proposed that the remainder of the mass may be lost through a second arylation at 
the α-position of the enamide (Scheme 75). Evidence for such reactivity is provided by Pannecoucke, 
Gillaizeau and Kesavan’s observation that cyclic enamides react with iodonium salts under copper-
catalysed arylation conditions.136,137  
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Figure 6 – Side products of enamide formation reaction  
 
Scheme 75 – Plausible over-reaction of enamide 332 
Separately, a sample of the purified product 332 was re-exposed to the reaction environment to test the 
stability of the enamide to the reaction conditions. This experiment gave 66% product recovery after 24 
hours (Scheme 76). Although tentative evidence for the formation of a ter-aryl species was observed by 
LCMS analysis, no such derivatised product could be isolated or observed by NMR. It was concluded 
that a 24-hour reaction-time provided optimum conversion of allylic amide to enamide whilst 
minimising product decomposition. 
 
Scheme 76 – Investigation into the stability of enamide 332 on exposure to the reaction conditions 
2.4.2. Catalyst loading 
The effect of varying the amount of catalyst was next tested (Table 5). A reduced catalyst-loading gave 
low starting material conversions and therefore poor product yields (entry 1, 5 mol% catalyst, 60% 315 
remaining). Enamide production was observed to more than double on increasing the loading of 248 to 
10 mol% (entry 1 vs. entry 2 – 30 to 70% yield). Little further improvement was seen with a catalyst 
loading of 20 mol% (75% yield, entry 3) and the yield of the reaction dropped on the addition of 50 
mol% 248 (entry 4). Introduction of a second equivalent of catalyst to the reaction mixture after 14 
hours appeared to have no effect on the yield or conversion of the transformation (entry 5 vs. entry 2). 
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Catalyst loading was maintained at 10 mol% as the slight increase in yield observed with 20 mol% 
copper was not sufficiently significant to justify using twice the amount of the pre-catalyst. 
 
Entry Catalyst loading / mol% Yield / %a,b e.e. / %c 
1 5  30 (60) 92 
2 10 70 (10) 93 
3  20 75 (05) 92 
4 50 50 (20) 88 
5 10 + 10d 70 (10) 93 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay; d added after 14 hours 
Table 5 – Effect of catalyst loading on the reaction 
2.4.3. Pre-stirring studies 
Qualitative observations indicated that the enamide-formation reaction undergoes a lag-phase prior to 
the generation of product, attributable to a slow catalyst activation process. It was questioned whether 
the yield of the reaction could be improved by mixing the pre-catalyst with individual reagents before 
heating as normal (Table 6), hopefully leading to more rapid catalyst activation. However, as all 
reactions gave yields and enantioselectivities comparable with, or worse than, the control reaction (entry 
1), little advantage from pre-stirring the reaction components with the pre-catalyst was apparent. Despite 
the lack of improvement, it was interesting to note that pre-stirring the catalyst with the substrate (entries 
2 and 4) resulted in lower conversion of starting material. In contrast, a relative increased consumption 
of starting material was observed when the iodonium salt was pre-stirred with the catalyst (entries 3 and 
5). These results could indicate that the allylic amide substrate inhibits the catalyst activation process.  
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Entry Prestirred componentsa Yield / %b,c e.e. / %d 
1 – 77 (05) 93 
2  248 and 315 60 (20) 93 
3  248 and 338 78 94 
4  248, 315 and DTBP 70 (20) 92 
5  248, 338 and DTBP 75 (05) 91 
a Pre-stirred at room-temperature for 2 hours before the addition of the remainder of the reagents and stirring for 
24 hours; b yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; c bracketed quantity 
denotes remaining starting material; d e.e. determined by chiral HPLC assay 
Table 6 – Assessment of the effect of pre-stirring reaction components 
2.4.4. Atmosphere and radical activity 
In order to test for possible oxygen sensitivity, a control reaction was performed alongside two further 
reactions (Table 7, entries 1–3). The first of these reactions was carried out under an atmosphere of 
argon; the second was performed in freeze-pump-thawed degassed dichloromethane and under an 
atmosphere of nitrogen. Whilst the use of both standard nitrogen and argon atmospheres gave similar 
results (entries 1 and 2), degassed solvent gave reduced substrate conversion (entry 3). This poor result 
led to speculation that the solvent of the standard reaction may contain dissolved oxygen. It was 
considered that associated radical behaviour might promote the reaction. The process was therefore 
performed both under an oxygen headspace (entry 4) and with the radical trap 1,1-diphenylethylene 
(entry 5). Whilst, the oxygen atmosphere gave a poor yield and low starting material conversion, the use 
of the radical trap gave a similar yield to the control reaction (70%). It was concluded that oxygen and 
any resulting radical behaviour were not important for reactivity and that use of a simple nitrogen 
atmosphere was sufficient for good results. 
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Entry Conditions Yield / %a,b e.e. / %c 
1 N2 atmosphere 72 (04) n.d. 
2 Ar atmosphere 72 (03) n.d. 
3d 
N2 atmosphere, degassed 
CH2Cl2 
60 (20) 93 
4 O2 atmosphere 57 (20) 92 
5e 
N2 atmosphere, 1,1-DPE 
(4 equiv.)d 
70 (10) 92 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay; d freeze-pump-thaw degassed; e DPE = 
diphenylethylene 
Table 7 – Effects of varying atmosphere, degassing solvent and introduction of a radical trap 
2.4.5. Temperature 
The effect of both increasing and decreasing the reaction temperature was next examined (Table 8). It 
was thought that a higher reaction rate could be attained by increasing temperature, maximising product 
yields within twenty-four hours. Similarly, it was considered that lowering the reaction temperature may 
improve catalyst stability, allowing for a greater number of catalyst turn-overs. However, both increased 
and decreased reaction temperatures gave reduced yields relative to results observed at 50 ºC. The 
reaction run at 70 ºC gave poor mass balance and low e.e., whilst the 40 ºC process gave poor conversion 
and still only 80% mass balance. Temperature was not investigated further. 
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Entry Temperature / ºC Yield / %a,b e.e. / %c 
1 70 45 (20) 65 
2 40 50 (30) 91 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay 
Table 8 – Effect of varying temperature 
2.4.6. Catalyst counter-ion 
It was noted by Robert Phipps, a former PhD student in the Gaunt laboratory, that reactions employing 
diaryliodonium triflates catalysed by copper(I)-thiophene-2-carboxylate (CuTC, 341) gave catalytic 
amounts of phenolic ester 343. The generation of 343 was proposed to give concomitant production of 
copper(I) triflate, then acting as the active catalyst in the system (Scheme 77a).  
 
Scheme 77 – a) Counterion exchange from CuTC 341 to CuOTf, b) hypthothetical generation of catalytic 
hexafluorophosphate adduct 345 
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It was therefore hypothesised that the active allylic amide arylation catalyst would be the ligand-bound 
Cu(I) hexafluorophosphate species 345, formed by single-electron reduction of Cu(II) triflate species 248 
followed by a counter-ion exchange process (Scheme 77b). It was thought that higher yields may be 
achieved by removing the need for the copper centre to undergo either one or both activation processes. 
Accordingly, use of the three Cu(I) and Cu(II) triflate and hexafluorophosphate (pre-)catalysts shown 
below in Table 9 were assessed for competence in the allylic amide arylation process. Disappointingly, 
all reactions furnished the enamide product in similar yields, conversions and e.e.s to the standard 
catalytic system. Despite providing no improvement, it was interesting to observe these reactions to give 
such similar yields and levels of enantioselectivity, providing tentative evidence that the active catalyst is 
the same in all cases. Optimisation studies were continued with Cu(II) pre-catalyst 248 due to its relative 
ease of handling and preparation. 
 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay; d performed by Elise Cahard 
Table 9 – Alternative carbonyl-bearing substrates tested in the reaction 
2.4.7. Use of alternative substrates 
It was next considered whether the amide group of the substrate could be exchanged for a different 
carbonyl-bearing functionality. Four alternative substrates, predicted to direct functionalisation to the 
less nucleophilic alkene position were therefore prepared and tested under the arylation conditions 
(Table 10). None of the analogues provided any enamide product. The more electron-rich substrates, 
urea 350 and benzoyl amide 351, were unstable to the reaction conditions whilst the more electron-
deficient ester 349 and phthalimide 352 were inert. It was concluded that a pivaloyl amide group was 
crucial for reactivity to give enamide formation. 
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a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c Substrate 90% purity – contaminated with corresponding alkane 
Table 10 – Alternative carbonyl-bearing substrates tested in the reaction 
2.4.8. Overview 
No significant increase in yield was recorded throughout these optimisation investigations. A balance 
between reaction conversion and product stability was observed, with the process apparently sensitive 
to parameters including time, temperature and catalyst-loading. It was concluded that the reaction was 
not easily controlled by external parameters beyond the use of a specific catalyst and iodonium salt 
combination. As the observed yields of approximately 70% with accompanying excellent 
enantioselectivities were considered acceptable for the arylation process, the scope of the allylic amide 
functionalisation procedure was next evaluated. 
2.5 Reagent Synthesis 
Attention was directed towards the generation of a range of allylic pivalamide substrates and 
diaryliodonium hexafluorophosphate salts suitable for future investigations. Twelve allylic amide 
substrates were prepared from propargylic amide 353 by a two-step reaction sequence comprising a 
Sonogoshira coupling and cis-selective alkyne reduction (Table 11).157 Separately, ten diaryliodonium 
hexafluorophosphate salts were generated in good yields from the corresponding triflate or 
tetrafluoroborate salt through an ion exchange process (Table 12). 
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a performed by Elise Cahard; b reduction performed with 0.6 equiv. Ni(OAc)2•4H2O, 0.6 equiv. NaBH4, 2.1 equiv. 
ethylenediamine 
Table 11 – Two-step Sonogoshira coupling and cis-selective reduction procedure yielding Z-allylic amides 
20 mol% Ni(OAc)2•4H2O
20 mol% equiv NaBH4
0.7 equiv. ethylenediamine
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a performed by Elise Cahard; b from corresponding tetrafluoroborate iodonium salt 
Table 12 – Synthesis of hexafluorophosphate iodonium salts by ion-exchange 
2.6 Enamide Formation Scope Investigations 
2.6.1. Initial studies 
Six allylic amides were exposed to the optimised reaction conditions with iodonium salt 338 as a 
preliminary substrate scope (Table 13). Despite the observation of a good 75% yield for the control 
reaction (enamide 332), all other substrates gave poorer yields of the corresponding products. The use 
of substrates 356–358 gave low conversions (32–90% starting material remaining), though excellent 
enantioselectivities were recorded for the formation of para-chlorophenyl and ortho-tolyl enamides 378 
and 380 (92 and 96% e.e. respectively). Dienyl substrate 359 appeared unstable to the reaction 
conditions and gave no desired product. The electron-rich para-methoxyphenyl substrate 360 gave the 
desired enamide 382 in 35% NMR yield with no residual starting material. Disappointingly, this 
enamide product was found to be unstable to isolation. 
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a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay; d e.e. could not be determined due to product 
instability 
Table 13 – Initial investigation into the scope of the enamide formation process 
A brief optimisation survey was carried out on the reactions giving enamide products 378–380 (Table 
14). Increasing the reaction time from 24 to 48 or 72 hours led to higher yields and improved conversions 
in all cases (entries 1–3). However, this advantageous increase in yield was countered by a universal drop 
in e.e. (60–66% vs. >90%). Likewise, increasing the reaction temperature from 50 to 60 ºC (entries 4–6) 
gave higher starting material consumption but significantly reduced enantioselectivities (45, 15 and 35% 
e.e. respectively). Finally, increasing the reaction concentration from 0.05 M to 0.1 M (entries 7–9) gave 
little change in the yield or e.e. of the enamide products. As such, it appears from these studies that the 
original reaction conditions provide the best trade-off between yield and enantioselectivity. Further, the 
lack of improvement observed throughout this investigation reinforces our previous conclusion that 
enamide formation cannot be readily ameliorated by deviating from the standard reaction conditions of 
heating at 50 ºC for 24 hours at a 0.05 M concentration. 
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Entry Product Conditionsa Yield / %b,c e.e. / %d 
1 378 A 55 60 
2 379 Ae 40 (42) 65 
3 380 A 47 66 
4 378 B 45 (15) 45 
5 379 B 20 (70) 15 
6 380 B 24 (33)f 35 
7g 378 C 42 (29) 93 
8g 379 C 12 (72) 89 
9g 380 C 34 (51) 97 
a conditions: A – CH2Cl2 (0.05 M), 50 ºC, 48 h; B – CH2Cl2 (0.05 M), 60 ºC, 24 h; C – CH2Cl2 (0.1 M), 50 ºC, 24 
h; b yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; c bracketed quantity denotes 
remaining starting material; d e.e. determined by chiral HPLC assay; e 72 hours; f 10% trans-enamide and 8% 
oxazine additionally observed; g isolated yields 
Table 14 – Investigations into the effect of reaction length, temperature and concentration on the yields and e.e. 
of enamides 378–380 
Attention was next turned to the iodonium salt scope of the enamide generation procedure. Initial 
investigations employed electron-poor and sterically-encumbered diaryliodonium salts as these are 
reported to be poorly-tolerated in the racemic oxazine-formation reaction (Table 15).157,162 Beyond the 
use of the standard meta-bromophenyl iodonium salt 338, giving the corresponding enamide in 75% 
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yield and 94% e.e., three further iodonium salts gave appreciable product yields. Para-
trifluoromethylphenyl enamide 383 was formed in 58% yield and in high enantioselectivity (92% e.e.) 
whilst the ortho-tolyl and ortho-fluorophenyl enamides were produced in 20% and 35% yield respectively. 
Interestingly, the generation of ortho-tolyl enamide 384 is accompanied by the production of 8% of the 
corresponding oxazine, indicating some mechanistic cross-over in the reaction. Neither para-nitrophenyl 
nor pyridinyl-iodonium salts were tolerated under the reaction conditions. 
 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay; d 8% corresponding oxazine observed; e 72 
hour reaction time. 
Table 15 – Initial evaluation of the iodonium salt scope of the enamide formation  
It was discovered that increasing the concentrations of the reactions giving enamides 383–385 gave 
improved conversions and product yields (Table 16, 0.1 M). An 11% increase in yield was observed for 
para-trifluoromethylphenyl enamide 383 with only a slight drop in e.e. relative to the comparative 
reaction at 0.05 M. Ortho-tolyl enamide 384 was produced in 47% yield and 94% e.e. with no competitive 
formation of the undesired oxazine side-product. A small increase in yield was also observed for ortho-
fluorophenyl enamide 385, giving the product in 39% yield and very high enantioselectivity. 
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a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes 
remaining starting material; c e.e. determined by chiral HPLC assay; d 5% trans-enamide observed 
Table 16 – Initial evaluation of the iodonium salt scope of the enamide formation  
2.6.2. Isolated reaction scope 
In collaboration with Elise Cahard, the scope of the reaction was investigated on a 0.5 mmol scale with 
the isolation of the product enamides. Attention was first directed towards variation in the iodonium salt 
component of this alkene functionalisation transformation (Table 17). It was observed that moderate to 
good yields (40–70%) are achieved with iodonium salts bearing electron-withdrawing groups with 
Hammett σ-values in the range of 0.6–0.3. Enantioselectivities were generally recorded to be excellent, 
giving >90% e.e. in all cases except for the formation of para-acetylphenyl enamide 391 (82% e.e.). Both 
σ- and π-electron-withdrawing groups are tolerated in the meta- and para-positions of the transferred aryl 
ring. Ortho-substitution of the transferred aryl-group is also tolerated, with enamide 384 generated in 
40% yield despite the electron-rich nature of the iodonium salt employed.  
383d
67%
88% e.e.
Me3C NH
O
F6P
I Me
Me
Me
2 equiv. DTBP
CH2Cl2 (0.1 M), 50 ºC, 24 h
315 324 (2 equiv.) 326a,b,c
+
Me3C NH
O
N
OO
N
Me Me
Ph Cu PhTfO OTf
10 mol% 248
Ar
Ar
Me3C NH
O
CF3
385
39% (55%)
>98% e.e.
Me3C NH
O
F
384
Me3C NH
O
Me
47% (26%)
94% e.e.
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a isolated yields; b e.e. determined by chiral HPLC assay; c performed by Elise Cahard 
Table 17 – Isolated iodonium salt scope of the enamide formation reaction  
The scope of the enamide formation reaction towards variation in the allylic amide substrate was next 
investigated (Table 18). Para-trifluoromethylphenyl iodonium salt 367 was employed in these studies as 
it provided the greatest isolated yield in the iodonium salt scope above. Interestingly, whilst levels of 
enantioselectivity are consistently high, there appears to be a relationship between the electronic 
properties of the starting materials and the yields of the reactions. Electron-neutral substrates (Hammett 
σ-parameters ~0 ± 0.2) gave the best results in the study, with the para-tolyl, 2-napthyl and meta-
methoxyphenyl substituted enamides, 395, 396 and 397 formed in the yields in the range of 52 to 74%. 
More electron-poor substrates gave lower yields, attributable to reduced nucleophilicity of the alkene. 
Such an effect is illustrated by inspecting the trend of reactivity from para-chloro- and para-bromophenyl 
substrates 356 and 363 (σ 0.37 and 0.39, giving 34 and 28% enamide formation respectively) to para-
ester-substituted substrate (σ 0.45, only trace enamide formation). Intriguingly, more electron-rich 
substrates such as the para-methoxyphenyl- (σ –0.27) and indole species appear to give enamide 
332
55%
95% e.e.
383
70%
91% e.e.
384
40%
97% e.e.
Me3C NH
O
F6P
I Me
Me
Me
2 equiv. DTBP
CH2Cl2 (0.1 M), 50 ºC, 24 h
315 324 (2 equiv.) 326a,b
+
Me3C NH
O
N
OO
N
Me Me
Ph Cu PhTfO OTf
10 mol% 248
Ar
Ar
Me3C NH
O
Br
Me3C NH
O
CF3
Me3C NH
O
Me
385
42%
>98% e.e.
Me3C NH
O
F
389
58%
93% e.e.
Me3C NH
O
390c
55%
93% e.e.
Me3C NH
O
Cl CO2Et
Cl
391c
42%
82% e.e.
Me3C NH
O
392c
52%
92% e.e
Me3C NH
O
393c
60%
94% e.e.
Me3C NH
O
CO2Et CF3
Me
O
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formation but unstable products. Finally, ortho-substitution of the substrate (product 403) gives low yields 
of enamide (26%) but very high levels of enantioselectivity (>98% e.e.). 
 
a isolated yields; b e.e. determined by chiral HPLC assay; c performed by Elise Cahard; d yields determined by 1H 
NMR using 1,3,5-trimethoxybenzenetricarboxylate, bracketed quantity denotes % residual starting material; e 
enamide product unstable to isolation 
Table 18 – Substrate scope of the enamide formation transformation 
Brominated enamide 399 was crystalline, allowing the determination of the absolute configuration of 
this compound by X-ray diffraction (Figure 7). The crystal structure revealed a unit cell of two S-
configured enamide molecules. The remainder of the enamide products were configurationally assigned 
by analogy.  
399
28%
89% e.e.
395c
74%
96% e.e.
396
52%
95% e.e.
Me3C NH
O
F6P
I Me
Me
Me
2 equiv. DTBP
CH2Cl2 (0.1 M), 50 ºC, 24 h
355 367 (2 equiv.) 394a,b
+
Me3C NH
O
N
OO
N
Me Me
Ph Cu PhTfO OTf
10 mol% 248
Ar Ar
Me3C NH
O
Me3C NH
O
CF3
Me3C NH
O
403
26%
>98% e.e.
Me3C NH
O
398
34%
92% e.e.
Me3C NH
O
397c
69%
90% e.e.
Me3C NH
O
CF3
CF3
CF3
Me CF3
CF3Me
Cl
MeO
Br
402d,e
21% (55%)
Me3C NH
O
CF3
PhO2SN
400c,d
3% (84%)
Me3C NH
O
CF3EtO2C
401d,e
30%
Me3C NH
O
CF3MeO
F3C
CF3
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Figure 7 – X-ray crystal structure of enamide 399 
2.7 Oxazine Formation 
2.7.1. Discovery 
Elise Cahard noted that a 3:2 mixture of enamide 405 and oxazine 406 was produced from the 
combination of para-brominated iodonium salt 404 and the standard allylic amide substrate 315 
(Scheme 78). Most interestingly, both products were formed in high e.e., indicating the enantioselective 
arylation strategy to be extendable to oxazine formation. 
 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b e.e. determined by chiral HPLC 
assay 
Scheme 78 – Regiodivergent arylation with iodonium salt 404 to give enantioenriched products – Elise Cahard 
As enamide formation appears to be favoured with electron-poor iodonium salts, the above product 
mixture was attributed to the relatively poor electron-withdrawing ability of the para-bromophenyl group 
(Hammett σ-value 0.23). This result suggested that the use of a more electron-rich iodonium salt would 
further bias the reaction towards oxazine formation. Such a hypothesis was tested by exposing 
phenyl(mesityl)iodonium hexafluorophosphate 373 to the reaction conditions with para-tolyl allylic 
amide 361 (Scheme 79). Pleasingly, it was observed that increased aryl electron-density did indeed 
favour oxy-arylation, with the transfer of a phenyl group (σ 0.0) giving predominant oxazine production 
Me3C NH
O
F6P
I Me
Me
Me
2 equiv. DTBP
CH2Cl2 (0.05 M), 50 ºC, 24 h
315 404 (2 equiv.) 405
+
Me3C NH
O
N
OO
N
Me Me
Ph Cu PhTfO OTf
10 mol% 248
N
OMe3C
Br
Br
Br
+
406
50%
94% e.e.
36%
89% e.e.
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(65%) and minor enamide formation (26%). High product enantioselectivity was conserved, giving 97 
and 95% e.e. for enamide and oxazine products respectively. The described arylation procedure 
therefore represents an enantioselective and regiodivergent alkene functionalisation reaction wherein 
the regioselectivity may be controlled by the electronic nature of the iodonium salt employed.  
 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b e.e. determined by chiral HPLC 
assay 
Scheme 79 – Regiodivergent arylation with iodonium salt 373 to give enantioenriched products 407 and 408 
2.7.2. Substrate scope 
Attention was turned towards the application of the combination of allylic amides and electron-rich 
diaryliodonium salts towards the generation of a range of oxazine products in high e.e.. The substrate 
scope of this enantioselective oxy-arylation reaction was first examined by testing three substrates 
spanning Hammett σ-values in the range of –0.2 to 0.2 (Table 19). Oxazine formation was favoured 
with the use of the highly electron-rich para-methoxyphenyl iodonium salt 374. Firstly, para-
methoxyphenyl substrate 360 gave good starting material conversion but a low overall yield of oxazine 
410 (26%) and a lower e.e. (84%) than has been previously observed. Secondly, the electron-neutral 
phenyl substrate 315 gave the desired product in a good 74% yield and in an excellent 93% e.e.. Thirdly, 
despite the observation of 12% residual starting material, the electron-deficient para-bromo substrate 
363 gave good product yield and enantioselectivity following an extended reaction time of 43 hours 
(64% and 90% e.e.). As such, it is apparent that oxazine instability, good product yields and low starting 
material conversion are observed respectively with the use of electron-rich, electron-neutral and 
electron-poor substrates. This pattern replicates the reactivity seen with enamide formation (see Table 
13). 
Me3C NH
O
F6P
I Me
Me
Me
2 equiv. DTBP
CH2Cl2 (0.05 M), 50 ºC, 24 h
361 373 (2 equiv.) 407
+
Me3C NH
O
N
OO
N
Me Me
Ph Cu PhTfO OTf
10 mol% 248
N
OMe3C
+
408
26%
97% e.e.
65%
95% e.e.
Me Me Me
Enantioselective and Regiodivergent Copper-Catalysed Arylation of Allylic Amides with Diaryliodonium Salts 
 65 
 
a isolated yields, bracketed quantity denotes residual starting material; b e.e. determined by chiral HPLC assay; c 
performed by Elise Cahard; d Reacted for 43 hours – 2:1 ratio of oxazine product to starting material observed by 
1H NMR after 24 hours 
Table 19 – Initial investigation into the tolerance of substrate electronics on oxazine formation 
Efforts were first focused on improving the yield of the oxazine-formation reaction employing the para-
methoxyphenyl substrate. The major problem to be addressed was that substantial quantities of alkene 
413 were observed to be formed in the reaction, evidenced by time-course studies to result from oxazine 
decomposition (Scheme 80).  
 
Scheme 80 – Generation of E-/Z- configured substituted allylic amide 413 
The effects of altering the time, catalyst concentration and temperature of the reaction were surveyed 
towards reducing levels of oxazine 410 decomposition (Table 20). Relative to the outcome with the 
original conditions (entry 1, 26% yield, 84% e.e.), a 7-hour reaction time furnished the oxazine product 
in a significantly improved yield (73%) but in reduced e.e. (75%). An intermediate 20-hour reaction 
period (entry 2) gave the product in 40% yield and 80% e.e., both quantities between the values observed 
in the two previous studies. 5 mol% catalyst loading (entry 4) gave increased oxazine yield relative to the 
control reaction with 10 mol% copper, although still too low to be useful. Finally, a pronounced 
improvement was observed on lowering the reaction temperature to 40 ºC, giving oxazine 410 in 79% 
Me3C NH
O
F6P
I Me
Me
Me
365 374 (2 equiv.)
+ N
OMe3C
409a,b
Ar
N
OMe3C
412d
64% (12%)
90% e.e.
OMe
N
OMe3C
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26%
84% e.e.
OMe
N
OMe3C
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74%
93% e.e.
OMe
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2 equiv. DTBP
CH2Cl2 (0.05 M), 50 ºC, 24 h
N
OO
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Me Me
Ph Cu PhTfO OTf
10 mol% 248
MeO
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I Me
Me
Me
360 374 (2 equiv.)
+
2 equiv. DTBP
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OO
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Me Me
Ph Cu PhTfO OTf
10 mol% 248
MeO
MeO
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3:2 E-/Z-
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yield and 84% e.e. (entry 5). No further decrease in reaction temperature was explored owing to the slow 
rate of starting material conversion at 40 ºC. Interestingly, both the trend of increased product 
enantioselectivity with prolonged reaction times (entries 1–3) and the observation of improved oxazine 
yields with reduced copper loading (entry 4) indicate a (diastereoselective) catalyst effect in degrading 
the product.  
 
Entry Conditions Yield / %a e.e. / %b 
1 10 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 24 h 26 84 
2 10 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 7 h 73 75 
3 10 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 20 h 40 80 
4c 5 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 24 h 48 n.d. 
5 10 mol% 248, CH2Cl2 (0.05 M), 40 ºC, 30 h 79 84 
a isolated yields; b e.e. determined by chiral HPLC assay; c yield determined by 1H NMR using 1,3,5-
trimethoxybenzenetricarboxylate 
Table 20 – Investigations towards increasing the yield of oxazine 360 
Attention was next turned to the reaction between para-bromophenyl substrate 363 and diaryliodonium 
salt 374, previously observed to give good levels of oxazine formation only after prolonged reaction 
times (64% yield with 12% residual starting material after 43 hours). It was hoped that improved 
conversion to product could be obtained by increasing the catalyst loading, the iodonium salt loading, 
the reaction temperature or the reaction time (Table 21). Assessing two such modifications, further 
quantities of catalyst (entry 2) and iodonium salt (entry 3) were added to the reaction mixture after 
heating for 17 hours. Although these changes both gave increased product yield after a 24-hour period 
(relative to entry 1, control reaction), little further consumption of starting material was recorded after 
this time. Overall yields were lower than was observed for the initial test reaction in Table 19 (64%). 
Similarly, although increasing the temperature of the reaction to 60 ºC (entry 4) provided a slight 
increase in NMR yield, starting material conversion remained moderate after a 24-hour period. Finally, 
increasing the catalyst loading to 15 mol% at the outset of the reaction gave greater oxazine yields than 
Me3C NH
O
F6P
I Me
Me
Me
360 374 (2 equiv.)
+
2 equiv. DTBP
conditions
N
OO
N
Me Me
Ph Cu PhTfO OTf
cat. 248
MeO
N
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were observed in earlier reactions (74% isolated) but provided low enantioselectivity (79% e.e.). The 
initial conditions (Table 19) remain the best compromise between reactivity and enantioselectivity. 
 
Entry Conditions Yield / % 
1 10 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 24h 48 (40) 
2 
10 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 17 h 
then: 5 mol% 248 – 24 h 
48 h 
 
62 (32) 
51 (25) 
3 
10 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 17 h 
then: 1 equiv. 374 – 24 h 
48 h 
 
56 (43) 
53 (41) 
4 10 mol% 248, CH2Cl2 (0.05 M), 60 ºC, 24 h 56 (37) 
5c 15 mol% 248, CH2Cl2 (0.05 M), 50 ºC, 43 h 74 [79% e.e.] 
a yield determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b bracketed quantity denotes residual 
starting material; c isolated yield, e.e. determined by chiral HPLC assay 
Table 21 – Investigations into increasing the yield of oxazine 248 
Having determined that electron-donating substrates are tolerated under the oxy-arylation manifold, 
three further electron-rich allylic amides were tested and optimised (Table 22). Firstly, the use of 
dioxolane substrate 365 gave 73% isolated oxazine yield and 87% e.e. under the standard reaction 
conditions (entry 1). The reaction was then performed at 40 ºC, in line with the improved formation of 
bis-para-methoxyphenyl oxazine 410 (entry 2). However, these reduced temperature conditions gave 
slow starting material conversion, ultimately furnishing the desired product in only 70% isolated yield 
after 46 hours and in an identical e.e. to the previous reaction. Lastly, the reaction time at 50 ºC was 
shortened (entry 3), giving 80% product formation after 15 hours in a very good 89% e.e.. Next, exposing 
indole substrate 364 to the standard reaction conditions returned the desired oxazine product in 35% 
yield with no recovery of starting material (entry 4). As with the previous example, the reaction time was 
Me3C NH
O
F6P
I Me
Me
Me
363 374 (2 equiv.)
+
2 equiv. DTBP
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N
OO
N
Me Me
Ph Cu PhTfO OTf
cat. 248
MeO
N
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OMe
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reduced to three hours, giving the desired product in 62% NMR yield (entry 5). Finally, it was recorded 
that quenching the reaction after two hours furnished the oxazine product in 78% NMR yield, 62% 
isolated yield and in an excellent 91% e.e.. No product formation was detected on exposure of thiophenyl 
substrate 366 to reaction with iodonium salt 374. Substantial thiophene decomposition was recorded, 
with 70% allylic amide lost within 15 minutes of heating. 
 
Entry Product Temperature/ T Time / h Yield / %a e.e. / %b 
1 414  50 20 73 87 
2 414 40 46 70 87 
3 414  50 15 80 89 
4c 415 50 24 35 n.d. 
5c 415 50 3 62 90 
6d 415 50 2 62 91 
7c 416 50 24 0 n/a 
8c 416 50 2 0 n/a 
9 416 50 0.25 0 (30) n/a 
a isolated yield; b e.e. determined by chiral HPLC assay; c 0.1 mmol scale, yield determined by 1H NMR using 1,3,5-
trimethoxybenzenetricarboxylate; d 78% by NMR yield (1,2-dimethoxyethane as internal standard) 
Table 22 – Scope investigations with electron-donating substrates 
Me3C NH
O
F6P
I Me
Me
Me
365 374 (2 equiv.)
+
2 equiv. DTBP
CH2Cl2 (0.05 M), temperature, time
N
OO
N
Me Me
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10 mol% 248
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N
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The scope of the substrate tolerance to the oxy-arylation reaction was compiled and further evaluated in 
collaboration with Elise Cahard and Dr Matthieu Tissot (Table 23). It was observed that a variety of 
aryl groups were tolerated as substituents on the allylic amide substrate to give oxazine products in 46–
84% yield. The reaction appears to proceed faster for more electron-rich substrates (2 hours for 364) 
and slower for more electron-poor allylic amides. The reduced reactivity with electron-deficient starting 
materials is evidenced by para-bromophenyl substrate 363 (σ 0.23) giving 12% recovered starting 
material after 43 hours and meta-methoxyphenyl substrate 417 (σ 0.12) requiring 15 mol% catalyst for 
good yields. Interestingly, ortho-substitution of the allylic amide aromatic ring is tolerated under the 
standard reaction conditions (421), though low yields (46%) are observed. No product was observed 
with the use of the thiophenyl substrate 366. Levels of enantioselectivity are generally excellent, with 
slight reductions in e.e. observed with more electron-rich substrates.  
 
a isolated yield; b e.e. determined by chiral HPLC assay; c 40 ºC, 30 h; d performed by Dr Elise Cahard; e 43 h, 12% 
residual starting material; f performed by Dr Matthieu Tissot; g 15 mol% 248; h 15 h; i 2 h 
Table 23 – Isolated substrate scope 
410c
79%
84% e.e.
418d
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Enantioselective and Regiodivergent Copper-Catalysed Arylation of Allylic Amides with Diaryliodonium Salts 
 70 
2.7.3. Iodonium salt scope 
Attention was next directed towards the iodonium salt scope of the enantioselective oxy-arylation 
reaction. As previous work has provided knowledge into the breadth of the iodonium salt tolerance to 
oxazine formation, studies were directed towards the challenging transfer of both 2-napthyl- and 
thiophenyl groups (Table 24, entries 1 and 2).157 Exposure of the iodonium salts to the standard reaction 
conditions with simple phenyl substrate 315 furnished the desired compounds 423 and 424 in 36 and 
32% isolated yield and 93 and 92% e.e respectively. These low yields can be attributed to low starting 
material conversions and could not be significantly improved by increasingly either catalyst loading or 
reaction time (entries 3–8). However, use of the more electron rich para-methoxyphenyl substrate with 
the same iodonium salts overcame the problem of low starting material conversion (entries 9 and 10) - 
both systems were observed to reach completion after 24 hours, giving moderate product yields of 42 
and 55% respectively for oxazines 425 and 426. Disappointingly, these products were formed in 
significantly lower enantioselectivity than is generally observed (52 and 63% e.e.). A mixture of 
diastereoisomers for oxazine 426 was also produced. Lastly, although slight improvements in yield and 
e.e. were observed with a 6-hour reaction time, enantioselectivity remained too low to be useful (entries 
11 and 12). 
 
Entry Product Conditions Yield / %a,b 
1c 423 10 mol% 248, 50 ºC, 24 h 36 [93% e.e.] 
2c 424 10 mol% 248, 50 ºC, 24 h 32 [92% e.e.] 
3 423 
10 mol% 248, 50 ºC, 24 h 
48 h 
41 (59) 
26 (59) 
4 423 15 mol% 248, 50 ºC, 24 h 41 (58) 
Me3C NH
O
F6P
I Me
Me
Me
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48 h 29 (54) 
5 423 
20 mol% 248, 50 ºC, 24 h 
48 h 
42 (58) 
26 (57) 
6 424 10 mol% 248, 50 ºC, 24 h 37 (58) 
7 424 10 mol% 248, 50 ºC, 50 h 38 (55) 
8 424 15 mol% 248, 50 ºC, 24 h 35 (63) 
9c 425 10 mol% 248, 50 ºC, 24 h 42 [52% e.e.] 
10c 426 10 mol% 248, 50 ºC, 24 h 55, 5:1 d.r. [63% e.e.] 
11 425 10 mol% 248, 50 ºC, 6 h 60 [62% e.e.] 
12 426 10 mol% 248, 50 ºC, 6 h 67, 4:1 d.r. [68% e.e.] 
a yield determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate, bracketed quantity denotes residual 
starting material; b e.e. determined by chiral HPLC assay; c isolated yields 
Table 24 – Investigations into increasing the transferral of under-reactive iodonium salts 
The diaryliodonium salt scope of the reaction was also evaluated in collaboration with Elise Cahard and 
Dr Matthieu Tissot (Table 25). Synthetically useful to good oxazine yields (32–74%) and universally 
excellent levels of enantioselectivity (e.e. >90%) were observed with all the iodonium salts that were 
tested. Use of the phenyl-transferring iodonium salt 373 gave oxazine 428 together with achiral diphenyl 
enamide in an overall yield of 81%, in line with expectations for this electron-neutral iodonium salt. 
Complete oxazine selectivity and product yields in the range of 63–74% were observed with the use of 
para-alkylphenyl- and para-methoxyphenyl-substituted iodonium salts (429–431). As was previously 
described, the transfer of thiophenyl- and napthyl groups could be achieved to give oxazines 423 and 
424 in low yields but with complete product selectivity and high e.e..  
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a isolated yield; b e.e. determined by chiral HPLC assay; c performed by Elise Cahard; d 28% diphenyl enamide 
isolated e performed by Dr Matthieu Tissot 
Table 25 – Isolated iodonium salt scope 
Oxazine 428 gave high quality crystals suitable for X-ray analysis (Figure 8). These data allowed for the 
determination of the absolute configuration of this product as the (S,S)-enantiomer and allowed 
configurational assignment of the remainder of the oxazine products by analogy. Interestingly, when 
compared with the crystal structure of enamide 399 (Figure 7, page 63), it was noted that the two allylic 
amide arylation products appear to arise from reaction on opposite faces of the alkene.  
 
Figure 8 – X-ray crystal structure of enamide 428 – Elise Cahard 
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2.8 Applications 
Attention was turned towards the application of our enantioselective and regiodivergent allylic amide 
arylation to the production of molecules useful to the wider chemical community. In line with such an 
aim, Elise Cahard has previously determined that oxazine products can be cleaved to amino-alcohol 
salts (Scheme 81).157 This hydrolysis reaction will now allow enantioselective access to compounds such 
as the anti-depressant PRC050.163 
 
Scheme 81 – Hydrolysis of oxazine 428 to amino-alcohol 432,157 application to the synthesis of PRC050 
Similarly, it was considered that hydrolysis of the enamide products would give β,β’-diaryl aldehydes 
(Figure 9a). This class of molecule comprises the backbone of a number of pharmaceutically important 
compounds such as the antimuscarinic tolteridine (434) and the monoamine transporter inhibitor 
indatraline 435 (Figure 9b).164 It was envisaged that there would be industrial interest in the formation 
of these aldehydes by a novel enantioselective means. 
 
Figure 9 – a) β-diaryl aldehyde; b) pharmaceutical agents derived from β-diarylaldehydes 
Eleven conditions were studied for the hydrolysis of enamide 389 (Table 26), chosen for these 
investigations as the aldehyde product is an intermediate in Aggarwal’s synthesis of indatraline.165–168 
Biphasic conditions of mild aqueous acid and dichloromethane were initially tested as the enamide 
hydrolysis medium, allowing production of the desired aldehyde in moderate yields only after prolonged 
heating (entries 1 and 2). The poor mass balance observed in the reactions was attributed to hydrate 
formation in the aqueous phase, precluding extraction into the organic medium. Anhydrous acidic 
conditions were therefore next tested (entries 3 and 4), disappointingly giving enamide decomposition 
and apparent polymerisation. Attention was then turned to monophasic acidic conditions with the use 
of concentrated aqueous hydrochloric acid in 1,4-dioxane (entries 5 and 6). Relative to heating at 50 ºC 
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for 14 hours, improved product yields were attained at room-temperature with stirring for 90 minutes 
(62 vs. 44%) although no further improvement in yield was achieved by quenching the reaction with 
aqueous sodium hydroxide (entry 7). Pleasingly, improved product yields were observed on reducing the 
concentrations of the reaction (entries 9 and 10, 75 and 79% yield), although further dilution (entry 11) 
gave poorer conversion. Finally, tetrahydrofuran was employed as the reaction solvent to improve 
miscibility (entry 12). Excellent conversion to product was observed, allowing aldehyde production in a 
92% yield following work-up with solid sodium carbonate and drying over anhydrous sodium sulfate. 
 
Entry Conditions Work-upa Yield / %b 
1 3M HCl (aq.):CH2Cl2 (1:1, 0.025 M), 60 ºC, 24 h A 50 
2c 3M HCl (aq.):CH2Cl2 (1:1, 0.025 M), 60 ºC, 27 h A 58 
3 
1.1 equiv. TfOH, CH2Cl2 (0.1 M), rt, 2 h 
50 ºC, 24 h 
A 
A 
0d 
0 
4 4 M HCl in 1,4-dioxane (0.05 M), rt, 2 h; A 0e 
5 Conc. HCl:1,4-dioxane (1:5, 0.04 M), 50 ºC, 14 h A 44 
6 Conc. HCl:1,4-dioxane (1:5, 0.04 M), rt, 1.5 h A 62 
7 Conc. HCl:1,4-dioxane (1:5, 0.04 M), rt, 4 h B 58 
8 Conc. HCl:1,4-dioxane (1:10, 0.05 M), rt, 0.5 h B 75 
9 Conc. HCl:1,4-dioxane (1:20, 0.025 M), rt, 4 h B 79 
10 Conc. HCl:1,4-dioxane (1:50, 0.01 M), rt, 4 h B 74 
11 Conc. HCl:THF (1:20, 0.025 M), rt, 4 h C 92 
a A: quench with sat. aq. NaHCO3, extract with CH2Cl2; dry over MgSO4 and concentrate; B: quench with 10% 
aqueous NaOH, extract with CH2Cl2, dry over MgSO4 and concentrate; C: addition solid Na2CO3, filter solution 
through Na2SO4 and concentrate: b yield determined following work-up by 1H NMR using 1,2-dimethoxyethane; 
c isolated yield; d 100% conversion to trans-enamide; e polymerisation suspected 
Table 26 – Optimisation of the enamide hydrolysis procedure 
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With conditions for the hydrolysis of enamide products in hand, enantioenriched enamide 389 was 
freshly prepared and converted into aldehyde 436 in a good overall yield (Scheme 82).  
 
Scheme 82 – a) enantioselective generation of enamide 389; b) enamide hydrolysis to furnish the desired highly 
enantioenriched β-diaryl aldehyde 436 
All enantioselective methods for the generation of β-diarylaldehydes reported to date have proceeded 
via the addition of a nucleophilic aryl group to some cinnamaldehyde derivative (Scheme 83a). Three 
types of reaction based on this strategy have been developed: organocatalysed (Scheme 83b),169 metal-
catalysed (Scheme 83c)170–172 and synergistically catalysed (Scheme 83d).173 Compared with these formal 
conjugate addition reactions, the generation of enantioenriched aldehydes via the production of 
enamides represents a polarity-reversed process. Rather than employing a nucleophilic aryl group and 
an electrophilic alkene equivalent, our copper-catalysed process employs an electrophilic aryl group 
(iodonium salt) and a nucleophilic alkene (allylic amide). It is envisaged that this umpolung strategy will 
provide a useful orthogonal method for the synthesis of challenging β-diarylaldehydes. 
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Scheme 83 – a) simplified reaction overview; b) MacMillan’s organocatalysed addition of anilines to 
cinnamaldehydes;169 c) Carreira’s rhodium-catalysed addition of boronic acids to cinnamaldehydes;170 d) 
Cordova’s synergistic palladium-catalysed addition of boronic acids to in situ generated iminum species.173  
2.9 Mechanistic Rationale 
The system under investigation appears to lie at a point of mechanistic cross-over with one pathway 
leading to enamide formation and the other to oxazine generation. Tentatively, it is proposed that these 
two products result from two different alkene functionalisation modes. 
A carbonyl-directed carbocupration process (437) has been evidenced in Li and Wu’s computational 
evaluation of Gaunt’s meta-arylation procedure (Scheme 84a).126,129 It is proposed that an analogous 
functionalisation mode (438) may occur with allylic amide substrates to give enamide formation (Scheme 
84b). Such a concerted carbocupration process could be rationalised to be favoured with the use of 
electron-deficient diaryliodonium salts as the putative aryl-copper(III) intermediate will be relatively 
more electrophilic, driving association of the carbonyl moiety.  
Nuc
ArAr
O
H
Ar
O
H
+Ar
chiral ligand, chiral catalyst
nucleophilic
aryl group
cinnamaldehyde
derivative
enantioenriched
aldehyde
O
H
O
H
+
N
OMe N OMe
N
H
Me
N
Bn
O
CMe320 mol%
CH2Cl2 (0.1 M), –50 ºC, 36 h
82%
84% e.e.
O
H
O
H
+
B(OH)2
1.5 mol% [Rh(C2H2)2Cl]2
50 mol% KOH
80%
92% e.e.
MeO
Me
MeO Me
Bn
i-Pr
3.3 mol%
MeO
MeOH/H2O (10:1), 50 ºC, 1.25 h
a)
b)
c)
MacMillan
Carreira
O
H
O
H
+
B(OH)2
5 mol% Pd(OAc)2
25 mol% CsCO3
80%
88% e.e.
Me
Me
5 equiv. MeOH
PhMe (0.2 M), rt, 3h
N
H
20 mol%
Ph
OTMS
Ph
d)
Córdova
Enantioselective and Regiodivergent Copper-Catalysed Arylation of Allylic Amides with Diaryliodonium Salts 
 77 
 
Scheme 84 – a) computed concerted carbocupration to give meta-arylation;129 b) proposed concerted 
carbocupration to give enamide formation 
Conversely, oxazine formation might occur via benzylic carbocation 443, generated through reductive 
elimination-like transition state 441 from a highly-polarised alkene-copper(III) complex (Scheme 85). 
Mono-dentate alkene co-ordination may be expected to be favoured under the reaction conditions 
employing electron-rich iodonium salts. The relatively increased electron density on the copper(III) 
centre would preclude carbonyl-binding, thereby disfavouring enamide formation. 
 
Scheme 85 – proposed oxazine-formation pathway proceeding though a reductive elimination-like process to 
give carbocation 443 
Computational evidence for both carbocupration and reductive elimination-like alkene functionalisation 
processes are provided in chapter 4 of this thesis. 
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2.10 Summary 
This chapter has described the development of a novel copper-catalysed enantioselective and 
regiodivergent process for the functionalisation of alkenes with diaryliodonium salts. A range of allylic 
amides were shown to react with diaryliodonium hexafluorophosphates to furnish diaryl oxazines and 
enamides in high enantioselectivity. The regioselectivity of the arylation process was demonstrated to be 
dependent on the electronic nature of the transferred aryl group, with electron-rich iodonium salts giving 
oxazine products and electron-poor salts giving enamides. The products are shown to have applications 
in pharmaceutical development, with it demonstrated that enamide products may be hydrolysed to 
enantioenriched β-diaryl aldehydes.  
A full reaction scope is given on the following pages (Tables 27 and 28). Compounds synthesised 
personally are marked ‘HPJM’ whilst compounds synthesised by my collaborators Elise Cahard and Dr 
Matthieu Tissot are marked ‘EC’ and ‘MT’ respectively.  
The work described in this chapter was published in the Journal of the American Chemical Society.174
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Table 27 – Full and attributed enamide scope of the enantioselective and regiodivergent alkene arylation 
procedure employing allylic amides and diaryliodonium salts 
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Table 28 – Full and attributed oxazine scope of the enantioselective and regiodivergent alkene arylation 
procedure employing allylic amides and diaryliodonium salts 
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3 Studies Towards the Total Synthesis of (–)-Lyngbyaloside B 
3.1 Project Overview 
This chapter describes efforts towards the total synthesis of the polyketide natural product (–)-
lyngbyaloside B. Our strategy was based on the use of a copper-catalysed oxy-alkenylation as the key 
disconnection, unifying an elaborate homoallylic carbamate and a complex alkenyl iodonium salt. Work 
was carried out towards fragment synthesis and coupling studies. 
3.2 (–)-Lyngbyaloside B 
3.2.1. Isolation and structure determination 
In 2002 Moore and Paul reported the isolation of a polyketide derived from the Palauan cyanobacterium 
Lyngbya sp.175 This compound was determined to display structural similarity to the previously-reported 
homologues lyngbyaloside 445 and lyngbouilloside 446 and was accordingly named (–)-lyngbyaloside 
B.176,177 Following extensive NMR analysis, the stereochemical structure of the macrolidal natural 
product was tentatively assigned as 447 (Figure 10).  
 
Figure 10 – Members of the lyngbyaloside family (proposed, partial and confirmed structures)175–178 
Interested in both the backbone structure and the reported cytotoxicity of (–)-lyngbyaloside B, the Fuwa 
group chose to independently synthesise the described compound. However, following the generation 
of 447, they found the characterisation data to not match those of the Moore and Pauls’ isolated 
material.178 A similar result was observed following efforts by the groups of Cossy, Ley and Hansen 
towards the synthesis of the known aglycone of Lyngbouilloside.179–181  
Comparing the NMR data of the isolated and synthesised (–)-lyngbyaloside B, Fuwa noted that the 
greatest degree of stereochemical disagreement lay in the C-9–13 region of the polyketide backbone. 
Extensive computational conformational analysis was performed on candidate isomers with this 
backbone portion altered. It was concluded from these studies that the (10S,11S,13S)-isomer 448 would 
most closely fit the observed spectroscopic data. The new stereochemical assignment was confirmed in 
Fuwa’s 2015 synthesis of 448.178,182  
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3.2.2. Reported total synthesis 
Fuwa’s 2015 synthesis remains the only total synthesis of (–)-lyngbyaloside B reported in the literature. 
The retrosynthetic approach for this target initially focused on the formation of aglycone 449 by 
disconnecting the peripheral groups by Stille coupling and glycosylation. The simplified structure was 
accessed from linear precursor 450 via an acyl-ketene macrolactonisation. Following some simple 
oxidative manipulations on a pendant alkene, the introduction of the dioxinone handle was achieved 
through a vinylogous Mukaiyama aldol reaction. It was determined that the advanced polyketide 
backbone could be constructed with an Abiko-Masamune anti-aldol from the relatively simple fragments 
451 and 452 (Scheme 86).  
 
Scheme 86 –Fuwa’s retrosynthetic strategy to access (–)-lyngbyaloside B182 
Abiko-Masamune ester 451 can be accessed in eight steps from commercial starting materials (Scheme 
87). The key step in this synthesis is the installation of the desired C-6 and C-7 stereochemistry through 
a Brown crotylation with known aldehyde 453.183 Following generation of crotylated compound 454, 
the desired fragment 451 was produced in five steps through high-yielding protecting group 
manipulations, oxidation chemistry and an auxiliary coupling.  
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Scheme 87 –Fuwa’s synthesis of Akibo-Masamune ester 451182 
The aldehyde coupling partner 452 was accessed in twelve steps from commercial materials (Scheme 
88). Following simple synthetic manipulations, a Sharpless asymmetric epoxidation of allylic alcohol 
455, followed by regioselective reductive epoxide opening, gave key enantiopure diol 456 in excellent 
yield and set the stereochemistry of the C-13 position of (–)-lyngbyaloside B. With diol 456 in hand, a 
two-step PMB protection of the tertiary alcohol group and a Parakh-Doering oxidation furnished the 
desired aldehyde fragment.  
 
Scheme 88 –Fuwa’s synthesis of aldehyde coupling partner 452182 
The fragments were joined by a diastereoselective Abiko-Masamune anti-aldol reaction to give the 
desired aldol adduct 457 in 86% yield and to fix the C-10 and C-11 stereocentres of the target compound 
(Scheme 89).184  
 
Scheme 89 –Abiko-Masamune aldol reaction furnishing 457182 
Aldol product 457 was converted to advanced aldehyde 458 in a six-step reaction sequence involving 
silyl protection of the secondary alcohol, reduction of the ester moiety, alkene dihydroxylation and 
oxidative diol cleavage. However, following the generation of the aldehyde, a vinylogous Mukaiyama 
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aldol reaction between 458 and enol ether 459 easily furnished the dioxinone-bearing linear precursor 
460 in quantitative yield and in good diastereoselectivity (Scheme 90). 
 
Scheme 90 –Manipulations to furnish linear precursor 460182 
Following simple protecting-group manipulations to give intermediate tertiary alcohol 450, the 
compound underwent an acyl-ketene macrolactonisation on heating in toluene. Direct treatment of the 
crude lactone with mild acid in methanol furnished the protected aglycone in 80% yield over two steps 
(Scheme 91). 
 
Scheme 91 –Macrolactonisation of tertiary alcohol 450 to furnish aglycon 461182 
Transformation of aglycone 461 into vinyl iodide 462 required a laborious six-step reaction sequence 
involving deprotection, oxidation, alkynylation, hydrostannylation and iodination processes. However, 
with the vinyl iodide in hand, modified Stille coupling with stannane 463 and subsequent treatment with 
NBS cleanly furnished dienyl-bromide 464. This late-stage intermediate was glycosylated then the 
hydroxyl-protecting groups removed to finally furnish (–)-lyngbyaloside B 448 (Scheme 92).  
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Scheme 92 –Stille coupling and glycosylation end-game to give (–)-Lyngbyaloside B 448182 
Whilst Fuwa’s 32-step synthesis effectively generates the target molecule, inefficiencies are apparent in 
the production of both the polyketide backbone (22 steps to 460) and the pendant dienyl bromide 
moiety. We believed that there was scope to improve this synthesis with the use of more contemporary 
synthetic methods. 
3.3 Retrosynthetic Strategy 
The Gaunt group has recently developed a diastereoselective copper-catalysed oxy-alkenylation reaction 
employing homoallylic carbamates and alkenyl(aryl)iodonium salts (Scheme 93).158 The resulting 
homoallylic carbonates represent masked 1,3-syn-diols, a common substitution pattern observed in 
polyketides. It was questioned whether this alkene functionalisation process could be used in natural 
product synthesis, particularly as a fragment coupling method. 
 
Scheme 93 –Gaunt’s copper-catalysed oxy-alkenylation procedure towards homoallylic carbonates 468158 
(–)-Lyngbyaloside B was chosen as a target for the complex fragment unification strategy as it contains 
an all-syn relationship in the C-10–13 region of the molecule and an adjacent fully saturated C2 unit. It 
was recognised that a formal synthesis of the target compound could be achieved by converting 
homoallylic carbonate 469 to dioxinone 450, an advanced intermediate in Fuwa’s total synthesis. The 
carbonate would be produced from the coupling of highly functionalised carbamate southern fragment 
470 with complex iodonium salt northern fragment 471 (Scheme 94). The unification of these 
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components would test not only the application of our C–C bond-forming methodology, but also the 
accessibility and utility of functionality-rich iodonium salts. 
 
Scheme 94 – Proposed retrosynthesis from intermediate 450 
3.4 Model System Studies 
Gaunt’s copper-catalysed homoallylic carbamate alkenylation methodology tolerates the use of a variety 
of iodonium salts. Within the reported scope of the reaction, the generation of three carbonate examples 
are particularly relevant to the formation of (–)-lyngbyaloside B – allylic disubstituted carbonate 474 and 
allylic oxygenated compounds 475 and 476 (Table 29).158  
 
Table 29 – Relevant substitution tolerance of the alkenyl iodonium salt 472 to Gaunt’s oxy-alkenylation158 
The above examples provide evidence that the desired complex fragment coupling will be tolerated 
under copper-catalysed oxy-alkenylation conditions. However, no examples are shown for the transfer 
of iodonium salts bearing a more relevant secondary allylic ether motif. Initial efforts were therefore 
directed towards the investigation of a model reaction between homoallylic carbamate 317 and some 
more representative iodonium salt (477) (Scheme 95). 
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Scheme 95 – Model fragment coupling to give a homoallylic carbonate with a secondary allylic ether motif 
A three-step procedure was identified for the production of iodonium salts bearing the desired allylic 
substitution. The reaction sequence employs a copper-catalysed alkyne borylation,185 a boronic ester 
hydrolysis and a Lewis-acid promoted iodonium salt formation. Three alkenyl(aryl)iodonium salts were 
synthesised by this method (Table 30) in order to assess the effect of both the oxygen protecting group 
and the steric bulk of the iodonium salt aryl group on the outcome of the model oxy-alkenylation reaction. 
 
Table 30 – Production of model iodonium salts 481, 482 and 483 
The coupling of the new iodonium salts with model homoallylic carbamate substrate 317 was then tested 
(Table 31). Investigations began by employing the original coupling conditions reported by our group,158 
giving moderate to good starting material conversions but little desired product formation (<8% yield 
in all cases, entries 1–3). Diene 484 was observed to be the major product of all the reactions (19–13% 
yield), implying either the iodonium salts or the products to be unstable with respect to a deleterious 
elimination of the protected allylic alcohol.  
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Entry 
Iodonium 
Salt 
Conditions 
Yield / %a 
478b 484c 317 
1  481 10 mol% [Cu], CH2Cl2 (0.025 M), rt, 18 h <8 19 22 
2 483 10 mol% [Cu], CH2Cl2 (0.025 M), rt, 18 h <5 15 53 
3 482 10 mol% [Cu], CH2Cl2 (0.025 M), rt, 18 h <7 13 13 
4  481 10 mol% [Cu], CH2Cl2 (0.025 M), 0 ºC, 24 h 23 0 77 
5  481 10 mol% [Cu], CH2Cl2 (0.1 M), 0 ºC, 24 h 33 0 63 
6  481 
10 mol% [Cu], CH2Cl2 (0.05 M), 0 ºC, 24 h 
44 h 
64 h 
33 
29 
27 
0 
tr 
8 
54 
44 
37 
7  481 10 mol% [Cu], CH2Cl2 (0.05 M), –15 ºC, 24 h 0 0 70 
8  481 10 mol% [Cu], CH2Cl2 (0.05 M), 10 ºC, 24 h 20 tr 29 
9  481 
10 mol% [Cu], CH2Cl2 (0.05 M), 0 ºC, 24 h 
+10mol% [Cu], 42 h 
33 
29 
0 
tr 
43 
39 
10 483 10 mol% [Cu], CH2Cl2 (0.05 M), 0 ºC, 24 h <5 0 66 
11 482 10 mol% [Cu], CH2Cl2 (0.05 M), 0 ºC, 24 h 46 0 47 
a yield determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b yield quoted as the sum of four 
possible diastereoisomers; c yield quoted as the sum of two possible diastereoisomers 
Table 31 – Investigations into the viability of the model coupling between homoallylic carbamate 317 and 
iodonium salts 481, 482 and 483  
Work was directed towards disfavouring the elimination process (Table 31, entries 4–9). It was 
discovered that lowering the temperature of the reaction employing iodonium salt 481 to 0 ºC precluded 
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formation of the diene and gave increased product yields (23%) despite reduced levels of starting material 
conversion (entry 4). Similarly, increasing the concentration of the reaction at 0 ºC (entry 5, 0.05 M) 
provided an improved 33% homoallylic carbonate yield, although no further increase in yield was 
observed at 0.1 M (entry 6). Extending the reaction time from 24 to 44 and 64 hours resulted in 
significant starting material decomposition and no further product formation. Finally, no improvement 
in carbonate yield was obtained by further varying the reaction temperature (–15 ºC for entry 7 and +10 
ºC for entry 8) or by increasing the loading of the catalyst in the reaction (entry 9). 
It was hoped that changing either the oxygen protecting group or the non-transferring aryl group of the 
iodonium salt would lead to increased oxy-alkenylation yields. As such, the conditions giving the best 
reactivity with benzyl-protected alkenyl(mesityl)iodonium salt 481 (0.05 M, 0 ºC, 10 mol% Cu) were 
applied to coupling reactions employing TIPS-protected and ortho-tolyl-bearing iodonium salts 483 and 
482 (Table 31, entries 10 and 11). Although only trace product was observed with the allylic hydroxyl 
group being protected as a tri-iso-propylsilyl ether, the use of the less sterically-encumbered benzyl-
protected iodonium salt furnished the coupled product in 46% yield. This result demonstrates that 
iodonium salts bearing secondary allylic ether motifs will react with homoallylic carbamates to give the 
corresponding carbonate in useful yields, thereby evidencing the viability of the proposed complex 
fragment coupling. Further, reducing the sterics of the iodonium salt appears to improve conversion. 
My colleague Dean Holt extended the model coupling studies to the use of acetonide-protected 
iodonium salt 485, designed to bear the relative stereochemistry and oxygenation pattern of the C-5,6,7 
portion of (–)-lyngbyaloside B (Scheme 96).186 Although no reaction with homoallylic carbamate 317 
was detected after 24 hours at –10 ºC, carbonates 486 and 487 were obtained in 21% combined yield 
after a further six hours of reaction time at room-temperature and with an additional portion of catalyst. 
The observed 1:1 diastereoselectivity was expected given the achiral nature of the homoallylic carbonate 
substrate. Despite the low yields, the production of carbonate products 486 and 487 proves that 
polyoxygenated and stereochemically-rich alkenyl(aryl)iodonium salts can be tolerated in our copper-
catalyed oxy-alkenylation reaction. This result provides crucial evidence for the likely tolerance of our 
desired complex iodonium salt 471 under the same reaction manifold. 
 
Scheme 96 – Model coupling between model substrate 317 and iodonium salt 485 – Dean Holt186 
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Efforts were next directed towards the synthesis of the key synthetic fragments. Dean Holt turned his 
attention towards the synthesis of homallylic carbamate 470, later investigated by Dominik Reich. The 
following work focuses on the synthesis of complex iodonium salt 471.  
3.5 First Generation Synthetic Strategy 
3.5.1. Synthetic strategy 
It was planned to generate iodonium salt 471 from parent alkyne 488 using the previously-described 
borylation, oxidative pinacol ester cleavage and iodonium salt formation sequence (see Table 30 above). 
The intermediate alkyne was to be accessed in two steps from aldehyde 489 by a diastereoselective 
Mukaiyama aldol reaction with dioxionone nucleophile 459 followed by benzyl protection of the 
resulting hydroxyl group (Scheme 97). Attention was therefore first turned to the production of 489. 
 
Scheme 97 –Retrosynthetic strategy to iodonium salt 471 from key aldehyde intermediate 489 
3.5.2. Generation of aldehyde 489 
In 2002, MacMillan described an enantioselective cross-aldol procedure using simple aldehydes as 
substrates and proline as a catalyst (Scheme 98).187 No pre-functionalisation of the reagents is required 
as the reaction is controlled by the donor and acceptor nature of the two different aldehyde components.  
 
Scheme 98 – MacMillan’s proline-catalysed cross-aldol187 
Matsumoto and Hayashi modified MacMillan’s organocatalytic chemistry for their synthesis of RQN-
18690A (499) (Scheme 99).188,189 In their studies, prolinol 495 was employed to catalyse an aldol union 
between 493 and 494. The resulting product then underwent an in situ Ando reaction to give enyne 496 
in high e.e. and d.r.. Subsequent synthetic manipulations gave tetrahydropyran western fragment 497, 
directly consumed in a Stille coupling with eastern fragment 498 to furnish the protected target.  
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Scheme 99 – Matsumoto and Hayashi’s synthesis of RQN-18690A 499; Ar = 3,5-(CF3)2-Ph189 
The above catalytic and enantioselective aldol reactions would provide a concise route towards target 
aldehyde 489. The coupling of propionaldehyde to propargylic aldehydes 500 and 501 was therefore 
tested using both MacMillan’s proline- and Hayashi’s prolinol-catalysed cross-aldol reactions (Table 32). 
However, despite significant efforts, it was disappointing to note that no desired product was observed 
with the use of MacMillan’s cross-aldol process (entries 1 and 2). Similarly, although Matsumoto and 
Hayashi’s conditions gave the observation of product formation (entry 3, 80% NMR yield, 10:1 d.r.), the 
resulting aldol adduct could not be isolated and decomposed with all efforts to protect the sensitive 
hydroxyl group. The instability of the product aldehyde explains why Matsumoto and Hayashi perform 
an Ando coupling without intermediate isolation. Such a strategy is not viable in our synthesis as the 
aldehyde functionality is required for the later Mukaiyama aldol reaction. 
 
Entry Aldehyde Conditions Yield / %a 
1187 500 
2.0 equiv. 493, 10 mol% 504 
DMF, 4 ºC, 20 h 
0 
2187 501 
2.0 equiv. 493, 10 mol% 504 
DMF, 4 ºC, 20 h 
0 
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3189 501 
1.5 equiv. 493, 20 mol% 495b 
1,4-dioxane/H2O (19:1), rt, 4 h 
80 (10:1 d.r.) 
unstable to isolation 
a yields determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate; b Ar = 3,5-(CF3)2-Ph 
Table 32 – Efforts towards the generation of aldehydes 502 and 503 by organocatalytic aldol processes  
Alternative methods were sought for the enantioselective generation of the desired 1,2-anti configured 
aldehyde 489. Attention was turned towards the use of an anti-crotylation and alkene oxidation strategy 
(Scheme 100). 
 
Scheme 100 – Crotylation/oxidation strategy towards aldehyde 489 
Krische has recently reported a versatile anti-diastereoselective iridium-catalysed transfer hydrogenation 
crotylation procedure, employed to generate a wide range of crotylated adducts from the combination 
of crotyl acetate (506) and primary alcohols (Scheme 101).190 This methodology, together with a milder 
procedure employing pre-formed iridium catalyst 513,191 was tested for the crotylation of propargylic 
alcohols 509 and 510 (Table 33). Disappointingly, no desired product formation was detected in any 
reaction. It was concluded that the Krische methodologies will not tolerate these propargylic alcohols as 
substrate, possibly due to catalyst poisoning. 
 
Scheme 101 – Krische’s iridium-catalysed transfer-hydrogenation crotylation procedure190 
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Entry Alcohol Conditions Yield / % 
1190 509 
2.5 mol% [Ir(cod)Cl]2, 5 mol% (R)-SegPhos 
10 mol% 4-CN-3-NO2BzOH, 20 mol% CsCO3 
THF, 90 ºC, 48 h 
0 
2190 510 
2.5 mol% [Ir(cod)Cl]2, 5 mol% (R)-SegPhos 
10 mol% 4-CN-3-NO2BzOH, 20 mol% CsCO3 
THF, 90 ºC, 48 h 
0 
3191 509 
5 mol% 513, 50 mol% K3PO4, 5 equiv. H2O 
THF, 60 ºC, 48 h 
0 
4191 510 
5 mol% 513, 50 mol% K3PO4, 5 equiv. H2O 
THF, 60 ºC, 48 h 
0 
Table 33 – Attempts to generate crotylated species 511 and 512 using Krische’s methodologies 
Efforts were next directed towards the crotylation of propargyl aldehyde 500 using stoichiometric boron 
reagents (Table 34). Brown crotylation (entry 1), using an in situ-formed di-iso-pinocamphenylborane 
reagent, gave low yields of the desired product and only moderate levels of diastereoselectivity but 
provided very good levels of e.e..192 The low yield can be attributed to the desilylation of 511 to alcohol 
514, observed to form an azeotrope with the reaction solvent. Disappointingly, efforts to collect this 
product by distillation were unsuccessful. Gratifyingly, use of Roush’s crotylation method (entry 2) gave 
the desired product 511 in 86% yield, excellent diastereoselectivity and good enantioselectivity.193 The 
lack of product desilylation is attributed to the milder work-up conditions required with the di-iso-propyl 
tartrate boronic ester. Although crotyl alcohol 511 has been reported previously, there is disagreement 
in the literature regarding the sign of the optical rotation.192,194 Mosher ester analysis was therefore 
carried out, confirming the product to be the desired R,R-isomer and supporting Hall’s configurational 
assignment.194 7.6 g of crotyl alcohol 511 was produced for further studies using Roush’s method. 
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Entry Conditions Result 
1192  
17.5 mmol 
excess trans-butene, 2.0 equiv. KOt-Bu, 2.0 n-BuLi 
2.0 equiv. MeOB((+)-ipc)2, THF, –78 ºC to –40 ºC to –78 ºC, 30 min 
then: 1.0 equiv. 500, 2.0 equiv. BF3•OEt2, THF, –78 ºC, 2 h 
then: MeOH, –78 ºC to rt 
then: NaBO3•(H2O)4, THF/H2O (2:1), 18 h, 18 h 
15% yield 
11:1 d.r. 
88% e.e. 
2193 
48.7 mmol 
1.0 equiv. 500, 1.2 equiv. 515 
4 Å MS, PhMe, –78 ºC 
then: NaOH (2M aq.), –78 ºC to rt 
86% yield 
>20:1 d.r. 
75% e.e. 
Table 34 – Crotylation of aldehyde 500 with stoichiometric boron reagents 
Attention was then focused on the benzyl-protection of secondary alcohol 511, first attempted with 
Garcia’s propargylic alcohol benzylation conditions using sodium hydride, benzyl bromide and catalytic 
tetrabutylammonium iodide (Scheme 102).195 Interestingly, no product 516 was formed from this 
reaction, with it instead observed that desilylated ene-yne-ol 517 was produced in 42% yield. As the 
synthetic plan ultimately requires the removal of the terminal silyl group, this result was not considered 
disadvantageous. However, the overall yield of the transformation was clearly too low to be synthetically 
useful and required optimisation.  
 
Scheme 102 – Attempted direct benzylation of enyne 511 
The limited yields of the above reaction were attributed to the transfer of the trimethylsilyl groups from 
the alkynes to the in situ-generated oxy-anions, blocking oxygen benzylation and leading to starting 
material decomposition. As such, a two-step procedure to first desilylate the alkyne and then benzylate 
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the alcohol was tested. Though this benzylation strategy gave a superior yield to the previous experiment, 
it was still lower than was desired (Scheme 103). 
 
Scheme 103 – Two-step deprotection/protection of 511 to give 517 (3 mmol scale) 
Both the volatility of intermediate alcohol 514 and the removal of the excess benzyl bromide from the 
crude product mixture were considered to be the major causes of the low yield of the benzylation process. 
Efforts were therefore directed towards the isolation the intermediate alcohol and the use of reaction 
conditions employing reduced equivalents of benzylating reagent (Table 35). Pleasingly, volatile alcohol 
514 could be isolated in 72% yield on a large scale by careful kugelrohr distillation. A subsequent 
benzylation reaction employing 1.4 equivalents of benzyl bromide and using sodium hydride as a base 
gave 71% yield of the desired product (entry 1). However, although both yields in this reaction sequence 
are good, the two-step yield was reduced relative to the previous conditions. Pleasingly, it was observed 
that use of sodium hydroxide (entry 2) gave significantly improved product yields (87%, 63% over two 
steps). Up to 2.4 g of benzyl ether 517 was synthesised in a single batch using this latter method. 
 
Entry Conditions Yield / %a 
1196 
5 mmol 
1.2 equiv. NaH, 10 mol% TBAI, 1.4 equiv. BnBr 
THF, rt, 18 h 
71  
(51% over two steps) 
2197 
5 mmol 
1.3 equiv. BnBr, 5 mol% TBAI, 4 equiv. NaOH 
H2O, rt, 18 h 
87 
(63% over two steps) 
Table 35 – Assay of benzylation conditions employed reduced equivalents of benzyl bromide 
A two-operation dihydroxylation/oxidative cleavage method was chosen to transform alkene 517 into 
the desired aldehyde. Using Curran’s reported method, the alkene substrate was dihydroxylated with 
catalytic osmium tetroxide and one equivalent of NMO. Meta-periodic acid was added to the reaction 
mixture after 16 hours to oxidatively cleave the crude diol,192 initially giving a poor (41%) product yield 
and high levels of stereochemical erosion (3:1 d.r.) (Table 36, entry 1). On repeating the reaction, it was 
Me
OH
SiMe3
511
Me
OH
514
10 equiv. K2CO3
MeOH (0.2 M), rt, 15 mins Me
OBn
517
1.3 equiv. NaH
10 mol% TBAI
2.2 equiv. BnBr
THF/DMF (3:1), rt, 18 h
57%not isolated
Me
OH
SiMe3
511
Me
OH
514
10 equiv. K2CO3
MeOH (0.2 M), rt, 15 min Me
OBn
517
72 % (29 mmol)
conditions
Studies Towards the Total Synthesis of (–)-Lyngbyaloside B 
 96 
observed that improved yields and reduced C-2 epimerisation could be achieved by concentrating the 
crude aldehyde at 0 ºC following work-up (52% yield, 7:1 d.r., entry 2). Likewise, use of periodic acid 
rather than meta-periodic acid (entry 3) led to further improvements in both yield and d.r. (71%, 9:1, 
entry 3). Finally, it was discovered that a two-step procedure employing silica-supported sodium meta-
periodate allowed the production of the desired aldehyde in very good yields and with minimal loss of 
stereochemical integrity (80%, >20:1 d.r., entry 4).198 The configurationally-unstable aldehyde 518 was 
directly consumed following production. 
 
Entry Conditions Work-up Resulta 
1192 
1.5 mol% OsO4, 1 equiv. NMO 
 Me2CO/H2O (8:1), rt, 16 h  
then: 1.5 equiv. HIO4, 0 ºC, 0.5 h 
Na2S2O3 (sat. aq.) 
EtOAc extract 
concentrate at rt 
41% 
 (3:1 d.r.) 
2 
1.5 mol% OsO4, 1 equiv. NMO 
Me2CO/H2O (8:1), 0 ºC to rt, 16 h 
then: 1.5 equiv. HIO4, 0 ºC, 0.5 h 
Na2S2O3 (sat. aq.) 
EtOAc extract 
concentrate at 0 ºC 
52%  
(7:1 d.r.) 
3 
1.5 mol% OsO4, 1 equiv. NMO 
 Me2CO/H2O (8:1), 0 ºC to rt, 16 h 
then: 1.5 equiv. H5IO6, 0 ºC, 0.5 h 
Na2S2O3 (sat. aq.) 
EtOAc extract 
concentrate at 0 ºC 
71%  
(9:1 d.r.) 
4198 
1. 0.4 mol% OsO4, 4 equiv. NMO 
THF/H2O (4:3), rt, 168 h 
2. NaIO4•SiO2, CH2Cl2b 
Na2S2O3 (sat. aq.) 
EtOAc extract 
concentrate at 0 ºC 
80%  
(>20:1 d.r.) 
a yields and diastereomeric ratios determined on isolation; b work-up performed between steps 1 and 2. 
Table 36 – Assay of dihydroxylation/periodate cleavage conditions 
3.5.3. Efforts towards iodonium salt 471 
Dioxinone-derived vinylogous enol silane 459 was prepared (Scheme 104a),199 and was then directly 
coupled to aldehyde 518 with treatment of the reaction mixture with boron trifluoride diethyl etherate 
at –95 ºC (Scheme 104b).178 When performed on an initial 1.0 mmol scale, this aldol reaction gave the 
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conditions
>20:1 d.r.
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desired product in an excellent 91% yield and in a synthetically useful 5:1 d.r.. Reproducing the reaction 
on a 4.0 mmol scale gave 89% product formation with the same diastereoselectivity. A pleasing 76% 
isolated yield of diastereopure isomer 520 was achieved following chromatographic purification of the 
larger-scale reaction. 
 
Scheme 104 – a) Synthesis of nucleophile 459;199 b) Synthesis of aldol adduct 520 by a vinylogous Mukaiyama 
aldol reaction with aldehyde 518 and nucleophile 459. 
Work next focused on the benzyl protection of aldol-derived secondary alcohol 520. Four distinct 
benzylation conditions were tested to effect this transformation (Table 37). Disappointingly, 
decomposition was observed on exposure of 520 to classical benzylation conditions, Groth’s benzyl 
trichloroacetamidate method and Dudley’s pyridinium salt methodology (entries 1–3).196,200,201 However, 
conversion to the desired product was observed with the use of Kunishima’s acid catalysed benzylation 
using TriBOT (523) (entry 4, 18% yield by NMR after 5 h). Disappointingly, further extending the 
reaction time to 22 hours gave only a moderate improvement in yield (25%) with no starting material 
remaining (entry 5).  
 
Entry Conditions Result 
1196 
1.2 equiv. NaH, 10 mol% TBAI, 1.4 equiv. BnBr 
DMF, 0 ºC to rt, 18 h 
520 
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1.4 equiv. Me3SiCl
80%
Me
OBn
518
H
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2200 
1.5 equiv. BnOTCA, 20 mol% TMSOTf 
CH2Cl2, 0 ºC to rt, 24 h 
520 
decomposition 
3201 
2 equiv. 522, 2 equiv. MgO 
PhCF3, 83 ºC, 24 h 
520 
decomposition 
4202 
0.4 equiv. TriBOT (523), 5 Å MS, 0.2 equiv. TfOH 
1,4,-dioxane, rt, 5 h 
18% yielda 
5202 
0.4 equiv. TriBOT (523), 5 Å MS, 0.2 equiv. TfOH 
1,4,-dioxane, rt, 22 h 
25% yield 
a determined by 1H NMR using 1,3,5-trimethoxybenzenetricarboxylate 
Table 37 – Assay of benzylation conditions  
As no benzylation conditions could be identified that gave good yields of the desired product 521, 
alternative alcohol protecting groups were evaluated. Use of a benzylidene acetal was considered 
advantageous as no modification to our original synthetic strategy would be required as such a group 
could be removed by hydrogenation.203 In line with Oikawa’s method for the generation of PMB 
acetals,204 it was thought that the benzylidene acetal could be produced by intramolecular reaction of 
the secondary alcohol with the previously-installed benzyl group. Compound 521 was therefore oxidised 
with DDQ under anhydrous conditions to give 40% conversion to the acetal product after 24 hours 
(Scheme 105). Unfortunately, attempting to improve conversion by increasing the reaction temperature 
(70 ºC, 1,2-dichlorethane) resulted in complete decomposition of the starting material and gave no 
further product formation. Moreover, it was disappointing to note that these reactions both gave a 1:1 
ratio of diastereoisomers 524 and 525, precluding the use of the benzylidene acetal protection strategy 
in our synthetic route.  
 
Scheme 105 – Formation of benzylidene acetals 524 and 525 
The use of silyl protecting groups were next investigated (Scheme 106). Efforts to TBS protect the 
secondary alcohol furnished the corresponding silylated product in low yield (9%), likely due to the 
sterically demanding substrate/reagent combination. However, treatment of alcohol 520 with 3 
equivalents of triethylsilyl chloride and 4 equivalents of imidazole gave the desired TES-protected 
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product in 85% yield, demonstrating that this sterically constrained substrate can be protected with some 
silyl groups.  
 
Scheme 106 – Silyl protection of 520 
It was recognised that the use of a mixed silyl-/benzyl-protected system would require inelegant 
functional group manipulations later in the synthesis. The synthetic strategy was therefore re-evaluated. 
3.6 Second Generation Synthetic Strategy 
As it was shown that triethylsilyl groups, unlike benzyl groups, may be installed to protect sterically-
demanding secondary alcohols, efforts next focused on the synthesis of bis-silylated iodonium salt 531 
(Scheme 107). Advantageously, this modification would avoid the need to re-protect the secondary 
alcohols of 530 following hydrogenation of fragment-coupled linear precursor 529. 
 
Scheme 107 – Proposed retrosynthesis from intermediate 528 to the key fragment union step 
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3.6.1. Initial studies 
To minimise the consumption of valuable advanced intermediates, initial studies focused on the 
generation of model alkenyl(aryl)iodonium salts for the desired fragment 531. The tolerance of 
triethylsilyl-protected model substrate 532 to the alkyne borylation/oxidation procedure was first tested 
(Scheme 108). Disappointingly, complete starting material decomposition was observed following 
oxidative hydrolysis, indicating such a route to be unsuitable for our synthetic strategy. 
 
Scheme 108 – Test borylation on model silane 532  
It was considered that Stang’s procedure for the synthesis of iodonium salts from vinyl stannanes may 
provide an effective alternative route to fragment iodonium salt 531.205 Model benzyl/triethylsilyl alkyne 
527 was accordingly hydrostannylated using a sterically-demanding palladium catalyst to give the 
desired E-vinyl stannane in 72% yield and complete regio- and diastereoselectivity (Scheme 109).206 
 
Scheme 109 – Hydrostannylation of alkyne 527 
Stang’s cyanated iodane precursor 535 was then prepared and mixed with stannane 534. 
Disappointingly no formation of the corresponding iodonium salt was observed (Scheme 110).205 LCMS 
analysis indicated that both benzyl and silyl protecting groups were lost under the reaction conditions, 
possibly due to attack by the cyanide group of precursor 535.  
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Scheme 110 – Attempted conversion of 534 to iodonium salt 536 
It was questioned whether Stang’s procedure for the generation of iodane 535 (Scheme 111a) could be 
modified to furnish alkenyl(aryl)iodonium salts directly from PIFA and a vinyl stannane (Scheme 111b). 
Benzyl-substituted vinyl-stannane 540 was synthesised to test the viability of this one-pot iodonium salt-
formation strategy (Scheme 112a), chosen as it was anticipated that a benzyl group would be more stable 
than a triethylsilyl group under Lewis acidic conditions. Gratifyingly, it was observed that adding 
stannane 540 at –40 ºC to a pre-mixed solution of PIFA and TMSOTf led to the production of the 
desired alkenyl(phenyl)iodonium salt 541 in 80% isolated yield (Scheme 112b).  
 
Scheme 111 – a) Synthesis of Stang’s iodonium precursor; b) application to a one-pot iodonium salt formation 
reaction from PIFA (537) 
 
Scheme 112 – a) Synthesis of vinyl-stannane 540; b) conversion to iodonium salt 541 
The same method for alkenyl(aryl)iodonium salt generation was next applied to the synthesis of TES-
protected iodane 543 (Table 38). Disappointingly, initial exposure of stannane 542 to the mixture of 
PIFA and trimethylsilyl triflate gave a 5:1 crude ratio of the desilylated iodonium salt 544 to the desired 
product (entry 1). Pleasingly, production of 543 could be biased with the use of triethylsilyl triflate as the 
Lewis acidic promoter (entry 2, 82:18 ratio of 543 to 544).  
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Entry Conditions 
Ratio / %a 
543 544 542 
1b 
1. 1.0 equiv. TMSOTf, CH2Cl2, –40 ºC to rt 
2. 1.0 equiv. 542, CH2Cl2, –40 ºC to rt 
17 83 0 
2c 
1. 1.0 equiv. TESOTf, CH2Cl2, –40 ºC to rt 
2. 1.0 equiv. 542, CH2Cl2, –40 ºC to rt 
82 18 0 
a calculated from crude 1H NMR; b 1H NMR yield determined using 1,3,5-trimethoxybenzenetricarboxylate as 
74% 544 and 15% desired 543; c 12% 543 was isolated by silica column chromatography. 
Table 38 – Formation of iodonium salt 543 
Formation of the fragment-like mixed benzyl/triethylsilyl protected iodonium salt 536 was next 
surveyed (Table 39). Whilst the combination of PIFA and TESOTf with stannane 534 (entry 1) gave 
full conversion of the starting material, the presence of desilylated iodonium salt 545 as the major 
product was observed, attributed to the presence of acid in the reaction mixture. The reaction was 
therefore next performed in the presence of anhydrous sodium carbonate to neutralise any effects of acid 
formation. Use of this base gave 35% conversion to 536 with no apparent decomposition to the 
desilylated analogue (entry 2). Increasing the equivalents of the reagents (1.2 equiv., entry 3) gave 
increased production of 536 (45%) with only traces of desilylation. Finally, increasing the reagent 
equivalents further (3 equiv. TESOTf and PIFA) whilst maintaining excess base (15 equiv.) led to 70% 
conversion to the desired product with 30% 545 (entry 4). Chromatographic purification of this latter 
product mixture led to the isolation of only 8% 536, indicating purification to be problematic despite 
the neutralisation of the reaction mixture with sodium carbonate. With the insight gathered so far, it was 
decided that the problem of iodonium salt instability should be addressed during investigations into the 
formation of the desired bis-silylated iodonium fragment 531.  
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Entry Conditions 
Ratio / %a 
536 545 534 
1 
1. 1.0 equiv. PIFA and TESOTf 
CH2Cl2, –40 ºC to rt 
2. 1.0 equiv. 534, CH2Cl2, –40 ºC to rt 
25 75 0 
2 
1. 1.0 equiv. PIFA and TESOTf, 5.0 equiv. Na2CO3 
CH2Cl2, 0 ºC to rt 
2. 1.0 equiv. 534, CH2Cl2, –78 ºC to rt 
35 0 65 
3 
1. 1.2 equiv. PIFA and TESOTf, 6.0 equiv. Na2CO3 
CH2Cl2, 0 ºC to rt 
2. 1.0 equiv. 534, CH2Cl2, –78 ºC to rt 
45 3 52 
4b 
1. 3.0 equiv. PIFA and TESOTf, 15 equiv. Na2CO3 
CH2Cl2, 0 ºC to rt 
2. 1.0 equiv. 534, CH2Cl2, –78 ºC to rt 
70 30 0 
a calculated from crude 1H NMR; b 8% 536 was isolated following silica column chromatography. 
Table 39 – Formation conditions for iodonium salt 536 
3.6.2. Forwards synthesis 
As a result of the studies outlined in sections 3.5.3 and 3.6.1, the synthetic strategy was amended both 
to utilise triethylsilyl protecting groups and to employ a vinyl stannane as the nucleophilic precursor to 
the iodonium salt (Scheme 113). 
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Scheme 113 – Second-generation retrosynthetic analysis to 531 
Vinyl stannane 546 was generated in five synthetic steps from crotylated alcohol 514 (Scheme 114). 
Protection of 514 using TESCl and imidazole furnished the desired triethylsilyl ether 550 in 71% yield. 
The alkene group then underwent an osmium-catalysed dihydroxylation over three days before 
exposure to solid-supported sodium periodate, giving aldehyde 549 in 79% yield and with excellent 
retention of the α-stereochemistry. The aldehyde was directly exposed to a vinylogous Mukaiyama aldol 
reaction with dioxinone nucleophile 459 to give the desired aldol adduct in 94% yield and in 5:1 d.r.. 
Purification yielded the desired diastereomerically pure product 548 in 77% yield. A subsequent TES 
protection of the secondary alcohol was carried out to give 547 in an excellent 96% yield. Finally, the 
alkyne of 547 underwent a diastereo- and regioselective hydrostannylation using a palladium catalyst to 
furnish the target alkenyl-tin compound 546 in 80% yield.  
  
Scheme 114 – Forward synthesis of vinyl stannane 546 from alcohol 514 
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With stannane 546 in hand, investigations proceeded to the generation of the desired bis-triethylsilyl 
substituted iodonium salt 531 (Table 40). Although high levels of starting material conversion to the 
desired product (84%) were observed on exposure of the stannane to a solution of excess PIFA, TESOTf 
and sodium carbonate (entry 1), all efforts to isolate the resulting iodonium salt were unsuccessful. It was 
considered that the iodonium salt may desilylate when separated from the insoluble base as any acid 
formed would no longer be neutralised. The reaction was therefore performed with the use of the non-
nucleophilic and soluble base di-tert-butyl pyridine (DTBP) (entry 2), ultimately allowing 38% product 
to be isolated for the first time as a mixture with the pyridine base.  
 
Entry Conditions 
Ratio / %a,b 
531 546 
1 
1. 3.0 equiv. PIFA and TESOTf, 15 equiv. Na2CO3 
CH2Cl2, 0 ºC to rt 
2. 1.0 equiv. 546, CH2Cl2, –78 ºC to rt 
84 (0) - 
2 
1. 4.0 equiv. PIFA, TESOTf and DTBP 
CH2Cl2, 0 ºC to rt 
2. 1.0 equiv. 546, CH2Cl2, –78 ºC to rt 
86 (38) - 
a calculated from crude 1H NMR; b bracketed quantity denotes isolated yield following chromatography 
Table 40 – Formation conditions for iodonium salt 531 
It was hoped that the use of an intermediate aqueous work-up prior to chromatographic purification of 
the iodonium salt would slow any acid-catalysed decomposition processes by removal of acid into the 
aqueous phase (Table 41, entries 1–3). Disappointingly, quenching the reaction with saturated sodium 
bicarbonate solution (entry 2) gave 20% eliminated alkyne 547 and a 60% NMR yield of the desired 
product, lower than the 80% yield recorded for the control reaction (no work-up, entry 1). However, it 
was gratifying to observe that quenching with water (entry 3) furnished improved iodonium salt stability 
in NMR solvent and gave only a marginally reduced 78% NMR yield.  
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Next investigating reagent equivalents, it was observed that superior product yields could be achieved 
with three equivalents each of PIFA, DTBP and TESOTf (85% yield following extraction, entry 4). 
Reduced yields and incomplete starting material conversions were observed with lower reagent 
equivalencies (entries 5 and 6). Finally, attempts were made to isolate the desired complex iodonium 
fragment by chromatographic purification. Although alumina chromatography (entry 7) was observed 
to give poor iodonium salt recovery, we were delighted to note that isolation of the iodonium salt could 
be achieved from silica, giving the desired salt in a very good 76% yield (entry 8). However, it was 
disappointing to observe that even purified iodonium salt 531 rapidly decomposes on standing. 
 
Entry 
Equivs. PIFA, 
DTBP and TESOTf 
Scale / μmol Purificationa Yield 531 / %b 
1 4.0 10 - 80 
2 4.0 10 NaHCO3/CH2Cl2 60 (20% 547) 
3 4.0 20 H2O/CH2Cl2 78 
4 3.0 10 H2O/CH2Cl2 85 
5 2.0 10 H2O/CH2Cl2 75 
6c 1.0 10 H2O/CH2Cl2 17 
7d 3.0 50 
H2O/CH2Cl2 
Al2O3 column 
85 (14) 
8 3.0 50 
H2O/CH2Cl2 
SiO2 column 
89 (76) 
a Work up conditions with chromatographic solid phase given if applicable; b yield determined by 1H NMR using 
1,3,5-trimethoxybenzenetricarboxylate, bracketed quantity indicates isolated yield; c 55% starting material 546 
observed by 1H NMR; d 7% alkyne 547 co-eluted with product  
Table 41 – Further optimisation of formation conditions for iodonium salt 531 
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Despite the instability, iodonium salt 531 was tested in a model copper-catalysed oxy-alkenylation 
process with substrate 317 (Scheme 115). Although there was no apparent evidence for the conversion 
of the starting materials to the desired coupled product 551, tricylic product 552 was observed and was 
obtained in 24% isolated yield with respect to the introduced iodonium salt. A proposed acid-catalysed 
mechanism for the formation of this tricycle from monodesilylated adduct 553 is outlined below (Scheme 
116). 
 
Scheme 115 – Attempted coupling of model substrate 317 and iodonium salt 531 
 
Scheme 116 – Proposed mechanism for the generation of cyclised product 552 
The coupling of model substrate 317 to iodonium salt 531, used directly following work-up of the 
iodonium salt, was next tested. It was anticipated that the presence of residual DTBP would preclude 
the formation of tricycle 552 by removing acid from the system (Scheme 117). Disappointingly, only the 
production of alkyne 547 was observed from the crude product mixture, presumed to be generated 
through the syn-elimination of the iodonium salt (Scheme 118). 
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Scheme 117 – Proposed two-step iodonium salt formation copper-catalysed alkene oxy-alkenylation 
 
Scheme 118 – Proposed syn-elimination of 531  
The studies discussed in this section indicate iodonium salt 531 to undergo decomposition processes 
faster than fragment coupling. Furthermore, the triethylsilyl groups of this iodonium salt appear to be 
particularly vulnerable to deprotection. As Dean Holt previously has showed that acetonides can be 
tolerated under oxy-alkenylation conditions (Scheme 96, page 89),186 attention was next turned to the use 
of this protecting group in our synthetic route. The strategy was accordingly modified towards the 
coupling of homoallylic carbonate southern fragment 470 to an acetonide-protected iodonium salt such 
as 558 (Scheme 119).  
 
Scheme 119 – Third generation iodonium salt 558 for coupling to southern fragment 470 
3.7 Third Generation Synthetic Strategy 
3.7.1. Synthesis of vinyl stannane 560 
It was planned to access acetonide-protected iodonium salt 558 from vinyl stannane 560 (Figure 11). 
Although it was thought that this key stannane could be accessed by modifying the route detailed in 
section 3.5.3, efforts were first directed towards the attempted development of synthetic routes that were 
thought to provide higher-yielding and more rapid access to the advanced alkenyl-tin intermediate.  
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Figure 11 – Target vinyl stannane 560 
3.7.1.1 Crotylation of stannylated substrates 
Seeking to avoid the need for alkyne desilylation and a late-stage hydrostannylation, it was questioned 
whether a vinyl-stannane functionality may be carried through our synthesis. As allylic alcohols are 
tolerated under Krische’s crotylation process,190 stannylated alcohol 561 underwent iridium-catalysed 
transfer hydrogenation to furnish the crotylated product 562 in 18% yield, 7:1 d.r. and 18% e.e. (Scheme 
120).  
 
Scheme 120 – Krische crotylation of stannylated allylic alcohol 561 
Despite the low yield and enantioenrichment obtained using Krische’s methodology, efforts were made 
to silyl protect and dihydroxylate the crotylated product. Disappointingly, although treatment of alcohol 
561 with triethylsilyl triflate gave the TES-protected product 563 in good yield, dihydroxylation with 
osmium tetroxide led to complete starting material decomposition (Scheme 121). Introduction of the 
vinyl stannane functionality at an early stage in the synthesis was therefore not pursued further. 
 
Scheme 121 – TES protection and attempted dihydroxylation of crotylated product 562 
3.7.1.2 Alternative silyl protection 
Returning to the original crotylation strategy, it was thought that tri-iso-propylsilyl protection of the 
secondary alcohol 511 would allow for the removal of the acetylenic trimethylsilyl group without the 
danger of product volatility. Further, it was considered that the increased steric bulk of the protecting 
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group may provide improved diastereoselectivity for the later vinylogous Mukaiyama aldol reaction. 
This was thought as, by evaluating aldehyde 567, it can be seen that both 1,2- (Felkin-Anh) and 1,3- 
(Evans) models reinforce the desired stereochemical outcome of the vinylogous Mukaiyama aldol 
reaction.207 Crotyl alcohol 511 was therefore reacted with TIPSOTf to furnish the corresponding tri-
iso-propylsilylether 565 in 97% yield (Scheme 122). As predicted, treatment of 565 with potassium 
carbonate in methanol gave the corresponding monosilylated enyne product in an excellent 92% yield 
with easy product recovery. Alkene 566 then underwent the previously-developed osmium-catalysed 
dihydroxylation/periodate cleavage sequence to generate aldehyde 567 in 77% yield and with minimal 
α-epimerisation. However, despite the observation of a high yield, the addition of dioxinone nucleophile 
459 to the aldehyde furnished the desired aldol adduct in only 3:1 d.r., too low to be synthetically useful.  
 
Scheme 122 – Investigation into the use of TIPS alcohol protection in the early steps of the synthesis  
It was next thought that by installing a bulky acetylenic group on aldehyde 567, the reactive 
conformation leading to the minor Mukiyama aldol product would be further disfavoured, thereby 
giving improved diastereoselectivity (Figure 12). A TIPS group was chosen as the bulky group as, should 
the strategy be successful, the total synthesis could instead begin with the tri-iso-propylsilyl substituted 
propargyl aldehyde.  
 
Figure 12 – Stereochemical prediction of Mukaiyama aldol selectivity 
TIPS bearing aldehyde 570 was prepared from 566 by an acetylenic tri-iso-propylsilylation, an alkene 
dihydroxylation and an oxidative cleavage in 82% overall yield (Scheme 123a). Aldehyde 570 then 
underwent reaction with nucleophile 459 to furnish Mukaiyama aldol adduct 571 in 89% yield and in 
an improved but inseparable 5:1 d.r. (Scheme 123b).  
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Scheme 123 – a) Generation of aldehyde 530 and b) Mukaiyama aldol reaction toward aldol adduct 571 
Attempts were next made to remove the two tri-iso-propylsilyl groups from 571. It was considered that 
diol 572 could then be converted to the acetonide-protected alkyne required for synthesis of vinyl 
stannane 560. Disappointingly, all efforts to deprotect 571 with TBAF led to either starting material 
decomposition or the formation of only mono-deprotected derivative 573 (Table 42).208 Owing to this 
challenging desilylation, no further investigations were carried out towards the generation of vinyl 
stannane 560 using TIPS groups as either acetylenic or alcoholic protecting groups. 
 
Entry Conditions 
Yield / %a 
572 573 571 
1b 2.4 equiv TBAF•3H2O, THF, 0 ºC, 1 h 0 80 0 
2c 2.4 equiv TBAF•3H2O, THF, 0 ºC, 2 h 0 45 0 
3 2.2 equiv TBAF (1M in THF), THF, 0 ºC to rt, 18 h 0 0 0 
4 2.2 equiv TBAF (1M in THF), THF/H2O, 0 ºC to rt, 72 h 0 70 0 
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5 4.0 equiv TBAF (1M in THF), THF/H2O, 0 ºC to rt, 192 h 0 44 0 
a yield determined by 1H NMR using mesitylene as an internal standard; b using 1,3,5-
trimethoxybenzenetricarboxylate; c isolated yield 
Table 42 – Unsuccessful attempts to deprotect aldol adduct 571 
3.7.1.3 Desilylation of intermediate 547 
Following the unsuccessful explorations of alternative synthetic routes to vinyl stannane 560, efforts were 
directed towards the production the key stannane from TES-protected advanced intermediate 547. To 
this end, alkyne 547 was treated with TFA to give intermediate diol 572 in an excellent 90% yield.209 
The diol product was then reacted with 2,2-dimethoxypropane in the presence of an acid catalyst to give 
acetonide-protected alkyne 574 in 87% yield (Scheme 124).210 
 
Scheme 124 – Generation of acetal-protected alkyne 574 
Alkyne 574 was then hydrostannylated using a sterically-demanding palladium catalyst to afford the 
vinyl stannane 560 in 78% yield and complete diastereoselectivity (Scheme 125). However, it was 
disappointing to note that the alkenyl-tin compound was produced in an inseparable 8:1 mixture of 
regioisomers, attributable to the relatively low steric demands of the acetonide group. Further, product 
560 was observed to undergo homodimerisation with a half-life of approximately one week. The vinyl 
stannane was therefore used in the subsequent iodonium salt formation shortly following its production. 
 
Scheme 125 – Hydrostannylation of terminal alkyne 574 to furnish vinyl stannane 560 
3.7.2. Formation of iodonium salt 558 
Previous work within the Gaunt group has demonstrated that only terminal vinyl stannanes can be 
converted to iodonium salts.186 As such, the regioisomeric mixture of 560 was directly exposed to a 
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mixture of ortho-tolyliodoniumditrifluoroacetate 576 and TMSOTf to give a 90% crude yield of 
iodonium salt 577 (Scheme 126). Disappointingly, despite using an ortho-tolyl group to increase the 
iodane stability, only 40% product could be isolated following purification. Moreover, the iodonium salt 
was found to rearrange to tricylic adduct 552 on standing in NMR solvent. Residual acid formed during 
the reaction was suspected to catalyse this cyclisation process. 
 
Scheme 126 – Formation and decomposition of iodonium salt 577 
It was anticipated that Stang’s method for the generation of iodonium salts would preclude the formation 
of cyclised product 552 as no Lewis acid is present in the reaction.205 Gratifyingly, reaction of vinyl 
stannane 560 with cyanated iodane 535 led to the formation of the desired iodonium salt 558 in a good 
yields following chromatographic purification (Scheme 127). Furthermore, 558 could be precipitated 
on treatment with hexanes to enable storage of the iodonium salt at –18 ºC. To the best of our 
knowledge, 558 represents the most complex alkenyl iodonium salt synthesised to date.  
 
Scheme 127 – Formation of iodonium salt 558 by Stang’s method205 
3.7.3. Southern fragment synthesis (Dean Holt and Dominik Reich) 
Dean Holt and Dominik Reich worked together to develop the following synthesis of southern fragment 
470 (Scheme 128).186,211 Starting from (R)-epichlorohydrin 578, a copper(I) catalysed epoxide ring-
opening with isopropenylmagnesium bromide furnished secondary alcohol 579 in an excellent 90% 
yield.212 Subsequent treatment with 1,1-carbonyldiimidazole (CDI) and dimethylamine gave 
homoallylic carbamate 580 in 94% yield.158 580 then underwent a copper-catalysed oxy-alkenylation 
reaction with propenyl iodonium salt 581 to furnish homoallylic carbonate 582 in an excellent 90% 
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yield but in a low 2.8:1 d.r.. Although extensive investigations towards improving this reaction were 
carried out by Dominik Reich, no significant improvement in diastereoselectivity was observed.211 
Pleasingly, the product diastereoisomers formed in the oxy-alkenylation of 580 were found to be 
separable, allowing isolation of the desired syn-configured product. Carbonate 582 then underwent 
decarboxylation, induced by C–Cl bond reduction, to give an intermediate volatile alcohol that was 
directly carbamylated to furnish homoallylic carbamate 583 in 78% yield over three steps. Finally, a 
hydroboration/oxidation sequence was carried out on the terminal alkene portion of 583 with the 
resulting primary alcohol then TBDPS protected to give the southern fragment in 55% yield over two 
steps. 
 
Scheme 128 – Synthesis of southern fragment 470 – Dominik Reich211 
3.7.4. Coupling studies 
Finally, attention was turned towards the copper-catalysed coupling of our complex fragments to form 
the desired precursor to (–)-lyngbyaloside B. The conditions developed by Dean Holt (Scheme 65, page 
41) were first applied towards this key fragment union, but were observed to give decomposition of the 
iodonium salt with no apparent coupling to the desired product (Table 43, entry 1). Interestingly, diene 
584 was recovered in 32% yield from the reaction mixture, presumably formed via the elimination of 
the carbamoyl group from substrate 470. The identity of this product was confirmed by a de novo 
synthesis (Scheme 129). Secondly, due to uncertainty over the reliability of the (CuOTf)2•PhH, the 
catalytic combination of copper(I) iodide and silver triflate was tested for the desired oxy-alkenylation 
(entry 2). In addition to the production of diene 584, this reaction gave a 47% crude yield of tricycle 
552 but still produced no desired product. Sodium carbonate was then added to the reaction mixture in 
order to prevent the acid-mediated cyclisation. This reaction unfortunately led to the elimination of the 
iodonium salt and no starting material conversion (entry 3). 
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Entry Conditions 
Yield / % 
470 584 574 552 
1 
5 mol% (CuOTf)2•PhH 
CH2Cl2 (0.05 M), rt, 3 h 
0 32 0 tr 
2a 
10 mol% CuI, 10 mol% AgOTf 
CH2Cl2 (0.05 M), rt, 24 h 
0 40 0 47 
3a 
10 mol% CuI, 10 mol% AgOTf, 1.5 equiv. K2CO3 
CH2Cl2 (0.05 M), rt, 5 h 
100 0 94 0 
a yield determined by 1H NMR with 1,3,5-trimethoxybenzenetricarboxylate as internal standard 
Table 43 – Initial attempts to couple fragments 470 and 558  
 
Scheme 129 – Formation of diene 584 via Wittig coupling of ketone 586 and phosphonium salt 584 
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was thought to be the more stable of the two fragments, it was questioned whether this carbamate would 
undergo the desired reaction with a simple iodonium salt, thereby allowing coupling conditions to be 
developed that would maximise the stability of the substrate. These conditions could then be applied to 
the key fragment union. Accordingly, Dominik Reich investigated the coupling of the southern fragment 
with propenyl iodonium salt 581. Following extensive studies, it was discovered that the oxy-alkenylation 
could be effected with 30 mol% copper(I) triflate, one equivalent di-tert-butylpyridine and one mass 
equivalent of 4 Å molecular sieves. These conditions gave the desired carbonate in 45% yield and in an 
intractable mixture of diastereoisomers (Scheme 130).213 
 
Scheme 130 – Coupling of southern fragment 470 with iodonium salt 581 (NMR) – Dominik Reich213 
The low diastereoselectivity of the oxy-alkenylation process (2:2:1, 589:590:other) was attributed to the 
tertiary alcohol-appended carbamate substrate. With the presence of a tertiary centre, it was considered 
that the putative transition states leading to the two suspected major isomers would differ only with 
respect to the steric demands of an axial methyl group compared with an axial methylene group (Scheme 
131). Consistent with the similar A-values of a methyl and an ethyl group (1.70 vs. 1.75),214 there appears 
to be little energetic preference for either transitions state structure and hence no appreciable 
diastereoselectivity. 
 
Scheme 131 – Proposed origin of poor oxy-alkenylation diastereoselectivity 
However, as the model reaction proceeded with no apparent decomposition of the carbamate substrate, 
the same conditions were applied to a fragment union reaction using our northern fragment iodonium 
salt 558 (Scheme 132). Pleasingly, evaluation of the crude reaction mixture by 1H NMR and LCMS 
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indicated the presence of trace amounts of the desired product. Extensive chromatographic purification 
allowed the isolation of 1 mg (2%) of a species observed to bear 1H signals and COSY cross-peaks 
consistent with coupled product 559 (Figure 13). The assignment was further supported by high 
resolution mass spectrometry with the observation of a diagnostic [M+Na]+ signal. However, consistent 
with the model reactions performed by Dominik Reich, the NMR data indicated the coupled polyketide 
backbone to be formed in a low d.r. of 5:5:2 (559:591:other). 
 
Scheme 132 – Coupling of southern fragment 470 and northern fragment 558 to furnish linear polyketide 
backbone 559 
 
Figure 13 – 1H spectrum of linear polyketide backbone 559 (500 MHz) 
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Whilst the above reaction was low yielding and poorly diastereoselective, this study indicates that our 
oxy-alkenylation methodology may be used as a fragment union strategy in polyketide synthesis. It is 
hoped that our approach will be pursued further in the future to produce (–)-lyngbyaloside B or other 
natural products. 
3.8 Summary 
This project has described investigations into the application of Gaunt’s oxy-alkenylation strategy to the 
synthesis of the macrolide (–)-lyngbyaloside B. Efforts were directed toward the use of this reaction as a 
novel fragment union for polyketide synthesis. As such, this chapter has detailed studies into model 
fragment couplings, the synthesis of a highly complex polyoxygenated iodonium salt and the coupling 
of this fragment to an elaborate homoallylic carbamate substrate. 
It has been demonstrated that protected, secondary, α-oxygenated alkenyl iodonium salts can be 
generated and isolated in moderate yields. Similarly, it was observed that model reactions for the desired 
fragment coupling proceed in synthetically useful yields. It was noted that the temperature of the reaction 
and steric parameters of the iodonium salt are important factors in controlling carbamate conversion 
and product stability. Furthermore, it was shown that an iodonium salt bearing a protected 1,3-diol with 
three contiguous stereocentres can be transferred to a simple homoallylic carbamate. 
It was discovered that the choice of alcohol protecting group is very important in the synthesis of complex 
iodonium salts. Such elaborate iodanes were generally observed to be unstable to both acid and base, 
cyclising and eliminating under these conditions respectively. Finally, it was determined that acetonide 
protection was suitable for the generation and isolation of northern fragment iodonium salt 558. 
Following extensive investigations, the desired oxy-alkenylative fragment coupling was achieved in 2% 
yield and in 5:5:2 d.r.. Although the result of this reaction is not synthetically useful, it does evidence that 
the coupling of polyketide fragments using our methodology is possible.  
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4 Towards a Mechanistic Understanding of Copper-Catalysed 
Alkene Functionalisation with Diaryliodonium Salts 
4.1 Project Overview 
This project details very preliminary studies towards the computational evaluation of copper-catalysed 
alkene functionalisation processes. The reactivity of styrene with copper(I) triflate and diphenyliodonium 
triflate was first investigated, focusing on the distinct oxidative addition and alkene functionalisation 
steps of the reaction mechanism. It was demonstrated that the generation of a key copper(III) 
intermediate was thermodynamically favoured under the computed conditions and could proceed with 
only a small energetic barrier. Two accessible reaction modes have been determined for the 
functionalisation of styrene with the key Cu(III) intermediate. Subsequent work applied these insights 
towards the reaction of allylic amides under copper-catalysed arylation conditions and gave tentative 
results regarding the accessibility of regioisomeric reaction mechanisms. 
4.2 Simple Alkene Functionalisation 
Despite the recent interest in copper-catalysed alkene functionalisation reactions using diaryliodonium 
salts, no mechanistic investigations into such processes have been reported in the literature. Although 
most of the transformations in this class appear to display carbocationic behaviour (see Section 1.5.5), 
exceptions to such reactivity are apparent, most notably the enamide generation procedure detailed in 
Chapter 2.174 The reactivity of these alkene functionalisation processes is therefore clearly more complex 
than simply acting as a method to generate carbocations at the most stabilising centre. Disappointingly, 
all mechanistic investigations carried out within the Gaunt group towards understanding our copper-
catalysed processes have so far given few results. The lack of insight gained can be attributed to the high 
reactivity of the copper-centred species, making sampling processes intrinsically difficult and the 
crystallisation of on-cycle intermediates problematic. With such challenges, computational studies were 
considered to be the best method for investigating the reactivity of copper-catalysed alkene 
functionalisation reactions using diaryliodonium salts.  
At the outset of our computational investigations, it was thought that the reactivity observed in previous 
studies was best rationalised though carbocupration of the alkene substrate with a transiently-generated 
Cu(III)–aryl intermediate (Scheme 133). Such an alkene functionalisation process would give alkyl-
copper(III) intermediates (e.g. 594 and 596), able to undergo carbocation-like behaviour due to the 
extreme polarisation of the Cu(III)–alkyl bond. Variation in the regioselectivity of the carbocupration 
process would allow for the formation of both alkene arylation regioisomers. As such, efforts were 
directed towards understanding both the generation of a copper(III)–aryl intermediate and the ability of 
this species to undergo carbocupration with alkenes. 
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Scheme 133 – Proposed a) oxidative addition to furnish aryl–Cu(III) intermediate; b) alkene association and 
carbocupration to give more substituted carbocation-like intermediate; c) alkene insertion to give less substituted 
carbocation-like intermediate 
The arylation of styrene 35 with diphenyliodonium triflate 168 was chosen as the model system for our 
preliminary studies (Scheme 134).155 As is shown above, the mechanism of the reaction may be split into 
two distinct sections: oxidative addition (Scheme 133a) and alkene functionalisation (Schemes 133b and 
c). As it was anticipated that the oxidative addition process would be general across copper-catalysed 
carbofunctionalisation methods employing diaryliodonium salts, the individual sections of the reaction 
were investigated independently. 
 
Scheme 134 – Gaunt’s copper-catalysed styrene arylation giving stilbene 37155 
4.2.1. Oxidative addition 
In line with work described by Lockhart, it is proposed that the active copper(I) triflate catalyst is 
produced from the copper(II) pre-catalyst by an in situ reduction (not shown).98 The benchmarked 
calculation methods and basis sets used in Sanford’s copper-catalysed fluorination reaction (Scheme 29, 
page 22)101,102 were then applied to the system under investigation to allow an energy profile for the 
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oxidative addition of copper(I) triflate 592 with diphenyliodonium triflate 168 to be elaborated (Scheme 
135). It was initially computed that the transfer of a triflate ion from the iodonium salt to the neutral 
copper(I) species was energetically favourable, giving anionic copper(I) species 178 and diaryliodonium 
cation 179. The charge-separated species were then calculated to recombine to form adduct Int-1, with 
this intermediate then rearranging through transition state TS-1 (ΔG‡ = +1.8 kcal-1) to the stable ipso-
coordinated oxidative addition precursor Int-2. Oxidative addition was computed to occur through 
transition state TS-2 (ΔG‡ = +8.2 kcal mol-1) to give square-based pyramidal Cu(III) adduct Int-3. 
Entropically favoured dissociation of iodobenzene generates the key κ2-triflate stabilised copper(III) 
intermediate Int-4 (180). Although the existence of lower energy pathways to key intermediate Int-4 
cannot be discounted, this study demonstrates that the generation of this key copper(III) intermediate is 
thermodynamically favourable and kinetically accessible.  
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Scheme 135 – Oxidative addition of copper(I) triflate 592 into diphenyliodonium triflate 168 (Gaussian 09 - 
BP86 functional, Def2SVP (SDD) [Cu,I], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
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4.2.2. Styrene coupling 
Attention was next directed towards modelling the reactivity of styrene with high-valent copper 
intermediate Int-4. It was initially anticipated that the alkene coordination and migratory insertion steps 
would occur analogously to those processes described for the palladium-catalysed Heck reaction.215 
However, in contrast to the Heck reaction, it was predicted that the stilbene formation would occur by 
an E2-type process rather than by a β-hydride elimination. This hypothesis derives from the observed 
production of alkene products that do not lie in conjugation with the introduced arene (Scheme 136).155 
Such compounds are not consistent with the β-hydride elimination behaviour of palladium species with 
acylic alkene substrates.216 Computational investigations therefore targeted a reaction profile involving 
two key transition states: a concerted carbocupration to transfer the aryl group (597) and an E2-type 
elimination to furnish the stilbene product (598) (Figure 14).  
 
Scheme 136 – Gaunt’s copper-catalysed arylation of alkene 301 to give non-conjugated product 302155 
 
Figure 14 – Expected styrene functionalisation transition states 
On introduction of styrene to the copper(III) intermediate Int-4, it was interesting to note that 
copper(III)-alkene adducts could only be identified with copper-alkene binding dominantly occurring 
through the alkene terminus. This binding mode differs from the expected Dewer-Chatt-Duncanson-
type bonding where both alkene p-orbitals participate in the metal–alkene interaction.28 An example of 
this interesting alkene-copper binding mode can be seen with Int-5 (Figure 15). The observed 
unsymmetrical alkene binding can be rationalised through the electron-deficient copper centre acting to 
strongly polarise the bound alkene, formally placing a negative charge at the alkene terminus and 
building positive charge at the styrene benzylic position. Such extreme induced polarity is evidenced by 
the lengthened C=C bond and shortened C–Ph bond computed for the styrene in Int-5 relative to the 
free alkene 35 (Figure 16, Int-5: 1.41 Å, 1.43 Å respectively; styrene: 1.35 Å, 1.47 Å). 
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Figure 15 – Terminal π-bound styrene-Cu(III) complex Int-5 
 
Figure 16 – Shortening of styrene C=C bond and lengthening of C–Ar bond on binding to Int-5 
From Int-5, only one transition state (TS-3) was discovered that would lead towards the desired 1,2-
substituted adduct (ΔG‡ = +2.3 kcal mol-1, Figure 17). Intriguingly, this transition structure appears to 
most closely resemble an early reductive elimination transition state.217 Such reactivity can be 
rationalised by considering Int-5 at its charge-separated resonance extreme 600, bearing a formal alkyl-
copper bond. Reductive elimination from such an anionic copper(III) centre reflects the computed 
behaviour (Scheme 137).  
 
Figure 17 – Transition state leading to the desired stilbenium connectivity (TS-3) 
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Scheme 137 – Rationale of alkene functionalisation through copper(III)-induced polarisation of alkene π-bond 
With transition state TS-3 in hand, work was carried out to elaborate a plausible functionalisation 
pathway towards the observed stilbene product (Scheme 138). It was calculated that styrene-bound 
adduct Int-5 could be produced with only a slight energetic penalty on alkene association to the κ2-
stabilised copper(III) intermediate Int-4 (ΔG = +6.8 kcal mol-1). Subsequent aryl insertion occurs via 
computed transition state TS-3 to furnish the aryl-coupled intermediate Int-6 with a large associated 
gain in energy (ΔG = –30.1 kcal mol-1). In line with our hypothesis, an E2 transition state (TS-4) was 
identified to lie 8.5 kcal mol-1 higher in energy than arylated intermediate adduct, providing exergonic 
access to stilbene-bound copper(I) triflate anion Int-7. Dissociation of the coupled stilbene product was 
computed to be thermodynamically favourable, allowing regeneration of the free anionic copper(I) 
triflate species 178. 
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Scheme 138 – Association of styrene 35 to key κ2-bound copper(III) species Int-4 and reaction towards trans-
stilbene production (Gaussian 09 - BP86 functional, Def2QZVP (SDD) [Cu], 6-311G+(2d,p) [C,H,O,F,S,N]); 
energies given as ΔG (kcal mol-1) 
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Based on the observed reductive elimination-like chemistry of TS-3, it was considered that Int-6 could 
alternatively be viewed as ionically-paired copper(I) anion-carbocation complex. Interestingly, the 
dissociation of Int-6 into the free benzylic-stabilised carbocation 601 and copper(I) triflate anion 178 
was determined to be favourable (Scheme 139, ΔG = –1.0 kcal mol-1). Importantly, this result implies 
that copper-catalysed alkene arylation can take place to give free carbocationic intermediates with the 
charge localised at the most stabilising position. This is consistent with many of the experimental 
observations described in the literature and allows rationalisation of elimination, fragmentation, 
isomerisation and hydride-shift processes (see Schemes 63 and 66, Section 1.5.5).153,155,157  
 
Scheme 139 – Dissociation of Int-6 to stilbenium ion 601 and copper(I) triflate anion 178 (Gaussian 09 - BP86 
functional, Def2QZVP (SDD) [Cu], 6-311G+(2d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
However, the free carbocationic behaviour detailed above does not explain the potential for 
functionalisation at the non-nucleophilic position of alkene substrates.174 Although no such reaction 
product is observed on the reaction of styrene with diaryliodonium salts under copper-catalysis, attention 
was turned towards further evaluating the reactivity of the copper(III)-styrene adduct. Mechanistic 
pathways were sought that would give functionalistion of the styrene with opposite regioselectivity to 
that described above. Interestingly, on re-orientating the bound alkene to give complex Int-8, a 
concerted carbocupration transition state (TS-5) could be identified leading to 1,1-disubstuted adduct 
Int-9 (Scheme 140). It should be noted that this complex is calculated to have alkyl-copper bond length 
of 2.02 Å, considerably shorter than the computed analogous bond length for the 1,2-substituted adduct 
Int-6 (2.16 Å). The relative difference in bond length implies a stronger copper-carbon interaction for 
the 1,1-insertion intermediate, indicative of a true copper(III) intermediate. Intriguingly, the transition 
state for this carbocupration process lies only very slightly higher in energy than the transition state 
calculated to give the stilbene product (TS-5 vs. TS-3, ΔΔG‡ = +0.2 kcal mol-1). This result implies the 
kinetic accessibility of two transition states giving regioisomeric products, offering a potential explanation 
for observed regiodivergence in the functionalisation of allylic amides.174 
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Scheme 140 – Association of styrene 35 to key κ2-bound copper(III) species Int-4 and reactions towards 1,1-
diphenylethylene production (Gaussian 09 - BP86 functional, Def2QZVP (SDD) [Cu], 6-311G+(2d,p) 
[C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
It is anticipated that elimination processes from Int-9 will be unfavourable due to the energetic penalty 
of losing the stabilising co-ordination of the aryl group. Such an energy barrier allows the absence of 
1,1-diphenylethylene in the crude reaction mixture to be rationalised. Furthermore, given the relatively 
high energy of arylated intermediate Int-9, it is possible that the carbocupration process proceeding 
through TS-5 will be reversible. Finally, an alternative explanation for the absence of 1,1-
diphenylethylene in the reaction mixture would be the occurrence of a 1,2-aryl migration from Int-9 to 
give the more stable Int-6, thereby ultimately giving stilbene formation.  
4.2.3. Summary 
Whilst further work is required to more fully understand the copper-catalysed arylation of alkenes with 
diaryliodonium salts, the investigations described in the above sections have given insight into the 
functionalisation modes that alkenes may undergo in the presence of high-valent copper intermediates. 
Tentatively, it can be concluded that at least two energetically accessible alkene functionalisation 
processes exist under such a reaction manifold. These two computed arylation modes resemble a 
reductive-elimination-like process (TS-3, Figure 18a) and a concerted carbocupration process (TS-5, 
Figure 18b) respectively and proceed to give regiosiomeric reaction products. 
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Figure 18 – Computed styrene functionalisation transitions states  
4.3 Regiodivergent Arylation of Allylic Amides 
The regiodivergent arylation mechanisms computed for the reactivity of styrene were next applied to 
the allylic amide arylation process investigated in chapter 2. Initial efforts were directed towards 
rationalising the outcome of a simple racemic model reaction shown to give both enamide and oxazine 
products (Scheme 141). As more oxazine product is observed in the crude reaction, it was anticipated 
that the transition state leading to oxazine formation would be slightly lower in energy than that giving 
enamide formation (ΔΔG‡ 0–1 kcal mol-1). 
 
Scheme 141 – Racemic regiodivergent allylic amide arylation to furnish oxazine 428 and enamide 602 (NMR 
yields with 1,3,5-trimethoxybenzenetricarboxylate) 
The functionalisation of the allylic amide towards oxazine 428 was first evaluated. In analogy with the 
computed reaction of styrene to give stilbene formation, alkene-binding adducts resembling the key 
styrene-bound intermediate Int-5 were sought. Given the coordinating nature of the allylic amide 
carbonyl group, calculations were directed towards the generation of bidentate adducts. Cationic 
copper(III) complex Int-10 was identified to fit these constraints (Figure 19). 
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Figure 19 – Computed bidentate cationic allylic amide-bound copper(III) adduct Int-10 
With Int-10 in hand, an energy profile for reductive-elimination-like substrate arylation towards 
oxazine formation was generated to ultimately give arylated allylic amide complex Int-11 (Scheme 142). 
These investigations indicated arylation of the substrate by this mechanism to be energetically accessible, 
though significantly higher in energy than the comparative styrene functionalisation (TS-6 vs. TS-3: 
ΔG‡ = 9.1 kcal mol-1 vs. 14.0 kcal mol-1). It is proposed that arylated intermediate Int-11 may be 
converted to the oxazine product through carbocation dissociation and carbonyl trapping (Scheme 143).  
 
Scheme 142 – Reaction of amide 315 with Int-4 towards oxazine formation (Gaussian 09 - BP86 functional, 
Def2SVP (SDD) [Cu], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
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Scheme 143 – Proposed generation of oxazine 428 from copper-bound intermediate Int-11 
Interestingly, there appears to be a close resemblance between the transition state leading to oxazine 
formation and that leading to the production of stilbene (Figure 20). The styrene functionalisation 
appears to be stabilised by a hydrogen-bonding interaction from the alkene to a triflate ligand, placing 
a triflate oxygen where the carbonyl appears to bind to the copper centre for allylic amide arylation. 
 
Figure 20 – Isostructural arylation transition states with styrene and allylic amide 315 respectively 
Attention was next directed towards the identification of a concerted carbocupration transition state 
leading to enamide formation. Surprisingly, all efforts to coordinate the allylic amide to the copper centre 
in the expected reactive conformation led directly to the production of insertion intermediate Int-12. 
Interestingly, this species is observed to be lower in energy than the comparable intermediate leading to 
oxazine formation (Int-11), thereby implying a thermodynamic preference for enamide generation. No 
intermediate alkene-bound complex (604) or carbocupration transition state (605) could be identified 
on path towards the formation of Int-12 (Scheme 144). 
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Scheme 144 – Reaction of amide 315 with Int-4 towards enamide formation (Gaussian 09 - BP86 functional, 
Def2SVP (SDD) [Cu], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
An enamide-formation energy profile with identifiable intermediate adducts was computed for a 
different substrate using a more rigorous basis set (Scheme 145). It was revealed that cationic bidentate 
allylic amide copper(III) adduct Int-14 is more stable than the neutral bistriflated species Int-13. 
Interestingly, the carbocupration transition state (TS-7) leading to enamide formation was calculated to 
lie just 2.1 kcal mol-1 higher in energy than Int-14. The low calculated activation energy explains the 
difficulty encountered for the convergence of alkene-bound intermediates in the above study. 
 
Scheme 145 – Reactivity of amide 361 with Int-4 towards enamide formation (Gaussian 09 - BP86 functional, 
Def2QZVP (SDD) [Cu], 6-311G+(2d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Towards a Mechanistic Understanding of Copper-Catalysed Alkene Functionalisation with Diaryliodonium Salts 
 133 
Disappointingly, a transition state analogous to TS-6 (oxazine formation, Scheme 142) could not be 
converged at the desired level of theory with para-tolyl substrate 361. As such, no direct comparisons 
between the reaction profiles leading to oxazine and enamide generation can be made. However, it 
appears that the concerted carbocupration process giving enamide formation is remarkably facile, whilst 
the energetic profile calculated towards oxazine production appears too high in energy to be competitive 
(Scheme 142). It is therefore anticipated that a lower-energy process giving oxazine formation must exist 
on the potential-energy surface for the copper-catalysed arylation of allylic amides with diaryliodonium 
salts.  
4.3.1. Future calculations 
Owing to time limitations, no further work could be carried out to improve our understanding of the 
origins of the observed regiodivergence. It is hoped that further investigations in this area will be pursued 
in the future. In this eventuality, work should be first directed towards computing two other potential 
reaction pathways for oxazine formation: 
Firstly, in direct analogy with the styrene functionalisation process, the reaction of allylic amide 315 with 
the key phenyl-Cu(III) electrophile Int-4 should be computed with monodentate alkene binding 
(Scheme 146). As is discussed in Section 2.9, reaction through such a mechanism would allow for the 
rationalisation of oxazine selectivity with electron-rich iodonium salts 
 
Scheme 146 – Possible monodentate allylic amide functionalisation mechanism towards oxazine formation 
Secondly, the computations detailed in Scheme 142 should be re-computed with the amide 
deprotonated. It is anticipated that this change would give increased charge donation to the copper 
centre, stabilising the reductive elimination-like transition state (Scheme 147). 
 
Scheme 147 – Formally anionic allylic amide functionalisation towards oxazine formation 
Following the identification of a low-energy alkene functionalisation pathway giving oxazine formation, 
the effect of changing the aryl-group electronics should be investigated. It is anticipated that more 
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electron-rich aryl groups will alter the energies of the alkene functionalisation transition states to bias 
oxazine formation. Contrastingly, it is expected that more electron-poor aryl groups will relatively lower 
the energy of the carbocupration transition state, thereby favouring enamide formation. 
4.4 Summary  
Although the studies detailed in this section are incomplete, some important insights have been gained 
into the behaviour of copper-catalysed alkene functionalisation processes using iodonium salts. Firstly, 
it has been evidenced that little energy input is required to generate copper(III) intermediates from the 
combination of copper(I) species and iodonium salts. Furthermore, these copper(III) adducts have so far 
been computationally demonstrated to react with alkenes by two mechanisms, consistent with behaviour 
that has been observed experimentally. One such process resembles reductive elimination, directly 
coupling the aryl group from the iodonium salt to the more nucleophilic alkene position. The second 
reactivity mode appears as a concerted carbocupration – transferring the aryl group to the less 
intrinsically nucleophilic position of the alkene. The former process has been demonstrated to allow the 
formation of free carbocations in the reaction mixture, whilst the latter pathway permits rationalisation 
of the functionalisation of the non-nucleophilic alkene position. Further work is required to more fully 
understand and apply the behaviour of these systems.  
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5 Conclusion and Outlook 
This thesis has described three projects related to the development, application and understanding of 
copper-catalysed alkene functionalisation processes using iodonium salts.  
Chapter 2 details the development of a regiodivergent and enantioselective allylic amide arylation 
procedure. It was observed that the combination of diaryliodonium hexafluorophosphates and a specific 
copper(II)-bisoxazoline pre-catalyst allowed highly enantioselective alkene arylation to give enamide and 
oxazine products. The product distribution is controlled by the electronic properties of the 
diaryliodonium salt employed, wherein electron-rich aryl groups give oxazine production and electron-
deficient arenes provide enamides. The reaction was shown to proceed using a variety of substrates and 
a number of diaryliodonium salts to provide a range of both products in high e.e. and synthetically-useful 
yields. It was further demonstrated that the enamide products may be converted to enantioentiched β,β’-
diarylaldehydes, providing an umpolung strategy for the generation of these useful compounds. 
Chapter 3 describes efforts towards the application of a copper-catalysed oxy-alkenylation procedure to 
the production of the polyketide natural product (–)-lyngbyaloside B. It was proposed that Gaunt’s 
copper-catalysed methodology could be employed as a fragment union in the total synthesis of the 
macrolidal target, coupling an elaborate homoallylic carbamate fragment and a complex 
polyoxygenated alkenyl(aryl)iodonium salt. Following extensive studies, it was discovered that an 
acetonide-derivative of the desired iodane could be prepared and isolated in good yields. Reaction of 
the iodonium fragment with the relevant homoallylic carbamate (prepared by Dominik Reich) allowed 
the production of the coupled complex carbonate in 2% yield and as a mixture of diastereoisomers. 
These studies provide evidence that Gaunt’s copper-catalysed oxy-alkenylation reaction may be used for 
the synthesis of polyketide backbones, though further work is required to make this strategy synthetically 
viable. 
Chapter 4 presents preliminary studies towards the computational evaluation of the copper-catalysed 
arylation of simple alkenes. In line with work reported in the literature, it is shown that copper(III)-aryl 
adducts may be readily accessed from the combination of copper(I) sources and diaryliodonium salts. 
The interaction of a high-valent copper intermediate with styrene was then studied. Copper(III)-alkene-
binding is evidenced to be unsymmetrical, with association occurring exclusively through the most 
nucleophilic carbon centre of the alkene. Two energetically-similar transition states, where the aryl 
group is transferred from the copper to the alkene, were identified. Arylation was predicted to be possible 
at both positions of the double bond. It was computed that a reductive elimination-like process can occur 
at the more nucleophilic alkene position to give terminal arylation whilst a concerted carbocupration 
can proceed to give internal arylation. These functionalisation modes were noted to be consistent with 
the regiodivergent behaviour observed on the exposure of allylic amides to diaryliodonium salts in the 
presence of a copper catalyst (chapter 2). Initial efforts investigating arylation towards enamide and 
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oxazine production were carried out and indicated concerted carbocupration giving enamide formation 
to be accessible. Further studies are required to elaborate a comparable low-energy oxazine-formation 
pathway. 
Although the combination of diaryl- and alkenyl(aryl)iodonium salts and copper catalysts has been 
demonstrated to be a powerful method for the functionalisation of alkenes, there is a clear need for more 
in-depth understanding into the workings of this reactive system. Future work should be directed towards 
further elaborating the tentative results obtained by computationally modelling the behaviour of alkenes 
with copper(III)-aryl species. Insights could lead to the development of ligands to improve existing 
copper-catalysed reactions (e.g. greater levels of oxy-alkenylation diastereoselectivity) and may allow the 
rational design of new synthetic processes.  
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6 Experimental 
6.1 General Information 
Solvents: Unless otherwise stated, all reaction solvents were dried by standard techniques and freshly 
distilled before use or purchased in anhydrous form and used directly. Diethyl ether and tetrahydrofuran 
were distilled from lithium aluminium hydride and calcium hydride; acetonitrile, toluene and 
dichloromethane were distilled from calcium hydride; 1,2-dichloroethane and 1,4-dioxane were 
purchased from Acros Organics. Ethanol was used as purchased from Fisher Scientific. HPLC grade iso-
propanol and n-hexane were purchased from Fisher Scientific. For purification purposes, petroleum 
ether 40–60, hexanes, ethyl acetate, dichloromethane, acetone and toluene were distilled before use; 
diethyl ether was used as purchased from Sigma Aldrich, acetonitrile was used as purchased from Fisher 
Scientific.  
Reagents: All reagents were purified by standard procedures or used as purchased at the highest 
commercial quality.i Copper(II) triflate was stored and transferred in a glove-box under an atmosphere 
of nitrogen. Bisoxazoline ligand (+)-2,2′-Isopropylidenebis[(4R)-4-phenyl-2-oxazoline] was stored at –18 
ºC under a head-space of nitrogen and transferred in a glove-box under an atmosphere of nitrogen. 
Reactions: Unless otherwise stated, all reactions were carried out in oven-dried glassware under an 
atmosphere of nitrogen and were monitored by TLC, LCMS, GCMS or 1H NMR as appropriate. 
Iodonium salts: All aryl(mesityl)iodonium hexafluorophosphate salts were synthesised from the 
corresponding triflate or tetrafluoroborate species according to the procedure given in section 2, were 
dried in vacuo for a minimum of 18 hours and were stored in a vacuum desiccator over P4O10.  
Chromatography: All flash chromatography for the preparation of allylic amides and enamides was 
carried out using Merck 9385 Kieselgel 60 silica gel under a positive pressure of nitrogen. All flash 
chromatography for the preparation of oxazines was carried out using Merck aluminium oxide 90 
standardized under a positive pressure of nitrogen. All flash chromatography employed towards the total 
synthesis of (–)-Lyngbyaloside B was carried out under compressed air. Thin layer chromatography was 
carried out on Merck Kieselgel 60 PF254 0.2 mm plates. Visualisation was accomplished using 
ultraviolet light (254 nm) and chemical staining with ceric ammonium molybdate or acidic potassium 
permanganate solutions as appropriate.  
Data collection: 1H NMR spectra were recorded on a Bruker DPX 400 or 500 spectrometer. 13C 
NMR spectra were recorded at 100 or 125 MHz on the same machines. 19F NMR spectra were recorded 
at 376 MHz on a Bruker DPX 400 spectrometer. Chemical shifts (δ) are quoted in parts per million 
(p.p.m.) relative to residual solvent (CDCl3: δ = 7.26 p.p.m. for 1H and δ = 77.16 p.p.m. for 13C; d6-
DMSO: δ = 2.50 p.p.m. for 1H and δ = 39.52 p.p.m. for 13C; d3-MeCN: δ = 1.94 p.p.m. for 1H and δ = 
                                               
i Armarego, W. L. F.; Perrin, D. D., Purification of Laboratory Chemicals, 5th Ed. Butterworth-Heinemann, 1996. 
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118.26 and 1.32 p.p.m. for 13C; d6-Me2CO: δ = 2.05 p.p.m. for 1H and δ = 206.26 and 29.84 p.p.m. for 
13C) to the nearest 0.1 p.p.m for 13C and 19F NMR spectroscopy and to the nearest 0.01 p.p.m for 1H 
NMR spectroscopy. Coupling constants (J) are quoted to the nearest 0.1 Hz and are assumed to be JH–
H unless otherwise stated. Minor isotopes are given in squre brackets. The following abbreviations are 
used to indicate the form and multiplicity of the signals: s = singlet; d = doublet; t = triplet; q = quartet; 
qn = quintet; sx = sextet, sp = septet; m = multiplet; br. = broad; app. = apparent; and associated 
combinations, e.g. dd = doublet of doublets. Minor isotope couplings and partly obscured signals are 
indicated as such with square brackets. Mixtures of compounds are assigned individually where possible. 
The temperature of the acquisition of the NMR spectra was 298 ± 3K. DEPT135 and 2-dimensional 
experiments (COSY, HMBC, HSQC and NOESY) were used to support assignments where 
appropriate but are not included in this document. NMR yields were determined with trimethyl 
benzene-1,3,5-tricarboxylate, 1,2-dimethoxyethane or mesitylene as an internal standard. High-
resolution mass spectra (HRMS) were measured either in the department or at the EPSRC Mass 
Spectrometry Service at the University of Swansea using electrospray ionisation (ESI), electron impact 
(EI) or atmospheric pressure solids analysis probe (ASAP) methods. Infared (IR) spectra were recorded 
on a Perkin Elmer FT-IR spectrometer fitted with an ATR sampling accessory as either solids or neat 
films, either through direct application or deposited in chloroform or dichloromethane, with absorptions 
reported in wavenumbers (cm-1). Optical rotations were measured in chloroform or acetone on a Perkin 
Elmer 343 Polarimeter using a sodium lamp (λ 589 nm, D-line). [α]D values are reported at a given 
temperature (ºC) in 10-1 degrees cm2 g-1 with concentration in mg mL-1. Melting points (Tm) were 
recorded using a Gallenkamp hot stage apparatus and are reported uncorrected. Chiral HPLC analysis 
was performed on a Shimadzu XR-LC apparatus with chiralpak (IB, IC and AD-H) or chiralcel OD 
columns in a mixed solvent system of n-hexane and iso-propanol. Chiral GC-FID analysis was performed 
on a Shimadzu GC-2010+ apparatus with a chiraldex B-DM column with compressed air, hydrogen 
and helium as carrier gases. X-ray crystallography was performed on a Nonius Kappa CCD 
diffractometer or a Bruker D8-QUEST PHOTON-100 diffractometer using CuKa radiation (lambda 
= 1.5418 Å) at the Cambridge University Chemistry X-Ray Laboratory. 
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6.2 The Enantioselective and Regiodivergent Copper-Catalysed Arylation of 
Allylic Amides with Diaryliodonium Salts 
6.2.1. General procedures 
General procedure A 
Preparation of Sonogoshira coupled alkynes: 
 
Dry triethylamine (2.0 equiv) was added slowly at 0 ºC to a stirred solution/suspension of propargylic 
alkyne (1.0 equiv, 0.60 M), aryl iodide (1.1 equiv), Pd(PPh3)2Cl2 (1.3 mol%) and CuI (2.7 mol%) in either 
dry tetrahydrofuran or acetonitrile. The reaction mixture was warmed to room temperature and was 
stirred for the stated time. The resulting solution/suspension was concentrated in vacuo and the residue 
dissolved in ethyl acetate, washed with water and brine, then dried over anhydrous MgSO4. The filtrate 
was concentrated in vacuo and the residue purified by silica column chromatography to furnish the 
desired aryl-coupled product. 
General procedure B 
Preparation of allylic amide substrates: 
 
Adapted from a procedure reported by Suffert et al.218 NaBH4 (0.2 equiv, 1 M in abs. ethanol) was introduced to 
a stirred suspension of Ni(OAc)2•4H2O (0.2 equiv, 0.1 M in abs. ethanol) under an atmosphere of 
hydrogen gas. The resulting reductive mixture was stirred for a further two hours before undergoing the 
addition of a solution of ethylenediamine (0.7 equiv) and the alkyne (1.0 equiv, 1 M in abs. ethanol). 
This black suspension was then stirred for the given time under an atmosphere of hydrogen before being 
concentrated in vacuo. The resulting residue was suspended in ethyl acetate, then filtered through a plug 
of silica eluting with further quantities of ethyl acetate. This crude product solution was concentrated in 
vacuo and purified by silica column chromatography to furnish the desired allylic amide substrate. 
General procedure C 
Production by diaryliodonium hexafluorophosphate salts by ion exchange: 
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An equal volume of a saturated aqueous solution of sodium hexafluorophosphate was added to a solution 
of aryl(mesityl)iodonium triflate/tetrafluroborate in dichloromethane (0.5 M). The resulting biphasic 
mixture was stirred at room temperature for the stated time before the phases were separated and the 
aqueous layer extracted with a further three portions of dichloromethane. The combined organic 
fractions were dried over anhydrous MgSO4 and concentrated in vacuo to give the corresponding 
aryl(mesityl)iodonium hexafluorophosphate. 
General Procedure D 
Regiodivergent copper-catalysed enantioselective allylic amide arylation:  
 
An oven-dried microwave tube was charged with the appropriate allylic amide (1.0 equiv) and 
diaryliodonium hexafluorophosphate (2.0 equiv), then sealed and back-filled with nitrogen gas. 
Dichloromethane was added via syringe, followed by the addition of 2,6-di-tert-butyl pyridine (DTBP, 
2.0 equiv) and a pre-formed stock solution of 248ii (10 mol%, unless otherwise stated). The resulting 
green solution (0.05–0.1 M wrt allylic amide loading) was heated at 50 ºC for 24 hours (unless otherwise 
stated), cooled to room temperature and poured into an equal volume of sat. aq. NaHCO3 solution. The 
phases were separated and the aqueous layer extracted with two portions of dichloromethane. The 
combined organic fractions were dried over anhydrous MgSO4, concentrated in vacuo, and the crude 
residue purified by column chromatography to furnish the desired enantioenriched arylated product.  
                                               
ii The stock solution of 248 is prepared as follows: in a glove-box under an inert atmosphere, an oven-dried microwave tube 
containing ~200 mg freshly activated 4 Å molecular sieves and a stirrer bar was charged with anhydrous Cu(OTf)2 (72 mg, 0.2 
mmol) and sealed. Subsequently, a solution of (+)-2,2-isopropylidenebis[(4R)-4-phenyl-2-oxazoline] ((+)PhBOX) (74 mg, 0.22 
mmol) in dry dichloromethane (2 mL) was introduced to the anhydrous Cu(OTf)2 and the resulting green solution stirred at 
room temperature for 15 hours. The resulting green solution was stored in the sealed tube under N2 at -18 oC and used as 
required. 
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6.2.2. Substrate synthesis 
6.2.2.1 Alkyne synthesis 
N-(prop-2-yn-1-yl)pivalamide 353157 
 
Dry triethylamine (34.0 mL, 241 mmol) was added dropwise at 0 ºC to a solution of pivaloyl chloride 
(30.0 mL, 241 mmol) and propargylamine (14.0 mL, 219 mmol) in dichloromethane (340 mL). The 
resulting yellow suspension was warmed to room temperature and stirred for 15 hours before being 
quenched by the addition of sat. aqueous NH4Cl solution (250 mL). The phases were separated and the 
aqueous layer washed with dichloromethane (2 x 50 mL). The organic layers were combined, washed 
with brine (100 mL), dried over anhydrous MgSO4 and concentrated in vacuo. The resulting crude 
product was purified by silica flash column chromatography, eluting with 50% ethyl acetate in petroleum 
ether 40–60, to give the title compound as an off-white crystalline solid (30.0 g, 216 mmol, 99%).  
1H NMR (400 MHz, CDCl3) δ: 5.81 (br. s, 1H, H-4), 4.04 (dd, J = 5.0, 2.5 Hz, 2H, H-5), 2.24 (t, J = 
2.5 Hz, 1H, H-7), 1.21 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 178.5 (C-3), 80.2 (C-6), 72.0 (C-7), 
39.0 (C-2), 29.8 (C-5), 27.9 (C-1). Experimental data in agreement with previous literature report.2 
1,1-Dimethyl-3-(prop-2-yn-1-yl)urea 350a 
 
Dry triethylamine (7.10 mL, 51.0 mmol) was added dropwise at 0 ºC to a solution of dimethylcarbamic 
chloride (4.70 mL, 51.0 mmol) and propargylamine (2.94 mL, 46.0 mmol) in dichloromethane (70 mL). 
The resulting yellow suspension was warmed to room temperature and stirred for 18 hours before being 
quenched by the addition of sat. aq. NH4Cl solution (50 mL). The phases were separated and the 
aqueous layer extracted with dichloromethane (2 x 25 mL). The organic layers were combined, washed 
with brine (50 mL), dried over anhydrous MgSO4 and concentrated in vacuo. The resulting crude product 
was purified by silica flash column chromatography, eluting with 5% methanol in dichloromethane, to 
give the title compound as an off-white crystalline solid (2.46 g, 19.5 mmol, 42%).  
Tm 71–73 ºC; IR νmax/cm-1 (film): 3293 (br., N–H), 2925, 1631 (C=O), 1522, 1377, 1263, 1221; 1H 
NMR (400 MHz, CDCl3) δ: 4.55 (br. s, 1H, H-3), 4.01 (dd, J = 5.3, 2.5 Hz, 2H, H-4), 2.90 (s, 6H, H-
1), 2.20 (t, J = 2.5 Hz, 1H, H-6); 13C NMR (100 MHz, CDCl3) δ: 157.7 (C-2), 81.1 (C-5), 71.0 (C-6), 
36.2 (C-1), 30.7 (C-4); HRMS-ESI (m/z) found [M]+ 126.0786, C6H10N2O requires 126.0788. 
 
 
2
3 NH
4
O
1 5 6
7
N 2 NH
3
O 4
5 6
1
Experimental 
 142 
N-(3-phenylprop-2-yn-1-yl)pivalamide 315a 157  
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (3.88 g, 27.9 mmol), 
iodobenzene (3.43 mL, 30.7 mmol), Pd(PPh3)2Cl2 (253 mg, 0.36 mmol) and CuI (143 mg, 0.75 mmol) in 
acetonitrile (45 mL) with stirring for 15 hours. Crude residue purified by silica column chromatography, 
eluting with 20 to 30% diethyl ether in petroleum ether 40–60 to furnish the title compound as a yellow 
solid (5.78 g, 26.8 mmol, 71%).  
1H NMR (500 MHz, CDCl3) δ: 7.44–7.42 (m, 2H, H-9), 7.32–7.30 (m, 3H, H-10,11), 5.89 (br. s, 1H, 
H-4), 4.28 (d, J = 5.0 Hz, 2H, H-5), 1.24 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 178.3 (C-3), 
132.1 (C-9), 128.8 (C-11), 128.6 (C-10), 122.9 (C-8), 85.4 (C-7), 83.8 (C-6), 39.0 (C-2), 30.6 (C-5), 27.8 
(C-1). Experimental data in agreement with previous literature report.157 
1,1-Dimethyl-3-(3-phenylprop-2-yn-1-yl)urea 350b  
 
Prepared according to general procedure A with 1,1-dimethyl-3-(prop-2-yn-1-yl)urea 350a (2.46 g, 19.5 
mmol), iodobenzene (2.40 mL, 21.5 mmol), Pd(PPh3)2Cl2 (177 mg, 0.25 mmol) and CuI (100 mg, 0.53 
mmol) in acetonitrile (35 mL) with stirring for 48 hours. Crude product purified by silica flash column 
chromatography, eluting with 5% MeOH in dichloromethane, to yield the title compound as an orange 
crystalline solid (2.70 g, 13.3 mmol, 68%).  
Tm 72–75 ºC; IR νmax/cm-1 (film): 3325 (br., N–H), 2928, 1638 (C=O), 1530, 1379, 1346, 1224; 1H 
NMR (400 MHz, CDCl3) δ: 7.42–7.40 (m, 2H, H-8), 7.29–7.27 (m, 3H, H-9,10), 4.63 (br. s, 1H, H-3), 
4.25 (d, J = 5.2 Hz, 2H, H-4), 2.92 (s, 6H, H-1); 13C NMR (100 MHz, CDCl3) δ: 157.8 (C-2), 131.8 (C-
8), 128.3 (C-10), 128.3 (C-9), 122.8 (C-7), 86.4 (C-6), 82.9 (C-5), 36.2 (C-1), 31.5 (C-4); HRMS-ESI (m/z) 
found [M+H]+ 203.1177, C12H15N2O requires 203.1179. 
N-(3-(4-chlorophenyl)prop-2-yn-1-yl)pivalamide 356a 
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (1.01 g, 7.20 mmol), 4-
chloroiodobenzene (1.91 g, 7.99 mmol), Pd(PPh3)2Cl2 (65.8 mg, 93 μmol) and CuI (37.2 mg, 0.20 mmol) 
in acetonitrile (12 mL) with stirring for 18 hours. Crude residue purified by silica column 
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chromatography, eluting with 50% diethyl ether in petroleum ether 40–60 to furnish the title compound 
as a yellow crystalline solid (1.39 g, 5.50 mmol, 77%).  
Tm 92–94 ºC; IR νmax/cm-1 (film): 3339 (br., N–H), 2966, 1644 (C=O), 1520, 1489, 1349, 1207, 1091, 
1015; 1H NMR (400 MHz, CDCl3) δ: 7.35 (d, J = 8.6 Hz, 2H, H-9), 7.28 (d, J = 8.6 Hz, 2H, H-10), 
5.83 (br. s, 1H, H-4), 4.26 (d, J = 5.1 Hz, 2H, H-5), 1.23 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 
178.2 (C-3), 134.7 (C-11), 133.1 (C-9), 128.8 (C-10), 121.2 (C-8), 86.2 (C-7), 82.4 (C-6), 38.9 (C-2), 30.3 
(C-5), 27.6 (C-1); HRMS-ESI (m/z) found [M+H]+ 250.0993, C14H17NOCl requires 250.0993. 
N-(3-(4-methoxyphenyl)prop-2-yn-1-yl)pivalamide 360a  
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (1.01 g, 7.20 mmol), 4-
iodoanisole (1.87 g, 7.99 mmol), Pd(PPh3)2Cl2 (65.8 mg, 93 μmol) and CuI (37.2 mg, 0.20 mmol) in of 
acetonitrile (12 mL) with stirring for 14 hours. Crude residue purified by silica column chromatography, 
eluting with 50% diethyl ether in petroleum ether 40–60 to furnish the title compound as a white 
crystalline solid (1.52 g, 6.20 mmol, 86%).  
Tm 58–60 ºC; IR νmax/cm-1 (film): 3331 (br., N–H), 2960, 2937, 1640 (C=O), 1606, 1508, 1289, 1246, 
1205, 1172, 1032; 1H NMR (400 MHz, CDCl3) δ: 7.36 (d, J = 8.9 Hz, 2H, H-9), 6.83 (d, J = 8.9 Hz, 
2H, H-10), 5.80 (br. s, 1H, H-4), 4.25 (d, J = 4.9 Hz, 2H, H-5), 3.81 (s, 3H, H-12), 1.23 (s, 9H, H-1); 
13C NMR (100 MHz, CDCl3) δ: 178.1 (C-3), 159.9 (C-11), 133.3 (C-9), 114.8 (C-8), 114.1 (C-10), 83.7 
(C-7), 83.5 (C-6), 55.4 (C-12), 38.8 (C-2), 30.5 (C-5), 27.7 (C-1); HRMS-ESI (m/z) found [M+H]+ 
246.1489, C15H20NO2 requires 246.1489.  
N-(3-(p-tolyl)prop-2-yn-1-yl)pivalamide 361a  
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (2.99 g, 21.5 mmol), 4-
iodotoluene (5.14 g, 23.6 mmol), Pd(PPh3)2Cl2 (195 mg, 0.28 mmol) and CuI (110 mg, 0.58 mmol) in 
tetrahydrofuran (40 mL) with stirring for 4 hours. Crude residue purified by silica column 
chromatography, eluting with 5 to 20% ethyl acetate in petroleum ether 40–60 to furnish the title 
compound as a white crystalline solid (3.55 g, 15.5 mmol, 72%).  
Tm 90–92 ºC; IR νmax/cm-1 (film): 3340 (br., N–H), 2966, 1640 (C=O), 1509, 1480, 1351, 1205, 1007, 
1H NMR (400 MHz, CDCl3) δ: 7.31 (d, J = 8.1 Hz, 2H, H-9), 7.11 (d, J = 8.1 Hz, 2H, H-10), 5.84 (br. 
s, 1H, H-4), 4.25 (d, J = 4.9 Hz, 2H, H-5), 2.34 (s, 3H, H-12), 1.22 (s, 9H, H-1); 13C NMR (100 MHz, 
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CDCl3) δ: 178.1 (C-3), 138.7 (C-11), 131.8 (C-9), 129.2 (C-10), 119.6 (C-8), 84.4 (C-7), 83.7 (C-6), 38.8 
(C-2), 30.5 (C-5), 27.6 (C-1), 21.6 (C-12); HRMS-ESI (m/z) found [M+H]+ 230.1539, C15H20NO 
requires 230.1539. 
N-(3-(naphthalen-2-yl)prop-2-yn-1-yl)pivalamide 362a  
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (834 mg, 6.00 mmol), 
2-iodonapthalene (1.68 g, 6.60 mmol), Pd(PPh3)2Cl2 (54.4 mg, 77 μmol) and CuI (30.7 mg, 0.16 mmol) 
in acetonitrile (10 mL) with stirring for 18 hours. Crude residue purified by silica column 
chromatography, eluting with 20 to 35% ethyl acetate in petroleum ether 40–60 to furnish the title 
compound as a yellow crystalline solid (1.20 g, 4.90 mmol, 82%).  
Tm 104–107 ºC; IR νmax/cm-1 (film): 3329 (br., N–H), 3056, 2968, 1637 (C=O), 1597, 1514, 1483, 1352, 
1201, 817, 743; 1H NMR (500 MHz, CDCl3) δ: 7.96 (s, 1H, H-17), 7.83–7.77 (m, 2H, H-13,14), 7.78 
(d, J = 8.4 Hz, 1H, H-10), 7.51–7.48 (m, 2H, H-12,15), 7.47 (dd, J = 8.4, 1.6 Hz, 1H, H-9), 5.88 (br. s, 
1H, H-4), 4.33 (d, J = 5.0 Hz, 2H, H-5), 1.25 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 178.0 (C-3), 
132.9 (C-11), 132.9 (C-16), 131.7 (C-17), 128.4 (C-9), 128.0 (C-10), 127.7 (2C, C-13,14), 126.7 (2C, C-
12,15), 119.8 (C-8), 85.3 (C-7), 83.8 (C-6), 38.7 (C-2), 30.4 (C-5), 27.5 (C-1); HRMS-ESI (m/z) found 
[M+H]+ 266.1542, C18H20NO requires 266.1539. 
N-(3-(4-bromophenyl)prop-2-yn-1-yl)pivalamide 363a  
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (1.01 g, 7.20 mmol), 4-
bromoiodobenzene (2.26 g, 7.99 mmol), Pd(PPh3)2Cl2 (65.8 mg, 93 μmol) and CuI (37.2 mg, 0.20 mmol) 
in acetonitrile (12 mL) with stirring for 18 hours. Crude residue purified by silica column 
chromatography, eluting with 50% diethyl ether in petroleum ether 40–60 to furnish the title compound 
as a yellow crystalline solid (1.71 g, 5.80 mmol, 81%).  
Tm 108–110 ºC; IR νmax/cm-1 (film): 3338 (br., N–H), 2966, 1642 (C=O), 1518, 1485, 1349, 1292, 1259, 
1206, 1071, 1011; 1H NMR (400 MHz, CDCl3) δ: 7.43 (d, J = 8.5, Hz, 2H, H-10), 7.27 (d, J = 8.5 Hz, 
2H, H-9), 5.85 (br. s, 1H, H-4), 4.24 (d, J = 5.0 Hz, 2H, H-5), 1.22 (s, 9H, H-1); 13C NMR (100 MHz, 
CDCl3) δ: 178.2 (C-3), 133.3 (C-10), 131.7 (C-9), 122.8 (C-11), 121.7 (C-8), 86.4 (C-7), 82.5 (C-6), 38.8 
(C-2), 30.3 (C-5), 27.6 (C-1); HRMS-ESI (m/z) found [M+H]+ 294.0490, C14H17NOBr requires 
294.0488. 
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N-(3-(1-(phenylsulfonyl)-1H-indol-3-yl)prop-2-yn-1-yl)pivalamide 364a  
 
To a solution of indole (2.00 g, 17.1 mmol) in dimethylformamide (30 mL) was added potassium 
hydroxide (2.39 g, 42.7 mmol) and the resulting suspension stirred for 20 minutes. A solution of iodine 
(4.38 g, 17.2 mmol) in dimethylformamide (5 mL) was then added, and the reaction mixture stirred for 
a further 45 minutes. The resulting solution was then poured into ice water (400 mL) and the precipitate 
collected by filtration. The resulting solid was washed with further portions of cold water and dried on 
the filter paper. The red powder was re-dissolved in tetrahydrofuran (5 mL) and added at 0 ºC to a 
stirred solution of sodium hydroxide (8.7 g, 220 mmol), tetrabutylammonium bromide (0.30 g, 0.93 
mmol) and tetrabutylammonium chloride (1.00 g, 3.60 mmol) in water (35 mL). To this rapidly stirring 
suspension was added dropwise a solution of benzenesulfonyl chloride (3.90 g, 22.1 mmol) in 
tetrahydrofuran (15 mL). The resulting reaction mixture was warmed to room temperature and stirred 
for a further three hours. The crude reaction solution was diluted with water and extracted with three 
portions of ethyl acetate, dried over anhydrous MgSO4, and concentrated in vacuo. The resulting residue 
was passed through a plug of silica, eluting with 10% ethyl acetate in petroleum ether 40–60, to furnish 
3-iodo-1-(phenylsulfonyl)-1H-indole (3.10 g, 8.1 mmol, 47%) for direct consumption in the second step of 
the reaction.  
1H NMR (400 MHz, CDCl3) δ: 8.00–7.96 (m, 1H, H-13), 7.93–7.89 (m, 2H, H-17), 7.72 (s, 1H, H-15), 
7.57 (t, J = 7.5 Hz, 1H, H-19), 7.47 (app. t, J = 7.7 Hz, 2H, H-18), 7.41–7.36 (m, 2H, H-10,12), 7.35–
7.30 (m, 1H, H-11). Experimental data in agreement with previous literature report.219 
Subsequently prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (512 mg, 
3.70 mmol), the freshly prepared 3-iodo-1-(phenylsulfonyl)-1H-indole (1.55 g, 4.05 mmol), Pd(PPh3)2Cl2 
(33.4 mg, 48 mg) and CuI (18.9 mg, 0.10 mmol) in tetrahydrafuran (6 mL) with stirring for 18 hours. 
Crude residue purified by silica column chromatography, eluting with 20 to 50% ethyl acetate in 
petroleum ether 40–60 to furnish the title compound as a yellow crystalline solid (1.25 g, 3.20 mmol, 
86%). 
Tm 144–147 ºC; IR νmax/cm-1 (film): 3345 (br., N–H), 2964, 1647 (C=O), 1516, 1447, 1372, 1276, 1229, 
1177, 1128, 733; 1H NMR (500 MHz, CDCl3) δ: 7.98 (app. dt, 1H, J = 8.3, 0.9 Hz, H-13), 7.91–7.87 
(m, 2H, H-17), 7.73 (s, 1H, H-15), 7.61 (ddd, J = 7.8, 1.2, 0.8 Hz, 1H, H-10), 7.55 (tt, J = 7.5, 1.3 Hz, 
1H, H-19), 7.47–7.42 (m, 2H, H-18), 7.36 (ddd, J = 8.6, 7.4, 1.2 Hz, 1H, H-12), 7.29 (ddd, J = 7.8, 7.4, 
1.1 Hz, 1H, H-11), 5.89 (br. s, 1H, H-4), 4.33 (d, J = 5.0 Hz, 2H, H-5), 1.24 (s, 9H, H-1); 13C NMR 
(125 MHz, CDCl3) δ: 178.0 (C-3), 137.8 (C-16), 134.15 (C-19) 135.13 (C-14), 130.7 (C-9), 129.4 (C-18), 
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129.1 (C-15), 126.9 (C-17), 125.6 (C-12), 123.9 (C-11), 120.5 (C-10), 113.6 (C-13), 104.8 (C-8), 89.5 (C-
7), 74.4 (C-6) 38.7 (C-2), 30.4 (C-5), 27.5 (C-1); HRMS-ESI (m/z) found [M+H]+ 395.1417, 
C22H23N2O3S requires 395.1424. 
N-(3-(benzo[d][1,3]dioxol-5-yl)prop-2-yn-1-yl)pivalamide 365a  
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (2.02 g, 14.4 mmol), 
and 5-iodobenzo[d][1,3]dioxole (3.97 g, 16.0 mmol), Pd(PPh3)2Cl2 (132 mg, 0.19 mmol) and CuI (74.4 
mg, 0.39 mmol) in tetrahydrofuran (12 mL) with stirring for 6 hours. Crude residue purified by silica 
column chromatography, eluting with 20 to 40% ethyl acetate in petroleum ether 40–60 to furnish the 
title compound as an orange crystalline solid (2.84 g, 11.0 mmol, 76%).  
Tm 83–85 ºC; IR νmax/cm-1 (film): 3337 (br., N–H), 2964, 2905, 1641 (C=O), 1502, 1489, 1441, 1330, 
1245, 1209, 1102, 1037; 1H NMR (400 MHz, CDCl3) δ: 6.93 (dd, J = 8.0, 1.6 Hz, 1H, H-9), 6.85 (d, J 
= 1.6 Hz, 1H, H-13), 6.72 (d, J = 8.0 Hz, 1H, H-10), 5.95 (s, 2H, H-14), 5.92 (br. s, 1H, H-4), 4.22 (d, 
J = 5.0 Hz, 2H, H-5), 1.21 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 178.1 (C-3), 148.1 (C-11), 147.5 
(C-12), 126.5 (C-9), 115.9 (C-8), 111.8 (C-13), 108.5 (C-10), 101.4 (C-14), 83.5 (C-7), 83.3 (C-6), 38.8 
(C-2), 30.3 (C-5), 27.6 (C-1); HRMS-ESI (m/z) found [M+H]+ 260.1280, C15H18NO3 requires 260.1281.  
N-(3-(thiophen-2-yl)prop-2-yn-1-yl)pivalamide 366a 
 
Prepared according to general procedure A with N-(prop-2-yn-1-yl)pivalamide 353 (1.97 g, 14.2 mmol), 2-
iodothiophene (1.73 mL, 15.7 mmol), Pd(PPh3)2Cl2 (129 mg, 0.18 mmol) and CuI (72.9 mg, 0.38 mmol) 
in tetrahydrafuran (24 mL) with stirring for 1 hour. Crude residue purified by silica column 
chromatography, eluting with 20 to 30% ethyl acetate in petroleum ether 40–60 to furnish the title 
compound as a yellow crystalline solid (2.28 g, 10.3 mmol, 74%).  
Tm 63–66 ºC; IR νmax/cm-1 (film): 3333 (br., N–H), 2964, 1645 (C=O), 1520, 1478, 1358, 1292, 1207, 
1193; 1H NMR (500 MHz, CDCl3) δ: 7.24 (dd, 1H, J = 5.3, 1.0 Hz, 1H, H-11), 7.20 (dd, J = 3.6, 1.0 
Hz, 1H, H-9), 6.96 (dd, J = 5.3, 3.6 Hz, 1H, H-10), 5.86 (br. s, 1H, H-4), 4.28 (d, J = 5.0 Hz, 2H, H-
5), 1.22 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 178.2 (C-3), 132.5 (C-9), 127.4 (C-11), 127.1 (C-
10), 122.6 (C-8), 89.1 (C-7), 76.9 (C-6), 38.8 (C-2), 30.5 (C-5), 27.6 (C-1); HRMS-ESI (m/z) found 
[M+H]+ 222.0948, C12H16NOS requires 222.0947. 
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6.2.2.2 Alkene synthesis 
(Z)-N-(3-phenylallyl)pivalamide 315157 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (955 mg, 3.84 mmol), NaBH4 (145 
mg, 3.84 mmol), ethylenediamine (0.90 mL, 13.4 mmol) and N-(3-phenylprop-2-yn-1-yl)pivalamide 315a 
(4.13 g, 19.2 mmol) in a total volume of 40 mL ethanol with stirring for 5 hours. Crude product purified 
by silica column chromatography, eluting with a gradient of 5–20% ethyl acetate in pet. ether 40–60, to 
yield the title compound as a white crystalline solid (3.71 g, 17.1 mmol, 89%).  
1H NMR (500 MHz, CDCl3) δ: 7.39–7.35 (m, 2H, H-9), 7.28–7.24 (m, 3H, H-10,11), 6.59 (dt, J = 11.6, 
1.9 Hz, 1H, H-7), 5.72–5.61 (m, 2H, H-4,6), 4.19 (ddd, J = 6.7, 5.5, 1.9 Hz, 2H, H-5), 1.19 (s, 9H, H-
1); 13C NMR (125 MHz, CDCl3) δ: 178.5 (C-3), 136.6 (C-8), 131.9 (C-7), 129.0 (C-6), 128.6 (C-10), 128.6 
(C-9), 127.6 (C-11), 38.9 (C-2), 38.2 (C-5), 27.8 (C-1). Experimental data in agreement with previous 
literature report.157 
(Z)-3-phenylallyl pivalate 349 
 
Precursor prepared according to general procedure B with Ni(OAc)2•4H2O (498 mg, 2.00 mmol), 
NaBH4 (75.8 mg, 2.00 mmol), ethylenediamine (0.47 mL, 7.00 mmol) and 3-phenyl-2-propyn-1-ol (1.25 
ml, 10.0 mmol) in a total volume of 37 mL ethanol with stirring for 18 hours. The crude reaction mixture 
was concentrated in vacuo and the residue suspended in diethyl ether (50 ml) and filtered through a plug 
of silica. The fitrate was concentrated in vacuo to give the crude intermediate (2Z)-3-phenylprop-2-en-1-ol 
(ca. 1.3 g, 10 mmol) as a pale yellow oil. Consumed without further purification. 
1H NMR (400 MHz, CDCl3) δ: 7.37 (app. t, J = 7.7 Hz, 2H, H-9), 7.29 (t, J = 7.3 Hz, 1H, H-10), 7.24 
(d, J = 7.5 Hz, 2H, H-8), 6.60 (d, J = 12.0 Hz, 1H, H-6), 5.90 (dt, J = 12.0, 6.4 Hz, 1H, H-5), 4.47 (dd, 
J = 6.4, 1.4 Hz, 2H, H-4), 1.51 (br. s, 1H, OH). 
Pivaloyl chloride (1.35 ml, 11.0 mmol) was added dropwise at room temperature to a stirred solution of 
the crude (2Z)-3-phenylprop-2-en-1-ol, Et3N (14.0 ml, 100 mmol) and DMAP (61 mg, 0.50 mmol) in 
dichloromethane (20 mL) and stirred for 3 hours. The resulting reaction mixture was then filtered 
through celite™ and concentrated in vacuo to give the crude product as a yellow oil. This residue was 
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purified by silica column chromatography, eluting with 0–5% diethyl in petroleum ether 40–60, to 
furnish the title compound as a colourless oil (1.57 g, 7.19 mmol, 72% over two steps).  
RF 0.35 (5% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 2972, 1726 (C=O), 1481, 1397, 1368, 
1278, 1141, 1031, 975, 771; 1H NMR (400 MHz, CDCl3) δ: 7.32–7.36 (m, 2H, H-8), 7.21–7.28 (m, 3H, 
H-9,10), 6.64 (dt, J = 12.0, 1.6 Hz, 1H, H-6), 5.79 (dt, J = 12.0, 6.4 Hz, 1H, H-5), 4.82 (dd, J = 6.4, 1.6 
Hz, 2H, H-4), 1.20 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 178.5 (C-3), 136.3 (C-7), 132.9 (C-6), 
128.7 (C-9), 128.5 (C-8), 127.6 (C-10), 126.3 (C-5), 61.5 (C-4), 38.9 (C-2), 27.3 (C-1); HRMS-ESI (m/z) 
found [M+NH4]+ 236.1647, C14H22O2N requires 236.1645. 
(Z)-1,1-dimethyl-3-(3-phenylallyl)urea 350 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (668 mg, 2.69 mmol), NaBH4 (102 
mg, 2.69 mmol), ethylenediamine (0.63 mL, 9.38 mmol) and 1,1-dimethyl-3-(3-phenylprop-2-yn-1-yl)urea 
350a (2.71 g, 13.4 mmol) in a total volume of 40 mL ethanol with stirring for 3.5 hours. Silica plug 
eluted with 5% methanol in dichloromethane. Crude product purified by silica column 
chromatography, eluting with a gradient of 0 to 3% methanol in dichloromethane to furnish the title 
compound as an off-white crystalline solid (2.29 g, 11.2 mmol, 84%).  
Tm 80–83 ºC; IR νmax/cm-1 (film): 3339 (br., N–H), 2928, 1630 (C=O), 1528, 1494, 1374, 1221; 1H 
NMR (400 MHz, CDCl3) δ: 7.30–7.34 (m, 2H, H-8), 7.21–7.25 (m, 3H, H-9,10), 6.52 (dt, J = 11.7, 1.8 
Hz, 1H, H-6), 5.71 (dt, J = 11.7, 6.7 Hz, 1H, H-5), 4.46 (br. s, 1H, H-3), 4.13 (ddd, J = 6.7, 5.5, 1.8 Hz, 
2H, H-4), 2.86 (s, 6H, H-1); 13C NMR (100 MHz, CDCl3) δ: 158.4 (C-2), 136.7 (C-7), 130.8 (C-6), 130.0 
(C-5), 128.9 (C-9), 128.4 (C-8), 127.2 (C-10), 39.4 (C-4), 36.3 (C-1); HRMS-ESI (m/z) found [M+Na]+ 
227.1155, C12H16N2NaO requires 227.1155. 
(Z)-N-(3-phenylallyl)benzamide 351157 
 
Trifluoroacetic acid (1.99 mL, 25.8 mmol) was added dropwise to a solution of tert-butyl (Z)-(3-
phenylallyl)carbamate 351a (400 mg, 1.72 mmol) in dichloromethane (20 mL) and the resulting yellow 
solution stirred for 20 hours. The reaction mixture was then quenched with the addition of 10 % aqueous 
sodium hydroxide solution (10 mL), the organic layer extracted with dichloromethane (2 x 20 mL), the 
combined organic layers washed with brine (20 mL), dried over anhydrous MgSO4 and concentrated in 
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vacuo to give the free allylic amine, (Z)-3-phenylprop-2-en-1-amine (115 mg, 0.86 mmol) as white crystalline 
solid. Consumed without further purification.  
1H NMR (400 MHz, CDCl3) δ: 7.35 (app. t, J = 7.6 Hz, 2H, H-12), 7.30–7.27 (m, 3H, H-11,13), 6.48 
(d, J = 11.7 Hz, 1H, C-9), 5.76 (dt, J = 11.7, 6.4 Hz, 1H, H-8), 3.61 (br. s, 2H, H-7), 1.44 (br. s, 2H, H-
6). 
Benzoyl chloride (49 μL, 0.42 mmol) was added dropwise at 0 ºC to a stirred solution of (Z)-3-phenylprop-
2-en-1-amine (50 mg, 0.38 mmol) in dichloromethane (1 mL). The resulting reaction mixture then 
underwent a dropwise addition of triethylamine (31 μL, 0.42 mmol) before being warmed to room 
temperature and stirred for 14 hours. The resulting solution was then quenched with sat. aq. NH4Cl 
solution (1 mL), extracted with dichloromethane (2 x 2 mL), and the organic fractions combined, dried 
over anhydrous MgSO4, and concentrated in vacuo. The crude residue was purified by silica column 
chromatography, eluting with 20% ethyl acetate in petroleum ether 40–60 to furnish the title product 
as a white crystalline solid (41 mg, 0.17 mmol, 23% over two steps).  
1H NMR (400 MHz, CDCl3) δ: 7.76–7.74 (m, 2H, H-3), 7.52–7.49 (m, 1H, H-1), 7.45–7.41 (m, 2H, H-
2), 7.39–7.36 (m, 2H, H-12), 7.30–7.28 (m, 3H, H-11,13), 6.66 (d, J = 11.6 Hz, 1H, H-9), 6.23 (br. s, 
1H, H-6), 5.79 (dt, J = 11.6, 6.7 Hz, 1H, H-8), 4.37–4.40 (m, 2H, H-7); 13C NMR (100 MHz, CDCl3) 
δ: 167.7 (C-5), 136.6 (C-10), 134.8 (C-4), 132.4 (C-9), 131.8 (C-1), 129.1 (C-11), 128.9 (C-2), 128.7 (C-
13), 128.1 (C-8), 127.7 (C-13), 127.2 (C-3), 38.7 (C-7). Experimental data in agreement with previous 
literature report.157 
 (Z)-2-(3-phenylallyl)isoindoline-1,3-dione 352 
 
Dry triethylamine (2.79 mL, 20.0 mmol) was added dropwise to a suspension of N-propargylphthalimide 
(1.85 g, 10.0 mmol), iodobenzene (1.23 mL, 11.0 mmol), Pd(PPh3)2Cl2 (91 mg, 0.13 mmol) and CuI (51 
mg, 0.27 mmol) in dry acetonitrile (20 mL) held at 0 ºC, with the resulting brown suspension then 
allowed to warm to room temperature and stirred for 18 hours. The yellow reaction mixture was then 
concentrated in vacuo and the residue dissolved in ethyl acetate (50 mL). This solution was then washed 
with water (20 mL) and brine (2 x 20 mL), dried over MgSO4 and concentrated in vacuo to give the crude 
coupled alkyne, 2-(3-phenylprop-2-yn-1-yl)isoindoline-1,3-dione (2.01 g, 7.70 mmol) as an orange powder, 
reacted on without further purification.  
1H NMR (400 MHz, CDCl3) δ: 7.93 (dd, J = 5.4, 3.2 Hz, 2H, H-1), 7.77 (dd, J = 5.4, 3.2 Hz, 2H, H-
2), 7.46–7.42 (m, 2H, H-9), 7.32–7.27 (m, 3H, H-10,11), 4.71 (s, 2H, H-5). 
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Subsquently prepared according to general procedure B with Ni(OAc)2•4H2O (383 mg, 1.54 mmol), 
NaBH4 (56.9 mg, 1.50 mmol), ethylenediamine (0.36 mL, 5.39 mmol) and the crude alkyne, 2-(3-
phenylprop-2-yn-1-yl)isoindoline-1,3-dione, (2.01 g, 7.70 mmol) in a total volume of 47 mL ethanol with 
stirring for 6 hours. Crude product purified by silica column chromatography, eluting with a gradient 
of 0 to 20% ethyl acetate in a 10% solution of dichloromethane in petroleum ether 40–60, to give the 
solid product (Z)-2-(3-phenylallyl)isoindoline-1,3-dione (137 mg, 0.52 mmol, 5% over two steps) as an 
inseparable 10:1 mixture of alkene product to corresponding over-reduced alkane by-product.  
RF 0.24 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3044, 3026, 1771, 1702 (C=O), 1427, 
1395, 1323, 1109; 1H NMR (400 MHz, CDCl3) δ: 7.84–7.80 (m, 2H, H-1), 7.71–7.67 (m, 2H, H-2), 
7.38–7.36 (m, 4 H, H-9,10), 7.30 (m, 1H, H-11), 6.60 (dt, J = 11.6, 1.9 Hz, 1H, H-7), 5.65 (dt, J = 11.6, 
6.4 Hz, 1H, H-6), 4.57 (dd, J = 6.4, 1.9 Hz, 2H, H-5); 13C NMR (100 MHz, CDCl3) δ: 168.1 (C-4), 
136.3 (C-8), 134.0 (C-2), 132.2 (C-3), 132.1 (C-7), 128.9 (C-9), 128.5 (C-10), 127.4 (C-11), 125.9 (C-6), 
123.3 (C-1), 36.6 (C-5); HRMS-ESI (m/z) found [M+H]+ 264.1018, C17H14NO requires 264.1019. 
(Z)-N-(3-(4-chlorophenyl)allyl)pivalamide 356 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (296 mg, 1.19 mmol), NaBH4 (45.0 
mg, 1.19 mmol), ethylenediamine (0.28 mL, 4.15 mmol) and N-(3-(4-chlorophenyl)prop-2-yn-1-yl)pivalamide 
356a (1.50 g, 6.00 mmol) in a total volume of 20 mL ethanol with stirring for 14 hours. Crude product 
purified by silica column chromatography, eluting with a gradient of 10 to 20% ethyl acetate in 
petroleum ether 40–60, to yield the title compound as a pale yellow crystalline solid (1.09 g, 4.3 mmol, 
78%).  
Tm 74–76 ºC; IR νmax/cm-1 (film): 3340 (br., N–H), 2964, 2905, 1635 (C=O), 1524, 1491, 1366, 1207, 
1092, 1013; 1H NMR (400 MHz, CDCl3) δ: 7.28 (d, J = 8.4 Hz, 2H, H-9), 7.14 (d, J = 8.4 Hz, 2H, H-
10), 6.47 (d, J = 11.6 Hz, 1H, H-7), 5.83 (br. s, 1H, H-4), 5.63 (dt, J = 11.6, 6.3 Hz, 1H, H-6), 4.09 
(ddd, J = 6.3, 5.2, 1.7 Hz, 2H, H-5), 1.16 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 178.4 (C-3), 
134.9 (C-8), 133.1 (C-11), 130.2 (C-7), 130.1 (C-10), 129.3 (C-6), 128.5 (C-9), 38.7 (C-2), 38.0 (C-5), 27.6 
(C-1); HRMS-ESI (m/z) found [M+H]+ 252.1152, C14H19NOCl requires 252.1150. 
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(Z)-N-(3-(4-methoxyphenyl)allyl)pivalamide 360157 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (296 mg, 1.19 mmol), NaBH4 (45.0 
mg, 1.19 mmol), ethylenediamine (0.28 mL, 4.15 mmol) and N-(3-(4-methoxyphenyl)prop-2-yn-1-
yl)pivalamide 360a (1.47 g, 6.00 mmol) in a total volume of 20 mL ethanol with stirring for 24 hours. 
Crude product purified by silica column chromatography, eluting with a gradient of 20 to 50% ethyl 
acetate in petroleum ether 40–60, to yield the title compound as a white crystalline solid (1.17 g, 4.68 
mmol, 78%).  
1H NMR (400 MHz, CDCl3) δ: 7.17 (d, J = 8.7 Hz, 2H, H-9), 6.89 (d, J = 8.7, Hz, 2H, H-10), 6.53 (d, 
J = 11.6 Hz, 1H, H-7), 5.67 (br. s, 1H, H-4), 5.56 (dt, J = 11.6, 6.7 Hz, 1H, H-6), 4.15–4.18 (m, 2H, H-
5), 3.82 (s, 3H, H-12), 1.19 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 178.7 (C-3), 159.2 (C-11), 131.6 
(C-7), 130.5 (C-9), 129.4 (C-8), 126.9 (C-6), 114.2 (C-10), 55.7 (C-12), 39.0 (C-2), 38.4 (C-5), 28.0 (C-1). 
Spectroscopic data consistent with those reported in the literature.157 
(Z)-N-(3-(p-tolyll)allyl)pivalamide 361157 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (74.5 mg, 0.30 mmol), NaBH4 (11.3 
mg, 0.30 mmol), ethylenediamine (70 μL, 1.04 mmol) and N-(3-(p-tolyl)prop-2-yn-1-yl)pivalamide 361a 
(344 mg, 1.50 mmol) in a total volume of 5 mL ethanol with stirring for 18 hours. Crude product purified 
by silica column chromatography, eluting with 5% ethyl acetate in petroleum ether 40–60, to yield the 
title compound as a pale yellow crystalline solid (198 mg, 0.86 mmol, 58%).  
1H NMR (400 MHz, CDCl3) δ: 7.17–7.10 (m, 4H, H-9,10), 6.54 (d, J = 11.6 Hz, 1H, H-7), 5.72 (br. s, 
1H, H-4), 5.60 (dt, J = 11.6, 6.7 Hz, 1H, H-6), 4.15 (ddd, J = 6.7, 5.3, 1.6 Hz, 2H, H-5), 2.34 (s, 3H, 
H-12), 1.18 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 178.3 (C-3), 137.2 (C-11), 133.6 (C-8), 131.7 
(C-7), 129.1 (C-10), 128.8 (C-9), 127.7 (C-6), 38.7 (C-2), 38.0 (C-5), 27.6 (C-1), 21.3 (C-12). Spectroscopic 
data consistent with those reported in the literature.157 
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(Z)-N-(3-(naphthalen-2-yl)allyl)pivalamide 362 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (210 mg, 0.840 mmol), NaBH4 (31.9 
mg, 0.840 mmol), ethylenediamine (0.200 mL, 2.95 mmol) and N-(3-(naphthalen-2-yl)prop-2-yn-1-
yl)pivalamide 362a (1.11 g, 4.20 mmol) in a total volume of 10 mL ethanol with stirring for 18 hours. 
Crude residue purified by silica column chromatography, eluting with 20% ethyl acetate in petroleum 
ether 40–60 to furnish the title compound as a white crystalline solid (880 mg, 3.27 mmol, 78%).  
Tm 93–97 ºC; IR νmax/cm-1 (film): 3341 (br., N–H), 3059, 2952, 1633 (C=O), 1528, 1481, 1362, 1288, 
1203, 822; 1H NMR (500 MHz, CDCl3) δ: 7.84–7.79 (m, 3H, H-10,12,15), 7.68 (s, 1H, H-17), 7.51–
7.45 (m, 2H, H-13,14), 7.38 (dd, J = 8.3, 1.7 Hz, 1H, H-9), 6.23 (dt, J = 11.5, 1.9 Hz, 1H, H-7), 5.74 
(dt, J = 11.5, 5.7 Hz, 2H, H-3,6), 4.27 (ddd, J = 7.1, 5.7, 1.9 Hz, 2H, H-5), 1.18 (s, 9H, H-1); 13C NMR 
(125 MHz, CDCl3) δ: 178.4 (C-3), 134.0 (C-11), 133.3 (C-16), 132.6 (C-8), 131.7 (C-7), 128.9 (C-6), 128.2 
(C-10), 128.0 (C-15), 127.9 (C-17), 127.7 (C-12), 127.0 (C-9), 126.4 (C-13/14), 126.2 (C-13/14), 38.8 
(C-2), 38.1 (C-5), 27.7 (C-1); HRMS-ESI (m/z) found [M+H]+ 268.1697, C18H22NO requires 268.1696. 
(Z)-N-(3-(4-bromophenyl)allyl)pivalamide 363157 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (287 mg, 1.15 mmol), NaBH4 (43.5 
mg, 1.15 mmol), ethylenediamine (0.27 mL, 4.02 mmol) and N-(3-(4-bromophenyl)prop-2-yn-1-yl)pivalamide 
363a (1.71 g, 5.80 mmol) in a total volume of 20 mL ethanol with stirring for 18 hours. Crude product 
purified by silica column chromatography, eluting with a gradient of 20 to 50% ethyl acetate in 
petroleum ether 40–60, to yield the title compound as a pale yellow crystalline solid (1.02 g, 3.42 mmol, 
59%).  
1H NMR (500 MHz, CDCl3) δ: 7.47 (d, J = 8.4 Hz, 2H, H-9), 7.12 (d, J = 8.4 Hz, 2H, H-10), 6.50 (d, 
J = 11.6 Hz, 1H, H-7), 5.73 (br. s, 1H, H-4), 5.67 (dt, J = 11.6, 6.6 Hz, 1H, H-6), 4.12 (td, J = 6.6, 1.8 
Hz, 2H, H-5), 1.19 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 178.6 (C-3), 135.6 (C-8), 131.8 (C-10), 
130.7 (C-9), 130.6 (C-7), 129.6 (C-6), 121.6 (C-11), 39.0 (C-2), 38.2 (C-5), 27.9 (C-1). Spectroscopic data 
consistent with those reported in the literature.157 
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(Z)-N-(3-(1-(phenylsulfonyl)-1H-indol-3-yl)allyl)pivalamide 364 
 
Prepared according to general procedure B with increased equivalents of Ni(OAc)2•4H2O (900 mg, 3.62 
mmol), NaBH4 (138 mg, 3.65 mmol) and ethylenediamine (0.85 mL, 12.7 mmol) and N-(3-(1-
(phenylsulfonyl)-1H-indol-3-yl)prop-2-yn-1-yl)pivalamide 364a (2.40 g, 6.10 mmol) in total volume of 6 mL 
ethanol with stirring for 24 hours. Crude residue purified by silica column chromatography, eluting with 
20 to 50% ethyl acetate in petroleum ether 40–60 to furnish the title compound as a white crystalline 
solid (1.69 g, 4.27 mmol, 70%).  
Tm 115–118 ºC; IR νmax/cm-1 (film): 3349 (br., N–H), 2968, 2909, 1641 (C=O), 1518, 1447, 1368, 1175, 
1136, 1092, 749; 1H NMR (500 MHz, CDCl3) δ: 8.01 (d, 1H, J = 8.3 Hz, H-13), 7.94–7.90 (m, 2H, H-
17), 7.57–7.48 (m, 3H, H-10,15,19), 7.47–7.43 (m, 2H, H-18), 7.35 (ddd, J = 8.3, 7.2, 0.9 Hz, 1H, H-
12), 7.27 (ddd, J = 7.9, 7.2, 1.1 Hz, 1H, H-11), 6.56 (app. dq, J = 11.3, 0.9 Hz, 1H, H-7), 5.85–5.75 (m, 
2H, H-4,6), 4.33 (app. td, J = 6.4, 1.8 Hz, 2H, H-5), 1.22 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 
178.5 (C-3), 138.1 (C-16), 134.8 (C-14), 134.1 (C-19), 130.5 (C-9), 130.4 (C-6), 129.5 (C-18), 127.0 (C-
17), 125.3 (C-12), 124.1 (C-15), 123.6 (C-11), 120.3 (C-7), 119.6 (C-10), 118.3 (C-8), 113.8 (C-13), 38.8 
(C-5), 27.7 (C-1); HRMS-ESI (m/z) found [M+H]+ 397.1577, C22H25N2O3S requires 397.1580. 
(Z)-N-(3-(benzo[d][1,3]dioxol-5-yl)allyl)pivalamide 365 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (487 mg, 1.96 mmol), NaBH4 (74.0 
mg, 1.96 mmol), ethylenediamine (0.46 mL, 6.83 mmol) and N-(3-(benzo[d][1,3]dioxol-5-yl)prop-2-yn-1-
yl)pivalamide 365a (2.54 g, 9.80 mmol) in a total volume of 30 mL ethanol with stirring for 22 hours. 
Crude residue purified by silica column chromatography, eluting with 10 to 30% ethyl acetate in 
petroleum ether 40–60 to furnish the title compound as a white crytalline solid (2.09 g, 7.94 mmol, 81%).  
Tm 53–55 ºC; IR νmax/cm-1 film): 3333 (br., N–H), 2964, 2901, 1633 (C=O), 1524, 1504, 1488, 1441, 
1237, 1207, 1037; 1H NMR (400 MHz, CDCl3) δ: 6.77 (d, J = 7.9 Hz, 1H, H-10), 6.72–6.69 (m, 2H, 
H-9,13), 6.45 (dt, J = 11.7, 1.8 Hz, 1H, H-7), 5.94 (s, 2H, H-14), 5.78 (br. s, 1H, H-4), 5.54 (dt, J = 11.7, 
6.7 Hz, 1H, H-6), 4.12 (ddd, J = 6.7, 5.3, 1.8 Hz, 2H, H-5), 1.18 (s, 9H, H-1); 13C NMR (100 MHz, 
CDCl3) δ: 178.4 (C-3), 147.7 (C-12), 146.8 (C-11), 131.2 (C-7), 130.5 (C-8), 127.3 (C-6), 122.7 (C-13), 
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109.0 (C-9), 108.3 (C-10), 101.1 (C-14), 38.7 (C-2), 38.1 (C-5), 27.6 (C-1); HRMS-ESI (m/z) found 
[M+H]+ 262.1437, C15H20NO3 requires 262.1438.  
 (Z)-N-(3-(thiophen-2-yl)allyl)pivalamide 366 
 
Prepared according to general procedure B with Ni(OAc)2•4H2O (502 mg, 2.03 mmol), NaBH4 (76.9 
mg, 2.03 mmol), ethylenediamine (0.48 mL, 7.10 mmol) and N-(3-(thiophen-2-yl)prop-2-yn-1-yl)pivalamide 
366a (2.24 g, 10.1 mmol) in total volume of 25 mL ethanol with stirring for 18 hours. The reaction 
mixture was observed to be incomplete following work-up and so was re-exposed to these conditions 
with increased equivalents of NaBH4 (308 mg, 8.12 mmol), Ni(OAc)2(H2O)4 (2.01 g, 8.12 mmol) and 
ethylene diamine (1.92 mL, 28.4 mmol) in 100 mL ethanol. Crude residue purified by silica column 
chromatography, eluting with 20–50% diethyl ether in petroleum ether 40–60 to furnish the title 
compound as an off-white solid (1.57 g, 7.00 mmol, 69%).  
Tm 47–49 ºC; IR νmax/cm-1 (film): 3341 (br., N–H), 2964, 1641 (C=O), 1526, 1481, 1366, 1292, 1211, 
852, 696; 1H NMR (500 MHz, CDCl3) δ: 7.29 (br. d, J = 5.0 Hz, 1H, H-11), 7.02 (dd, J = 5.0, 3.5 Hz, 
1H, H-10), 6.99 (br. d, J = 3.5 Hz, 1H, H-9), 6.63 (dt, J = 11.5, 1.7 Hz, 1H, H-7), 5.81 (br. s, 1H, H-4), 
5.57 (dt, J = 11.5, 6.8 Hz, 1H, H-6), 4.23 (ddd, J = 6.8, 5.4, 1.7 Hz, 2H, H-5), 1.21 (s, 9H, H-1); 13C 
NMR (125 MHz, CDCl3) δ: 178.5 (C-3), 139.3 (C-8), 128.2 (C-9), 127.3 (C-10), 126.6 (C-6), 126.2 (C-
11), 124.1 (C-7), 38.8 (C-2), 38.4 (C-5), 27.7 (C-1); HRMS-ESI (m/z) found [M+H]+ 224.1104, 
C12H18NOS requires 224.1104. 
6.2.2.3 Available alkene substrates 
I am grateful to Elise Cahard for the use of a number of alkene substrates and precursors that she 
prepared over the course of her PhD studies (Figure 21).  
 
Figure 21 – Substrates and precursors synthesised by Elise Cahard during her PhD studies 
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6.2.3. Hexafluorophosphate iodonium salt synthesis 
6.2.3.1 Available iodonium salt precursors 
The Gaunt laboratory maintains a stock of aryl(mesityl)iodonium triflates as reagents. Several of these 
iodonium salts were used during these studies (Figure 22). Full experimental procedures for the synthesis 
of the below aryl(mesityl)iodonium triflates have been reported by our laboratory and are not given 
within this document.iii I am grateful to previous members of the Gaunt group for this resource. 
 
Figure 22 – Iodonium salts available within the Gaunt group 
6.2.3.2 Iodonium salt synthesis 
(3-bromophenyl)(mesityl)iodonium hexafluorophosphate(V) 338139 
 
Prepared according to general procedure C with (3-bromophenyl)(mesityl)iodonium triflate 338a (866 mg, 
1.50 mmol) and sat. aq. NaPF6 solution (3.0 mL) in dichloromethane (3.0 mL) with stirring for 24 hours 
to yield the title compound as a white powder (699 mg, 1.28 mmol, 85%).  
1H NMR (400 MHz, d6-DMSO) δ: 8.28 (app. t, J = 1.7 Hz, 1H, H-12), 7.89 (ddd, J = 7.9, 1.6, 0.8 Hz, 
1H, H-8), 7.83 (ddd, J = 8.1, 1.8, 0.8 Hz, 1H, H-10), 7.44 (app. t, J = 8.1 Hz, 1H, H-9), 7.23 (s, 2H, H-
3), 2.61 (s, 6H, H-5), 2.30 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 143.4 (C-4), 141.7 (C-2), 
136.2 (C-11), 134.8 (C-12), 133.5 (C-8), 133.1 (C-10), 129.9 (C-3), 123.4 (C-9), 122.6 (C-1), 115.0 (C-7), 
26.3 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –71.0 (d, JF–P = 711.5 Hz). Experimental data 
in agreement with previous literature report.139 
                                               
iii (a) Phipps, R. J.; Gaunt, M. J. Science 2009, 323, 1593–1597; (b) Bigot, A.; Williamson, A. E.; Gaunt, M. J. J. Am. Chem. Soc. 
2011, 133, 13778–13781; (c) Suero, M. G.; Bayle, E. D.; Collins, B. S. L.; Gaunt, M. J. J. Am. Chem. Soc. 2013, 135, 5332–
5335. 
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(4-trifluoromethylphenyl)(mesityl)iodonium hexafluorophosphate(V) 367 
 
Prepared according to general procedure C with (4-trifluoromethylphenyl)(mesityl)iodonium triflate 367a (1.13 
g, 2.00 mmol) and sat. aq. NaPF6 solution (4.0 mL) in dichloromethane (4.0 mL) with stirring for 24 
hours to yield the title compound as a white powder (829 mg, 1.48 mmol, 74%).  
IR νmax/cm-1 (powder): 1596, 1399, 1322, 1179, 1132, 1064, 999, 840, 773, 739; 1H NMR (400 MHz, 
d6-DMSO) δ: 8.14 (d, J = 8.5 Hz, 2H, H-8), 7.86 (d, J = 8.5 Hz, 2H, H-9), 7.25 (s, 2H, H-3), 2.60 (s, 
6H, H-5), 2.31 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 143.5 (C-4), 141.8 (C-2), 135.1 (C-8), 
131.7 (q, 2JC–F = 32.4 Hz, C-10), 130.0 (C-3), 128.4 (q, 3JC–F = 4.0 Hz, C-9), 123.4 (q, 1JC–F = 274.3 Hz, 
C-11), 122.6 (C-1), 118.7 (q, 5JC–F = 1.5 Hz, C-7), 26.3 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-
DMSO) δ: –62.6, –71.1 (d, JF–P = 711.2 Hz); HRMS-ESI (m/z) found [M–PF6]+ 391.0161, C16H15F3I 
requires 391.0165. 
(mesityl)(o-tolyl)iodonium hexafluorophosphate(V) 368  
 
Prepared according to general procedure C with (mesityl)(o-tolyl)iodonium triflate 368a (1.02 g, 2.00 mmol) 
and sat. aq. NaPF6 solution (4.0 mL) in dichloromethane (4.0 mL) with stirring for 24 hours to yield the 
title compound as a white powder (792 mg, 1.64 mmol, 82%).  
IR νmax/cm-1 (powder): 3016, 1739, 1456, 1366, 1229, 822; 1H NMR (400 MHz, d6-DMSO) δ: 7.95 (d, 
1H, J = 8.0 Hz, H-8), 7.57–7.55 (m, 2H, H-10,11), 7.27–7.21 (m, 3H, H-9,3), 2.57–2.56 (m, 9H, H-
5,13), 2.29 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 143.4 (C-4), 142.1 (C-2), 141.1 (C-12), 137.1 
(C-8), 132.9 (C-10), 132.3 (C-3), 130.4 (C-11), 129.8 (C-9) 122.3 (C-1), 119.0 (C-7), 26.6 (C-5), 24.9 (C-
13), 20.9 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –70.1 (d, JF–P = 714.4 Hz); HRMS-ESI (m/z) found 
[M–PF6]+ 337.0450, C16H18I requires 337.0448.  
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(2-fluorophenyl)(mesityl)iodonium hexafluorophosphate(V) 369  
 
Prepared according to general procedure C with (2-fluorophenyl)(mesityl)iodonium triflate 369a (1.03 g, 2.00 
mmol) and sat. aq. NaPF6 solution (4.0 mL) in dichloromethane (4.0 mL) with stirring for 24 hours to 
yield the title compound as a white powder (923 mg, 1.90 mmol, 95%).  
IR νmax/cm-1 (film): 3011, 1739, 1474, 1366, 1231, 829, 759; 1H NMR (400 MHz, d6-DMSO) δ: 8.26 
(ddd, J = 8.0, 6.2, 1.3 Hz, 1H, H-10), 7.75–7.68 (m, 1H, H-8), 7.56 (app. td, J = 8.9, 1.3 Hz, 1H, H-9), 
7.35 (dd, J = 8.0, 1.3 Hz, 1H, H-11), 7.20 (s, 2H, H-3), 2.62 (s, 6H, H-5), 2.28 (s, 3H, H-6); 13C NMR 
(100 MHz, d6-DMSO) δ: 159.5 (d, 1JC–F = 248.8 Hz, C-12), 143.2 (C-4), 141.6 (C-2), 137.5 (C-8), 135.4 
(d, 3JC–F = 8.3 Hz, C-10), 129.8 (C-3), 127.6 (d, 4JC–F = 3.0 Hz, C-9), 122.8 (C-1), 117.1 (d, 2JC–F = 22.1 
Hz, C-11), 101.5 (d, 2JC–F = 23.5 Hz, C-7), 26.1 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –
97.6, –70.1 (d, JF–P = 714.4 Hz); HRMS-ESI (m/z) found [M-PF6]+ 341.0197, C15H15FI requires 
341.0197. 
 (mesityl)(6-bromopyridin-3-yl)iodonium hexafluorophosphate(V) 371  
 
Prepared according to general procedure C with (mesityl)(6-bromopyridin-3-yl)iodonium triflate 371a (867 
mg, 1.50 mmol) and sat. aq. NaPF6 solution (3.0 mL) in dichloromethane (3.0 mL) with stirring for 24 
hours to yield the title compound as an off-white powder (647 mg, 1.13 mmol, 75%).  
IR νmax/cm-1 (powder): 1541, 1435, 1355, 1281, 1240, 1086, 979, 843, 826, 809; 1H NMR (400 MHz, 
d6-DMSO) δ: 8.89 (d, J = 2.4 Hz, 1H, H-11), 8.29 (dd, J = 8.6, 2.4 Hz, 1H, H-8), 7.80 (d, J = 8.6 Hz, 
1H, H-9), 7.23 (s, 2H, H-3), 2.61 (s, 6H, H-5), 2.30 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 
153.9 (C-11), 144.6 (C-8), 144.4 (C-10), 143.5 (C-4), 141.7 (C-2), 131.4 (C-9), 129.9 (C-3), 122.8 (C-1), 
113.0 (C-7), 26.3 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –70.1 (d, JF–P = 711.7 Hz); 
HRMS-ESI (m/z) found [M–PF6]+ 401.9346, C14H14NBrI requires 401.9349. 
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(3,4-dichlorophenyl)(mesityl)iodonium trifluoromethanesulfonate 372a 
 
Adapted from a procedure reported by Olofsson et al.3 Trifluoromethanesulfonic acid (0.66 mL, 7.5 mmol) was 
added dropwise to a stirred solution of 1,2-dichloro-4-iodobenzene (1.36 g, 5.0 mmol) and mCPBA 
(70%, 1.27 g, 5.5 mmol - previously dried in vacuo for 2 hours) in dichloromethane (10 mL) held at 0 ºC. 
The resulting yellow suspension was warmed to room temperature and stirred for a further two hours 
before being cooled back to 0 ºC and undergoing a dropwise addition of mesitylene (0.77 mL, 5.5 mmol). 
The resulting orange suspension was warmed to room temperature and stirred for 15 hours. The 
reaction mixture was then concentrated in vacuo and the residue precipitated with cold diethyl ether (10 
mL). The solid was collected by filtration, washed on the filter with further portions of cold diethyl ether 
(3 x 5 mL) and dried in vacuo to yield the corresponding triflate as a white microcrystalline solid (2.46 g, 
4.55 mmol, 91%).  
Tm 161–164 ºC; IR νmax/cm-1 (powder): 1586, 1567, 1457, 1372, 1259, 1249, 1221, 1175, 1138, 1027; 
1H NMR (400 MHz, d6-DMSO) δ: 8.36 (d, J = 2.2 Hz, 1H, H-8), 7.85 (dd, J = 8.6, 2.2 Hz, 1H, H-12), 
7.75 (d, J = 8.6 Hz, 1H, H-11), 7.24 (s, 2H, H-3), 2.60 (s, 6H, H-5), 2.31 (s, 3H, H-6); 13C NMR (100 
MHz, d6-DMSO) δ: 143.5 (C-4), 141.8 (C-2), 135.7 (C-8), 135.4 (C-10), 134.3 (C-12), 133.5 (C-9), 133.4 
(C-11), 129.9 (C-3), 122.8 (C-1), 120.7 (q, 1JC–F = 322.3 Hz, C-Tf), 112.4 (C-7), 26.3 (C-5), 20.6 (C-6); 
19F NMR (376 MHz, d6-DMSO) δ: –77.7; HRMS-ESI (m/z) found [M–OTf]+ 390.9514, C15H14Cl2I 
requires 390.9512. 
(3,4-dichlorophenyl)(mesityl)iodonium hexafluorophosphate(V) 372 
 
Prepared according to general procedure C with (3,4-dichlorophenyl)(mesityl)iodonium triflate 372a (1.13 g, 
2.00 mmol) and sat. aq. NaPF6 solution (4.0 mL) in dichloromethane (4.0 mL) with stirring for 24 hours 
to yield the title compound as a white powder (978 mg, 1.82 mmol, 91%).  
IR νmax/cm-1 (powder): 1588, 1560, 1453, 1380, 1368, 1302, 1251, 1136, 1027, 824; 1H NMR (500 
MHz, d6-DMSO) δ: 8.35 (d, J = 2.2 Hz, 1H, H-8), 7.84 (dd, J = 8.7, 2.2 Hz, 1H, H-12), 7.75 (d, J = 8.7 
Hz, 1H, H-11), 7.24 (s, 2H, H-3), 2.60 (s, 6H, H-5), 2.31 (s, 3H, H-6); 13C NMR (125 MHz, d6-DMSO) 
δ: 143.5 (C-4), 141.9 (C-2), 135.7 (C-8), 135.4 (C-10), 134.3 (C-12), 133.6 (C-9), 133.5 (C-11), 130.0 (C-
3), 122.9 (C-1), 112.5 (C-7), 26.4 (C-5), 20.6 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –71.1 (d, JF–P = 
711.3 Hz); HRMS-ESI (m/z) found [M–PF6]+ 390.9500, C15H14Cl2I requires 390.9512. 
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(mesityl)(phenyl)iodonium hexafluorophosphate(V) 373 
 
Prepared according to general procedure C with (mesityl)(phenyl)iodonium triflate 247 (748 mg, 1.50 mmol) 
and sat. aq. NaPF6 solution (3.0 mL) in dichloromethane (3.0 mL) with stirring for 24 hours to yield the 
title compound as a white powder (554 mg, 1.18 mmol, 79%).  
IR νmax/cm-1 (powder): 1582, 1471, 1447, 1302, 1243, 1029, 991, 979, 824, 745; 1H NMR (400 MHz, 
d6-DMSO) δ: 7.99 (d, J = 7.4 Hz, 2H, H-8), 7.63 (t, J = 7.5 Hz, 1H, H-10), 7.50 (app. t, J = 7.8 Hz, 
2H, H-9), 7.22 (s, 2H, H-3), 2.61 (s, 6H, H-5), 2.29 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 
143.2 (C-4), 141.6 (C-2), 134.5 (C-9), 131.9 (C-10), 131.8 (C-8), 129.8 (C-3), 122.6 (C-1), 114.5 (C-7), 
26.3 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –71.0 (d, JF–P = 711.4 Hz); HRMS-ESI (m/z) 
found [M–PF6]+ 323.0291, C15H16I requires 323.0291. 
(4-methoxyphenyl)(mesityl)iodonium hexafluorophosphate(V) 374139 
 
Prepared according to general procedure C with (4-methoxyphenyl)(mesityl)iodonium triflate 374a (793 mg, 
1.50 mmol) and sat. aq. NaPF6 solution (3.0 mL) in dichloromethane (3.0 mL) with stirring for 24 hours 
to yield the title compound as a white powder (663 mg, 1.33 mmol, 87%).  
1H NMR (400 MHz, d6-DMSO) δ: 7.93 (d, J = 9.1 Hz, 2H, H-8), 7.19 (s, 2H, H-3), 7.04 (d, J = 9.1 Hz, 
2H, H-9), 3.78 (s, 3H, H-11), 2.62 (s, 6H, H-5), 2.28 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 
161.8 (C-10), 142.9 (C-4), 141.4 (C-2), 136.6 (C-8), 129.7 (C-3), 123.1 (C-1), 117.5 (C-9), 103.4 (C-7), 
55.7 (C-11), 26.2 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –71.1 (d, JF–P = 711.5 Hz). 
Experimental data in agreement with previous literature report.6 
(2-napthyl)(mesityl)iodonium tetrafluoroborate 375a 
 
Boron trifluoride diethyl etherate (0.400 mL, 3.30 mmol) was added dropwise at 0 ºC to a stirred solution 
of 2-napthylboronic acid (516 mg, 3.00 mmol) in dichloromethane (30 mL). To this suspension was 
added a solution of iodomesitylene diacetate (1.20 g, 3.30 mmol) in dichloromethane (10 mL) and the 
resulting solution was stirred at 0 ºC for two hours. The reaction was quenched upon the addition of sat. 
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aq. NaBF4 solution (60 mL) and the resulting biphasic mixture was stirred vigorously for a further thirty 
minutes. The phases were then separated and the aqueous layer extracted with dichloromethane (2 x 20 
mL). The organic layers were combined, dried over anhydrous MgSO4 and concentrated in vacuo. The 
solid residues were suspended in diethyl ether (20 mL), vigorously stirred for 15 minutes and then stored 
at – 18 ºC for 18 hours. The resulting cold suspension was filtered and the solid washed with further 
quantities of diethyl ether to furnish the title compound as a brown powder (1.09 g, 2.37 mmol, 79%).  
IR νmax/cm-1 (powder): 1576, 1499, 1453, 1443, 1386, 1347, 1303, 1282, 1046, 1029, 930; 1H NMR 
(400 MHz, d6-DMSO) δ: 8.72 (s, 1H, H-16), 8.07–7.90 (m, 4H, H-8,9,11,14), 7.69–7.60 (m, 2H, H-
12,13), 7.16 (s, 2H, H-3), 2.64 (s, 6H, H-5), 2.22 (s, 3H, H-6); 13C NMR (100 MHz, d6-DMSO) δ: 143.5 
(C-4), 141.9 (C-2), 135.8 (C-16), 134.3 (C-15), 133.6 (C-10), 131.9 (C-9), 130.1 (C-3), 130.0 (C-8), 129.2 
(C-12), 128.4 (C-14), 128.34 (C-11), 128.26 (C-13), 123.0 (C-1), 111.7 (C-7), 26.7 (C-5), 20.7 (C-6); 19F 
NMR (376 MHz, d6-DMSO) δ: [–148.9, –149.0]; HRMS-ESI (m/z) found [M–BF4]+ 373.0438, C19H18I 
requires 373.0448. 
(2-napthyl)(mesityl)iodonium hexafluorophosphate(V) 375 
 
Prepared according to general procedure C with (2-napthyl)(mesityl)iodonium tetrafluoroborate 375a (972 mg, 
2.00 mmol) and sat. aq. NaPF6 solution (4.0 mL) in dichloromethane (4.0 mL) with stirring for 20 hours 
to yield the title compound as a white powder (890 mg, 1.72 mmol, 86%).  
IR νmax/cm-1 (film): 3079, 2990, 2925, 1576, 1500, 1450, 1381, 1301, 1132, 931, 825; 1H NMR (400 
MHz, d6-DMSO) δ: 8.72 (s, 1H, H-16), 8.07–7.96 (m, 3H, H-9,11,14), 7.93 (dd, J = 8.8, 1.6 Hz, 1H, 
H-8), 7.69–7.60 (m, 2H, H-12,13), 7.17 (s, 2H, H-3), 2.64 (s, 6H, H-5), 2.24 (s, 3H, H-6); 13C NMR (100 
MHz, d6-DMSO) δ: 143.6 (C-4), 141.9 (C-2), 135.8 (C-16), 134.3 (C-15), 133.6 (C-10), 131.9 (C-9), 130.1 
(C-3), 130.0 (C-8), 129.2 (C-12), 128.4 (C-14), 128.4 (C-11), 128.3 (C-13), 123.0 (C-1), 111.7 (C-7), 26.7 
(C-5), 20.7 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –70.0 (d, JF–P = 711.7 Hz); HRMS-ESI (m/z) found 
[M–PF6]+ 373.0446, C16H18I requires 373.0448; 
(thiophen-3-yl)(mesityl)iodonium hexafluorophosphate(V) 376 
 
Prepared according to general procedure C with (thiophen-3-yl)(mesityl)iodonium triflate 376a (756 mg, 1.50 
mmol) and sat. aq. NaPF6 solution (3.0 mL) in dichloromethane (3.0 mL) with stirring for 24 hours to 
yield the title compound as a white powder (636 mg, 1.16 mmol, 77%).  
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IR νmax/cm-1 (powder): 1576, 1451, 1381, 1302, 1201, 1080, 1035, 981, 824, 773; 1H NMR (400 MHz, 
d6-DMSO) δ: 8.50 (dd, J = 2.9, 1.2 Hz, 1H, H-8), 7.79 (dd, J = 5.2, 2.9 Hz, 1H, H-9), 7.53 (dd, J = 5.2, 
1.2 Hz, 1H, H-10), 7.20 (s, 2H, H-3), 2.63 (s, 6H, H-5), 2.28 (s, 3H, H-6); 13C NMR (100 MHz, d6-
DMSO) δ: 143.0 (C-4), 141.2 (C-2), 135.2 (C-8), 131.3 (C-9), 130.7 (C-10), 129.7 (C-3), 123.6 (C-1), 98.8 
(C-7), 26.3 (C-5), 20.5 (C-6); 19F NMR (376 MHz, d6-DMSO) δ: –70.2 (d, JF–P = 711.5 Hz); HRMS-ESI 
(m/z) found [M–PF6]+ 328.9854, C13H14IS requires 328.9855. 
6.2.4. Enamide products and derivatives 
(R)-N-[(1Z)-3-(3-bromophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 332 
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (109 mg, 0.500 
mmol), (3-bromophenyl)(mesityl)iodonium hexafluorophosphate 338 (547 mg, 1.00 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50.0 μmol) in 
dichloromethane (4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 20% ethyl 
acetate in petroleum ether 40–60, provided the title compound as a white amorphous solid (102 mg, 
0.280 mmol, 55%).  
RF 0.50 (20% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 2963, 2849, 2321, 1649 (C=O), 1487, 1277, 
1181, 749; 1H NMR (400 MHz, CDCl3) δ: 7.42 (app. t, J = 2.5 Hz, 1H, H-17), 7.32–7.39 (m, 3H, H-
10,13), 7.26–7.29 (m, 3H, H-9,11), 7.18–7.21 (m, 2H, H-14,15), 6.91 (ddd, J = 10.7, 8.6, 1.9 Hz, 1H, 
H-5), 6.84 (br. d, J = 10.7 Hz, 1H, H-4), 5.17 (dd, J = 8.6 Hz, 5.9 Hz, 1H, H-6), 4.78 (dd, J = 5.9, 1.9 
Hz, 1H, H-7), 0.96 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 175.6 (C-3), 146.1 (C-12), 142.7 (C-8), 
131.3 (C-17), 130.6 (C-14), 130.1 (C-13), 129.3 (C-10), 128.3 (C-9), 127.4 (C-11), 126.9 (C-15), 123.2 
(C-5), 123.1 (C-16), 111.9 (C-6), 49.1 (C-7), 38.8 (C-2), 27.2 (C-1); HRMS-ESI (m/z) found [M]+ 
372.0963, C20H22NOBr requires 372.0958; [α]20D = –8.2 º (c = 1.0, CHCl3), calculated with sample e.e. 
of 92%; HPLC analysis (IC, 20% i-PrOH in n-hexane, 1 mL/min, 219 nm) indicated 95% e.e.: tR (minor) 
= 9.24 minutes, tR (major) = 12.57 minutes. 
(R)-N-[(1Z)-3-(3-bromophenyl)-3-(4-chlorophenyl)prop-1-en-1-yl]-2,2-dimethylpropanamide 378 
 
Prepared according to general procedure D with (Z)-N-(3-(4-chlorophenyl)allyl)pivalamide 356 (126 mg, 
0.50 mmol), (3-bromophenyl)(mesityl)iodonium hexafluorophosphate 338 (547 mg, 1.00 mmol), 2,6-di-tert-butyl 
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pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 20% ethyl acetate in petroleum 
ether 40–60, provided the title compound as a colourless oil (86.0 mg, 0.21 mmol, 42%).  
RF 0.40 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3436 (br., N–H), 2968, 1683, 1653 (C=O), 
1590, 1566, 1485, 1272, 1177, 1094, 1013, 785; 1H NMR (400 MHz, CDCl3) δ: 7.43–7.37 (m, 2H, H-
13,17), 7.32 (d, J = 8.1 Hz, 2H, H-10), 7.25–7.15 (m, 4H, H-9,14,15), 6.92 (ddd, J = 10.9, 8.8, 1.9 Hz, 
1H, H-5), 6.84 (br. d, J = 10.9 Hz, 1H, H-4), 5.13 (dd, J = 8.8, 6.0 Hz, 1H, H-6), 4.76 (d, J = 6.0 Hz, 
1H, H-7), 0.99 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 175.6 (C-3), 145.5 (C-12), 141.3 (C-8), 
133.2 (C-11), 131.2 (C-17), 130.8 (C-14), 130.4 (C-13), 129.6 (C-9), 129.4 (C-10), 126.9 (C-15), 123.4 
(C-5), 123.3 (C-16), 111.3 (C-6), 48.2 (C-7), 38.9 (C-2), 27.2 (C-1); HRMS-ESI (m/z) found [M+H]+ 
408.0546, C20H22NOClBr requires 408.0545; [α]20D = +2.2 º (c = 1.0, CHCl3); HPLC analysis (IC, 20% 
i-PrOH in n-hexane, 1 mL/min, 231 nm) indicated 93% e.e.: tR (major) = 10.81 minutes, tR (minor) = 
11.73 minutes. 
(S)-N-[(1Z)-3-(3-bromophenyl)-3-(2-fluorophenyl)prop-1-en-1-yl]-2,2-dimethylpropanamide 379 
 
Prepared according to general procedure D with (Z)-N-(3-(2-fluorophenyl)allyl)pivalamide 357 (118 mg, 
0.50 mmol), (3-bromophenyl)(mesityl)iodonium hexafluorophosphate 338 (547 mg, 1.00 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 20% ethyl acetate in petroleum 
ether 40–60, provided the title compound as a colourless oil (25.0 mg, 0.06 mmol, 12%).  
RF 0.40 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3448 (br., N–H), 3349, 2964, 1677, 1649 
(C=O), 1588, 1483, 1456, 1399, 1253, 1223, 1175, 1090, 755; 1H NMR (400 MHz, CDCl3) δ: 7.45 (app. 
t, J = 1.7 Hz, 1H, H-19), 7.39 (app. dt, J = 7.4, 1.6 Hz, 1H, H-17), 7.29–7.20 (m, 4H, H-9,11,15,16), 
7.14 (app. td, J = 7.7, 1.7 Hz, 1H, H-10), 7.11–7.03 (m, 2H, H-4,12), 6.92 (dd, J = 10.9, 8.2 Hz, 1H, 
H-5), 5.20–5.11 (m, 2H, H-6,7), 1.05 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 175.7 (C-3), 160.4 
(d, 1JC–F = 246.1 Hz, C-13), 144.6 (C-14), 131.2 (C-19), 130.6 (C-16), 130.3 (C-17), 129.8 (d, 2JC–F = 
15.1 Hz, C-8), 129.6 (d, 3JC–F = 3.9 Hz, C-9), 129.0 (d, 3JC–F = 8.4 Hz, C-11), 126.9 (C-15), 125.0 (d, 
4JC–F = 3.5 Hz, C-10), 123.3 (C-5), 123.1 (C-18), 115.9 (d, 2JC–F = 22.5 Hz, C-12), 110.6 (C-6), 40.7 (d, 
3JC–F = 2.8 Hz, C-7), 38.9 (C-2), 27.2 (C-1); HRMS-ESI (m/z) found [M+H]+390.0858, C20H22NOFBr 
requires 390.0863; [α]22D = –23.4 º (c = 1.3, CHCl3); HPLC analysis (IC, 20% i-PrOH in n-hexane, 1 
mL/min, 200 nm) indicated 89% e.e.: tR (minor) = 8.36 minutes, tR (major) = 11.87 minutes. 
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(S)-N-[(1Z)-3-(3-bromophenyl)-3-(2-methylphenyl)prop-1-en-1-yl]-2,2-dimethylpropanamide 380 
 
Prepared according to general procedure D with (Z)-N-(3-(o-tolyl)allyl)pivalamide 358 (116 mg, 0.50 
mmol), (3-bromophenyl)(mesityl)iodonium hexafluorophosphate 338 (547 mg, 1.00 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 20% ethyl acetate in petroleum 
ether 40–60, provided the title compound as an amorphous white solid (67 mg, 0.17 mmol, 34%).  
RF 0.38 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3429 (br., N–H), 2964, 1679, 1647 (C=O), 
1593, 1566, 1479, 1461, 1179, 1072, 935, 749; 1H NMR (500 MHz, CDCl3) δ: 7.41–7.36 (m, 2H, H-
18,20), 7.24–7.13 (m, 6H, H-9,10,11,12,16,17), 6.90 (ddd, J = 10.5, 8.8, 1.5 Hz, 1H, H-5), 6.82 (br. d, 
J = 10.5 Hz, 1H, H-4), 5.10 (dd, J = 8.8, 5.9 Hz, 1H, H-6), 4.97 (dd, J = 5.9, 1.5 Hz, 1H, H-7), 2.32 (s, 
3H, H-14), 0.93 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 175.6 (C-3), 145.4 (C-15), 140.4 (C-8), 
136.5 (C-13), 131.6 (C-20), 131.3 (C-12), 130.5 (C-16), 130.1 (C-18), 128.6 (C-10), 127.5 (C-11), 127.3 
(C-17), 127.0 (C-9), 123.2 (C-19), 123.1 (C-5), 111.6 (C-6), 45.8 (C-7), 38.8 (C-2), 27.1 (C-1), 19.9 (C-
14); HRMS-ESI (m/z) found [M+H]+ 386.1105, C21H25NOBr requires 386.1114; [α]20D = –29.3 º (c = 
1.0, CHCl3); HPLC analysis (IC, 20% i-PrOH in n-hexane, 1 mL/min, 204 nm) indicated 97% e.e.: tR 
(minor) = 8.02 minutes, tR (major) = 11.04 minutes. 
(R)-2,2-dimethyl-N-[(1Z)-3-phenyl-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 383  
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (108 mg, 0.50 mmol), 
(4-trifluoromethylphenyl)(mesityl)iodonium hexafluorophosphate 367 (536 mg, 1.0 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(4.3 mL). Silica column chromatography, eluting with 5% ethyl acetate in petroleum ether 40–60, 
provided the title compound as a colourless oil (126 mg, 0.35 mmol, 70%). 
 RF 0.44 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3670, 3424 (br., N–H), 2972, 2901, 1651 
(C=O), 1484, 1326, 1249, 1165, 1118, 1066; 1H NMR (500 MHz, CDCl3) δ: 7.59 (d, J = 8.5 Hz, 2H, 
H-14), 7.42–7.34 (m, 4H, H-10,13), 7.32–7.27 (m, 3H, H-9,11), 6.93 (ddd, J = 11.0, 9.2, 2.2 Hz, 1H, 
H-5), 6.84 (br. d, J = 11.0 Hz, 1H, H-4), 5.20 (dd, J = 9.2, 6.0 Hz, 1H, H-6), 4.89 (d, J = 6.0 Hz, 1H, 
H-7), 0.95 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 175.6 (C-3), 147.9 (C-12), 142.5 (C-8), 129.4 
(C-10), 129.1 (q, 2JC–F = 32.4 Hz, C-15), 128.6 (C-13), 128.4 (C-9), 127.5 (C-11), 126.0 (q, 3JC–F = 3.1 
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Hz, C-14), 124.2 (q, 1JC–F = 272.5 Hz, C-16), 123.2 (C-5), 111.6 (C-6), 49.2 (C-7), 38.8 (C-2), 27.1 (C-
1); HRMS-ESI (m/z) found [M+H]+ 362.1726, C21H23F3NO requires 362.1726; [α]22D = –10.0 º (c = 
1.1, CHCl3); HPLC analysis (IC, 20% i-PrOH in n-hexane, 1 mL/min, 217 nm) indicated 91% e.e.: tR 
(minor) = 7.20 minutes, tR (major) = 9.14 minutes. 
(R)-2,2-dimethyl-N-[(1Z)-3-(2-methylphenyl)-3-phenylprop-1-en-1-yl]propanamide 384  
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (108 mg, 0.50 mmol), 
(2-methylphenyl)(mesityl)iodonium hexafluorophosphate 368 (482 mg, 1.00 mmol), 2,6-di-tert-butyl pyridine (225 
μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane (4.3 mL). 
Silica column chromatography, eluting with 5% ethyl acetate in petroleum ether 40–60, provided the 
title compound as an amorphous white solid (61 mg, 0.20 mmol, 40%).  
RF 0.48 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3671, 3437 (br., N–H), 2968, 2909, 1691 
(C=O), 1651, 1485, 1459, 1171, 1072, 1056; 1H NMR (500 MHz, CDCl3) δ: 7.36–7.20 (m, 2H, H-10), 
7.27–7.16 (m, 7H, H-9,11,13,14,15,16), 6.89 (ddd, J = 10.5, 9.1, 1.8 Hz, 1H, H-5), 6.82 (br. d, J = 10.5 
Hz, 1H, H-4), 5.14 (dd, J = 9.1, 5.8 Hz, 1H, H-6), 5.01 (dd, J = 5.8, 1.8 Hz, 1H, H-7), 2.33 (s, 3H, H-
18), 0.91 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 175.6 (C-3), 142.8 (C-8), 141.2 (C-12), 136.5 (C-
17), 131.0 (C-16), 129.0 (C-10), 128.7 (C-9), 128.6 (C-11), 127.2 (C-15), 126.9 (C-14), 126.8 (C-13), 122.8 
(C-5), 112.4 (C-6), 46.2 (C-7), 38.7 (C-2), 27.1 (C-1), 19.9 (C-18); HRMS-ESI (m/z) found [M+H]+ 
308.2011, C21H26NO requires 308.2009; [α]22D = +19.9 º (c = 0.9, CHCl3); HPLC analysis (IC, 20% i-
PrOH in n-hexane, 1 mL/min, 228 nm) indicated 97% e.e.: tR (major) = 7.74 minutes, tR (minor) = 8.57 
minutes.  
(R)-N-[(1Z)-3-(2-fluorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 385  
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (108 mg, 0.50 mmol), 
(2-fluorophenyl)(mesityl)iodonium hexafluorophosphate 369 (486 mg, 1.00 mmol), 2,6-di-tert-butyl pyridine (225 
μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane (4.3 mL). 
Silica column chromatography, eluting with 5% ethyl acetate in petroleum ether 40–60, provided the 
title compound as an amorphous white solid (65 mg, 0.21 mmol, 42%).  
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RF 0.44 (20% EtOAc in pet. ether 40-60); IR νmax/cm-1 (film): 3667 (br., N–H), 3440, 2972, 2899, 1687 
(C=O), 1651, 1483, 1455, 1225, 1175, 755, 697; 1H NMR (500 MHz, CDCl3) δ: 7.37–7.31 (m, 4H, H-
9,10), 7.30–7.21 (m, 3H, H-11,13,15), 7.13 (app. td, J = 7.8, 1.1 Hz, 1H, H-14), 7.10–7.00 (m, 2H, H-
4,16), 6.92 (ddd, J = 10.9, 8.2, 0.5 Hz, 1H, H-5), 5.25–5.17 (m, 2H, H-6,7), 1.02 (s, 1H, H-1); 13C NMR 
(125 MHz, CDCl3) δ: 175.6 (C-3), 160.4 (d, 1JC–F = 243.9 Hz, C-17), 142.2 (C-8), 130.7 (d, 2JC–F = 17.7 
Hz, C-12), 129.7 (d, 3JC–F = 3.1 Hz, C-13), 129.1 (C-10), 128.6 (d, 3JC–F = 8.7 Hz, C-15), 128.3 (C-9), 
127.1 (C-11), 124.8 (d, 4JC–F = 2.5 Hz, C-14), 123.0 (C-5), 115.7 (d, 2JC–F = 21.5 Hz, C-16), 111.4 (C-6), 
41.2 (C-7), 38.8 (C-2), 27.2 (C-1); HRMS-ESI (m/z) found [M+H]+ 312.1760, C20H23NOF requires 
312.1758; [α]22D = –54.3 º (c = 1.0, CHCl3); HPLC analysis (IC, 10% i-PrOH in n-hexane, 1 mL/min, 
209 nm) indicated >98% ee: tR (major) = 13.08 minutes, tR (minor) = 13.79 minutes. 
(R)-N-[(1Z)-3-(3,4-dichlorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 389  
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (108 mg, 0.50 mmol), 
(3,4-dichlorophenyl)(mesityl)iodonium hexafluorophosphate 372 (537 mg, 1.00 mmol), 2,6-di-tert-butyl pyridine 
(225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane (4.3 mL). 
Silica column chromatography, eluting with 5% ethyl acetate in petroleum ether 40–60, provided the 
title compound as an amorphous white solid (105 mg, 0.29 mmol, 58%).  
RF 0.43 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3671 (br., N–H), 3428, 2672, 2904, 2325, 
1649 (C=O), 1485, 1467, 1395, 1179, 1035; 1H NMR (500 MHz, CDCl3) δ: 7.41–7.33 (m, 4H, H-
10,13,16), 7.31–7.24 (m, 3H, H-9,11), 7.11 (ddd, J = 8.3, 2.1, 0.4 Hz, 1H, H-17), 6.92 (ddd, J = 11.0, 
8.9 Hz, 1.7 Hz, 1H, H-5), 6.84 (br. d, J = 11.0 Hz, 1H, H-4), 5.14 (dd, J = 8.9, 5.9 Hz, 1H, H-6), 4.78 
(dd, J = 5.9, 1.7 Hz, 1H, H-7), 0.97 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 175.6 (C-3), 144.1 (C-
12), 142.3 (C-8), 133.0 (C-14), 131.0 (C-15), 130.9 (C-16), 130.1 (C-13), 129.5 (C-10), 128.3 (C-9), 127.6 
(2C, C-11,17), 123.5 (C-5), 111.3 (C-6), 48.5 (C-7), 38.8 (C-2), 27.1 (C-1); HRMS-ESI (m/z) found 
[M+H]+ 362.1076, C20H22NOCl2 requires 362.1073; [α]22D = –15.9 º (c = 0.8, CHCl3); HPLC analysis 
(IC, 20% i-PrOH in n-hexane, 1 mL/min, 246 nm) indicated 93% e.e.: tR (minor) = 9.34 minutes, tR 
(major) = 20.85 minutes. 
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(R)-3-(3,4-dichlorophenyl)-3-phenylpropanal 436165 
 
To a stirred solution of (R)-N-[(1Z)-3-(3,4-dichlorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 
389 (91 mg, 0.25 mmol, 94% e.e.) in tetrahydrofuran (10 mL) was added concentrated hydrochloric acid 
(0.50 mL, 37% aqueous w/v solution) and the resulting yellow solution stirred for two hours at room 
temperature before undergoing a portion-wise addition of sodium carbonate (1.00 g). The suspension 
was stirred for a further fifteen minutes, filtered through anhydrous Na2SO3 and concentrated in vacuo. 
The crude residue was purified by silica column chromatography, eluting with 2 to 20% ethyl acetate in 
hexane, to give the title compound as a pale yellow oil (59 mg, 0.21 mmol, 84%).  
1H NMR (400 MHz, CDCl3) δ: 9.75 (t, J = 1.5 Hz, 1H, H-1), 7.37 (d, J = 8.3 Hz, 1H, H-12) 7.35–7.29 
(m, 3H, H-6,9), 7.26–7.18 (m, 3H, H-5,7), 7.08 (dd, J = 8.3, 2.2 Hz, 1H, H-13), 4.60 (app. t, J = 7.7 
Hz, 1H, H-3), 3.23–3.11 (m, 2H, H-2); 13C NMR (100 MHz, CDCl3) δ: 200.0 (C-1), 143.8 (C-8), 142.2 
(C-4), 132.8 (C-10), 130.9 (C-11), 130.8 (C-12), 129.8 (C-9), 129.1 (C-6), 127.7 (C-5), 127.3 (2C, C-7,13), 
49.3 (C-2), 44.1 (C-3); [α]24D = –11.1 º (1.05, CHCl3), lit. [α]25D = –7.3 º (c = 0.95, CHCl3, 93% e.e.); 
HPLC analysis of the alcohol derivative (NaBH4 treatment in MeOH/CH2Cl2) (AD-H, 2% i-PrOH in 
n-hexane, 1 mL/min, 209 nm) indicated 94% ee: tR (major) = 33.54 minutes, tR (minor) = 35.15 minutes. 
Experimental data in agreement with previous literature report.165 
(S)-2,2-dimethyl-N-[(1Z)-3-(naphthalen-2-yl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 396 
 
Prepared according to general procedure D with (Z)-N-(3-(naphthalen-2-yl)allyl)pivalamide 362 (134 mg, 
0.50 mmol), (4-trifluoromethylphenyl)(mesityl)iodonium hexafluorophosphate 367 (536 mg, 1.0 mmol), 2,6-di-tert-
butyl pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in 
dichloromethane (4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 10% ethyl 
acetate in petroleum ether 40–60, provided the title compound as a yellow oil (107 mg, 0.26 mmol, 
52%).  
RF 0.40 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3687 (br., N–H), 2972, 2904, 1651 (C=O), 
1483, 1465, 1322, 1259, 1165, 1118, 1068, 1021, 815; 1H NMR (400 MHz, CDCl3) δ: 7.87–7.78 (m, 
3H, H-10,13,14), 7.73 (s, 1H, H-17), 7.61 (d, J = 8.2 Hz, 2H, H-20), 7.54–7.47 (m, 2H, H-12,15), 7.45 
(d, J = 8.2 Hz, 2H, H-19), 7.39 (dd, J = 8.6, 2.1 Hz, 1H, H-9), 7.00 (ddd, J = 10.8, 8.8, 2.2 Hz, 1H, H-
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5), 6.92 (br. d, J = 10.8 Hz, 1H, H-4), 5.29 (dd, J = 8.8, 6.2 Hz, 1H, H-6), 5.07 (d, J = 6.2 Hz, 1H, H-
7), 0.86 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 175.6 (C-3), 147.6 (C-18), 139.8 (C-8), 133.6 (C-
15), 132.6 (C-11), 129.3 (C-10), 129.3 (q, 2JC–F = 33.1 Hz, C-21), 128.8 (C-19), 127.8 (2C, C-13,14), 
126.8 (C-17), 126.7 (C-12), 126.5 (C-9), 126.4 (C-15), 126.0 (q, 3JC–F = 3.7 Hz, C-20), 124.2 (q, 1JC–F = 
270.7 Hz, C-22), 123.5 (C-5), 111.4 (C-6), 49.2 (C-7), 38.7 (C-2), 27.0 (C-1); HRMS-ESI (m/z) found 
[M+H]+ 412.1871, C25H25NOF3 requires 412.1883; [α]22D = –17.7 º (c = 1.5, CHCl3); HPLC analysis 
(IC, 20% i-PrOH in n-hexane, 1 mL/min, 227 nm) indicated 95% e.e.: tR (major) = 9.69 minutes, tR 
(minor) = 10.36 minutes. 
(S)-N-[(1Z)-3-(4-chlorophenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]-2,2-dimethylpropanamide 398 
 
Prepared according to general procedure D with (Z)-N-(3-(4-chlorophenyl)allyl)pivalamide 356 (125.9 mg, 
0.5 mmol), (4-trifluoromethylphenyl)(mesityl)iodonium hexafluorophosphate 367 (536 mg, 1.0 mmol), 2,6-di-tert-
butyl pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in 
dichloromethane (4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 10% ethyl 
acetate in petroleum ether 40–60, provided the title compound as a colourless oil (67 mg, 0.17 mmol, 
34%).  
RF 0.40 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3444 (br., N–H), 2968, 1649 (C=O), 
1617, 1486, 1463, 1324, 1165, 1118, 1068, 1015, 822; 1H NMR (500 MHz, CDCl3) δ: 7.60 (d, J = 7.9 
Hz, 2H, H-14), 7.40–7.31 (m, 4H, H-10,13), 7.21 (d, J = 8.5 Hz, 2H, H-9), 6.94 (ddd, J = 11.1, 9.0, 2.0 
Hz, 1H, H-5), 6.80 (br. d, J = 11.1 Hz, 1H, H-4), 5.15 (dd, J = 9.0, 6.5 Hz, 1H, H-6), 4.85 (d, J = 6.5 
Hz, 1H, H-7), 0.97 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 175.6 (C-3), 147.3 (C-12), 141.0 (C-
8), 133.3 (C-11), 129.6 (C-9), 129.5 (q, 2JC–F = 32.4 Hz, C-15), 129.4 (C-10), 128.6 (C-13), 126.1 (q, 3JC–
F = 3.7 Hz, C-14), 124.1 (q, 1JC–F = 271.9 Hz, C-16), 123.6 (C-5), 111.1 (C-6), 48.4 (C-7), 38.8 (C-2), 
27.1 (C-1); HRMS-ESI (m/z) found [M+H]+ 396.1333, C21H22NOF3Cl requires 396.1337; [α]20D = –
3.1 º (c = 1.0, CHCl3); HPLC analysis (IC, 20% i-PrOH in n-hexane, 1 mL/min, 233 nm) indicated 
92% e.e.: tR (major) = 8.05 minutes, tR (minor) = 8.66 minutes. 
(S)-N-[(1Z)-3-(4-bromophenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]-2,2-dimethylpropanamide 399  
 
Prepared according to general procedure D with (Z)-N-(3-(4-bromophenyl)allyl)pivalamide 363 (148 mg, 
0.50 mmol), (4-trifluoromethylphenyl)(mesityl)iodonium hexafluorophosphate 367 (536 mg, 1.0 mmol), 2,6-di-tert-
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butyl pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in 
dichloromethane (4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 10% ethyl 
acetate in petroleum ether 40–60, provided the title compound as an amorphous white solid (62 mg, 
0.14 mmol, 28%).  
RF 0.36 (20% EtOAc in pet. ether 40–60); Tm (recrystallised from CH2Cl2:Hexane) 98–100 ºC; IR 
νmax/cm-1 (film): 3678 (br., N–H), 2972, 2909, 1649 (C=O), 1615, 1487, 1461, 1324, 1120, 1066, 1015, 
801; 1H NMR (400 MHz, CDCl3) δ: 7.60 (d, J = 8.3 Hz, 2H, H-14), 7.48 (d, J = 8.5 Hz, 2H, H-10), 
7.37 (d, J = 8.3 Hz, 2H, H-13), 7.15 (d, J = 8.3 Hz, 2H, H-9), 6.94 (ddd, J = 10.7 Hz, 8.9, 2.0 Hz, 1H, 
H-5), 6.80 (br. d, J = 10.7 Hz, 1H, H-4), 5.15 (dd, J = 8.9, 6.1 Hz, 1H, H-6), 4.84 (d, J = 6.1 Hz, 1H, 
H-7), 0.98 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 175.6 (C-3), 147.2 (C-12), 141.6 (C-8), 132.4 
(C-10), 130.0 (C-9), 129.6 (q, 2JC–F = 31.9 Hz, C-15), 128.6 (C-13), 126.1 (q, 3JC–F = 3.7 Hz, C-14), 124.1 
(q, 1JC–F = 271.4 Hz, C-16), 123.6 (C-5), 121.3 (C-11), 111.0 (C-6), 48.4 (C-7), 38.8 (C-2), 27.1 (C-1); 
HRMS-ESI (m/z) found [M+H]+ 440.0826, C21H21NOF3Br requires 440.0831; [α]22D = –4.4 º (c = 1.4, 
CHCl3); HPLC analysis (IC, 20% i-PrOH in n-hexane, 1 mL/min, 237 nm) indicated 89% e.e.: tR (major) 
= 8.28 minutes, tR (minor) = 9.45 minutes; An X-Ray crystal structure is deposited in the Cambridge 
Crystallographic Data Centre, reference number CCDC 1050909.  
Crystals were grown by vial-in-vial diffusion of hexanes into a dichloromethane solution of the enamide 
at –18 ºC. Formula C21H21BrF3NO and formula weight: 440.30; Temperature: 180(2) K; λ = 0.71073 
Å; Space group P2(1)2(1)2(1); Cell lengths: a = 10.0251(2) Å, b = 11.4891(2) Å, c = 34.7369(2) Å; Cell 
angles α = 90 o, β = 90 o, γ = 90 o; Cell volume 4000.97(11) Å3; Z = 8; Goodness-of-fit on F2 = 1.021. 
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(S)-2,2-dimethyl-N-[(1Z)-3-(2-methylphenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 403 
 
Prepared according to general procedure D with (Z)-N-(3-(2-tolyl)allyl)pivalamide 358 (116 mg, 0.50 
mmol), (4-trifluoromethylphenyl)(mesityl)iodonium hexafluorophosphate 367 (536 mg, 1.0 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(4.3 mL). Silica column chromatography, eluting with a gradient of 0 to 10% ethyl acetate in petroleum 
ether 40–60, provided the title compound as a colourless oil (49 mg, 0.13 mmol, 26%).  
RF 0.44 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3428 (br., N–H), 2964, 1681, 1647 (C=O), 
1484, 1461, 1322, 1163, 1120, 1066, 1016, 749; 1H NMR (500 MHz, CDCl3) δ: 7.59 (d, J = 8.3 Hz, 
2H, H-17), 7.35 (d, J = 8.3 Hz, 2H, H-16), 7.25–7.17 (m, 4H, H-9,10,11,12), 6.90 (ddd, J = 10.5, 9.0, 
1.7 Hz, 1H, H-7), 6.77 (br. d, J = 10.5 Hz, 1H, H-4), 5.12 (dd, J = 9.0, 5.9 Hz, 1H, H-6), 5.05 (d, 5.9 
Hz, 1H, H-7), 2.32 (s, 3H, H-14), 0.92 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 175.6 (C-3), 147.1 
(C-15), 140.1 (C-8), 136.6 (C-13), 131.3 (C-12), 129.2 (q, 2JC–F = 33.0 Hz, C-18), 128.9 (C-14), 128.6 (C-
9), 127.6 (C-11), 127.1 (C-10), 125.8 (q, 3JC–F = 3.4 Hz, C-17), 124.2 (q, 1JC–F = 271.9 Hz, C-19), 123.3 
(C-5), 111.3 (C-6), 45.9 (C-7), 38.7 (C-2), 27.1 (C-1), 19.9 (C-14); HRMS-ESI (m/z) found [M+H]+ 
376.1878, C22H25NOF3 requires 376.1883; [α]20D = –31.2 º (c = 1.9, CHCl3); HPLC analysis (IC, 20% 
i-PrOH in n-hexane, 1 mL/min, 202 nm) indicated >98% e.e.: tR (minor) = 6.50 minutes, tR (major) = 
8.51 minutes. 
6.2.5. Oxazine products and derivatives 
(S,Z)-N-(3-phenyl-3-(p-tolyl)prop-1-en-1-yl)pivalamide 405 and (5R,6R)-2-(tert-butyl)-5-phenyl-6-(4-tolyl)-5,6-
dihydro-4H-1,3-oxazine 4072 – Prepared by Dr Matthieu Tissot 
 
Prepared according to general procedure D with (Z)-N-(3-(p-tolyl)allyl)pivalamide 361 (116 mg, 0.50 
mmol), (mesityl)(phenyl)iodonium hexafluorophosphate 373 (468 mg, 1.00 mmol), 2,6-di-tert-butyl pyridine (225 
μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane (9.3 mL). 
Alumina column chromatography, eluting with a gradient of 5 to 10% diethyl ether in petroleum ether 
40–60, provided the title oxazine product as a crystalline white solid (45 mg, 0.15 mmol, 29%) together 
with the regioisomeric enamide product an amorphous white solid (16 mg, 0.05 mmol, 10%). 
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(S,Z)-N-(3-phenyl-3-(p-tolyl)prop-1-en-1-yl)pivalamide 405  
 
IR νmax/cm-1 (film): 3427 (br., N–H), 2962, 1651 (C=O), 1484, 1278, 1177, 801, 747, 699; 1H NMR 
(400 MHz, CDCl3) δ: 7.35–7.27 (m, 4H. H-14,15), 7.25–7.13 (m, 5H, H-9,10,16), 6.89–6.87 (m, 2H, H-
4,5), 5.22 (dd, J = 8.4, 5.8 Hz, 1H, H-6), 4.79 (d, J = 5.8 Hz, 1H, H-7), 2.32 (s, 3H, H-12), 0.93 (s, 9H, 
H-1); 13C NMR (125 MHz, CDCl3) δ: 175.5 (C-3), 143.9 (C-13), 140.6 (C-8), 136.7 (C-11), 129.8 (C-10), 
129.1 (C-15), 128.3 (C-14), 128.2 (C-9), 126.9 (C-16), 122.7 (C-5), 113.0 (C-6), 49.1 (C-7), 27.1 (C-2), 
21.1 (C-1); HRMS-ESI (m/z) found [M+H]+ 308.2009, C21H26NO requires 308.2012. [α]26D = –10.8 º 
(c = 1.0, CHCl3), calculated with sample e.e. of 94%; HPLC analysis (OD, 1% i-PrOH in n-hexane, 1 
mL/min, 236 nm) indicated 96% e.e.: tR (major) = 13.13 minutes, tR (minor) = 14.09 minutes. 
(5R,6R)-2-(tert-butyl)-5-phenyl-6-(4-tolyl)-5,6-dihydro-4H-1,3-oxazine 407157 
 
1H NMR (400 MHz, CDCl3) δ: 7.25–7.15 (m, 3H, H-10,13), 7.04–7.00 (m, 4H, H-8,9), 6.97 (d, J = 8.1 
Hz, 2H, H-12), 5.10 (d, J = 10.0 Hz, 1H, H-6), 3.74–3.65 (m, 2H, H-4), 2.91 (app. td, J = 9.5, 6.7 Hz, 
1H, H-5), 2.28 (s, 3H, H-15), 1.27 (s, 9H, H-1); 13C NMR (100 MHz, CDCl3) δ: 166.6 (C-3), 139.4 (C-
7), 137.7 (C-14), 136.4 (C-11), 128.9 (C-9), 128.6 (C-13), 128.3 (C-8), 127.1 (C-10), 126.7 (C-12), 81.2 
(C-6), 49.8 (C-4), 45.6 (C-5), 37.6 (C-2), 28.0 (C-1), 21.2 (C-15); [α]26D = +92.9 º (c = 1.0, CHCl3); HPLC 
analysis (OD, 1% i-PrOH in n-hexane, 1 mL/min, 202 nm) indicated 98% e.e.: tR (major) = 6.94 minutes, 
tR (minor) = 8.34 minutes. Experimental data in agreement with previous literature report.157 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(4-methoxyphenyl)-5,6-dihydro-4H-1,3-oxazine 410 
 
Prepared according to general procedure D with (Z)-N-(3-(4-methoxyphenyl)allyl)pivalamide 360 (124 mg, 
0.50 mmol), (mesityl)(4-methoxyphenyl)iodonium hexafluorophosphate 374 (498 mg, 1.00 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(9.3 mL) with stirring at 40 ºC for 30 hours. Alumina column chromatography, eluting with 5% ethyl 
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acetate in petroleum ether 40–60, provided the title compound as a white solid (139 mg, 0.39 mmol, 
79%).  
Tm 120–125 ºC; IR νmax/cm-1 (film): 2960, 2917, 2837, 1667, 1613, 1512, 1245, 1177, 1136, 1033; 1H 
NMR (500 MHz, CDCl3) δ: 6.97 (d, J = 8.7 Hz, 2H, H-13), 6.88 (d, J = 8.7 Hz, 2H, H-8), 6.74 (app. d, 
J = 8.5 Hz, 4H, H-9,14), 5.00 (d, J = 10.1 Hz, 1H, H-6), 3.75 (s, 3H, H-16), 3.74 (s, 3H, H-11), 3.67–
3.57 (m, 2H, H-4), 2.81 (app. td, J = 9.9, 6.4 Hz, 1H, H-5), 1.24 (s, 9H, H-1); 13C NMR (125 MHz, 
CDCl3) δ: 166.3 (C-3), 159.2 (C-15), 158.5 (C-10), 131.8 (C-12), 131.4 (C-7), 129.2 (C-8), 128.0 (C-13), 
114.1 (C-9), 113.6 (C-14), 81.1 (C-6), 55.3 (2C, C-11,16), 50.1 (C-4), 44.9 (C-5), 37.6 (C-2), 28.1 (C-1); 
HRMS-ESI (m/z) found [M+H]+ 354.2065, C22H28NO3 requires 354.2064; [α]29.D = +92.4 º (c = 1.0, 
CHCl3); HPLC analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 238 nm) indicated 82% e.e.: tR (major) 
= 12.23 minutes, tR (minor) = 14.45 minutes. 
(E/Z)-N-(2,3-bis(4-methoxyphenyl)allyl)pivalamide 413  
 
Prepared according to general procedure D with (Z)-N-(3-(4-methoxyphenyl)allyl)pivalamide 360 (24.7 mg, 
0.10 mmol), (mesityl)(4-methoxyphenyl)iodonium hexafluorophosphate 374 (105 mg, 0.20 mmol), 2,6-di-tert-butyl 
pyridine (45 μL, 0.20 mmol) and Cu-BOX complex 248 (100 μL, 0.1 M, 5 μmol) in dichloromethane 
(1.85 mL). Silica column chromatography, eluting with 10 to 20% ethyl acetate in petroleum ether 40–
60, provided the Z- isomer of the title compound as an amorphous white solid (3.6 mg, 10 μmol, 10%) 
and the E- isomer of the title compound as a colourless oil (5.8 mg, 16 μmol, 16%). 
(E)-N-(2,3-bis(4-methoxyphenyl)allyl)pivalamide 413a  
 
RF 0.38 (50% EtOAc in pet. ether 40-60); IR νmax/cm-1 (film): 3353 (br., N–H), 2958, 2837, 1740, 1644 
(C=O), 1609, 1509, 1463, 1288, 1246, 1176; 1H NMR (500 MHz, CDCl3) δ: 7.12 (d, J = 8.8 Hz, 2H, 
H-8), 6.93 (d, J = 8.8 Hz, 2H, H-13), 6.85 (d, J = 8.8 Hz, 2H, H-9), 6.66 (d, J = 8.8 Hz, 2H, H-14), 
6.47 (s, 1H, H-6), 5.62 (br. t, J = 5.3 Hz, 1H, N–H), 4.24 (dd, J = 5.6, 0.7 Hz, 2H, H-4), 3.81 (s, 3H, H-
11/16), 3.74 (s, 3H, H-11/16), 1.08 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 178.2 (C-3), 159.0 (C-
N
H
O
OMe
OMe N
H
O
OMe
OMe
N
H
4
32
O
5
6
7
12
8
9
10
15
14
13
OMe 11
OMe 16
1
8 %n0e
Experimental 
 172 
10), 158.5 (C-15), 136.5 (C-6), 130.9 (C-12), 130.6 (C-13), 130.1 (C-8), 129.3 (C-7), 126.9 (C-6), 114.3 
(C-9), 113.5 (C-14), 55.4 (C-11), 55.3 (C-16), 47.3 (C-4), 38.8 (C-2), 27.6 (C-1); HRMS-ESI (m/z) found 
[M+H]+ 354.2063, C22H28NO3 requires 354.2064. 
(Z)-N-(2,3-bis(4-methoxyphenyl)allyl)pivalamide 413b  
 
RF 0.50 (50% EtOAc in pet. ether 40-60); IR νmax/cm-1 (film): 3306 (br., N–H), 2959, 1624 (C=O), 1610, 
1544, 1515, 1465, 1253, 1178, 1033; 1H NMR (500 MHz, CDCl3) δ: 7.42 (d, J = 8.7 Hz, 2H, H-8), 7.27 
(d, J = 8.7 Hz, 2H, H-13), 6.93–6.88 (m, 4H, H-9,14), 6.84 (s, 1H, H-6), 5.46 (br. t, J = 4.8 Hz, 1H, N–
H), 4.52 (d, J = 4.8 Hz, 2H, H-4), 3.83 (s, 6H, H-11,16), 1.04 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) 
δ: 178.3 (C-3), 159.4 (C-10), 158.9 (C-15), 136.1 (C-5), 133.0 (C-12), 130.2 (C-13), 129.6 (C-7), 129.4 (C-
6), 127.8 (C-8), 114.1 (2C, C-9,13), 55.5 (2C, C-11,16), 39.1 (C-2), 38.7 (C-4), 27.6 (C-1); HRMS-ESI 
(m/z) found [M+H]+ 354.2062, C22H28NO3 requires 354.2064. 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(4-bromophenyl)-5,6-dihydro-4H-1,3-oxazine 412  
 
Prepared according to general procedure D with (Z)-N-(3-(4-bromophenyl)allyl)pivalamide 363 (148 mg, 
0.50 mmol), (mesityl)(4-methoxyphenyl)iodonium hexafluorophosphate 374 (498 mg, 1.00 mmol), 2,6-di-tert-butyl 
pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane 
(9.3 mL) with stirring for 43 hours. Alumina column chromatography, eluting with 5% ethyl acetate in 
petroleum ether 40–60, provided the title compound as a white crystalline solid (129 mg, 0.32 mmol, 
64%).  
Tm 148–152 ºC; IR νmax/cm-1 (film): 2960, 2929, 1669, 1611, 1512, 1489, 1423, 1245, 1136, 1033; 1H 
NMR (500 MHz, CDCl3) δ: 7.33 (d, J = 8.5 Hz, 2H, H-14), 6.89 (d, J = 8.5 Hz, 2H, H-13), 6.87 (d, J 
= 8.8 Hz, 2H, H-8), 6.76 (d, J = 8.8 Hz, 2H, H-9), 4.98 (d, J = 10.2 Hz, 1H, H-6), 3.75 (s, 3H, H-11), 
3.60–3.67 (m, 2H, H-4), 2.75 (app. td, J = 9.8, 6.4 Hz, 1H, H-5), 1.23 (s, 9H, H-1); 13C NMR (125 
MHz, CDCl3) δ: 165.8 (C-3), 158.8 (C-10), 138.7 (C-12), 131.3 (C-14), 130.8 (C-7), 129.3 (C-8), 128.5 
(C-13), 121.9 (C-15), 114.2 (C-9), 80.8 (C-6), 55.3 (C-11), 49.9 (C-4), 50.0 (C-5), 37.6 (C-2), 28.0 (C-1); 
HRMS-ESI (m/z) found [M+H]+ 402.1063, C21H25BrNO2 requires 402.1063; [α]29D = +97.3 º (c = 1.0, 
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CHCl3), calculated with sample e.e. of 79%; HPLC analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 
227 nm) indicated 91% e.e.: tR (major) = 8.56 minutes, tR (minor) = 9.65 minutes. 
(5S,6S)-6-(benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)-5-(4-methoxyphenyl)-5,6-dihydro-4H-1,3-oxazine 414  
 
Prepared according to general procedure D with (Z)-N-(3-(benzo[d][1,3]dioxol-5-yl)allyl)pivalamide 365 
(131 mg, 0.50 mmol), (mesityl)(4-methoxyphenyl)iodonium hexafluorophosphate 374 (498 mg, 1.00 mmol), 2,6-
di-tert-butyl pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in 
dichloromethane (9.3 mL) with stirring for 15 hours. Alumina column chromatography, eluting with 
5% ethyl acetate in petroleum ether 40–60, provided the title compound as a white solid (148 mg, 0.40 
mmol, 80%).  
Tm 145–146 ºC; IR νmax/cm-1 (film): 2964, 1669, 1613, 1514, 1491, 1443, 1247, 1179, 1140, 1037; 1H 
NMR (400 MHz, CDCl3) δ: 6.89 (d, J = 8.7 Hz, 2H, H-8), 6.75 (d, J = 8.7 Hz, 2H, H-9), 6.62 (d, J = 
1.6 Hz, 1H, H-17), 6.60 (d, J = 8.0 Hz, 1H, H-14), 6.44 (dd, J = 8.0, 1.6 Hz, 2H, H-13), 5.91 (d, J = 
2.7 Hz, 1H, H-18a), 5.90 (d, J = 2.7 Hz, 1H, H-18b), 4.94 (d, J = 10.2 Hz, 1H, H-6), 3.74 (s, 3H, H-
11), 3.66–3.56 (m, 2H, H-4), 2.78 (app. td, J = 10.1, 5.9 Hz, 1H, H-5), 1.22 (s, 9H, H-1); 13C NMR (100 
MHz, CDCl3) δ: 166.2 (C-3), 158.6 (C-10), 147.6 (C-16), 147.2 (C-15), 133.5 (C-12), 131.2 (C-7), 129.2 
(C-8), 120.8 (C-13), 114.1 (C-9), 107.9 (C-14), 107.0 (C-17), 101.1 (C-18), 81.3 (C-6), 55.3 (C-11), 50.1 
(C-4), 44.9 (C-5), 37.5 (C-2), 28.0 (C-1); HRMS-ESI (m/z) found [M+H]+ 368.1858, C22H26NO4 
requires 368.1856; [α]24.D = +140.4 º (c = 1.0, CHCl3); HPLC analysis (AD-H, 1% i-PrOH in n-hexane, 
1 mL/min, 231 nm) indicated 89% e.e.: tR (major) = 22.46 minutes, tR (minor) = 29.61 minutes. 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(1-(phenylsulfonyl)-1H-indol-3-yl)-5,6-dihydro-4H-1,3-oxazine 415 
 
Prepared according to general procedure D with (Z)-N-(3-(1-(phenylsulfonyl)-1H-indol-3-yl)allyl)pivalamide 
364 (198 mg, 0.50 mmol), (mesityl)(4-methoxyphenyl)iodonium hexafluorophosphate 374 (498 mg, 1.00 mmol), 
2,6-di-tert-butyl pyridine (225 μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in 
dichloromethane (9.3 mL) with stirring for 2.5 hours. Alumina column chromatography, eluting with a 
gradient of 10 to 85% diethyl ether in petroleum ether 40–60, provided the title compound as an off-
white solid (153 mg, 0.31 mmol, 61%).  
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Tm 72–76 ºC; IR νmax/cm-1 (film): 2960, 2925, 1669, 1611, 1510, 1449, 1368, 1245, 1177, 1123; 1H 
NMR (400 MHz, CDCl3) δ: 7.87 (d, J = 8.3 Hz, 1H, H-15), 7.55 (d, J = 7.7 Hz, 1H, H-18), 7.51–7.47 
(m, 3H, H-21,23), 7.35–7.31 (m, 2H, H-22), 7.28 (app. t, J = 8.3 Hz, 1H, H-17), 7.24 (s, 1H, H-13), 
7.21 (app. t, J = 7.6 Hz, 1H, H-16), 6.88 (d, J = 8.7 Hz, 2H, H-8), 6.70 (d, J = 8.7 Hz, 2H, H-9), 5.29 
(d, J = 10.4 Hz, 1H, H-6), 3.77 (s, 3H, H-11), 3.71 (dd, J = 16.3, 5.2 Hz, 1H, H-4a), 3.60 (dd, J = 16.3, 
10.7 Hz, 1H, H-4b), 3.22 (app. td, J = 10.7, 5.2 Hz, 1H, H-5), 1.21 (s, 9H, H-1); 13C NMR (100 MHz, 
CDCl3) δ: 165.9 (C-3), 158.6 (C-10), 137.9 (C-20), 135.3 (C-14), 133.8 (C-23), 131.6 (C-7), 129.3 (C-22), 
129.0 (C-19), 128.8 (C-8), 126.7 (C-21), 125.1 (C-13), 125.0 (C-17), 123.5 (C-16), 120.7 (C-18), 120.5 
(C-12), 114.3 (C-9), 113.8 (C-15), 75.3 (C-6), 55.4 (C-11), 50.5 (C-4), 42.2 (C-5), 37.7 (C-2), 28.0 (C-1); 
HRMS-ESI (m/z) found [M+H]+ 503.1988, C29H31SN2O4 requires 503.1999; [α]24D = +49.6 º (c = 1.0, 
CHCl3); HPLC analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 222 nm) indicated 91% e.e.: tR (major) 
= 23.32 minutes, tR (minor) = 35.79 minutes. 
(5S,6S)-2-(tert-butyl)-5-(naphthalen-2-yl)-6-phenyl-5,6-dihydro-4H-1,3-oxazine 423 
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (109 mg, 0.50 mmol), 
(2-napthyl)(mesityl)iodonium hexafluorophosphate 375 (518 mg, 1.00 mmol), 2,6-di-tert-butyl pyridine (225 μL, 
1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane (9.3 mL). Alumina 
column chromatography, eluting with a gradient of 5 to 50% diethyl ether in petroleum ether 40–60, 
provided the title compound as a yellow solid (55 mg, 0.19 mmol, 37%).  
Tm 130–133 ºC; IR νmax/cm-1 (film): 2968, 2917, 1665, 1600, 1478, 1455, 1391, 1268, 1138, 1025; 1H 
NMR (400 MHz, CDCl3) δ: 7.78–7.67 (m, 3H, H-9,11,14), 7.49 (app. br. s, 1H, H-16), 7.46–7.39 (m, 
2H, H-12,13), 7.19–7.15 (m, 3H, H-19,20), 7.12–7.05 (m, 3H, H-8,18), 5.25 (d, J = 9.8 Hz, 1H, H-6), 
3.84–3.70 (m, 2H, H-4), 3.08 (app. td, J = 10.0, 5.4 Hz, 1H, H-5), 1.28 (s, 9H, H-1); 13C NMR (100 
MHz, CDCl3) δ: 166.2 (C-3), 139.5 (C-17), 136.9 (C-7), 133.5 (C-15), 132.6 (C-10), 128.30 (C-9), 128.26 
(C-19), 128.0 (C-20), 127.8 (C-11), 127.7 (C-14), 127.1 (C-16), 126.7 (C-18) 126.5 (C-8), 126.2 (C-
12/13), 125.8 (C-12/13), 81.1 (C-6), 49.8 (C-4), 45.8 (C-5), 37.7 (C-2), 28.1 (C-1); HRMS-ESI (m/z) 
found [M+H]+ 344.2009, C24H26NO requires 344.2009; [α]24D = +120.7 º (c = 1.0, CHCl3); HPLC 
analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 215 nm) indicated 92% e.e.: tR (major) = 5.80 minutes, 
tR (minor) = 6.21 minutes. 
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(5S,6S)-2-(tert-butyl)-6-phenyl-5-(thiophen-3-yl)-5,6-dihydro-4H-1,3-oxazine 4242  
 
Prepared according to general procedure D with (Z)-N-(3-phenylallyl)pivalamide 315 (109 mg, 0.50 mmol), 
(mesityl)(3-thiophenyl)iodonium hexafluorophosphate 376 (474 mg, 1.00 mmol), 2,6-di-tert-butyl pyridine (225 
μL, 1.00 mmol) and Cu-BOX complex 248 (500 μL, 0.1 M, 50 μmol) in dichloromethane (9.3 mL). 
Alumina column chromatography, eluting with a gradient of 5 to 20% diethyl ether in petroleum ether 
40–60, provided the title compound as a colourless oil (47 mg, 0.16 mmol, 32%).  
1H NMR (400 MHz, CDCl3) δ: 7.29–7.25 (m, 3H, H-13,14), 7.20 (dd, J = 5.0, 2.9 Hz, 1H, H-8), 7.09–
7.06 (m, 2H, H-12), 6.84 (dd, J = 2.9, 1.1 Hz, 1H, H-10), 6.72 (dd, J = 5.0, 1.1 Hz, 1H, H-9), 5.05 (d, 
J = 9.4 Hz, 1H, H-6), 3.69–3.67 (m, 2H, H-4), 3.08 (app. td, J = 8.7, 7.1 Hz, 1H, H-5), 1.26 (s, 9H, H-
1); 13C NMR (100 MHz, CDCl3) δ: 166.1 (C-3), 139.75 (C-7), 139.73 (C-11), 128.2 (C-13), 128.1 (C-14), 
127.2 (C-9), 126.5 (C-12), 125.7 (C-8), 121.8 (C-10), 81.2 (C-6), 49.0 (C-4), 41.1 (C-5), 37.6 (C-2), 28.0 
(C-1); [α]26D = +57.1 º (c = 1.0, CHCl3); HPLC analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 248 
nm) indicated 92% e.e.: tR (major) = 6.10 minutes, tR (minor) = 7.51 minutes. Experimental data in 
agreement with previous literature report.2 
(5S,6S)-2-(tert-butyl)-6-(4-methoxyphenyl)-5-(naphthalen-2-yl)-5,6-dihydro-4H-1,3-oxazine 425  
 
Prepared according to general procedure D with (Z)-N-(3-(4-methoxyphenyl)allyl)pivalamide 360 (49.4 mg, 
0.20 mmol), (2-napthyl)(mesityl)iodonium hexafluorophosphate 375 (218 mg, 0.40 mmol), 2,6-di-tert-butyl 
pyridine (90 μL, 0.40 mmol) and Cu-BOX complex 248 (200 μL, 0.1 M, 20 μmol) in dichloromethane 
(3.7 mL) with stirring for 20 hours. Alumina column chromatography, eluting with a gradient of 2.5 to 
5% ethyl acetate in petroleum ether 40–60, provided the title compound as a colourless oil (31.2 mg, 
0.08 mmol, 42%).  
RF 0.21 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 2959, 2928, 1770, 1614, 1515, 1480, 
1461, 1249, 1137, 1030; 1H NMR (500 MHz, CDCl3) δ: 7.76 (dd, J = 7.6, 2.2 Hz, 1H, H-9), 7.73–7.67 
(m, 2H, H-11,14), 7.49 (app. br. s, 1H, H-16), 7.46–7.39 (m, 2H, H-12,13), 7.11 (dd, J = 7.6, 1.5 Hz, 
1H, H-8), 7.02 (d, J = 8.7, 2H, H-18), 6.70 (d, J = 8.7 Hz, 2H, H-19), 5.20 (d, J = 10.0 Hz, 1H, H-6), 
3.79–3.72 (m, 2H, H-4), 3.70 (s, 3H, H-21), 3.06 (app. td, J = 10.0, 5.8 Hz, 1H, H-5), 1.26 (s, 9H, H-1); 
13C NMR (125 MHz, CDCl3) δ: 166.4 (C-3), 159.3 (C-20), 137.1 (C-7), 133.5 (C-15), 132.6 (C-10), 131.6 
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(C-17), 128.3 (C-9), 128.0 (C-18), 127.8 (C-11), 127.7 (C-14), 127.1 (C-16), 126.5 (C-8), 126.2 (C-12/13), 
125.8 (C-12/13), 113.7 (C-19), 80.8 (C-6), 55.2 (C-21), 50.1 (C-4), 45.8 (C-5), 37.6 (C-2), 28.1 (C-1); 
HRMS-ESI (m/z) found [M+H]+ 374.2115, C25H28NO2 requires 374.2115; [α]25D = +83.0 º (c = 0.5, 
CHCl3); HPLC analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 225 nm) indicated 52% e.e.: tR (major) 
= 6.96 minutes, tR (minor) = 7.55 minutes. 
(5S,6S)-2-(tert-butyl)-6-(4-methoxyphenyl)-5-(thiophen-3-yl)-5,6-dihydro-4H-1,3-oxazine 426  
 
Prepared according to general procedure D with (Z)-N-(3-(4-methoxyphenyl)allyl)pivalamide 360 (49.4 mg, 
0.20 mmol), (mesityl)(3-thiophenyl)iodonium hexafluorophosphate 376 (180 mg, 0.40 mmol), 2,6-di-tert-butyl 
pyridine (90 μL, 0.40 mmol) and Cu-BOX complex 248 (200 μL, 0.1 M, 20 μmol) in dichloromethane 
(3.7 mL) with stirring for 20 hours. Alumina column chromatography, eluting with a gradient of 2.5 to 
5% ethyl acetate in petroleum ether 40–60, provided the title compound as an inseparable 5:1 mixture 
of diasteroiosomers and as a yellow oil (34.7 mg, 0.11 mmol, 55%).  
RF 0.17 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 2958, 2925, 1670, 1614, 1515, 1480, 
1461, 1248, 1136, 1030; Major diastereoisomer: 1H NMR (500 MHz, CDCl3) δ: 7.18 (dd, J = 5.0, 3.0 Hz, 
1H, H-10), 7.00 (d, J = 8.7 Hz, 2H, H-12), 6.81 (d, J = 3.0 Hz, 1H, H-8), 6.78 (d, J = 8.7 Hz, 2H, H-
13), 6.70 (d, J = 5.0 Hz, 1H, H-9), 4.98 (d, 1H, J = 9.6 Hz, H-6), 3.77 (s, 3H, H-15), 3.71–3.57 (m, 2H, 
H-4), 3.05 (app. td, J = 9.6, 5.7 Hz, 1H, H-5), 1.23 (s, 9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 166.3 
(C-3), 159.4 (C-14), 139.9 (C-7), 131.9 (C-11), 127.8 (C-12), 127.2 (C-9), 125.7 (C-8), 121.7 (C-10), 113.7 
(C-12), 80.9 (C-6), 55.3 (C-15), 49.3 (C-4), 41.2 (C-5), 37.6 (C-2), 28.0 (C-1); Minor diasteroisomer: 1H NMR 
(500 MHz, CDCl3) δ: 7.15 (dd, J = 5.0, 3.1 Hz, 1H, H-10), 6.95 (d, J = 8.6 Hz, 2H, H-12), 6.90 (d, J = 
3.1 Hz, 1H, H-8), 6.80 (d, J = 8.6 Hz, 2H, H-13), 6.72 (d, J = 5.0 Hz, 1H, H-9), 5.17 (d, 1H, J = 10.0 
Hz, H-6), 3.77 (s, 3H, H-15), 3.71–3.57 (m, 2H, H-4), 2.82 (app. td, J = 10.0, 5.3 Hz, 1H, H-5), 1.24 (s, 
9H, H-1); 13C NMR (125 MHz, CDCl3) δ: 165.9 (C-3), 158.7 (C-14), 141.0 (C-7), 131.6 (C-11), 129.2 
(C-12), 125.9 (C-9), 125.5 (C-8), 122.0 (C-10), 114.2 (C-12), 77.7 (C-6), 55.3 (C-15), 50.0 (C-4), 44.5 (C-
5), 37.6 (C-2), 28.0 (C-1); HRMS-ESI (m/z) found [M+H]+ 330.1524, C19H24NSO2 requires 330.1522; 
[α]25D = +31.3 º (c = 1.0, CHCl3); HPLC analysis (IC, 5% i-PrOH in n-hexane, 1 mL/min, 215 nm) 
indicated: major diasteroisomer – 63% e.e.: tR (major) = 7.60 minutes, tR (minor) = 8.85 minutes; minor 
diasteroisomer – 6% e.e.: tR (minor) = 8.27 minutes, tR (major) = 12.78 minutes. 
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6.3 Studies Towards the Total Synthesis of (–)-Lyngbyaloside B 
6.3.1. General procedures 
General procedure E 
Three step synthesis of alkenyl iodonium salts via a borylation strategy: 
 
Adapted from procedures reported by Wong et al. and Gaunt et al.; all quantities given with respect to initial alkyne 
loading.158,220 
E1: An oven-dried Schlenk flask was charged with copper (I) chloride (3 mol%), XantPhos (3 mol%) and 
potassium tert-butoxide (9 mol%) and back-filled three times with nitrogen gas. The resulting mixture 
was suspended in the stated volume of tetrahydrofuran and stirred for 30 minutes before the addition of 
a solution of bis(pincolato)diboron (1.1 equiv. in the stated volume of THF) with stirring for a further 15 
minutes. A solution of alkyne (1.0 equiv.) in the stated volume of tetrahydrofuran was added to the 
resulting borylation mixture followed by a portion of methanol (4.0 equiv.) with the reaction mixture 
then allowed to stir for 15 hours. The resulting grey suspension was then filtered through a pad of 
celite™, eluting with diethyl ether, and concentrated in vacuo to give the corresponding vinyl boronic 
ester for immediate consumption in the following step. 
 
E2: To a stirred suspension of vinyl boronic acid in a 1:1 mixture of acetone/water was added 
ammonium acetate (5.0 equiv.) and sodium meta-periodate (5.0 equiv.). The resulting green reaction 
mixture was vigorously stirred for 18 hours before the acetone was removed in vacuo. The residual 
aqueous slurry was extracted with three portions of ethyl acetate and the organics combined, dried over 
anhydrous MgSO4 and concentrated in vacuo to give the crude intermediate vinyl boronic acid for 
immediate consumption in the following step.  
 
E3: The boronic acid residue was dissolved in a stated volume of dichloromethane and cooled to 0 ºC 
before undergoing subsquent dropwise additions of boron trifluoride diethyl etherate (1.2 equiv.) and a 
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solution of iodoarene diacetate (1.2 equiv.) in a stated volume of dichloromethane. The resulting reaction 
mixture was warmed to room temperature and was stirred for a further two hours before quenching 
with the given quantity of water and a portion of potassium trifluoromethanesulfonate (2.0 equiv.). The 
biphasic mixture was vigorously stirred for a further 15 minutes, the phases separated, and the aqueous 
layer extracted with three portions of dichloromethane. The combined organic layers were combined, 
dried over anhydrous MgSO4, and concentrated in vacuo. The resulting crude iodonium salt was purified 
by silica column chromatography, eluting with a gradient of acetone in dichloromethane, and 
subsequently precipitated to furnish the desired alkenyl iodonium salt. 
General Procedure F 
Two-step dihydroxylation and periodate cleavage of alkenes to give α-chiral aldehydes with high levels of stereoretention: 
 
All quantities given with respect to the initial alkene loading 
F1: NMO (50 wt% in H2O, 4.0 equiv.) and OsO4 (2.5 wt% in tBuOH, 0.4 mol%) were added to a stirred 
suspension of alkene (1.0 equiv.) in tetrahydrofuran and water (2:1, 0.03 M). The resulting solution was 
stirred for the stated time before quenching with the stated volumes of sat. aq. Na2S2O3 solution and 
ethyl acetate. The phases were separated and the aqueous phase extracted with further portions of ethyl 
acetate. The organic fractions were combined, washed with brine, dried over anhydrous Na2SO4 and 
concentrated in vacuo to furnish the intermediate diol as a mixture of diastereoisomers. 
F2: The crude diol mixture was re-dissolved in the stated volume of dichloromethane and silica-
supported sodium meta-periodateiv (approx. 15 wt% NaIO4, 7.0 equiv.) was added in one portion. The 
resulting suspension was stirred for 15 minutes then filtered, washing the silica cake with 50% diethyl 
ether in dichloromethane. The filtrate was concentrated in vacuo and the residue purified by silica column 
chromatography to furnish the title compound for immediate consumption. 
General Procedure G 
Vinylogous Mukaiyama aldol reaction: 
 
                                               
iv Silica-supported sodium meta-periodate was prepared as follows: Silica gel (20 g, Merck Kieselgel 60) was added to a suspension of NaIO4 
(5.14 g, 24 mmol) in water (10 mL) and the vessel shaken vigorously for 10 minutes to give the solid supported reagent as a free-flowing white 
powder.  
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All quantities given with respect to the initial aldehyde loading 
Adapted from a procedure reported by Fuwa et al.178 Solutions of ((2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-
yl)oxy)trimethylsilane (4.0 equiv.) in dichloromethane and boron trifluoride diethyl etherate (1.2 equiv.) in 
dichloromethane were added sequentially at –95 ºC (PhMe/N2(l)) to a solution of the aldehyde (1.0 
equiv.) in dichloromethane. The reaction mixture was maintained at –95 ºC for a further 40 minutes 
then quenched by the addition of the stated volumes of triethylamine and sat. aq. NaHCO3. The 
resulting product mixture was then allowed to warm to 0 ºC then to room temperature with vigorous 
stirring. The crude biphasic reaction mixture was separated and the aqueous layer extracted with 
portions of dichloromethane. The organic fractions were combined, washed with brine, dried over 
anhydrous Na2SO4 and concentrated in vacuo. The crude residue was purified by silica column 
chromatography to furnish the desired aldol adduct. 
General Procedure H 
Regio- and steroselective hydrostannylation of alkynes to give terminal, E-vinyl stannanes 
 
Adapted from a procedure reported by Chong et al, all quantities given with respect to alkyne loading.206 Freshly distilled 
diisopropylethylamine (2 mol%) was added to a solution of Pd2dba3 (0.5 mol%) and 
tricyclohexylphosphonium tetrafluoroborate (2 mol%) in the stated volume of the stated solvent. The 
resulting catalytic solution was stirred for fifteen minutes before cooling to 0 ºC. To this cooled solution 
was added the alkyne substrate (1.0 equiv.) in the stated volume of solvent, followed by the dropwise 
addition of tributyltin hydride (1.2 equiv.) in the stated volume of solvent over a five-minute period. The 
resulting solution was warmed to room temperature and was stirred for two hours. The reaction mixture 
was then concentrated onto silica gel and purified by silica column chromatography to furnish the 
desired vinyl stannane. 
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6.3.2. Model coupling studies 
(E)-(3-(benzyloxy)but-1-en-1-yl)(mesityl)iodonium trifluoromethanesulfonate 481 
 
Prepared according to general procedure E on a 3.5 mmol scale: 
Step E1 was performed with CuCl (12.0 mg, 0.113 mmol), XantPhos (70.0 mg, 0.113 mmol) and KOtBu 
(40.4 mg, 0.360 mmol) in THF (6.4 mL), B2Pin2 (1.12 g, 4.13 mmol) in THF (3.2 mL), ((but-3-yn-2-
yloxy)methyl)benzene 539 (560 mg, 3.50 mmol), and methanol (320 μL, 15.0 mmol) to furnish the 
intermediate pinicolatoboronic ester (E)-2-(3-(benzyloxy)but-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane as a yellow oil for direct consumption in step E2.  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.38–7.29 (m, 5H, H-13,14,15), 6.55 (dd, J = 18.2, 6.4 Hz, 1H, 
H-2), 5.64 (dd, J = 18.2, 0.9 Hz, 1H, H-1), 4.58 (d, J = 12.0 Hz, 1H, H-11a), 4.37 (d, J = 12.0 Hz, 1H, 
H-11b), 3.98 (app. qnd, J = 6.4, 0.9 Hz, 1H, H-3). H-4 obscured by pinacol methyl groups.  
Step E2 was performed with ammonium acetate (1.35 g, 17.5 mmol) and sodium meta-periodate (3.70 g, 
17.5 mmol) in acetone (20 mL) and water (20 mL) to furnish a crude yellow oil containing the 
intermediate boronic acid (E)-(3-(benzyloxy)but-1-en-1-yl)boronic acid for immediate use in step E3.  
1H NMR (400 MHz, CDCl3) δ (ppm): 6.94 (dd, J = 17.8, 6.3 Hz, 1H, H-2), 5.80 (dd, J = 17.8, 1.0 Hz, 
1H, H-1), 4.63 (d, J = 12.0 Hz, 1H, H-11a), 4.46 (d, J = 12.0 Hz, 1H, H-11b), 4.14–4.07 (m, 1H, H-3), 
1.36 (d, J = 6.5 Hz, 3H, H-4). Phenyl resonances obscured by impurities. 
Step E3 was performed in dichloromethane (28 mL) with boron trifluoride diethyl etherate (0.52 mL, 
4.20 mmol) and mesityl iodonium diacetate (1.53 g, 4.20 mmol) in a solution of dichloromethane (14 
mL). The reaction was quenched with the addition of potassium trifluoromethanesulfonate (1.40 g, 7.00 
mmol) and water (140 mL) and purified by silica column chromatography, eluting with 0–50% acetone 
in dichloromethane. The resulting purified iodonium salt was precipitated with diethyl ether to furnish 
the title compound as an amorphous off-white solid (1.18 g, 2.13 mmol, 61% over three steps).  
IR νmax/cm-1 (film): 3034, 2987, 2920, 1591 (C=C), 1455, 1405, 1248, 1225, 1156, 1080, 1059, 1027; 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.35–7.26 (m, 3H, H-14,15), 7.25–7.20 (m, 2H, H-13), 7.10 (s, 
2H, H-7), 6.86 (dd, J = 14.1, 0.7 Hz, 1H, H-1), 6.13 (dd, J = 14.1, 6.6 Hz, 1H, H-2), 4.43 (d, J = 11.8 
Hz, 1H, H-11a), 4.39 (d, J = 11.8 Hz, 1H, H-11b), 4.15 (app. qn, J = 6.4 Hz, 1H, H-3), 2.57 (s, 6H, H-
9), 2.36 (s, 3H, H-10), 1.23 (d, J = 6.5 Hz, 3H, H-4); 13C NMR (100 MHz, CDCl3) δ (ppm): 147.1 (C-
2), 144.6 (C-8), 142.9 (C-6) 137.5 (C-12), 130.4 (C-7), 128.6 (C-14), 128.0 (C-15), 127.8 (C-13), 120.3 (q, 
1J = 313.3 Hz, C-Tf), 116.7 (C-5), 99.4 (C-1), 76.1 (C-3), 71.2 (C-11), 30.0 (C-9), 21.2 (C-10), 20.7 (C-
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4); 19F NMR (376 MHz, CDCl3) δ: –79.2; HRMS-ESI (m/z) found [M–OTf]+ 407.0866, C20H24OI 
requires 407.0866. 
(E)-(3-(benzyloxy)but-1-en-1-yl)(o-tolyl)iodonium trifluoromethanesulfonate 482 
 
Prepared according to general procedure E on a 3.5 mmol scale. Steps E1 and E2 were performed 
analogously to the previous procedure. 
Step E3 was performed in dichloromethane (28 mL) with boron trifluoride diethyl etherate (520 μL, 4.20 
mmol) and ortho-tolyl iodonium diacetate (1.41 g, 4.20 mmol) in a solution of dichloromethane (14 mL). 
The reaction was quenched with the addition of potassium trifluoromethanesulfonate (1.40 g, 7.00 
mmol) and water (140 mL) and purified by silica column chromatography, eluting with 0–50% acetone 
in dichloromethane. The resulting purified iodonium salt was precipitated with diethyl ether to furnish 
the title compound as an amorphous off-white solid (0.90 g, 1.61 mmol, 46% over three steps).  
IR νmax/cm-1 (film): 3062, 2982, 2923, 1603 (C=C), 1469, 1455, 1272, 1238, 1223, 1154, 1104, 1025; 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.00 (d, J = 7.9 Hz, 1H, H-6), 7.56 (app. t, J = 7.4 Hz, 1H, H-
8), 7.49 (d, J = 6.9 Hz, 1H, H-9), 7.33–7.26 (m, 3H, H-15,16), 7.25–7.22 (m, 3H, H-7,14), 6.93 (d, J = 
13.9 Hz, 1H, H-1), 6.44 (dd, J = 13.9, 6.2 Hz, 1H, H-2), 4.46 (d, J = 11.8 Hz, 1H, H-12a), 4.41 (d, J = 
11.8 Hz, 1H, H-12b), 4.16 (qd, J = 6.5, 6.2 Hz, 1H, H-3), 2.59 (s, 3H, H-11), 1.25 (d, J = 6.5 Hz, 3H, 
H-4); 13C NMR (100 MHz, CDCl3) δ (ppm): 150.0 (C-2), 141.9 (C-10), 138.4 (C-6), 137.6 (C-13), 133.7 
(C-8), 132.0 (C-9), 129.8 (C-7), 128.6 (C-15), 128.0 (C-16), 127.8 (C-14), 120.3 (q, 1J = 319.9 Hz, C-Tf), 
115.4 (C-5), 100.1 (C-1), 76.1 (C-3), 71.2 (C-12), 25.6 (C-11), 20.5 (C-4); 19F NMR (376 MHz, CDCl3) 
δ: –79.2; HRMS-ESI (m/z) found [M–OTf]+ 379.0546, C18H20OI requires 379.0553. 
(E)-(3-((triisopropylsilyl)oxy)but-1-en-1-yl)(mesityl)iodonium trifluoromethanesulfonate 483 
 
Prepared according to general procedure E on a 2.2 mmol scale: 
Step Ε1 was performed with CuCl (12.0 mg, 0.113 mmol), XantPhos (70.0 mg, 0.113 mmol) and KOtBu 
(40.4 mg, 0.360 mmol) in THF (6.4 mL), B2Pin2 (1.12 g, 4.13 mmol) in THF (3.2 mL), (but-3-yn-2-
yloxy)triisopropylsilane 483a (500 mg, 2.20 mmol), and methanol (250 μL, 11.6 mmol) to furnish the 
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intermediate pinicolatoboronic ester (E)-triisopropyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-
2-yl)oxy)silane as a yellow oil for direct consumption in step Ε2.  
1H NMR (400 MHz, CDCl3) δ (ppm): 6.61 (dd, J = 18.0, 4.6 Hz, 1H, H-2), 5.62 (dd, J = 18.0, 1.5 Hz, 
1H, H-1), 4.47–4.39 (m, 1H, H-3). H-4,11,12 were obscured by pinacol methyl groups.  
Step E2 was performed with ammonium acetate (1.12 g, 14.5 mmol) and sodium meta-periodate (3.07 g, 
14.5 mmol) in acetone (15 mL) and water (15 mL) to furnish a crude yellow oil containing the 
intermediate boronic acid (E)-(3-((triisopropylsilyl)oxy)but-1-en-1-yl)boronic acid for immediate use in step 
E3.  
1H NMR (400 MHz, CDCl3) δ (ppm): 6.50 (dd, J = 17.9, 4.7 Hz, 1H, H-2), 5.59 (dd, J = 17.9, 1.4 Hz, 
1H, H-1), 4.47–4.38 (m, 1H, H-3). H-4,11,12 were obscured by impurities. 
Step E3 was performed in dichloromethane (18 mL) with boron trifluoride diethyl etherate (320 μL, 2.60 
mmol) and mesityl iodonium diacetate (1.05 g, 2.60 mmol) in a solution of dichloromethane (9 mL). The 
reaction was quenched with the addition of potassium trifluoromethanesulfonate (880 mg, 4.40 mmol) 
and water (50 mL) and purified by silica column chromatography, eluting with 0–20% acetone in 
dichloromethane. The resulting purified iodonium salt was precipitated with hexanes to furnish the title 
compound as an amorphous off-white solid (421 mg, 0.68 mmol, 31% over three steps).  
IR νmax/cm-1 (film): 2945, 2893, 2867, 1592 (C=C), 1463, 1405, 1382, 1276, 1237, 1224, 1159, 1099, 
1026; 1H NMR (400 MHz, CDCl3) δ (ppm): 7.09 (s, 2H, H-7), 6.72 (dd, J = 13.9, 1.2 Hz, 1H, H-1), 
6.29 (dd, J = 13.9, 5.0 Hz, 1H, H-2), 4.54 (app. qn, J = 5.7 Hz, 1H, H-3), 2.57 (s, 6H, H-9), 2.35 (s, 3H, 
H-10), 1.24 (d, J = 6.4 Hz, 3H, H-4), 0.97–0.90 (m, 21H, H-11,12); 13C NMR (100 MHz, CDCl3) δ 
(ppm): 150.2 (C-2), 144.5 (C-8), 142.8 (C-6), 130.3 (C-7), 120.3 (q, 1J = 313.3 Hz, C-Tf), 117.0 (C-5), 
97.8 (C-1), 70.6 (C-3), 27.0 (C-9), 23.9 (C-10), 21.2 (C-4), 18.0 (C-12), 17.9 (C-12’), 12.2 (C-11); 19F 
NMR (376 MHz, CDCl3) δ: –79.3; HRMS-ESI (m/z) found [M–OTf]+ 473.1720, C22H38OSiI requires 
473.1731. 
(E)-4-(hexa-3,5-dien-2-yl)-1,3-dioxan-2-one 484 
 
Prepared according to a procedure adapted from Gaunt et al.158 To a solution of (E)-pent-3-en-1-yl dimethylcarbamate 
317 (31.6 mg, 200 μmol) and (CuOTf)2•PhH (5.2 mg, 10 μmol) in dichloromethane (2 mL) was added 
(E)-(3-(benzyloxy)but-1-en-1-yl)(mesityl)iodonium trifluoromethanesulfonate 481 (222 mg, 400 μmol) in 
dichloromethane (2 mL), with the resulting mixture stirred at room temperature for 24 hours. The 
reaction was quenched by the addition of triethylamine (0.5 mL) and sat aq. NaHCO3 (5 mL) and was 
vigorously stirred for five minutes. The phases were separated and the aqueous phase extracted with 
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further portions of dichloromethane (2 x 5 mL). The organic fractions were combined, washed with 
brine (5 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The resulting residue was purified 
twice with silica column chromatography, eluting firstly with 20% ethyl acetate in petroleum ether 40–
60 and secondly in a gradient of 0–2% diethyl ether in dichloromethane, to furnish the title compound 
as an inseparable 3:1 mixture of diasteroisomers (2.0 mg, 11 μmol, 5%).  
RF 0.28 (2% Et2O in CH2Cl2); IR νmax/cm-1 (film): 2970, 2926, 2853, 1744 (C=O), 1605, 1481, 1457, 
1408, 1250, 1221, 1195; Major diastereoisomer: 1H NMR (500 MHz, CDCl3) δ (ppm): 6.37–6.24 (m, 1H, 
H-5 [obscured]), 6.20–6.10 (m, 1H, H-4 [obscured]), 5.57 (dd, J = 15.2, 8.2 Hz, 1H, H-3), 5.22–5.15 
(m, 1H, H-6a [obscured]), 5.10–5.06 (m, 1H, H-6b [obscured]), 4.46–4.30 (m, 2H, H-9 [obscured]), 
4.26 (ddd, J = 10.7, 7.2, 3.5, 1H, H-7), 2.53 (app. sx, J = 7.0 Hz, 1H, H-2 [obscured]), 2.07–1.87 (m, 
2H, H-8 [obscured]), 1.18 (d, J = 6.6 Hz, 1H, H-1 [obscured]); 13C NMR (125 MHz, CDCl3) δ (ppm): 
149.1 (C-10), 136.5 (C-5), 133.3 (C-4), 133.0 (C-3), 117.5 (C-6), 82.5 (C-7), 67.0 (C-9), 41.7 (C-2), 25.1 
(C-8), 15.8 (C-1); Minor diastereoisomer: 1H NMR (500 MHz, CDCl3) δ (ppm): 6.37–6.24 (m, 1H, H-5 
[obscured]), 6.20–6.10 (m, 1H, H-4 [obscured]), 5.65 (dd, J = 15.3, 8.2 Hz, 1H, H-3), 5.22–5.15 (m, 
1H, H-6a [obscured]), 5.10–5.06 (m, 1H, H-6b [obscured]), 4.46–4.30 (m, 3H, H-7,9 [obscured]), 2.53 
(m, 1H, H-2 [obscured]), 2.07–1.87 (m, 2H, H-8 [obscured]), 1.17 (d, J = 6.5 Hz, 1H, H-1); 13C NMR 
(125 MHz, CDCl3) δ (ppm): 13C NMR (125 MHz, CDCl3) δ (ppm): 149.2 (C-10), 136.6 (C-5), 133.4 (C-
4), 132.8 (C-3), 117.3 (C-6), 82.5 (C-7), 67.0 (C-9), 41.1 (C-2), 24.5 (C-8), 15.5 (C-1); HRMS-ESI (m/z) 
found M+ 183.1015, C10H15O3 requires 183.1016. 
(E)-4-(5-(benzyloxy)hex-3-en-2-yl)-1,3-dioxan-2-one 478 
 
A solution of (E)-(3-(benzyloxy)but-1-en-1-yl)(mesityl)iodonium trifluoromethanesulfonate 481 (222 mg, 400 μmol) 
in dichloromethane (2 mL) was added at 0 ºC to a solution of (E)-pent-3-en-1-yl dimethylcarbamate 317 (31.6 
mg, 200 μmol) and (CuOTf)2•PhH (5.2 mg, 10 μmol) in dichloromethane (2 mL). The resulting mixture 
was stirred at 0 ºC for 24 hours before quenching by the addition of triethylamine (0.5 mL) and sat. aq. 
NaHCO3 (5 mL) and vigorously stirring the reaction mixture for five minutes. The phases were 
separated and the aqueous phase was extracted with further portions of dichloromethane (2 x 5 mL). 
The organic fractions were combined, washed with brine (5 mL), dried over anhydrous Na2SO4 and 
concentrated in vacuo. The resulting residue was purified by silica column chromatography, eluting with 
20% ethyl acetate in petroleum ether 40–60 to furnish the title compound as an inseparable mixture of 
four diastereoisomers (11.6 mg, 40 μmol, 20%).  
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RF 0.11 (40% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 2976, 2930, 1749 (C=O), 1454, 1407, 
1250, 1194, 1116, 1071, 1028; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.37–7.27 (m, 5H, H-13,14,15), 
5.66–5.51 (m, 2H, H-3,4), 4.56–4.51 (m, 1H, H-11a), 4.67–4.25 (m, 4H, H-7,9,11b), 3.94 (app. sx, J = 
6.3 Hz, 1H, H-5), 2.57–2.48 (m, 1H, H-2), 2.05–1.87 (m, 2H, H-8), 1.31–1.28 (m, 3H, H-6), 1.20–1.14 
(m, 3H, H-1); 13C NMR (125 MHz, CDCl3) δ (ppm): 149.2 (C-10), 138.9 (C-12), 135.2 (C-3), 131.3 (C-
4), 131.1 (C-4’), 128.6 (C-14), 127.8 (2C, C-13,15), 82.6 (C-7), 82.5 (C-7’), 75.82 (C-5), 75.78 (C-5’), 75.7 
(C-5’’), 75.6 (C-5’’’), 70.5 (C-11), 70.3 (C-11’), 67.1 (C-9), 41.4 (C-2), 41.3 (C-2’), 40.9 (C-2’’), 25.1 (C-
8), 24.8 (C-8’), 21.8 (C-6), 16.0 (C-1), 15.7 (C-1’); HRMS-ESI (m/z) found [M+H]+ 291.1588, C17H23O4 
requires 291.1591. 
6.3.3. First generation synthetic approach 
 (3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-ol 511221 
 
Method 1: 
Adapted from a procedure reported by Curran et al.192 Freshly condensed trans-butene (approx. 3.0 mL, 34 mmol) 
was added via canula to a –78 ºC stirred solution of potassium tert-butoxide (510 mg, 4.30 mmol) in 
tetrahydrofuran (28 mL). n-BuLi (1.6 M in hexanes, 2.70 mL, 4.30 mmol) was then added to the reaction 
with the resulting vivid yellow solution then warmed to –45 ºC and maintained at this temperature for 
30 minutes. The mixture was cooled to –78 ºC and a solution of (+)–methoxydiisopinocampheylborane 
(1.36 g, 4.30 mmol) in tetrahydrofuran (7 mL) added. The resulting suspension was then stirred for a 
further 40 minutes before undergoing a dropwise addition of boron trifluoride diethyl etherate (540 μL, 
4.30 mmol) over a 30-minute period. 3-trimethylsilylpropynal (313 μL, 2.14 mmol) was introduced to 
the crotylation mixture and the resulting solution was stirred for 6 hours at –78 ºC. The reaction mixture 
was quenched by the dropwise addition of methanol (1.4 mL) and warmed to room temperature. The 
product mixture was concentrated in vacuo and the residue dissolved in 2:1 mixture of THF/H2O (21 
mL), cooled to 0 ºC. Sodium perborate tetrahydrate (2.15 g, 14.0 mmol) was added portionwise and the 
suspension stirred for 14 hours. The resulting mixture was diluted with water (15 mL) and extracted with 
ethyl acetate (3 x 15 mL). The organic layers were combined, washed with water (30 mL) and brine (30 
mL), dried over anhydrous MgSO4, and concentrated in vacuo. The residues were purified by silica 
column chromatography, eluting with 5% ethyl acetate in petroleum ether 40–60 to furnish the title 
compound as a colourless oil (100 mg, 0.55 mmol, 26%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 5.80 (ddd, J = 17.1, 10.5, 7.6 Hz, 1H, H-5), 5.18–5.12 (m, 2H, 
H-6), 4.18 (app. t, J = 5.9 Hz, 1H, H-3), 2.44 (app. sx, J = 6.9 Hz, 1H, H-4), 1.97 (d, J = 5.7 Hz, 1H, 
H-9), 1.12 (d, J = 7.1 Hz, 3H, H-7), 0.17 (s, 9H, H-8); 13C NMR (100 MHz, CDCl3) δ (ppm): 139.3 (C-
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5), 116.6 (C-6), 105.2 (C-2), 90.5 (C-1), 66.6 (C-3), 44.4 (C-4), 15.3 (C-7), –0.1 (C-8); [α]25D = +26.3 º (c 
= 1.0, CHCl3), literature (enant-X): [α]27D = –30 º (c = 1.1, CHCl3); GC-FID analysis (Chiraldex β-DM 
column, 70 ºC to 130 ºC at a rate of 6 ºC min-1 then hold for 5 minutes, linear velocity = 50 cm s-1, split 
ratio = 50.0) indicated 93% e.e.: tR (major) = 6.82 minutes, tR (minor) = 7.02 minutes. Experimental data 
in agreement with previous literature report.221  
Method 2: 
Adapted from a procedure reported by Roush et al.193 An oven-dried flask was charged with powdered 4 Å 
molecular sieves (14.4 g, previously dried by heating in vacuo for 18 hours) and backfilled with nitrogen 
gas. Anhydrous toluene (192 mL) and a solution of (S,S)-diisopropyl tartrate (E)-crotylboronate in toluene 
(82 mL, 0.72 M, 59.0 mmol – freshly prepared according to the procedure reported by Roush et al.)193 
were added via syringe. This suspension was stirred at room temperature for a period of 30 minutes 
before being cooled to –78 ºC and undergoing a dropwise addition of a solution of freshly-distilled 3-
trimethylsilylpropynal (6.16 g, 48.7 mmol) in anhydrous toluene (18 mL) over one hour. The reaction 
mixture was maintained at –78 ºC for two hours before quenching by the addition of 2 M aq. NaOH 
(156 mL). The resulting mixture was gradually warmed to room temperature over one hour and was 
vigorously stirred for a further 30 minutes. The quenched biphasic reaction mixture was separated and 
the aqueous layer extracted with diethyl ether (3 x 120 mL). The organic layers were combined, washed 
with sat. aq. NaHCO3 solution (100 mL) and brine (2 x 100 mL), dried over anhydrous Na2SO4 and 
concentrated in vacuo. The crude oily residue was purified by silica column chromatography, eluting with 
5% diethyl ether in petroleum ether 40–60, to give the title compound as a colourless oil (7.61 g, 41.7 
mmol, 86%).  
[α]26D = +23.7 º (c = 1.0, CHCl3), literature (enant-511): [α]27D = –30 º (c = 1.1, CHCl3); GC-FID 
analysis (Chiraldex β-DM column, 70 ºC to 130 ºC at a rate of 6 ºC min-1 then hold for 5 minutes, linear 
velocity = 50 cm s-1, split ratio = 50.0) indicated 75% e.e.: tR (major) = 6.86 minutes, tR (minor) = 7.06 
minutes. Spectroscopic data identical with those described in method 1. 
Mosher ester analysis was carried out to confirm enantiomer according to the method described by Shao et al.222 
 
R-(–)-MTPA-Cl (36 μL, 0.19 mmol) was added to a solution of (3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-
1-yn-3-ol 511 (18.2 mg, 0.100 mmol) and dry pyridine (23 μL, 0.30 mmol) in dichloromethane (1.5 mL) 
and the resulting mixture was stirred for 24 hours. The reaction was quenched with the addition of sat. 
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aq. NaHCO3 solution (1.5 mL), the phases separated, and the aqueous phase extracted with diethyl 
ether (2 x 2 mL). The organic phases were combined, dried over anhydrous Na2SO4 and concentrated 
under a stream of nitrogen gas. The resulting residues were purified by silica column chromatography, 
eluting in a gradient of 0–2% diethyl ether in petroleum ether 40–60, to furnish the S-MTPA ester 511a 
as a colourless oil (6.7:1 d.r.).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.59–7.50 (m, 2H, H-Ar), 7.42–7.35 (m, 3H, H-Ar), 5.74 (ddd, J 
= 17.5, 10.2, 7.6 Hz, 1H, H-5), 5.41 (d, J = 6.9 Hz, 1H, H-3), 5.17–5.08 (m, 2H, H-6), 3.54 (s, 3H, H-
OMe), 2.63 (app. sx, J = 7.0 Hz, 1H, H-4), 1.15 (d, J = 6.8 Hz, 3H, H-7), 0.15 (s, 9H, H-8).  
R-MTPA ester 511b (6.7:1 d.r.) was prepared in an identical fashion with S-(–)-MTPA-Cl.  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.59–7.50 (m, 2H, H-Ar), 7.42–7.35 (m, 3H, H-Ar), 5.68 (ddd, J 
= 17.2, 10.3, 7.6 Hz, 1H, H-5), 5.46 (d, J = 6.2 Hz, 1H, H-3), 5.08–5.01 (m, 2H, H-6), 3.59 (s, 3H, H-
OMe), 2.57 (app. sx, J = 6.8 Hz, 1H, H-4), 1.09 (d, J = 7.0 Hz, 3H, H-7), 0.18 (s, 9H, H-8). Comparitive 
analysis shown below (Table 44). 
Proton 
δ S-ester 
(511a) (ppm) 
δ R-ester 
(511a) (ppm) 
ΔδSR (δS – δR) 
ppm Hz (400 MHz) 
3 5.41 5.46 –0.05 –20 
8 0.15 0.18 –0.03 –12 
4 2.63 2.57 +0.06 +24 
5 5.74 5.68 +0.06 +24 
7 1.15 1.09 +0.06 +24 
Table 44 – Mosher ester analysis of crotylation product 511  
(3R,4R)-4-methylhex-5-en-1-yn-3-ol 514 
 
Potassium carbonate (56.0 g, 405 mmol) was added portionwise to a solution of (3R,4R)-4-methyl-1-
(trimethylsilyl)hex-5-en-1-yn-3-ol 511 (7.73 g, 96% purity, 40.7 mmol) in methanol (200 mL). The resulting 
cloudy suspension was stirred for 15 minutes then filtered through a pad of celite™ and the filter cake 
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washed with diethyl ether (2 x 200 mL) and water (100 mL). The resulting biphasic mixture was 
separated and the aqueous layer extracted with further portions of diethyl ether (2 x 100 mL). The 
combined organic fractions were dried over anhydrous MgSO4, concentrated in vacuo and purified by 
kugelrohr distillation to furnish the title compound as a colourless oil (3.22 g, 29.2 mmol, 72%).  
IR νmax/cm-1 (film): 3385 (br., O–H), 3298 (sp C–H), 2972, 2876, 1641 (C=C), 1457, 1417, 1374, 1288, 
1027, 997, 918; 1H NMR (400 MHz, CDCl3) δ (ppm): 5.82 (ddd, J = 17.1, 10.5, 7.5 Hz, 1H, H-5), 5.21–
5.14 (m, 2H, H-6), 4.22 (d, J = 5.1 Hz, 1H, H-3), 2.53–2.42 (m, 2H, H-1,4), 2.02 (br. s, 1H, H-8), 1.14 
(d, J = 6.8 Hz, 3H, H-7); 13C NMR (100 MHz, CDCl3) δ (ppm): 139.0 (C-5), 117.1 (C-6), 83.3 (C-2), 
74.0 (C-1), 66.1 (C-3), 44.3 (C-4), 15.2 (C-7); HRMS-ESI (m/z) found M+ 110.0733, C7H10O requires 
110.0732; [α] 26D = +31.3 º (c = 1.0, CHCl3). 
((((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)methyl)benzene 517 
 
Adapted from a procedure reported by Nakai et al.197 Benzyl bromide (2.32 mL, 19.5 mmol) was added dropwise 
at 0 ºC to a vigorously stirred mixture of (3R,4R)-4-methylhex-5-en-1-yn-3-ol 514 (1.65 g, 15.0 mmol), 
tetrabutylammonium iodide (276 mg, 0.75 mmol), NaOH (2.4 g, 60.0 mmol) and water (0.75 mL). The 
resulting reaction mixture was warmed to room temperature and stirred for 16 hours before being 
diluted with diethyl ether (20 mL) and filtered. Water (20 mL) was added to the filtrate and the biphasic 
mixture was separated, with the aqueous layer extracted with further portions of diethyl ether (3 x 20 
mL). The organic layers were combined, washed with brine (30 mL), dried over anhydrous MgSO4 and 
concentrated in vacuo. The crude residue was purified by alumina column chromatography, eluting with 
0 to 1% diethyl ether in petroleum ether 40–60, to give the title compound as colourless oil (2.41 g, 12.1 
mmol, 81%).  
RF 0.41 (2% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 3298 (sp C–H), 2980, 2869, 1643 (C=C), 
1496, 1453, 1344, 1205, 1084, 1066, 918, 696; 1H NMR (400 MHz, CDCl3) δ (ppm): 7.40–7.27 (m, 
5H, H-10,11,12), 5.88 (ddd, J = 17.4, 10.3, 7.2 Hz, 1H, H-5), 5.16–5.07 (m, 2H, H-6), 4.84 (d, J = 11.9 
Hz, 1H, H-8a), 4.53 (d, J = 11.9 Hz, 1H, H-8b), 4.01 (dd, J = 5.7, 2.0 Hz, 1H, H-3), 2.58 (app. sx, J = 
6.7 Hz, 1H, H-4), 2.49 (d, J = 2.1 Hz, 1H, H-1), 1.17 (d, J = 6.7 Hz, 3H, H-7); 13C NMR (100 MHz, 
CDCl3) δ (ppm): 139.7 (C-5), 138.0 (C-9), 128.5 (C-11), 128.1 (C-10), 127.8 (C-12), 115.5 (C-6), 81.4 (C-
2), 75.0 (C-1), 72.6 (C-3), 70.7 (C-8), 42.4 (C-4), 15.4 (C-7); HRMS-ESI (m/z) found [M+NH4]+ 
218.1541, C14H20ON requires 218.1539; [α] 26D = +83.9 º (c = 1.0, CHCl3). 
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(2S,3R)-3-(benzyloxy)-2-methylpent-4-ynal 518 
 
Prepared according to general procedure F on a 4.0 mmol scale. 
Step F1 was performed with NMO (3.33 mL, 50 wt% in water, 16.0 mmol), OsO4 (162 μL, 2.5 wt% in 
tert-butanol, 16.0 μmol) and ((((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)methyl)benzene 517 (800 mg, 4.00 
mmol) with stirring for 168 hours. The resulting solution was quenched with sat. aq. Na2S2O3 solution 
(200 mL) and ethyl acetate (200 mL). Following separation, the aqueous layer was washed with ethyl 
acetate (4 x 100 mL) to furnish the crude diol mixture as 2:1 mixture of diastereoisomers.  
Major diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 7.42–7.30 (m, 5H, H-9,10,11), 4.90 (d, J = 
11.4 Hz, 1H, H-7a [obscured]), 4.56 (d, J = 11.4 Hz, 1H, H-7b), 4.28 (dd, J = 7.0, 2.1 Hz, 1H, H-3), 
3.75 (dd, J = 11.0, 3.0 Hz, 1H, H-0a), 3.71–3.65 (m, 1H, H-1), 3.60–3.56 (m, 1H, H-0b [obscured]), 
2.76 (br. s, 2H, O–H), 2.58 (d, J = 2.1 Hz, 1H, H-5), 2.11 (app. sx, J = 7.1 Hz, 1H, H-2), 1.05 (d, J = 
6.8 Hz, 3H, H-6). Minor diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 7.42–7.30 (m, 5H, H-
9,10,11), 4.88 (d, J = 11.6 Hz, 1H, H-7a [obscured]), 4.51 (d, J = 11.6 Hz, 1H, H-7b), 4.19–4.11 (m, 
2H, H-1,3), 3.81 (br. t, J = 4.6 Hz, 1H, O–H), 3.66–3.55 (m, 2H, H-0 [obscured], 2.59 (d, J = 2.1 Hz, 
1H, H-5), 2.42 (br. s, 1H, O–H), 2.05–1.96 (m, 1H, H-3), 1.08 (d, J = 7.1 Hz, 3H, H-6). 
Step F2 was performed with silica-supported sodium meta-periodate (40.0 g, approx. 15 wt% NaIO4, 
28.0 mmol) in dichloromethane (400 mL). The crude residue was purified by silica column 
chromatography, eluting with 2–3% diethyl ether in petroleum ether 40–60, to furnish the title 
compound as a colourless oil (647 mg, >98% diasteromeric purity, 3.20 mmol, 80%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 9.76 (d, J = 1.7 Hz, 1H, H-1), 7.39–7.27 (m, 5H, H-9,10,11), 
4.84 (d, J = 11.7 Hz, 1H, H-7a), 4.53 (d, J = 11.7 Hz, 1H, H-7b), 4.34 (dd, J = 6.8, 2.1 Hz, 1H, H-3), 
2.72 (app. qd, J = 6.0, 1.8 Hz, 1H, H-2), 2.59 (d, J = 2.1 Hz, 1H, H-5), 1.20 (d, J = 7.2 Hz, 3H, H-6); 
13C NMR (100 MHz, CDCl3) δ (ppm): 202.3 (C-1), 137.2 (C-8), 128.6 (C-10), 128.2 (C-9), 128.1 (C-11), 
80.2 (C-4), 76.4 (C-5), 71.0 (C-7), 68.9 (C-3), 50.8 (C-2), 10.6 (C-6). Consumed directly. 
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6-((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 520 and 6-
((2R,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one epi-520 
 
Prepared according to general procedure G with ((2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-
yl)oxy)trimethylsilane 459 (2.94 g, 13.7 mmol) in dichloromethane (20 mL), boron trifluoride diethyl 
etherate (0.56 mL, 4.5 mmol) in dichloromethane (20 mL) and (2S,3R)-3-(benzyloxy)-2-methylpent-4-ynal 
518 (672 mg, 95% purity, 3.33 mmol) in dichloromethane (40 mL). The reaction mixture was quenched 
with triethylamine (5 mL) and sat. aq. NaHCO3 solution (20 mL) and the work-up performed with 
dichloromethane (2 x 50 mL) and brine (40 mL). The crude residue was purified by silica column 
chromatography, eluting with 10–50% ethyl acetate in petroleum ether 40–60 to give the title 
compounds in a 5:1 ratio. The mixture of diastereoisomers was further purified by silica column 
chromatography, eluting with 10% diethyl ether in toluene, to furnish the title compound 520 (872 mg, 
2.53 mmol, 76%) and its C-2 epimer epi-520 (152 mg, 0.44 mmol, 13%) as white crystalline solids. 
6-((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 520 
 
RF 0.20 (40% EtOAc in pet. ether 40–60); Tm 78–80 ºC; IR νmax/cm-1 (film): 3464 (br., O–H), 3290 (sp 
C–H), 2980, 1717 (C=O), 1633 (C=C), 1457, 1391, 1376, 1274, 1203, 1017; 1H NMR (500 MHz, 
CDCl3) δ (ppm): 7.39–7.30 (m, 5H, H-10,11,12), 5.31 (s, 1H, H-14), 4.86 (d, J = 11.7 Hz, 1H, H-8a), 
4.49 (d, J = 11.7 Hz, 1H, H-8b), 4.43 (dddd, J = 8.8, 5.0, 3.6, 1.8 Hz, 1H, H-2), 4.11 (dd, J = 5.4, 2.1 
Hz, 1H, H-4), 2.72 (d, J = 3.6 Hz, 1H, H-18), 2.58 (d, J = 2.1 Hz, 1H, H-6), 2.36 (dd, J = 14.6, 8.8 Hz, 
1H, H-1a), 2.24 (dd, J = 14.6, 5.0 Hz, 1H, H-1b), 1.91 (qdd, J = 7.1, 5.4, 1.8 Hz, 1H, H-3), 1.683 (s, 
3H, H-17a), 1.677 (s, 3H, H-17b), 1.05 (d, J = 7.1 Hz, 3H, H-7); 13C NMR (125 MHz, CDCl3) δ (ppm): 
169.4 (C-13), 161.3 (C-15), 136.9 (C-9), 128.8 (C-11), 128.4 (2C, C-10,12), 106.7 (C-16), 95.1 (C-14), 
81.3 (C-5), 76.0 (C-6), 72.4 (C-4), 71.3 (C-8), 68.5 (C-2), 42.4 (C-3), 38.7 (C-1), 25.5 (C-17a), 24.9 (C-
17b), 10.5 (C-7); HRMS-ESI (m/z) found [M+H]+ 345.1698, C20H25O5 requires 345.1697; [α]25D = 
+43.1o (c = 1.0, CHCl3). 
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6-((2R,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one epi-520 
 
RF 0.15 (40% EtOAc in pet. ether 40–60); Tm 69–72 ºC; IR νmax/cm-1 (film): 3440 (br., O–H), 3286 (sp 
C–H), 2929, 1709 (C=O), 1631 (C=C), 1455, 1391, 1378, 1276, 1203, 1013; 1H NMR (500 MHz, 
CDCl3) δ (ppm): 7.39–7.29 (m, 5H, H-10,11,12), 5.33 (s, 1H, H-14), 4.86 (d, J = 11.7 Hz, 1H, H-8a), 
4.51 (d, J = 11.7 Hz, 1H, H-8b), 4.20 (dd, J = 6.9, 2.1 Hz, 1H, H-4), 3.93–3.87 (m, 1H, H-2), 2.92 (d, 
J = 4.1 Hz, 1H, H-18), 2.57 (d, J = 2.1 Hz, 1H, H-6), 2.50 (dd, J = 14.7, 3.1 Hz, 1H, H-1a), 2.30 (dd, 
J = 14.7, 9.5 Hz, 1H, H-1b), 1.91 (app. sx, J = 7.0 Hz, 1H, H-3), 1.693 (s, 3H, H-17a), 1.687 (s, 3H, H-
17b), 1.04 (d, J = 7.0 Hz, 3H, H-7); 13C NMR (100 MHz, CDCl3) δ (ppm): 169.6 (C-13), 161.2 (C-15), 
137.2 (C-9), 128.7 (C-11), 128.3 (C-10), 128.2 (C-12) 106.7 (C-16), 95.5 (C-14), 81.0 (C-5), 76.0 (C-6), 
72.0 (C-4), 71.4 (C-2), 71.2 (C-8), 43.7 (C-3), 39.1 (C-1), 25.6 (C-17a), 24.7 (C-17b), 12.9 (C-7); HRMS-
ESI (m/z) found [M+H]+ 345.1698, C20H25O5 requires 345.1697; [α] 26D = +62.9 º (c = 1.0, CHCl3).  
6-((2S,3R,4R)-2,4-bis(benzyloxy)-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 521 
 
Adapted from a procedure reported by Kunishima et al.202 Trifluoromethanesulfonic acid (1.8 μL, 20 μmol) was 
added to a stirred suspension of 6-((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-
4H-1,3-dioxin-4-one 520 (34.4 mg, 100 μmol), 2,4,6-tris(benzyloxy)-1,3,5-triazine (TriBOT) 523 (13.8 mg, 
40 μmol) and 5 Å molecular sieves (13.0 mg, freshly dried) in 1,4-dioxane (0.5 mL). The resulting mixture 
was stirred at room temperature for 22 hours before quenching on the addition of triethylamine (10 μL). 
The product mixture was filtered through a pad of Celite™ and the resulting filtrate concentrated under 
a stream of nitrogen gas. The residue was re-dissolved in ethyl acetate (1 mL), washed with sat. aq. 
NaHCO3, and the organic layer passed through a plug of anhydrous MgSO4 and concentrated in vacuo. 
The crude residue was purified by silica column chromatography, eluting with a gradient of 0 to 10% 
ethyl acetate in petroleum ether 40–60, to furnish the title compound as a colourless oil (11.0 mg, 25 
μmol, 25%).  
RF 0.22 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3286 (sp C–H), 2924, 2857, 1730 (C=O), 
1633 (C=C), 1457, 1389, 1376, 1274, 1205, 1064; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.32–7.26 (m, 
8H, H-11,12,15,16,17), 7.21–7.17 (m, 2H, H-10), 5.28 (s, 1H, H-19), 4.79 (d, J = 11.4 Hz, 1H, H-13a), 
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4.48 (d, J = 11.4 Hz, 1H, H-8a), 4.33 (d, J = 11.4 Hz, 1H, H-13b), 4.31 (d, J = 11.4 Hz, 1H, H-8b), 
4.11–4.05 (m, 2H, H-2,4), 2.59 (dd, J = 14.3, 6.4 Hz, 1H, H-1a), 2.52 (d, J = 2.0 Hz, 1H, H-6), 2.39 
(dd, J = 14.3, 7.0 Hz, 1H, H-1b), 1.97 (app. dqd, J = 9.0, 7.0, 2.0 Hz, 1H, H-3), 1.63 (s, 3H, H-22a), 
1.60 (s, 3H, H-22b), 1.10 (d, J = 7.0 Hz, 3H, H-7); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.2 (C-18), 
161.1 (C-20), 138.2 (C-9), 137.8 (C-14), 128.5 (2C, C-11,16), 128.3 (C-15), 128.0 (C-17), 127.9 (C-12), 
127.7 (C-10), 106.7 (C-21), 95.1 (C-19), 82.0 (C-5), 75.5 (C-6), 74.9 (C-2), 72.4 (C-8), 70.7 (C-13), 70.2 
(C-4), 42.2 (C-3), 36.8 (C-1), 25.6 (C-22a), 24.8 (C-22b), 10.1 (C-7); HRMS-ESI (m/z) found [M+Na]+ 
457.1972, C27H30O5Na requires 457.1985; [α] 26D = +34.3 º (c = 0.3, CHCl3). 
6-(((2S,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 525 
and 6-(((2R,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 
524 
 
Adapted from a procedure reported by Oikawa et al.204 DDQ (17.0 mg, 75 μmol) was added to a stirred suspension 
of 6-((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 520 (17.2 
mg, 50 μmol) and 3 Å molecular sieves (20.0 mg, freshly activated) in dichloromethane (0.5 mL) 
contained in a microwave tube. The reaction vessel was sealed and the resulting mixture was heated to 
45 ºC for 24 hours before diluting with a further 2 mL dichloromethane and quenching with the addition 
of sat. aq NaHCO3 solution (2 mL). The phases were separated and the aqueous layer extracted with a 
further 2 mL of dichloromethane. The combined organic fractions were passed through a plug of 
anhydrous MgSO4 and concentrated under a stream of nitrogen gas. The resulting crude product 
mixture was combined with residues gathered from a second reaction (50 μmol substrate, performed 
analogously except for use of dichloroethane as reaction solvent and with heating to 70 ºC for 24 hours). 
The combined mixtures were purified by silica column chromatography, eluting with 10–30% ethyl 
acetate in petroleum ether 40–60, to furnish the title compounds 6-(((2S,4S,5R,6R)-6-ethynyl-5-methyl-2-
phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 525 (6.4 mg, 19 μmol, 19%) and 6-
(((2R,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 524 
(6.5 mg, 19 μmol, 19%) both as colourless oils. 
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6-(((2S,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 525 
 
RF 0.24 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3282 (sp C–H), 2920, 1722 (C=O), 1635 
(C=C), 1459, 1391, 1374, 1272, 1253, 1116, 1015; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.49–7.43 (m, 
2H, H-11), 7.39–7.34 (m, 3H, H-10,12), 6.04 (s, 1H, H-8), 5.39 (s, 1H, H-14), 4.75 (dd, J = 2.2, 1.4 Hz, 
1H, H-4), 4.66 (ddd, J = 8.8, 4.8, 2.2 Hz, 1H, H-2), 2.72 (d, J = 2.2 Hz, 1H, H-6), 2.59 (dd, J = 15.0, 
8.8 Hz, 1H, H-1a), 2.32 (ddd, J = 15.0, 4.8, 0.5 Hz, 1H, H-1b), 1.76 (qdd, J = 7.0, 2.2, 1.4 Hz, 1H, H-
3), 1.70 (s, 3H, H-17a), 1.68 (s, 3H, H-17b), 1.26 (d, J = 7.0 Hz, 3H, H-7); 13C NMR (125 MHz, CDCl3) 
δ (ppm): 168.3 (C-13), 161.1 (C-15), 137.9 (C-9), 129.2 (C-12), 128.5 (C-11), 126.2 (C-10), 106.8 (C-16), 
96.7 (C-8), 95.5 (C-14), 80.6 (C-5), 77.3 (C-6), 72.3 (C-2), 70.7 (C-4), 37.2 (C-1), 36.4 (C-3), 25.5 (C-17a), 
24.9 (C-17b), 12.0 (C-7); HRMS-ESI (m/z) found [M+Na]+ 365.1366, C20H22O5Na requires 365.1359; 
[α] 26D = –23.3 º (c = 0.15, CHCl3). 
6-(((2R,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 524 
 
RF 0.18 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3278 (sp C–H), 2925, 2853, 1724 (C=O), 
1635 (C=C), 1459, 1395, 1378, 1272, 1203, 1015; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.46–7.42 (m, 
2H, H-11), 7.38–7.31 (m, 3H, H-10,12), 5.75 (s, 1H, H-8), 5.37 (d, J = 0.8 Hz, 1H, H-14), 4.54–4.47 
(m, 2H, H-2,4), 2.93 (dd, J = 14.9, 12.0 Hz, 1H, H-1a), 2.60–2.52 (m, 2H, H-3,6), 2.46 (ddd, J = 14.9, 
3.9, 0.8 Hz, 1H, H-1b), 1.62 (s, 3H, H-17a), 1.57 (s, 3H, H-17b), 1.02 (d, J = 7.2 Hz, 3H, H-7); 13C 
NMR (125 MHz, CDCl3) δ (ppm): 168.5 (C-13), 161.0 (C-15), 137.3 (C-9), 129.3 (C-12), 128.5 (C-11), 
126.3 (C-10), 107.2 (C-16), 95.8 (C-14), 94.7 (C-8), 80.4 (C-5), 75.0 (C-6), 73.6 (C-2), 68.9 (C-4), 37.3 
(C-3), 30.4 (C-1), 26.0 (C-17a), 24.3 (C-17b), 13.0 (C-7); HRMS-ESI (m/z) found [M+Na]+ 365.1360, 
C20H22O5Na requires 365.1359; [α] 26D = –40.0 º (c = 0.13, CHCl3). 
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6-((2S,3S,4R)-4-(benzyloxy)-2-((tert-butyldimethylsilyl)oxy)-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-
4-one 526 
 
Tert-butyldimethylsilyl chloride (181 mg, 1.20 mmol) was added at 0 ºC to a stirred suspension of 6-
((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 520 (344 mg, 
1.00 mmol) and imidazole (102 mg, 1.50 mmol) in dichloromethane (5 mL). The resulting mixture was 
warmed to room temperature and stirred for 24 hours, then refluxed for a further 18 hours. The reaction 
mixture was cooled to room temperature, diluted with dichloromethane (20 mL), and quenched with 
sat. aq. NaHCO3 solution (25 mL). The phases were separated and the aqueous layer was extracted with 
further portions of dichloromethane (3 x 20 mL). The combined organic layers were washed with brine 
(25 mL), dried over anhydrous MgSO4 and concentrated in vacuo. The resulting crude reaction mixture 
(predominantly starting material) was purified by silica column chromatography, eluting with 0–30% 
ethyl acetate in petroleum ether 40–60, to furnish recovered starting material (305 mg, 0.91 mmol, 91%) 
as a white solid and the title compound as a colourless oil (40 mg, 87 μmol, 9%).  
RF 0.37 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3290 (sp C–H), 2926, 2853, 1728 (C=O), 
1633 (C=C), 1461, 1389, 1376, 1270, 1203, 1015, 834; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.36–
7.26 (m, 5H, H-13,14,15), 5.24 (s, 1H, H-17), 4.84 (d, J = 11.2, 1H, H-11a), 4.40 (d, J = 11.2 Hz, 1H, 
H-11b), 4.36 (ddd, 7.5, 6.1, 2.1 Hz, 1H, H-2), 4.08 (dd, J = 8.3, 2.0 Hz, 1H, H-4), 2.53 (d, J = 2.0 Hz, 
1H, H-6), 2.47–2.35 (m, 2H, H-1), 1.90 (qdd, J = 8.3, 6.9, 2.1 Hz, 1H, H-3), 1.62 (s, 3H, H-20a), 1.56 
(s, 3H, H-20b), 1.06 (d, J = 6.9 Hz, 3H, H-7), 0.85 (s, 9H, H-10), 0.04 (s, 3H, H8a), –0.01 (s, 3H, H-8b); 
13C NMR (125 MHz, CDCl3) δ (ppm): 168.8 (C-16), 161.2 (C-18), 138.0 (C-12), 128.4 (C-14), 127.9 (C-
13), 127.8 (C-15), 106.7 (C-19), 95.3 (C-17), 82.0 (C-5), 75.8 (C-6), 70.5 (C-11), 70.2 (C-4), 67.9 (C-2), 
42.9 (C-3), 39.8 (C-1), 26.0 (C-20a), 25.9 (C-10), 24.3 (C-20b), 18.1 (C-9), 9.8 (C-7), –4.3 (C-8a), –4.7 
(C-8b); HRMS-ESI (m/z) found [M+Na]+ 481.2370, C26H38O5SiNa requires 481.2381; [α] 26D = +12.3 
º (c = 1.0, CHCl3). 
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6-((2S,3S,4R)-4-(benzyloxy)-3-methyl-2-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 527 
 
Adapted from a procedure reported by Hiemstra et al.223 Triethylsilyl chloride (0.38 mL, 2.76 mmol) was added 
at 0 ºC to a stirred solution of imidazole (250 mg, 3.68 mmol) and 6-((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-
3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 520 (250 mg, 0.74 mmol) in dimethylformamide 
(2.5 mL). The resulting mixture was warmed to room temperature and stirred for one hour before it was 
diluted with water (5 mL) and extracted with diethyl ether (3 x 5 mL). The combined organic layers were 
washed with water (2 x 5 mL) and sat. aq. NaHCO3 solution (5 mL), dried over anhydrous MgSO4 and 
concentrated in vacuo. The product residue was subjected to prolonged high vacuum (approx. 0.5 mbar, 
24 hours) to remove residual silanol impurities then purified by silica column chromatography, eluting 
with 10–20% diethyl ether in petroleum ether 40–60, to furnish the title compound as a colourless oil 
(287 mg, 0.63 mmol, 85%).  
RF 0.65 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3294 (sp C–H), 2956, 2877, 1732 (C=O), 
1635 (C=C), 1459, 1389, 1372, 1272, 1203, 1066, 1013; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.38–
7.27 (m, 5H, H-12,13,14), 5.24 (s, 1H, H-16), 4.84 (d, J = 11.2, 1H, H-10a), 4.41 (d, J = 11.2 Hz, 1H, 
H-10b), 4.34 (ddd, J = 7.5, 6.1, 2.1 Hz, 1H, H-2), 4.08 (dd, J = 8.3, 2.1 Hz, 1H, H-4), 2.53 (d, J = 2.1 
Hz, 1H, H-6), 2.48–2.35 (m, 2H, H-1), 1.88 (dqd, J = 8.3, 6.9, 2.1 Hz, 1H, H-3), 1.61 (s, 3H, H-19a), 
1.56 (s, 3H, H-19b), 1.05 (d, J = 6.9 Hz, 3H, H-7), 0.92 (t, J = 8.2, 9H, H-9), 0.54 (q, J = 8.2 Hz, 6H, 
H-8); 13C NMR (125 MHz, CDCl3) δ (ppm): 168.9 (C-15), 161.2 (C-17), 138.0 (C-11), 128.4 (C-13), 
128.1 (C-12), 127.8 (C-14), 106.7 (C-18), 95.2 (C-16), 82.0 (C-5), 75.8 (C-6), 70.6 (C-10), 70.3 (C-4), 68.0 
(C-2), 43.0 (C-3), 39.9 (C-1), 26.0 (C-19a), 24.3 (C-19b), 9.7 (C-7), 7.0 (C-9), 5.2 (C-8); HRMS-ESI (m/z) 
found [M+H]+ 459.2555, C26H39O5Si requires 459.2561; [α] 26D = +10.7 º (c = 1.0, CHCl3). 
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6.3.4. Second generation approach 
6-((2S,3S,4R,E)-4-(benzyloxy)-3-methyl-6-(tributylstannyl)-2-((triethylsilyl)oxy)hex-5-en-1-yl)-2,2-dimethyl-4H-
1,3-dioxin-4-one 534 
 
Prepared according to general procedure H with Pd2dba3 (2.3 mg, 2.5 μmol) and 
tricylohexylphosphonium tetrafluoroborate (3.7 mg, 10 μmol) in dichloromethane (4 mL), di-iso-
proylethylamine (3.5 μL, 10 μmol), 6-((2S,3S,4R)-4-(benzyloxy)-3-methyl-2-((triethylsilyl)oxy)hex-5-yn-1-yl)-
2,2-dimethyl-4H-1,3-dioxin-4-one 527 (163 mg, 0.50 mmol) in dichloromethane (1 mL), and tributyltin 
hydride (162 μL, 0.60 mmol) in dichloromethane (2 mL). Purification was carried out by silica column 
chromatography, eluting with 0–10% diethyl ether in petroleum ether 40–60, to furnish the title 
compound as a pale yellow oil (267 mg, 0.36 mmol, 72%).  
RF 0.59 (40% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 2960, 2924, 2873, 1736 (C=O), 1637 
(C=C), 1457, 1389, 1376, 1269, 1203, 1066, 1015; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.34–7.26 (m, 
5H, H-12,13,14), 6.15 ([d+d]d, [2JH–119Sn = 73.9 Hz], [2JH–117Sn = 71.5 Hz], J = 19.0 Hz, 1H, H-6), 5.71 
([d+d]dd, [3JH–119Sn = 61.7 Hz], [3JH–117Sn = 59.6 Hz], J = 19.0, 8.1 Hz, 1H, H-5), 5.23 (s, 1H, H-20), 
4.58–4.50 (m, 2H, H-2,10a), 4.22 (d, J = 11.4 Hz, 1H, H-10a), 4.41 (app. d, J = 8.6 Hz, 1H, H-4), 2.47–
2.38 (m, 2H, H-1), 1.63–1.45 (m, 13H, H-3,16,23), 1.32 (app. sx, J = 7.3 Hz, 6H, H-17), 0.98–0.84 (m, 
24H, H-9,15,18), 0.79 (d, J = 7.0 Hz, 3H, H-7), 0.58 (q, J = 7.6 Hz, 6H, H-8); 13C NMR (125 MHz, 
CDCl3) δ (ppm): 169.3 (C-19), 161.4 (C-21), 148.0 (C-5), 139.2 (C-11), 134.1 (C-6), 128.3 (C-13), 127.7 
(C-12), 127.4 (C-14), 106.7 (C-22), 95.0 (C-20), 85.8 ([d], [3JC–[Sn] = 60.9 Hz], C-4), 70.0 (C-10), 67.8 
(C-2), 41.8 (C-3), 40.6 (C-1), 29.3 ([d], [3JC–[Sn] = 20.7 Hz], C-17), 27.4 ([d+d], [2JC–119Sn = 53.9 Hz], [2JC–
117Sn = 52.2 Hz], C-16), 26.1 (C-23a), 24.2 (C-23b), 13.9 (C-18), 9.7 ([d+d], [1JC–119Sn = 343.7 Hz], [1JC–
117Sn = 328.8 Hz], C-15), 9.2 (C-7), 7.1 (C-9), 5.3 (C-8); HRMS-ESI (m/z) found [M+Na]+ 773.3586, 
C38H66O5Si120SnNa requires 773.3601; [α] 26D = +4.8 º (c = 1.0, CHCl3). 
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(E)-(3-(benzyloxy)but-1-en-1-yl)tributylstannane 540 
 
Prepared according to general procedure H with Pd2dba3 (4.6 mg, 5.0 μmol) and 
tricylohexylphosphonium tetrafluoroborate (7.4 mg, 20 μmol) in toluene (8 mL), di-iso-proylethylamine 
(7.0 μL, 20 μmol), ((but-3-yn-2-yloxy)methyl)benzene 539 (160 mg, 1.00 mmol) in toluene (2 mL), and 
tributyltin hydride (323 μL, 1.20 mmol) in toluene (3 mL). Purification was carried out by silica column 
chromatography, eluting with 100% petroleum ether 40–60, to furnish the title compound as a 
colourless oil (187 mg, 0.41 mmol, 41%).  
RF 0.31 (2% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 2956, 2925, 2871, 2853, 1600, 1455, 1389, 
1135, 1098, 1070; 1H NMR (500 MHz, CDCl3) δ (ppm): 7.37–7.31 (m, 4H, H-11,12), 7.30–7.26 (m, 
1H, H-13), 6.12 ([d]d, [2JH–[Sn] = 73.5 Hz], J = 19.1 Hz, 1H, H-1), 5.91 ([d+d]dd, [3J119Sn–H = 63.4 Hz], 
[3J117Sn–H = 60.6 Hz], J = 19.1, 7.0 Hz, 1H, H-2), 4.58 (d, J = 11.9 Hz, 1H, H-9a), 4.38 (d, J = 11.9 Hz, 
1H, H-9b), 3.87 (app. q, J = 6.5 Hz, 1H, H-3), 1.62–1.44 (m, 6H, H-7), 1.38–1.27 (m, 9H, H-6,4), 0.95–
0.87 (m, 15H, H-8,5); 13C NMR (125 MHz, CDCl3) δ (ppm): 150.3 (C-2), 139.1 (C-10), 130.3 ([d+d], 
[1JC–119Sn = 367.8 Hz], [1JC–117Sn = 353.8 Hz], C-1), 128.5 (C-12), 127.9 (C-11), 127.5 (C-13), 79.3 ([d+d], 
[3JC–119Sn = 64.7 Hz], [3JC–117Sn = 62.6 Hz], C-3), 70.1 (C-9), 29.3 ([d], [3JC–[Sn] = 20.3 Hz], C-7), 27.4 
([d+d], [2JC–119Sn = 54.3 Hz], [2JC–117Sn = 52.2 Hz], C-6), 21.6 (C-4), 13.9 (C-8), 9.6 ([d+d], [1JC–119Sn = 
343.3 Hz], [1JC–117Sn = 328.4 Hz], C-5); HRMS-APCI (m/z) found [M–Bu]+ 395.1400, C19H31O120Sn 
requires 395.1420. 
(E)-(3-(benzyloxy)but-1-en-1-yl)(phenyl)iodonium trifluoromethanesulfonate 541 
 
Trimethylsilyltrifluoromethanesulfonate (38 μL, 0.20 mmol) was added at –40 ºC to a stirred solution of 
bis(trifluoroacetoxy)iodobenzene (86 mg, 0.20 mmol) in dichloromethane (1 mL). The mixture was 
warmed to room temperature then stirred for a further 10 minutes. The yellow mixture was then re-
cooled to –40 ºC and (E)-(3-(benzyloxy)but-1-en-1-yl)tributylstannane 540 (90.2 mg, 200 μmol) was added 
dropwise as a solution in dichloromethane (1 mL). The resulting solution was warmed to room 
temperature, stirred for a further 10 minutes and then loaded directly onto a packed silica column. The 
2
3 Me4
O 9
10
11
12
13
1
Sn
5
Me
6
7Me
8
Me
2
3 Me
4
O 9
10
11
12
13
1
OTf
5
6
78
I
Experimental 
 197 
crude reaction mixture was purified by silica column chromatography, eluting with 0–50% acetone in 
dichloromethane, to furnish the title compound as a colourless oil (83.4 mg, 160 μmol, 80%). 
IR νmax/cm-1 (film): 3063, 2980, 2869, 1670 (C=C), 1445, 1239, 1376, 1224, 1158, 1025, 990; 1H NMR 
(400 MHz, d6-acetone) δ (ppm): 8.28–8.25 (m, 2H, H-6), 7.81–7.76 (m, 1H, H-8), 7.66–7.60 (m, 2H, H-
7), 7.42 (dd, J = 13.9, 1.0 Hz, 1H, H-1), 7.34–7.24 (m, 5H, H-11,12,13), 7.15 (dd, J = 13.9, 6.0 Hz, 1H, 
H-2), 4.54 (d, J = 11.9 Hz, 1H, H-9a), 4.48 (d, J = 11.9 Hz, 1H, H-9b), 4.33 (app. qnd, J = 6.4, 1.0 Hz, 
1H, H-3), 1.29 (d, J = 6.4 Hz, 3H, H-4); 13C NMR (100 MHz, d6-acetone) δ (ppm): 154.7 (C-2), 139.1 
(C-10), 136.7 (C-6), 133.4 (C-8), 132.9 (C-7), 129.0 (C-12), 128.4 (C-11), 128.3 (C-13), 112.6 (C-5), 101.8 
(C-1), 76.7 (C-3), 71.3 (C-9), 20.6 (C-4); 19F NMR (376 MHz, d6-acetone) δ: –78.9; HRMS-ESI (m/z) 
found [M–OTf]+ 365.0387, C17H18OI requires 365.0397. 
 (E)-triethyl((4-(tributylstannyl)but-3-en-2-yl)oxy)silane 542 
 
Prepared according to general procedure H with Pd2dba3 (4.6 mg, 5.0 μmol) and 
tricylohexylphosphonium tetrafluoroborate (7.4 mg, 20 μmol) in toluene (8 mL), di-iso-proylethylamine 
(7.0 μL, 20 μmol), (but-3-yn-2-yloxy)triethylsilane 532 (184 mg, 1.00 mmol) in toluene (2 mL), and tributyltin 
hydride (323 μL, 1.20 mmol) in toluene (3 mL). Purification was carried out by silica column 
chromatography, eluting with 100% petroleum ether 40–60, to furnish the title compound as a 
colourless oil (176 mg, 0.37 mmol, 37%).  
RF 0.35 (100% pet. ether 40–60); IR νmax/cm-1 (film): 2955, 2925, 2875, 1603, 1458, 1377, 1240, 1127, 
1091, 1070, 1003, 984; 1H NMR (500 MHz, CDCl3) δ (ppm): 6.05 (d, J = 19.0 Hz, 1H, H-4), 5.98 (dd, 
J = 19.0, 4.7 Hz, 1H, H-3), 4.26–4.18 (m, 1H, H-2), 1.54–1.42 (m, 6H, H-9), 1.30 (app. sx, J = 7.3 Hz, 
6H, H-8), 1.22 (d, J = 6.4 Hz, 3H, H-1), 0.95 (t, J = 7.9 Hz, 9H, H-6), 0.91-0.85 (m, 15H, H-7,10), 0.60 
(q, J = 7.9 Hz, 6H, H-5); 13C NMR (125 MHz, CDCl3) δ (ppm): 152.8 (C-3), 125.4 ([d+d], [1JC–119Sn = 
384.0 Hz], [1JC–117Sn = 367.0 Hz], C-4), 72.2 ([d], [3JC–[Sn] = 66.3 Hz], C-2), 29.2 ([d], [3JC–[Sn] = 20.7 
Hz], C-9), 27.4 ([d+d], [2JC–119Sn = 54.7 Hz], [2JC–117Sn = 52.2 Hz], C-8), 24.5 (C-1), 13.9 (C-10), 9.5 
([d+d], [1JC–119Sn = 342.9 Hz], [1JC–117Sn = 327.6 Hz], C-7), 7.0 (C-6), 5.0 (C-5); HRMS-APCI (m/z) found 
[M–Bu]+ 419.1813, C18H39OSi120Sn requires 419.1795. 
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(E)-phenyl(3-((triethylsilyl)oxy)but-1-en-1-yl)iodonium trifluoromethanesulfonate 543 
 
Triethylsilyltrifluoromethanesulfonate (11 μL, 50 μmol) was added at –40 ºC to a stirred solution of 
bis(trifluoroacetoxy)iodobenzene (22 mg, 50 μmol) in dichloromethane (0.2 mL). The resulting mixture 
was warmed to room temperature then stirred for a further 10 minutes. The yellow mixture was then 
re-cooled to –40 ºC and (E)-triethyl((4-(tributylstannyl)but-3-en-2-yl)oxy)silane 542 (24.0 mg, 50 μmol) was 
added dropwise as a solution in dichloromethane (0.3 mL). The resulting solution was warmed to room 
temperature, stirred for a further ten minutes and loaded directly onto a packed silica column. The crude 
reaction mixture was purified by silica column chromatography, eluting with 0–50% acetone in 
dichloromethane, to furnish the title compound as a colourless oil (3.2 mg, 5.9 μmol, 12%).  
IR νmax/cm-1 (film): 2958, 2878, 1473, 1445, 1276, 1241, 1225, 1158, 1098, 1027; 1H NMR (500 MHz, 
CDCl3) δ (ppm): 7.94 (d, J = 8.4 Hz, 2H, H-6), 7.69 (t, J = 7.5 Hz, 1H, H-8), 7.52 (app. t, J = 7.9 Hz, 
2H, H-7), 6.92–6.84 (m, 2H, H-1,2), 4.54 (qd, J = 6.5, 2.7 Hz, 1H, H-3), 1.28 (d, J = 6.5 Hz, 3H, H-4), 
0.88 (t, J = 7.9 Hz, 9H, H-10), 0.55 (q, J = 7.9 Hz, 6H, H-9); 13C NMR (125 MHz, CDCl3) δ (ppm): 
155.6 (C-2), 135.8 (C-6), 133.0 (C-8), 132.6 (C-7), 110.2 (C-5), 99.0 (C-1), 70.2 (C-3), 23.6 (C-4), 6.8 (C-
10), 4.8 (C-9); 19F NMR (376 MHz, CDCl3) δ: –79.3; HRMS-ESI (m/z) found [M–OTf]+ 365.0387 
HRMS-ESI (m/z) found [M–OTf]+ 389.0776, C16H26OSiI requires 389.0792. 
 ((3R,4S,5S,E)-3-(benzyloxy)-6-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-4-methyl-5-((triethylsilyl)oxy)hex-1-en-
1-yl)(phenyl)-iodonium trifluoromethanesulfonate 536 
 
Triethylsilyltrifluoromethanesulfonate (43 μL, 0.20 mmol) was added at –78 ºC to a stirred suspension 
of bis(trifluoroacetoxy)iodobenzene (103 mg, 0.24 mmol) and anhydrous sodium carbonate (127 mg, 1.2 
mmol) in dichloromethane (2.5 mL). The resulting mixture was warmed to room temperature and stirred 
for a further 5 minutes. The reaction mixture was re-cooled to –78 ºC and 6-((2S,3S,4R,E)-4-(benzyloxy)-
3-methyl-6-(tributylstannyl)-2-((triethylsilyl)oxy)hex-5-en-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 534 (60.0 mg, 
80 μmol) was added dropwise as a solution in dichloromethane (2.5 mL). The product suspension was 
warmed to room temperature and loaded directly onto a packed silica column. The crude reaction 
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mixture was purified by two rounds of silica column chromatography, eluting with 0–50% acetone in 
dichloromethane, to furnish the title compound as a yellow oil (5.0 mg, 6.2 μmol, 8%). 
1H NMR (500 MHz, d3-MeCN) δ (ppm): 8.05 (d, J = 7.5 Hz, 2H, H-16), 7.76 (t, J = 7.5 Hz, 1H, H-
18), 7.58 (app. t, J = 7.5 Hz, 2H, H-17), 7.38–7.29 (m, 3H, H-13,14), 7.25 (d, J = 6.8 Hz, 2H, H-12), 
7.10 (d, J = 13.8 Hz, 1H, H-6), 6.85 (dd, J = 13.8, 8.1 Hz, 1H, H-5), 5.23 (s, 1H, H-20), 4.47–4.40 (m, 
2H, H-2,10a), 4.31 (d, J = 11.0 Hz, 1H, H-10b), 3.90 (app.t, J = 8.6 Hz, 1H, H-4), 2.45–2.39 (m, 2H, 
H-1), 1.75–1.68 (m, 1H, H-3), 1.58 (s, 3H, H-23a), 1.51 (s, 3H, H-23b), 0.93 (t, J = 7.8 Hz, 9H, H-9), 
0.72 (d, J = 7.0 Hz, 3H, H-7), 0.60–0.54 (m, 6H, H-8); 19F NMR (376 MHz, d3-MeCN) δ: –79.3. Further 
characterisation data could not be obtained due to product instability. 
triethyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 550 
 
Adapted from a procedure reported by Hiemstra et al.223 Triethylsilyl chloride (8.59 mL, 51.3 mmol) was added 
at 0 ºC to a stirred solution of imidazole (4.64 mg, 68.4 mmol) and (3R,4R)-4-methylhex-5-en-1-yn-3-ol 
514 (1.88 g, 17.1 mmol) in dimethylformamide (57 mL). The resulting mixture was warmed to room 
temperature and was stirred for a further hour before the product mixture was diluted with water (100 
mL) and extracted with diethyl ether (3 x 50 mL). The combined organic layers were washed with water 
(2 x 50 mL) and sat. aq. NaHCO3 solution (50 mL), dried over anhydrous MgSO4 and concentrated in 
vacuo. The resulting residue was subjected to prolonged high vacuum (approx. 0.5 mbar, 48 hours) to 
remove any residual silanol impurities then purified by silica column chromatography, eluting with 
100% petroleum ether 40–60, to furnish the title compound as a colourless oil (2.70 g, 12.1 mmol, 71%).  
RF 0.66 (1% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 3309 (sp C–H), 2956, 2884, 1643 (C=C), 
1461, 1415, 1344, 1239, 1080, 1005; 1H NMR (400 MHz, CDCl3) δ (ppm): 5.83 (ddd, J = 17.4, 10.2, 
7.3 Hz, 1H, H-5), 5.12–5.04 (m, 2H, H-6), 4.26 (dd, J = 5.5, 2.1 Hz, 1H, H-3), 2.45–2.35 (m, 2H, H-
1,4), 1.11 (d, J = 6.8 Hz, 3H, H-7), 0.98 (t, J = 7.9 Hz, 9H, H-9), 0.69–0.61 (m, 6H, H-8); 13C NMR 
(100 MHz, CDCl3) δ (ppm): 139.9 (C-5), 115.4 (C-4), 84.0 (C-2), 73.1 (C-1), 66.7 (C-3), 44.9 (C-4), 14.8 
(C-7), 6.9 (C-9), 4.9 (C-8); HRMS-ESI (m/z) found [M+H]+ 224.1602, C13H24OSi requires 224.1596; 
[α] 26D = +14.9 º (c = 1.0, CHCl3). 
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(2S,3R)-2-methyl-3-((triethylsilyl)oxy)pent-4-ynal 549 
 
Prepared according to general procedure F on a 3.1 mmol scale. 
Step F1 was performed with NMO (2.60 mL, 50 wt% in water, 12.5 mmol), OsO4 (127 μL, 2.5 wt% in 
tert-butanol, 13.0 μmol) and triethyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 550 (0.70 g, 3.13 mmol) 
with stirring for 72 hours. The resulting solution was quenched with sat. aq. Na2S2O3 solution (150 mL) 
and ethyl acetate (150 mL). Following separation, the aqueous layer was extracted with ethyl acetate (4 
x 100 mL) to furnish the crude diol mixture as 2.5:1 mixture of diastereoisomers.  
Major diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 4.52 (dd, J = 6.6, 2.1 Hz, 1H, H-3), 3.78–
3.52 (m, 3H, H-0,1), 3.38 (br. s, 1H, OH), 2.49 (d, J = 2.1 Hz, 1H, H-5), 2.00–1.90 (m, 1H, H-2), 1.02–
0.97 (m, 12H, H-6,8), 0.76–0.61 (m, 6H, H-7). Minor diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 
4.43 (dd, J = 4.3, 2.1 Hz, 1H, H-3), 4.30–4.24 (m, 1H, H-1), 3.78–3.52 (m, 2H, H-0), 3.10 (br. s, 1H, 
OH), 2.47 (d, J = 2.1 Hz, 1H, H-5), 1.87–1.79 (m, 1H, H-2), 1.05 (d, J = 7.1 Hz, 3H, H-6), 1.02–0.97 
(m, 9H, H-8), 0.76–0.61 (m, 6H, H-7). 
Step F2 was performed with silica-supported sodium meta-periodate (31.0 g, approx. 15 wt% NaIO4, 
21.7 mmol) in dichloromethane (300 mL). The crude residue was purified by silica column 
chromatography, eluting with 1–2% diethyl ether in petroleum ether 40–60, to furnish the title 
compound as a colourless oil (557 mg, >98% diasteromeric purity, 2.46 mmol, 79%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 9.81 (d, J = 1.6 Hz, 1H, H-1), 4.60 (dd, J = 5.9, 2.2 Hz, 1H, H-
3), 2.62 (app. qd, J = 7.1, 1.6 Hz, 1H, H-2), 2.51 (d, J = 2.2 Hz, 1H, H-5), 1.16 (d, J = 7.1 Hz, 3H, H-
6), 0.96 (t, J = 8.0 Hz, 9H, H-8), 0.73–0.59 (m, 6H, H-7); 13C NMR (100 MHz, CDCl3) δ (ppm): 203.1 
(C-1), 83.0 (C-4), 74.7 (C-3) 63.5 (C-5), 52.9 (C-2), 10.4 (C-6), 6.8 (C-8), 4.8 (C-7). Consumed directly. 
6-((2S,3R,4R)-2-hydroxy-3-methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 548 and 
6-((2R,3R,4R)-2-hydroxy-3-methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one epi-
548 
 
Prepared according to general procedure G with ((2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-
yl)oxy)trimethylsilane 459 (4.76 g, 22.2 mmol) in dichloromethane (24 mL), boron trifluoride diethyl 
etherate (0.57 mL, 4.5 mmol) in dichloromethane (18 mL) and (2S,3R)-2-methyl-3-((triethylsilyl)oxy)pent-4-
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ynal 549 (1.05 g, >98% purity, 4.62 mmol) in dichloromethane (45 mL). The reaction mixture was 
quenched with triethylamine (10 mL) and sat. aq. NaHCO3 solution (40 mL) and the work-up performed 
with dichloromethane (2 x 100 mL) and brine (50 mL). The crude residue was purified by silica column 
chromatography, eluting with 10% diethyl ether in petroleum ether 40–60, to give the title compounds 
in a 5:1 diastereomeric ratio. The mixture of diastereoisomers was further purified by silica column 
chromatography, eluting with 2–3% diethyl ether in toluene, to furnish the title compound 548 (1.31 g, 
3.56 mmol, 77%) and its C-2 epimer epi-548 (288 mg, 0.78 mmol, 17%), both as colourless oils. 
6-((2S,3R,4R)-2-hydroxy-3-methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 548 
 
RF 0.14 (10% Et2O in PhMe); IR νmax/cm-1 (film): 3469 (br., O–H), 3310 (sp C–H), 2957, 2912, 2878, 
1720 (C=O), 1635 (C=C), 1459, 1391, 1376, 1274, 1204, 1087, 1015; 1H NMR (500 MHz, CDCl3) δ 
(ppm): 5.35 (s, 1H, H-8), 4.59–4.54 (m, 1H, H-2), 4.44 (dd, J = 4.0, 2.2 Hz, 1H, H-4), 3.12 (d, J = 2.1 
Hz, 1H, H-12), 2.50 (d, J = 2.2 Hz, 1H, H-6), 2.45 (dd, J = 14.6, 8.4 Hz, 1H, H-1a), 2.26 (dd, J = 14.6, 
5.3 Hz, 1H, H-1b), 1.76–1.70 (m, 1H, H-3), 1.69 (s, 3H, H-11a), 1.68 (s, 3H, H-11b), 1.05 (d, J = 7.4 
Hz, 3H, H-13), 0.98 (t, J = 8.0 Hz, 9H, H-15), 0.75–0.61 (m, 6H, H-14); 13C NMR (125 MHz, CDCl3) 
δ (ppm): 169.4 (C-7), 161.3 (C-9), 106.7 (C-10), 95.0 (C-8), 83.8 (C-5), 74.4 (C-6), 68.4 (C-2), 67.7 (C-4) 
43.0 (C-3), 39.1 (C-1), 25.4 (C-11a), 25.0 (C-11b), 10.2 (C-13), 6.8 (C-15), 4.7 (C-14); HRMS-ESI (m/z) 
found [M+Na]+ 391.1900, C19H32O5SiNa requires 391.1911; [α] 25D = +13.2 º (c = 1.0, CHCl3). 
6-((2R,3R,4R)-2-hydroxy-3-methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one epi- 
548 
 
RF 0.11 (10% Et2O in PhMe); IR νmax/cm-1 (film): 3454 (br., O–H), 3310 (sp C–H), 2957, 2912, 2878, 
1716 (C=O), 1634 (C=C), 1459, 1392, 1377, 1276, 1204, 1080, 1015; 1H NMR (500 MHz, CDCl3) δ 
(ppm): 5.36 (s, 1H, H-8), 4.49 (dd, J = 6.4, 2.2 Hz, 1H, H-4), 3.93–3.87 (m, 1H, H-2), 3.06 (d, J = 3.2 
Hz, 1H, H-12), 2.56 (ddd, J = 14.6, 2.9, 0.8 Hz, 1H, H-1a), 2.48 (d, J = 2.2 Hz, 1H, H-6), 2.33 (dd, J 
= 14.6, 9.7 Hz, 1H, H-1b), 1.87 (app. sx, 1H, H-3), 1.70 (s, 3H, H-11a), 1.69 (s, 3H, H-11b), 1.01 (d, J 
= 6.9 Hz, 3H, H-13), 0.98 (t, J = 7.9 Hz, 9H, H-15), 0.75–0.61 (m, 6H, H-14); 13C NMR (125 MHz, 
CDCl3) δ (ppm): 169.7 (C-7), 161.2 (C-9), 106.7 (C-10), 95.5 (C-8), 83.7 (C-5), 74.4 (C-6), 71.5 (C-2), 
66.3 (C-4) 45.5 (C-3), 39.3 (C-1), 25.7 (C-11a), 24.7 (C-11b), 12.6 (C-13), 6.8 (C-15), 4.9 (C-14); HRMS-
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ESI (m/z) found [M+Na]+ 391.1901, C19H32O5SiNa requires 391.1911; [α] 25D = +31.0 º (c = 1.0, 
CHCl3). 
2,2-dimethyl-6-((2S,3R,4R)-3-methyl-2,4-bis((triethylsilyl)oxy)hex-5-yn-1-yl)-4H-1,3-dioxin-4-one 547 
 
Adapted from a procedure reported by Hiemstra et al.223 Triethylsilyl chloride (0.76 mL, 4.50 mmol) was added 
dropwise at 0 ºC to a stirred solution of imidazole (408 mg, 6.00 mmol) and 6-((2S,3R,4R)-2-hydroxy-3-
methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 548 (552 mg, 1.50 mmol) in 
dimethylformamide (5 mL). The resulting mixture was warmed to room temperature and was stirred for 
2 hours then diluted with water (10 mL) and extracted with diethyl ether (3 x 10 mL). The combined 
organic layers were washed with water (2 x 10 mL) and sat. aq. NaHCO3 solution (10 mL), dried over 
anhydrous MgSO4 and concentrated in vacuo. The product residue was subjected to prolonged high 
vacuum (approx. 0.5 mbar, 24 hours) to remove silanol impurities then purified by silica column 
chromatography, eluting with 5–10% diethyl ether in petroleum ether 40–60, to furnish the title 
compound as a colourless oil (696 mg, 1.44 mmol, 96%).  
RF 0.22 (20% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 3310 (sp C–H), 2955, 2912, 2877, 1735 
(C=O), 1636 (C=C), 1459, 1389, 1374, 1271, 1204, 1078, 1012; 1H NMR (500 MHz, CDCl3) δ (ppm): 
5.26 (s, 1H, H-8), 4.32–4.28 (m, 2H, H-2,4), 2.45–2.41 (m, 3H, H-1,6), 1.72 (app. qnd, J = 7.1, 2.9 Hz, 
1H, H-3), 1.68 (s, 3H, H-11a), 1.67 (s, 3H, H-11b), 0.99–0.93 (m, 21 H, H-13,14,16), 0.74–0.56 (m, 
12H, H-12,15); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.1 (C-7), 161.2 (C-9), 106.6 (C-10), 95.2 (C-
8), 84.7 (C-5), 74.5 (C-6), 68.3 (C-2), 63.8 (C-4) 45.4 (C-3), 40.0 (C-1), 25.9 (C-11a), 24.6 (C-11b), 9.6 
(C-14), 7.1 (2C, C-13,16), 5.4 (C-12/15), 5.3 (C-12/15); HRMS-ESI (m/z) found [M+Na]+ 505.2790, 
C25H46O5Si2Na requires 505.2776; [α] 25D = +11.6 º (c = 1.0, CHCl3). 
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2,2-dimethyl-6-((2S,3R,4R,E)-3-methyl-6-(tributylstannyl)-2,4-bis((triethylsilyl)oxy)hex-5-en-1-yl)-4H-1,3-dioxin-
4-one 546 
 
Prepared according to general procedure H with Pd2dba3 (2.3 mg, 2.5 μmol) and 
tricylohexylphosphonium tetrafluoroborate (3.7 mg, 10 μmol) in dichloromethane (4 mL), di-iso-
proylethylamine (3.5 μL, 10 μmol), 2,2-dimethyl-6-((2S,3R,4R)-3-methyl-2,4-bis((triethylsilyl)oxy)hex-5-yn-1-
yl)-4H-1,3-dioxin-4-one 547 (241 mg, 0.50 mmol) in dichloromethane (1 mL), and tributyltin hydride (162 
μL, 0.60 mmol) in dichloromethane (2 mL). Purification was carried out by silica column 
chromatography, eluting with 5% diethyl ether in petroleum ether 40–60, to furnish the title compound 
as a colourless oil (307 mg, 0.40 mmol, 80%).  
RF 0.40 (20% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 2955, 2914, 2875, 1739 (C=O), 1636 
(C=C), 1459, 1389, 1375, 1270, 1204, 1052, 1015, 742; 1H NMR (500 MHz, CDCl3) δ (ppm): 6.05 
([d+d]dd, [2JH–119Sn = 73.9 Hz], [2JH–117Sn = 71.7 Hz], J = 18.9, 0.5 Hz, 1H, H-6), 5.78 ([d+d]dd, [3JH–
119Sn = 62.6 Hz], [3JH–117Sn = 60.3 Hz], J = 18.9, 7.9 Hz, 1H, H-5), 5.25 (s, 1H, H-8), 4.42 (ddd, J = 7.9, 
5.9, 2.1 Hz, 1H, H-2), 3.85 (app. t, J = 8.1 Hz, 1H, H-4), 2.47–2.38 (m, 2H, H-1), 1.68 (s, 3H, H-11a), 
1.67 (s, 3H, H-11b), 1.57–1.40 (m, 7H, H-3,19), 1.31 (app. sx, J = 7.3 Hz, 6H, H-18), 0.99–0.86 (m, 
33H, H-13,16,17,20), 0.72 (d, J = 7.0 Hz, 3H, H-14), 0.64–0.54 (m, 12H, H-12,15); 13C NMR (125 
MHz, CDCl3) δ (ppm): 169.4 (C-7), 161.4 (C-9), 150.4 (C-5), 131.4 ([d+d], [1JC–119Sn = 367.1 Hz], [1JC–
117Sn = 351.1 Hz], C-6), 106.5 (C-10), 95.1 (C-8), 79.6 ([d], [3JC–[Sn] = 64.6 Hz], C-4), 68.2 (C-2), 43.7 (C-
3), 40.7 (C-1), 29.3 ([d], [3JC–[Sn] = 20.8 Hz], C-19), 27.4 ([d], [2JC–[Sn] = 53.9 Hz], C-18), 26.0 (C-11a), 
24.6 (C-11b), 13.8 (C-20), 9.5 ([d+d], [1JC–119Sn = 343.6 Hz], [1JC–117Sn = 328.7 Hz], C-17), 9.4 (C-14), 7.2 
(C-13/16), 7.1 (C-13/16), 5.8 (C-12/15), 5.5 (C-12/15); HRMS-ESI (m/z) found [M+Na]+ 797.3975, 
C37H74O5Si2120SnNa requires 505.2776; [α] 25D = +16.3 º (c = 1.0, CHCl3). 
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((3R,4R,5S,E)-6-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-4-methyl-3,5-bis((triethylsilyl)oxy)hex-1-en-1-
yl)(phenyl)iodonium trifluoromethanesulfonate 531 
 
Triethylsilyltrifluoromethanesulfonate (34 μL, 0.15 mmol) was added at –78 ºC to a stirred solution of 
bis(trifluoroacetoxy)iodobenzene (64.5 mg, 0.15 mmol) and di-tert-butyl pyridine (34 μL, 0.15 mmol) in 
dichloromethane (1 mL). The mixture was warmed to room temperature and stirred for 5 minutes then 
re-cooled to –78 ºC and 2,2-dimethyl-6-((2S,3R,4R,E)-3-methyl-6-(tributylstannyl)-2,4-bis((triethylsilyl)oxy)hex-
5-en-1-yl)-4H-1,3-dioxin-4-one 546 (39.0 mg, 80 μmol) added dropwise as a solution in dichloromethane 
(1.5 mL). The resulting suspension was warmed to room temperature and quenched with water (2 mL). 
The layers were separated, and the aqueous extracted with dichloromethane (2 x 1 mL). The organics 
were combined, dried over anhydrous MgSO4 and loaded directly onto a packed silica column. The 
crude reaction mixture was purified by silica column chromatography, eluting with 0–100% acetonitrile 
in dichloromethane then 100% acetone, to furnish the title compound as a colourless oil (32.1 mg, 38 
μmol, 76%).  
1H NMR (400 MHz, d3-MeCN) δ (ppm): 8.04 (d, J = 7.5 Hz, 2H, H-18), 7.76 (t, J = 7.4 Hz, 1H, H-
20), 7.58 (app. t, J = 7.9 Hz, 2H, H-19), 6.99–6.97 (m, 2H, H-5,6), 5.25 (s, 1H, H-8), 4.32–4.25 (m, 2H, 
H-2,4), 2.44 (app. d, J = 7.1 Hz, 2H, H-1), 1.72–1.66 (m, 1H, H-3), 1.64 (s, 3H, H-11a), 1.63 (s, 3H, H-
11b), 0.96 (t, J = 7.9 Hz, 9H, H-13/16), 0.85 (t, J = 7.9 Hz, 9H, H-16/13), 0.71 (d, J = 7.0 Hz, 3H, H-
14), 0.62 (q, J = 7.9 Hz, 6H, H-12/15), 0.50 (q, J = 7.9 Hz, 6H, H-15/12); 19F NMR (376 MHz, d3-
MeCN) δ: –77.3. Further characterisation data could not be obtained due to product instability. 
(5S,8S,9S)-2,2,8-trimethyl-5,8,9,10-tetrahydro-4H-5,9-epoxycycloocta[d][1,3]dioxin-4-one 552 
 
Prepared according to a procedure adapted from Gaunt et al.158 ((3R,4R,5S,E)-6-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-
6-yl)-4-methyl-3,5-bis((triethylsilyl)oxy)hex-1-en-1-yl)(phenyl)iodonium trifluoromethanesulfonate 531 (60 mg, 
~50% purity [desilylated iodonium salt impurities], 70 μmol) in dichloromethane (1.5 mL) was added at 
0 ºC to a solution of (E)-pent-3-en-1-yl dimethylcarbamate 317 (7.9 mg, 50 μmol) and (CuOTf)2•PhH (2.5 
mg, 5 μmol) in dichloromethane (1 mL), The resulting green solution was stirred at 0 ºC for 30 minutes 
then at 35 ºC for 6 hours before the reaction was quenched by the addition of triethylamine (0.5 mL) 
and sat aq. NaHCO3 (5 mL) and stirred vigorously. The phases were separated and the organic phase 
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was filtered through a plug of anhydrous Na2SO4 then concentrated under a stream of nitrogen gas. The 
resulting residue was purified by two rounds of silica column chromatography, eluting first with 10–40% 
ethyl acetate in petroleum ether 40–60 and secondly with 0–20% acetonitrile in dichloromethane, to 
furnish the title compound an orange oil (4.1 mg, 17 μmol, 24%).  
RF 0.22 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 2960, 2933, 2857, 1724 (C=O), 1659 
(C=C), 1409, 1391, 1378, 1272, 1269, 1203, 1117, 1063, 990; 1H NMR (500 MHz, d3-MeCN) δ (ppm): 
5.88 (ddd, J = 10.1, 3.8, 2.9 Hz, 1H, H-6), 5.57 (app. ddt, J = 10.1, 2.0, 1.0 Hz, 1H, H-5), 4.84 (d, J = 
3.9 Hz, 1H, H-4), 4.43 (dd, J = 8.6, 6.3, 1H, H-8), 2.88–2.80 (m, 1H, H-7), 2.62 (dd, J = 19.7, 8.6 Hz, 
1H, H-9a), 2.27 (dd, J = 19.7, 0.9 Hz, 1H, H-9b), 1.67 (s, 3H, H-11a), 1.62 (s, 3H, H-11b), 0.93 (d, J = 
7.5 Hz, 3H, H-12); 13C NMR (125 MHz, d3-MeCN) δ (ppm): 165.5 (C-10), 159.4 (C-2), 129.1 (C-6), 
128.9 (C-5), 108.2 (C-3), 107.6 (C-1), 70.7 (C-8), 63.8 (C-4), 33.9 (C-7), 26.3 (C-9), 25.7 (C-11a), 24.7 
(C-11b), 16.3 (C-12); HRMS-ESI (m/z) found [M+Na]+ 259.0941, C13H16O4Na requires 259.0941; [α] 
25D = –100.0 º (c = 0.1, MeCN). 
6.3.5. Third generation approach 
 (3R,4R,E)-4-methyl-1-(tributylstannyl)hexa-1,5-dien-3-ol 562 
 
Adapted from a procedure reported by Krische et al.190 Tetrahydrofuran (0.2 mL) and 3-buten-2-yl acetate (101 
μL, 0.80 mmol) were sequentially added to an oven-dried, sealed microwave tube charged with 
[Ir(cod)Cl]2 (6.7 mg, 10 μmol), (R)-SegPhos (12.2 mg, 20 μmol), Cs2CO3 (26.1 mg, 80 μmol), 4-cyano-3-
nitrobenzoic acid (7.7 mg, 40 μmol) under an atmosphere of nitrogen. The resulting mixture was heated 
at 90 ºC for 30 minutes and then cooled to room temperature before undergoing the addition of (E)-3-
(tributylstannyl)prop-2-en-1-ol 561 (139.2 mg, 0.40 mmol) in tetrahydrofuran (0.2 mL). The suspension was 
then heated to 90 ºC and stirred for 48 hours before being cooled back to room temperature. The crude 
reaction mixture was then filtered through a plug of silica, eluting with ethyl acetate, and concentrated 
in vacuo. The resulting residues were purified by two rounds of silica column chromatography, eluting 
firstly with 2% ethyl acetate in petroleum ether 40–60 and secondly in 1% ethyl acetate in petroleum 
ether, to furnish the title compound in 6:1 ratio of diastereoisomers and as a pale yellow oil (28.9 mg, 
0.072 mmol, 18%). 
 RF 0.36 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3381 (br., O–H), 2957, 2925, 2872, 2853, 
1640 (C=C), 1602, 1457, 1377, 1340, 1292, 1183, 1072, 990; Major diastereoisomer: 1H NMR (500 MHz, 
CDCl3) δ (ppm): 6.17 ([d+d]dd, [2JH–119Sn = 72.4 Hz], [2JH–117Sn = 69.5 Hz], J = 19.1, 1.2 Hz, 1H, H-1 
[obscured]), 5.93 ([d+d]dd, [3JH–119Sn = 63.7 Hz], [3JH–117Sn = 61.0 Hz], J = 19.1, 5.9 Hz, 1H, H-2 
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[obscured]), 5.76 (ddd, J = 17.8, 10.0, 7.3 Hz, 1H, H-5 [obscured]), 5.15–5.13 (m, 1H, H-6a), 5.12–
5.10 (m, 1H, H-6b [obscured]), 3.88–3.82 (m, 1H, H-3), 2.29 (app. sx, J = 7.0 Hz, 1H, H-4), 1.73 (d, J 
= 3.3 Hz, 1H, H-11), 1.55–1.44 (m, 6H, H-8 [obscured]), 1.30 (app. sx, J = 7.3 Hz, 1H, H-9 [obscured]), 
1.01 (d, J = 6.9 Hz, 3H, H-12 [obscured]), 0.97–0.81 (m, 15H, H-7,10 [obscured]); 13C NMR (125 
MHz, CDCl3) δ (ppm): 148.7 (C-2), 140.4 (C-5), 130.1 ([d+d], [1JC–119Sn = 369.7 Hz], [1JC–117Sn = 353.7 
Hz], C-1), 116.4 (C-6), 78.9 ([d], [3JC–[Sn] = 61.4 Hz], C-3), 44.2 (C-4), 29.3 ([d], [3JC–[Sn] = 20.8 Hz], C-
9), 27.4 ([d], [2JC–[Sn] = 53.8 Hz], C-8), 16.0 (C-12), 13.9 (C-10), 9.7 ([d+d], [1JC–119Sn = 344.7 Hz], [1JC–
117Sn = 328.7 Hz], C-7); Minor diastereoisomer: 1H NMR (500 MHz, CDCl3) δ (ppm): 6.16 (dd, J = 19.2, 1.3 
Hz, 1H, H-1 [obscured]), 5.99 (dd, J = 19.2, 5.3 Hz, 1H, H-2 [obscured]), 5.83–5.74 (m, 1H, H-5 
[obscured]), 5.11–5.09 (m, 1H, H-6a [obscured]), 5.08–5.07 (m, 1H, H-6b), 4.01 (app. q, J = 4.6 Hz, 
1H, H-3), 2.38 (app. sx, J = 6.7 Hz, 1H, H-4), 1.63 (d, J = 5.4 Hz, 1H, H-11), 1.55–1.44 (m, 6H, H-8 
[obscured]), 1.30 (app. sx, J = 7.3 Hz, 1H, H-9 [obscured]), 1.02 (d, J = 7.0 Hz, 3H, H-12 [obscured]), 
0.97–0.81 (m, 15H, H-7,10 [obscured]); 13C NMR (125 MHz, CDCl3) δ (ppm): 148.4 (C-2), 140.4 (C-
5), 129.1 (C-1), 115.8 (C-6), 78.2 (C-3), 43.7 (C-4), 29.3 (C-9), 27.4 (C-8), 14.8 (C-12), 13.9 (C-10), 9.7 
(C-7); HRMS-ESI (m/z) found [M+H]+ 403.2019, C19H39SnO requires 403.2021; [α] 25D = –2.3 º (c = 
0.75, CHCl3); HPLC analysis (OD, 0.2% i-PrOH in n-hexane, 1 mL/min, 218 nm) indicated 18% e.e.: 
tR (major) = 6.42 minutes, tR (minor) = 7.10 minutes. 
triethyl(((3R,4R,E)-4-methyl-1-(tributylstannyl)hexa-1,5-dien-3-yl)oxy)silane 563 
 
Triethylsilyl trifluoromethanesulfonate (13.4 μL, 68 μmol) was added at –78 ºC to a solution of 
(3R,4R,E)-4-methyl-1-(tributylstannyl)hexa-1,5-dien-3-ol 562 (6:1 d.r., 24.9 mg, 62 μmol) and 2,6-lutidine 
(14.4 μL, 0.12 mmol) in dichloromethane (0.5 mL). The resulting solution was stirred at –78 ºC for 30 
minutes then warmed to room temperature and stirred for a further two hours. The reaction mixture 
was quenched on the addition of sat. aq. NaHCO3 solution (0.5 mL). The phases were separated and 
the aqueous layer extracted with diethyl ether (3 x 1 mL). The combined organic layers were filtered 
through a plug of anhydrous MgSO4 and concentrated in vacuo. The resulting crude residues were 
purified by silica column chromatography, eluting with 100% petroleum ether 40–60, to furnish the title 
compound in a 6:1 ratio of diasteroisomers and as a colourless oil (24.0 mg, 47 μmol, 76%).  
RF 0.43 (100% pet. ether 40–60); IR νmax/cm-1 (film): 2956, 2928, 2875, 1459, 1417, 1377, 1342, 1238, 
1116, 1071, 1005, 992; Major diastereoisomer: 1H NMR (500 MHz, CDCl3) δ (ppm): 6.03 (dd, J = 19.1, 
0.6 Hz, 1H, H-1 [obscured]), 5.90 (dd, J = 19.1, 6.3 Hz, 1H, H-2 [obscured]), 5.86–5.76 (m, 1H, H-5), 
5.03–5.94 (m, 2H, H-6 [obscured]), 3.91–3.86 (m, 1H, H-3 [obscured]), 2.25 (app. sx, J = 6.7 Hz, 1H, 
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H-4 [obscured]), 1.54–1.40 (m, 6H, H-8), 1.30 (m, 6H, H-9 [obscured]), 0.98–0.84 (m, 27H, H-
7,10,13,14 [obscured]), 0.58 (q, J = 7.7 Hz, 6H, H-12 [obscured]); 13C NMR (125 MHz, CDCl3) δ 
(ppm): 149.9 (C-2), 141.3 (C-5), 128.5 ([d+d], [1JC–119Sn = 380.6 Hz], [1JC–117Sn = 363.6 Hz], C-1), 114.2 
(C-6), 80.6 ([d], [3JC–[Sn] = 65.1 Hz], C-3), 44.6 (C-4), 29.3 ([d], [3JC–[Sn] = 21.1 Hz], C-9), 27.4 ([d+d], 
[2JC–119Sn = 53.9 Hz], [2JC–117Sn = 52.2 Hz], C-8), 15.5 (C-14), 13.9 (C-7), 9.6 ([d+d], [1JC–119Sn = 342.5 Hz], 
[1JC–117Sn = 327.2 Hz], C-10), 7.1 (C-12), 5.1 (C-13); Minor diastereoisomer: 1H NMR (500 MHz, CDCl3) δ 
(ppm): 6.01 (d, J = 19.2 Hz, 1H, H-1 [obscured]), 5.89 (dd, J = 19.2, 6.2 Hz, 1H, H-2 [obscured]), 5.86–
5.76 (m, 1H, H-5), 5.03–5.94 (m, 2H, H-6 [obscured]), 3.91–3.86 (m, 1H, H-3 [obscured]), 2.25 (app. 
sx, J = 6.7 Hz, 1H, H-4 [obscured]), 1.54–1.40 (m, 6H, H-8), 1.30 (m, 6H, H-9 [obscured]), 0.98–0.84 
(m, 27H, H-7,10,13,14 [obscured]), 0.58 (q, J = 7.7 Hz, 6H, H-12 [obscured]); 13C NMR (125 MHz, 
CDCl3) δ (ppm): 150.0 (C-2), 141.3 (C-5), 128.4 (C-1), 114.1 (C-6), 80.7 (C-3), 44.4 (C-4), 29.3 (C-9), 
27.4 (C-8), 15.2 (C-14), 13.9 (C-7), 9.6 (C-10), 7.1 (C-12), 5.1 (C-13); HRMS-ASAP (m/z) found [M–
Bu]+ 459.2122, C21H43OSiSn requires 455.2108; [α] 25D = –2.0 º (c = 0.6, CHCl3). 
triisopropyl(((3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-yl)oxy)silane 565 
 
Tri-iso-propylsilyl trifluoromethanesulfonate (4.39 mL, 24.0 mmol) was added dropwise at 0 ºC to a 
solution of (3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-ol 511 (3.64 g, 20.0 mmol) and 2,6-lutidine 
(4.54 mL, 24.0 mmol) in dichloromethane (50 mL). The resulting reaction mixture was warmed to room 
temperature and stirred for 24 hours. Incomplete conversion was observed and so the reaction mixture 
was cooled back to 0 ºC and further portions of 2,6-lutidine (4.54 mL, 24.0 mmol) and tri-iso-propylsilyl 
trifluoromethanesulfonate (4.39 mL, 24.0 mmol) were added. The resulting suspension was warmed to 
room temperature and was stirred for a further 24 hours. The reaction was quenched with the addition 
of sat. aq. NaHCO3 solution (50 mL) and the layers were separated. The aqueous layer was extracted 
with further portions of dichloromethane (2 x 50 mL) before the the organic layers were combined and 
washed with brine (50 mL), dried over anhydrous MgSO4, and concentrated in vacuo. The resulting 
residues were purified by silica column chromatography, eluting with 100% petroleum ether 40–60, 
then by two rounds of kugelrohr distillation to furnish the title compound as a colourless oil (6.54 g, 19.3 
mmol, 97%).  
RF 0.62 (100% pet. ether 40–60); IR νmax/cm-1 (film): 2944, 2893, 2867, 2175 (CC), 1644 (C=C), 
1463, 1419, 1384, 1371, 1342, 1250, 1090, 1066; 1H NMR (400 MHz, CDCl3) δ (ppm): 5.83 (ddd, J = 
17.5, 10.2, 7.5 Hz, 1H, H-5), 5.10–5.00 (m, 2H, H-6), 4.36 (d, J = 5.2 Hz, 1H, H-3), 2.42 (app. sx, J = 
6.6 Hz, 1H, H-4), 1.13–1.05 (m, 24H, H-8,9,10), 0.15 (s, 9H, H-7); 13C NMR (100 MHz, CDCl3) δ 
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(ppm): 140.4 (C-5), 115.1 (C-6), 106.2 (C-2), 89.8 (C-1), 67.6 (C-3), 45.3 (C-4), 18.2 (C-9), 14.8 (C-10), 
12.5 (C-8), –0.1 (C-7); HRMS-ASAP (m/z) found [M+H]+ 339.2526, C19H39OSi2 requires 339.2539; 
[α] 25D = +7.2 º (c = 1.0, CHCl3). 
triisopropyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 566 
 
To a solution of triisopropyl(((3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-yl)oxy)silane 565 (6.10 g, 18.0 
mmol) in methanol (90 mL) was added potassium carbonate (24.0 g, 180 mmol) and the resulting cloudy 
suspension stirred for 45 minutes. The resulting mixture was then filtered through celite™ and the pad 
washed with diethyl ether (200 mL) and water (100 mL). The phases were separated and the aqueous 
layer was then extracted with further portions of diethyl ether (2 x 50 mL). The combined organic layers 
were washed with brine (2 x 100 mL), dried over anhydrous MgSO4, concentrated in vacuo, and then 
purified by kugelrohr distillation to furnish the title compound as a colourless oil (4.44 g, 16.6 mmol, 
92%).  
RF 0.52 (100% pet. ether 40–60); IR νmax/cm-1 (film): 3311 (sp C–H), 2964, 2944, 2867, 1643 (C=C), 
1463, 1384, 1371, 1345, 1249, 1092, 1066; 1H NMR (400 MHz, CDCl3) δ (ppm): 5.84 (ddd, J = 17.5, 
10.2, 7.4 Hz, 1H, H-5), 5.13–5.04 (m, 2H, H-6), 4.42 (dd, J = 4.9, 2.1 Hz, 1H, H-3), 2.46 (app. sx, J = 
6.5 Hz, 1H, H-4), 2.37 (d, J = 2.1 Hz, 1H, H-1), 1.16–1.06 (m, 24H, H-7,8,9); 13C NMR (100 MHz, 
CDCl3) δ (ppm): 140.0 (C-5), 115.4 (C-6), 83.9 (C-2), 73.2 (C-1), 67.1 (C-3), 45.1 (C-4), 18.20 (C-8), 
18.18 (C-8’), 14.3 (C-9), 12.4 (C-7); HRMS-EI (m/z) found M+ 266.2070 C16H30OSi requires 266.2066; 
[α]25D = +6.3 º (c = 1.0, CHCl3). 
(2S,3R)-2-methyl-3-((triisopropylsilyl)oxy)pent-4-ynal 567 
 
Prepared according to general procedure F on a 5.0 mmol scale. 
Step F1 was performed with NMO (4.12 mL, 50 wt% in water, 20.0 mmol), OsO4 (200 μL, 2.5 wt% in 
tert-butanol, 20.0 μmol) and triisopropyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 566 (1.33 g, 5.00 
mmol) with stirring for 72 hours. The resulting solution was quenched with sat. aq. Na2S2O3 solution 
(250 mL) and ethyl acetate (250 mL). Following separation, the aqueous layer was extracted with ethyl 
acetate (5 x 100 mL), and the combined organic layers washed with brine (200 mL), dried over Na2S2O4 
and concentrated in vacuo to furnish the crude diol mixture as 3:1 mixture of diastereoisomers.  
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Major diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 4.77 (dd, J = 5.3, 2.1 Hz, 1H, H-3), 3.78–
3.52 (m, 3H, H-0,1), 3.78 (dd, J = 11.0, 2.9 Hz, H-0a), 3.74–3.64 (m, 1H, H-1 [obscured]), 3.57 (dd, J 
= 11.0, 6.6 Hz, 1H, H-0b), 2.94 (br. s, 1H, O–H), 2.44 (d, J = 2.2 Hz, 1H, H-5), 2.42 (br. s, 1H, O–H), 
2.02–1.89 (m, 2H, H-2,O–H), 1.13–1.04 (m, 21H, H-7,8 [obscured]), 1.01 (d, J = 6.8 Hz, H-6). Minor 
diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 4.58 (dd, J = 3.8, 2.1 Hz, 1H, H-3), 4.28 (ddd, J = 
7.7, 4.0, 2.7 Hz, 1H, H-1), 3.74–3.64 (m, 2H, H-0 [obscured]), 3.04 (br. s, 1H, O–H), 2.50 (d, J = 2.1 
Hz, 1H, H-5), 2.42 (br. s, 1H, O–H), 1.89–1.80 (m, 1H, H-2), 1.13–1.04 (m, 24H, H-6,7,8 [obscured]).  
Step F2 was performed with silica-supported sodium meta-periodate (50.0 g, approx. 15 wt% NaIO4, 
35.0 mmol) in dichloromethane (500 mL). The crude residue was purified by silica column 
chromatography, eluting with 1% diethyl ether in petroleum ether 40–60, to furnish the title compound 
as a colourless oil (1.033 g, >98% diasteromeric purity, 3.84 mmol, 77%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 9.84 (d, J = 1.6 Hz, 1H, H-1), 4.77 (dd, J = 5.4, 2.2 Hz, 1H, H-
3), 2.66 (qdd, J = 7.1, 5.4, 1.6 Hz, 1H, H-2), 2.52 (d, J = 2.2 Hz, 1H, H-5), 1.22 (d, J = 7.1 Hz, 3H, H-
6), 1.18–1.11 (m, 3H, H-7), 1.08 (t, J = 6.4 Hz, 18 H, H-8); 13C NMR (100 MHz, CDCl3) δ (ppm): 203.2 
(C-1), 83.0 (C-4), 74.9 (C-5), 63.8 (C-3), 53.3 (C-2), 18.15 (C-8), 18.13 (C-8’), 12.4 (C-8), 10.3 (C-6). 
Consumed directly. 
6-((2S,3R,4R)-2-hydroxy-3-methyl-4-((triisopropylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 568 
 
Prepared according to general procedure G with ((2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-
yl)oxy)trimethylsilane 459 (5.36 g, 25.0 mmol) in dichloromethane (20 mL), boron trifluoride diethyl 
etherate (0.75 mL, 5.9 mmol) in dichloromethane (30 mL) and (2S,3R)-2-methyl-3-
((triisopropylsilyl)oxy)pent-4-ynal 567 (1.01 g, >98% purity, 3.75 mmol) in dichloromethane (50 mL). The 
reaction mixture was quenched with triethylamine (10 mL) and sat. aq. NaHCO3 solution (40 mL) and 
the work-up performed with dichloromethane (2 x 100 mL) and brine (50 mL). Excess 2,2,6-trimethyl-
4H-1,3-dioxin-4-one was removed by kugelrohr distillation and the resulting crude residue was purified 
by silica column chromatography, eluting with 0–3% diethyl ether in toluene to furnish the title 
compound together with its C-2 epimer in a 4:1 diastereomeric ratio as a colourless oil (95% purity, 1.49 
g, 3.62 mmol, 97%).  
RF 0.16 (10% Et2O in PhMe); IR νmax/cm-1 (film): 3456 (br., O–H), 3311 (sp C–H), 2945, 2868, 1722 
(C=O), 1636 (C=C), 1463, 1391, 1378, 1274, 1255, 1205, 1093, 1015; Major diastereoisomer: 1H NMR 
(500 MHz, CDCl3) δ (ppm): 5.32 (s, 1H, H-8 [obscured]), 4.58–4.52 (m, 2H, H-2,4), 3.05 (br. s, 1H, H-
12), 2.50 (d, J = 2.1 Hz, 1H, H-6), 2.44 (dd, J = 14.5, 8.7 Hz, 1H, H-1a [obscured]), 2.25 (dd, J = 14.5, 
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5.3 Hz, 1H, H-1b [obscured]), 1.75–1.69 (m, 1H, H-3), 1.68–1.62 (m, 6H, H-11 [obscured]), 1.19–0.99 
(m, 24H, H-13,14,15 [obscured]); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.3 (C-7), 161.2 (C-9), 106.6 
(C-10), 94.9 (C-8), 83.8 (C-5), 74.8 (C-6), 68.3 (C-2), 67.9 (C-4), 43.5 (C-3), 39.1 (C-1), 25.3 (C-11a), 24.9 
(C-11b), 18.1 (C-15), 12.3 (C-14), 10.0 (C-13); Minor diastereoisomer: 1H NMR (500 MHz, CDCl3) δ (ppm): 
5.32 (s, 1H, H-8 [obscured], 4.71 (dd, J = 5.1, 2.1 Hz, 1H, H-4), 3.87 (app. t, J = 8.1 Hz, 1H, H-2), 
2.80 (br. s, 1H, H-12), 2.56 (dd, J = 14.7, 2.4 Hz, 1H, H-1a), 2.44–2.42 (m, 1H, H-6 [obscured]), 2.29 
(dd, J = 14.7, 9.4 Hz, 1H, H-1b [obscured]), 1.93–1.83 (m, 1H, H-3), 1.68–1.62 (m, 6H, H-11 
[obscured]), 1.19–0.99 (m, 24H, H-13,14,15 [obscured]); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.7 
(C-7), 161.1 (C-9), 106.7 (C-10), 95.4 (C-8), 83.4 (C-5), 74.3 (C-6), 70.8 (C-2), 65.4 (C-4), 46.0 (C-3), 39.2 
(C-1), 25.6 (C-11a), 24.6 (C-11b), 18.1 (C-15), 12.3 (C-14), 11.6 (C-13); HRMS-ESI (m/z) found 
[M+Na]+ 433.2375, C22H38O5SiNa requires 433.2381; [α] 25D = +12.3 º (c = 1.0, CHCl3). 
triisopropyl(((3R,4R)-4-methyl-1-(triisopropylsilyl)hex-5-en-1-yn-3-yl)oxy)silane 569 
 
n-Butyllithium (1.6 M in hexanes, 5.84 mL, 9.34 mmol) was added dropwise at –78 ºC to a solution of 
triisopropyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 566 (2.27 g, 8.50 mmol) in diethyl ether (42 mL). 
The resulting solution was warmed to –40 ºC and stirred for one hour before undergoing the dropwise 
addition of tri-iso-propylsilyl trifluromethanesulfonate (2.52 mL, 9.35 mmol). The reaction mixture was 
then warmed to room temperature and stirred for a further 16 hours. The reaction was quenched by 
the addition of sat. aq. NaHCO3 solution (25 mL), the layers separated, and the aqueous layer extracted 
with further portions of diethyl ether (3 x 50 mL). The organic layers were combined, washed with brine 
(50 mL), dried over anhydrous MgSO4, and concentrated in vacuo. The resulting residues were purified 
by silica column chromatography, eluting with 100% petroleum ether 40–60, to furnish the title 
compound as a colourless oil (3.50 g, 8.30 mmol, 98%).  
RF 0.84 (100% pet. ether 40–60); IR νmax/cm-1 (film): 2943, 2866, 1644 (C=C), 1463, 1384, 1368, 1343, 
1246, 1091, 1066, 1015, 995; 1H NMR (400 MHz, CDCl3) δ (ppm): 5.84 (ddd, J = 17.5, 10.1, 7.6, 1H, 
H-5), 5.12–4.98 (m, 2H, H-6), 4.44 (d, J = 4.8, 1H, H-3), 2.45 (app. sx, J = 6.5 Hz, 1H, H-4), 1.16–1.05 
(m, 45H, H-7,8,9,10,11); 13C NMR (100 MHz, CDCl3) δ (ppm): 140.4 (C-5), 115.1 (C-6), 107.7 (C-2), 
85.7 (C-1), 67.7 (C-3), 45.6 (C-4), 18.7 (C-10), 18.2 (C-8), 14.4 (C-11), 12.5 (C-7), 11.4 (C-9); HRMS-
ESI (m/z) found [M+NH4]+ 440.3739, C25H54OSi2N requires 440.3738; [α]25D = +7.5 º (c = 1.0, 
CHCl3). 
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(2S,3R)-2-methyl-5-(triisopropylsilyl)-3-((triisopropylsilyl)oxy)pent-4-ynal 570 
 
Performed according to general procedure F on a 0.9 mmol scale. 
Step F1 was performed with NMO (0.74 mL, 50 wt% in water, 3.6 mmol), OsO4 (90 μL, 2.5 wt% in 
tert-butanol, 9.0 μmol) and triisopropyl(((3R,4R)-4-methyl-1-(triisopropylsilyl)hex-5-en-1-yn-3-yl)oxy)silane 566 
(379 mg, 900 μmol) with stirring for 144 hours. The resulting solution was quenched with sat. aq. 
Na2S2O3 solution (75 mL) and ethyl acetate (75 mL). Following separation, the aqueous layer was 
extracted with ethyl acetate (4 x 50 mL) and the combined organic layers washed with brine (150 mL), 
dried over MgSO4 and concentrated in vacuo to furnish the crude diol mixture as 3:1 mixture of 
diastereoisomers.  
Major diastereoisomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 4.75 (d, J = 5.4, 1H, H-3), 3.77 (dd, J = 10.9, 
3.1 Hz, 1H, H-0a), 3.72–3.60 (m, 1H, H-1 [obscured]), 3.5 (dd, J = 10.9, 6.2 Hz, 1H, H-0b [obscured]), 
3.08 (br. s, 1H, O–H), 2.01–1.92 (m, 1H, H-2), 1.57 (br. s, 1H, O–H [obscured]), 1.27–1.04 (m, 42H, 
H-7,8,9,10 [obscured]), 1.02 (d, J = 6.8 Hz, H-6 [obscured]. Minor diastereoisomer: 1H NMR (400 MHz, 
CDCl3) δ (ppm): 4.61 (d, J = 3.8 Hz, 1H, H-3), 4.27 (ddd, J = 7.7, 4.2, 2.8 Hz, 1H, H-1), 3.74–3.64 (m, 
2H, H-0a,O–H [obscured]), 3.59–3.53 (m, 1H, H-0b [obscured], 2.44 (br. s, 1H, O–H), 1.90–1.83 (m, 
1H, H-2), 1.27–1.04 (m, 42H, H-7,8,9,10 [obscured]), 1.02 (d, J = 6.8 Hz, H-6 [obscured].  
Step F2 was performed with silica-supported sodium meta-periodate (10.0 g, approx. 15 wt% NaIO4, 7.0 
mmol) in dichloromethane (100 mL). The crude residue was purified by silica column chromatography, 
eluting with 0.5% diethyl ether in petroleum ether 40–60 to furnish the title compound as a colourless 
oil (333 mg, >98% diasteromeric purity, 0.78 mmol, 87%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 9.87 (d, J = 1.6 Hz, 1H, H-1), 4.78 (d, J = 5.3 Hz, 1H, H-3), 2.66 
(qdd, J = 6.9, 5.3, 1.6 Hz, 1H, H-2), 1.25–1.10 (m, 9H, H-6,7,9), 1.10–1.05 (m, 36H, H-8,10); 13C NMR 
(100 MHz, CDCl3) δ (ppm): 203.5 (C-1), 106.5 (C-4), 88.0 (C-5), 64.5 (C-3), 53.8 (C-2), 18.65 (C-8), 
18.64 (C-8’), 18.20 (C-10), 18.18 (C-10’), 12.5 (C-9), 11.3 (C-7), 10.3 (C-6). Consumed directly. 
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6-((2S,3R,4R)-2-hydroxy-3-methyl-6-(triisopropylsilyl)-4-((triisopropylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-
1,3-dioxin-4-one 571 
  
Performed according to general procedure G with ((2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-
yl)oxy)trimethylsilane 459 (0.80 g, 3.71 mmol) in dichloromethane (4 mL), boron trifluoride diethyl etherate 
(111 μL, 0.88 mmol) in dichloromethane (6 mL) and (2S,3R)-2-methyl-5-(triisopropylsilyl)-3-
((triisopropylsilyl)oxy)pent-4-ynal 570 (313 mg, >98% purity, 0.74 mmol) in dichloromethane (10 mL). The 
reaction mixture was quenched with triethylamine (2 mL) and sat. aq. NaHCO3 solution (10 mL) and 
the work-up performed with dichloromethane (2 x 20 mL) and brine (20 mL). Excess 2,2,6-trimethyl-
4H-1,3-dioxin-4-one was removed by kugelrohr distillation and the resulting crude residue was purified 
by silica column chromatography, eluting with 0–2.5% diethyl ether in toluene, to furnish the title 
compound together with its C-2 epimer in a 6:1 diastereomeric ratio and as a colourless oil (376 mg, 
0.66 mmol, 89%). 
RF 0.22 (10% Et2O in PhMe); IR νmax/cm-1 (film): 3455 (br., O–H), 2944, 2892, 2867, 1721 (C=O), 
1637 (C=C), 1463, 1390, 1378, 1274, 1255, 1206, 1096, 1015; Major diastereoisomer: 1H NMR (500 MHz, 
CDCl3) δ (ppm): 5.33 (s, 1H, H-8), 4.65–4.61 (m, 1H, H-2), 4.60 (d, J = 3.6 Hz, 1H, H-4), 3.13 (br. s, 
1H, H-12), 2.44 (dd, J = 14.4, 9.7 Hz, 1H, H-1a), 2.21 (dd, J = 14.4, 3.8 Hz, 1H, H-1b [obscured]), 
1.76–1.70 (m, 1H, H-3 [obscured]), 1.66 (app. s, 6H, H-11 [obscured]), 1.25–0.93 (m, 45H, H-
13,14,15,16,17 [obscured]); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.5 (C-7), 161.2 (C-9), 107.5 (C-
5), 106.6 (C-10), 95.2 (C-8), 87.7 (C-6), 68.8 (C-2), 68.6 (C-4), 44.4 (C-3), 39.6 (C-1), 25.7 (C-11a), 24.5 
(C-11b), 18.6 (C-15/17), 18.2 (C-15/17), 12.4 (C-14/16), 11.3 (C-14/16), 10.3 (C-13); Minor 
diastereoisomer: 1H NMR (500 MHz, CDCl3) δ (ppm): 5.32 (s, 1H, H-8), 4.75 (d, J = 5.0 Hz, 1H, H-4), 
3.98–3.90 (m, 1H, H-2), 2.64–2.55 (m, 2H, H-1a,12), 2.31 (dd, J = 14.6, 9.9 Hz, 1H, H-1b), 1.90 (app. 
sx, J = 6.7 Hz, 1H, H-3), 1.66 (app. s, 6H, H-11 [obscured]), 1.25–0.93 (m, 45H, H-13,14,15,16,17 
[obscured]); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.7 (C-7), 161.1 (C-9), 107.2 (C-5), 106.6 (C-10), 
95.5 (C-8), 87.1 (C-6), 71.1 (C-2), 66.0 (C-4), 46.3 (C-3), 39.5 (C-1), 25.7 (C-11a), 24.5 (C-11b), 18.6 (C-
15/17), 18.2 (C-15/17), 12.4 (C-14/16), 11.8 (C-13), 11.3 (C-14/16); HRMS-ESI (m/z) found [M+Na]+ 
589.3712, C31H58O5Si2Na requires 589.3715; [α] 25D = +31.5 º (c = 1.0, CHCl3). 
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6-((2S,3R,4R)-2,4-dihydroxy-3-methyl-6-(triisopropylsilyl)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 573 
 
Tetrabutylammonium fluoride trihydrate (45.9 mg, 0.16 mmol) was added in one portion at 0 ºC to a 
stirred solution of 6-((2S,3R,4R)-2-hydroxy-3-methyl-6-(triisopropylsilyl)-4-((triisopropylsilyl)oxy)hex-5-yn-1-yl)-
2,2-dimethyl-4H-1,3-dioxin-4-one 571 (6:1 d.r., 38.0 mg, 0.67 mmol) in tetrahydrofuran (0.7 mL). The 
resulting pink solution was stirred for two hours before diluting with diethyl ether (2 mL) and quenching 
with the addition of sat. aq. NaCl solution (1 mL). The phases were separated and the aqueous layer was 
extracted with diethyl ether (2 x 2 mL). The combined organic layers were passed through a plug of 
anhydrous MgSO4 and concentrated under a steam of nitrogen gas. The resulting residues were purified 
by silica column chromatography, eluting in a gradient of 20–30% ethyl acetate in petroleum ether 40–
60, to furnish the title compound as a colourless oil (12.2 mg, 30 μmol, 45%).  
RF 0.24 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 3446 (br., O–H), 2943, 2889, 2866, 1713 
(C=O), 1634 (C=C), 1463, 1392, 1378, 1277, 1205, 1016; 1H NMR (500 MHz, CDCl3) δ (ppm): 5.35 
(s, 1H, H-8), 4.54–4.48 (m, 1H, H-2), 4.46 (app. t, J = 4.9 Hz, 1H, H-4), 2.66 (d, J = 3.9 Hz, 1H, H-
12/14), 2.51–2.43 (m, 2H, H-1a,12/14), 2.30 (dd, J = 14.4, 3.7 Hz, 1H, H-1b), 1.84 (qdd, J = 7.2, 5.2, 
1.9 Hz, 1H, H-3), 1.69 (s, 6H, H-11), 1.09 (d, J = 7.2 Hz, 3H, H-13), 1.08–1.04 (m, 21H, H-15,16); 13C 
NMR (125 MHz, CDCl3) δ (ppm): 169.3 (C-7), 161.2 (C-9), 107.3 (C-5), 106.8 (C-10), 95.3 (C-8), 87.9 
(C-6), 69.0 (C-2), 66.8 (C-4), 43.5 (C-3), 39.3 (C-1), 25.6 (C-11a), 24.8 (C-11b), 18.7 (C-16), 11.2 (C-15), 
10.2 (C-13); HRMS-ESI (m/z) found [M+H]+ 433.2383, C22H38O5SiNa requires 433.2381; [α]25D = 
+3.4 º (c = 0.5, CHCl3). 
6-((2S,3R,4R)-2,4-dihydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 572 
 
Trifluorocaetic acid (0.20 mL, 2.6 mmol) was added at 0 ºC to a solution of 2,2-dimethyl-6-((2S,3R,4R)-
3-methyl-2,4-bis((triethylsilyl)oxy)hex-5-yn-1-yl)-4H-1,3-dioxin-4-one 547 (289 mg, 600 μmol) in acetonitrile 
(1.6 mL) and water (0.2 mL). The resulting solution was warmed to room temperature and then stirred 
for a further 20 minutes before quenching with the addition of sat. aq. NaHCO3 solution (5 mL). The 
resulting mixture was extracted with dichloromethane (5 x 5 mL) with the organic extracts combined, 
dried over anhydrous MgSO4 and concentrated in vacuo. The crude residue was purified by silica column 
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chromatography, eluting with 50% ethyl acetate in petroleum ether 40–60, to furnish the title compound 
as a white crystalline solid (137.9 mg, 0.54 mmol, 90%).  
RF 0.14 (50% EtOAc in pet. ether 40–60); Tm 118–120 ºC; IR νmax/cm-1 (film): 3404 (br., O–H), 3292 
(sp C–H), 2977, 2941, 1703 (C=O), 1630 (C=C), 1461, 1392, 1376, 1276, 1202, 1086, 1015; 1H NMR 
(500 MHz, CDCl3) δ (ppm): 5.36 (s, 1H, H-8), 4.50 (app. dtd, J = 8.9, 4.4, 2.0 Hz, 1H, H-2), 4.44 (app. 
td, J = 5.6, 2.1 Hz, 1H, H-4), 2.66 (d, J = 5.3, 1H, H-14), 2.58–2.55 (m, 2H, H-6,12), 2.48 (dd, J = 
14.6, 8.9 Hz, 1H, H-1a), 2.33 (dd, J = 14.6, 4.1 Hz, 1H, H-1b), 1.85 (qdd, J = 7.1, 5.6, 2.0 Hz, 1H, H-
3), 1.71 (s, 6H, H-11), 1.09 (d, J = 7.1 Hz, 3H, H-13); 13C NMR (125 MHz, CDCl3) δ (ppm): 169.1 (C-
7), 161.2 (C-9), 106.9 (C-10), 95.3 (C-8), 83.8 (C-5), 74.7 (C-6), 68.9 (C-2), 66.2 (C-4), 42.9 (C-3), 39.1 
(C-1), 25.4 (C-11a), 25.0 (C-11b), 10.1 (C-13); HRMS-ESI (m/z) found [M+Na]+ 277.1043, 
C13H18O5Na requires 277.1046; [α]25D = –8.2 º (c = 0.5, MeCN). 
6-(((4S,5R,6R)-6-ethynyl-2,2,5-trimethyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 574 
 
2,2-Dimethoxypropane (123 μL, 1.00 mmol) and camphor sulfonic acid (1.2 mg, 5.0 μmol) were added 
sequentially at 0 ºC to a suspension of 6-((2S,3R,4R)-2,4-dihydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-
1,3-dioxin-4-one 572 (110.0 mg, 0.433 mmol) in dichloromethane (1.5 mL). The resulting mixture was 
stirred for 16 hours then quenched with the addition of sat aq. NaHCO3 solution (1.5 mL) and extracted 
with ethyl acetate (3 x 5 mL). The combined organic layers were dried over anhydrous Na2CO3 and 
concentrated in vacuo. The residues were purified by silica column chromatography, eluting in a gradient 
of 10–20% ethyl acetate in petroleum ether 40–60, to furnish the title compound as a white crystalline 
solid (111 mg, 0.378 mmol, 87%).  
RF 0.18 (20% EtOAc in pet. ether 40–60); Tm 90–92 ºC; IR νmax/cm-1 (film): 3273 (sp C–H), 2993, 2942, 
1726 (C=O), 1637 (C=C), 1462, 1391, 1273, 1252, 1203, 1127, 1014; 1H NMR (500 MHz, CDCl3) δ 
(ppm): 5.32 (s, 1H, H-8), 4.48 (app. dt, J = 9.5, 3.9 Hz, 1H, H-2), 4.32 (dd, J = 4.6, 2.4 Hz, 1H, H-4), 
2.53 (d, J = 2.4, 1H, H-6), 2.42 (dd, J = 15.0, 9.5 Hz, 1H, H-1a), 2.25 (dd, J = 15.0, 3.9 Hz, 1H, H-1b), 
1.91 (app. qt, J = 7.0, 4.0 Hz, 1H, H-3), 1.70 (s, 3H, H-11a), 1.69 (s, 3H, H-11b), 1.55 (s, 3H, H-13a), 
1.36 (s, 3H, H-13b), 1.07 (d, J = 7.0 Hz, 3H, H-14); 13C NMR (125 MHz, CDCl3) δ (ppm): 168.7 (C-7), 
161.1 (C-9), 106.7 (C-10), 101.3 (C-12), 95.1 (C-8), 83.6 (C-5), 74.5 (C-6), 66.5 (C-4), 65.2 (C-2), 38.6 
(C-3), 36.6 (C-1), 27.9 (C-13a), 25.5 (C-11a), 25.1 (C-11b), 23.8 (C-13b), 11.7 (C-14); HRMS-ESI (m/z) 
found [M+Na]+ 317.1359, C16H22O5Na requires 317.1359; [α] 25D = –6.8 º (c = 0.5, CHCl3). 
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2,2-dimethyl-6-(((4S,5R,6R)-2,2,5-trimethyl-6-((E)-2-(tributylstannyl)vinyl)-1,3-dioxan-4-yl)methyl)-4H-1,3-
dioxin-4-one 560 
 
Prepared according to general procedure H with Pd2dba3 (0.5 mg, 0.5 μmol) and 
tricylohexylphosphonium tetrafluoroborate (0.7 mg, 1.9 μmol) in dichloromethane (4 mL), 
disisoproylethylamine (0.7 μL, 1.9 μmol), 6-(((4S,5R,6R)-6-ethynyl-2,2,5-trimethyl-1,3-dioxan-4-yl)methyl)-
2,2-dimethyl-4H-1,3-dioxin-4-one 574 (28 mg, 9.4 μmol) in dichloromethane (0.5 mL), and tributyltin 
hydride (32 μL, 11.9 μmol) in dichloromethane (1.5 mL). Purification was carried out by silica column 
chromatography, eluting in a gradient of 0 to 20% diethyl ether in petroleum ether 40–60, to furnish 
the title compound (containing 6% 1,1-disubstuted analogue) as a colourless oil (44 mg, 7.4 μmol, 79%).  
RF 0.35 (20% EtOAc in pet. ether 40–60); IR νmax/cm-1 (film): 2956, 2926, 2873, 1734 (C=O), 1638 
(C=C), 1462, 1387, 1378, 1271, 1227, 1205, 1163, 1014; 1H NMR (500 MHz, CDCl3) δ (ppm): 6.15 
([d]dd, [2JH–[Sn] = 69.2 Hz], J = 19.0, 0.7 Hz, 1H, H-6), 5.98 ([d+d]dd, [3JH–119Sn = 62.3 Hz], [3JH–117Sn = 
60.9 Hz], J = 19.0, 6.1 Hz, 1H, H-5), 5.31 (s, 1H, H-8), 4.21 (ddd, J = 10.0, 5.2, 3.8 Hz, 1H, H-2), 3.73 
(app. t, J = 6.8 Hz, 1H, H-4), 2.39 (dd, J = 15.0, 10.0 Hz, 1H, H-1a), 2.26 (dd, J = 15.0, 3.8 Hz, 1H, 
H-1b), 1.82 (app. tq, J = 6.9, 6.5 Hz, 1H, H-3), 1.68 (s, 6H, H-11), 1.54–1.43 (m, 6H, H-17), 1.36 (s, 
3H, H-13a), 1.35 (s, 3H, H-13b), 1.33–1.26 (m, 6H, H-16), 0.92–0.84 (m, 18H, H-14,15,18); 13C NMR 
(125 MHz, CDCl3) δ (ppm): 169.3 (C-7), 161.2 (C-9), 146.7 (C-5), 130.6 ([d], [1JC–[Sn] = 364.2 Hz], C-
6), 106.5 (C-10), 101.1 (C-12), 94.8 (C-8), 79.0 (C-4), 65.8 (C-2), 39.2 (C-3), 35.9 (C-1), 29.2 ([d], [3JC–
[Sn] = 20.2 Hz],C-17), 27.4 ([d], [2JC–[Sn] = 27.4 Hz], C-16), 25.4 (C-11a), 25.1 (2C, C-11b,13b), 24.5 (C-
13a), 13.8 (C-18), 11.5 (C-14), 9.6 ([d+d], [1JC–119Sn = 345.0 Hz], [1JC–117Sn = 329.6 Hz], C-15); HRMS-
SMDI (m/z) found [M] 586.2689, C28H50O5Sn requires 586.2680; [α] 25D = +17.7 º (c = 1.0, CHCl3). 
6,6'-(((4S,4'S,5R,5'R,6S,6'S)-((1E,3E)-buta-1,3-diene-1,4-diyl)bis(2,2,5-trimethyl-1,3-dioxane-6,4-
diyl))bis(methylene))bis(2,2-dimethyl-4H-1,3-dioxin-4-one) 575 
 
Formed from 2,2-dimethyl-6-(((4S,5R,6R)-2,2,5-trimethyl-6-((E)-2-(tributylstannyl)vinyl)-1,3-dioxan-4-
yl)methyl)-4H-1,3-dioxin-4-one 560 on prolonged standing to give a crystalline white solid.  
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RF 0.38 (50% EtOAc in pet. ether 40–60); Tm 108–110 ºC; IR νmax/cm-1 (film): 2989, 2939, 1726 (C=O), 
1636 (C=C), 1460, 1387, 1378, 1272, 1226, 1204, 1164, 1014; 1H NMR (400 MHz, CDCl3) δ (ppm): 
6.24–6.15 (m, 2H, H-6), 5.76–5.65 (m, 2H, H-5), 5.28 (s, 2H, H-8), 5.22–5.15 (m, 2H, H-2), 3.78 (app. 
t, J = 7.2 Hz, 2H, H-4), 2.36 (dd, J = 15.0, 10.1 Hz, 2H, H-1a), 2.23 (dd, J = 15.0, 3.5 Hz, 2H, H-1b), 
1.80 (app. sx, J = 6.6 Hz, 2H, H-3), 1.66 (s, 12H, H-11), 1.32 (s, 6H, H-13a), 1.31 (s, 6H, H-13b), 0.86 
(d, J = 6.8 Hz, 6H, H-14); 13C NMR (100 MHz, CDCl3) δ (ppm): 169.1 (C-7), 161.1 (C-9), 132.8 (C-5 
[S-cis]) 132.6 (C-5 [S-trams]), 131.2 (C-6 [S-cis]), 130.8 (C-6 [S-trans]), 106.5 (C-10), 101.1 (C-12), 94.8 
(C-8), 75.6 (C-4 [S-cis]) 75.2 (C-4 [S-trans]), 65.7 (C-2), 39.7 (C-3), 35.6 (C-1), 25.3 (C-11a), 25.1 (C-11b), 
25.0 (C-13a), 24.2 (C-13b), 11.5 (C-14 [S-trams]), 11.4 (C-14 [S-cis]); HRMS-ESI (m/z) found [M+Na]+ 
613.2996, C32H46O10Na requires 613.2983; [α]25D = +25.4 º (c = 1.0, CHCl3). 
((E)-2-((4R,5R,6S)-6-((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)-2,2,5-trimethyl-1,3-dioxan-4-yl)vinyl)(o-
tolyl)-iodonium trifluoromethanesulfonate 577 
 
Trimethylsilyl trifluoromethanesulfonate (2.0 μL, 10 μmol) was added at –78 ºC too a solution of 2,2-
dimethyl-6-(((4S,5R,6R)-2,2,5-trimethyl-6-((E)-2-(tributylstannyl)vinyl)-1,3-dioxan-4-yl)methyl)-4H-1,3-dioxin-
4-one 560 (5.9 mg, 10 μmol), [Bis(trifluoroacetoxy)iodo]ortho-toluene (4.4 mg, 10 μmol) and 1,3,5-
trimethoxybenzene tricarboxylate (2.5 mg, 10 μmol) in dichloromethane (0.5 mL). The reaction mixture 
was stirred at –78 ºC for five minutes before warming to room temperature and stirring for a further five 
minutes. The resulting crude iodonium salt (90% assay yield) was concentrated under a stream of 
nitrogen gas then purified by silica column chromoatography, eluting in a gradient of 0 to 50% acetone 
in dichloromethane. The purified residues were precipated with diethyl ether to furnish the desired title 
compound as an amorphous white powder (3.1 mg, 4.5 μmol, 45%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 8.00 (dd, J = 8.1, 1.1 Hz, 1H, H-16), 7.62 (app. td, J = 7.5, 1.1 
Hz, 1H, H-18), 7.54 (dd, J = 7.8, 1.3 Hz, 1H, H-19), 7.31 (app. td, J = 7.8, 1.3 Hz, 1H, H-17), 6.87 (dd, 
J = 13.6, 3.7 Hz, 1H, H-5), 6.81 (dd, J = 13.6, 1.1 Hz, 1H, H-6), 5.28 (s, 1H, H-8), 4.15 (ddd, J = 10.1, 
5.2, 3.3 Hz, 1H, H-2), 4.02 (ddd, J = 8.7, 3.7, 1.1 Hz, 1H, H-4), 2.64 (s, 3H, H-21), 2.36 (dd, J = 14.9, 
10.1 Hz, 1H, H-1a), 2.23 (dd, J = 14.9, 3.3 Hz, 1H, H-1b), 1.94–1.84 (m, 1H, H-3), 1.69–1.66 (m, 6H, 
H-11), 1.30 (s, 6H, H-13), 0.94 (d, J = 6.7 Hz, 3H, H-14); 19F NMR (376 MHz, CDCl3) δ: –79.2. Further 
characterisation data could not be obtained due to product instability. 
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((E)-2-((4R,5R,6S)-6-((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)-2,2,5-trimethyl-1,3-dioxan-4-
yl)vinyl)(phenyl)-iodonium trifluoromethanesulfonate 558 
 
A solution of 2,2-dimethyl-6-(((4S,5R,6R)-2,2,5-trimethyl-6-((E)-2-(tributylstannyl)vinyl)-1,3-dioxan-4-
yl)methyl)-4H-1,3-dioxin-4-one 560 (93% purity, 31.4 mg, 50.0 μmol) in dichloromethane (2.5 mL) was 
added at –40 ºC to a suspension of cyano(phenyl)iodonium trifluoromethanesulfonate 535 (18.9 mg, 50.0 μmol) 
in dichloromethane (7.5 mL). The resulting suspension was warmed to room temperature and was 
stirred for 10 minutes then loaded directly onto a pre-packed silica column (dichloromethane) and eluted 
in a gradient of 0 to 100% acetone in dichloromethane. The fractions containing the iodonium salt were 
concentrated in vacuo and the resulting residues triturated with hexanes to furnish the title compound as 
an amorphous white powder (29.0 mg, 44.7 μmol, 89%).  
RF 0.21 (50% Me2CO in CH2Cl2); IR νmax/cm-1 (film): 3446 (br.), 2979, 2941, 1706 (C=O), 1636 (C=C), 
1403, 1379, 1270, 1244, 1225, 1163, 1027; 1H NMR (500 MHz, CDCl3) δ (ppm): 8.00 (d, J = 7.5 Hz, 
2H, H-16), 7.66 (t, J = 7.3 Hz, 1H, H-18), 7.51 (app. t, J = 7.9 Hz, 2H, H-17), 7.03 (dd, J = 13.8, 4.1 
Hz, 1H, H-5), 6.91 (dd, J = 13.8, 1.6 Hz, 1H, H-6), 5.28 (s, 1H, H-8), 4.14 (ddd, J = 10.2, 5.1, 3.4 Hz, 
1H, H-2), 4.02 (ddd, J = 8.6, 4.1, 1.6 Hz, 1H, H-4), 2.35 (dd, J = 15.0, 10.2 Hz, 1H, H-1a), 2.23 (dd, J 
= 15.0, 3.4 Hz, 1H, H-1b), 1.91 (app. sx, J = 6.8, 1H, H-3), 1.67 (s, 3H, H-11a), 1.66 (s, 3H, H-11b), 
1.293 (s, 3H, H-13a), 1.289 (s, 2H, H-13b), 0.94 (d, J = 6.9 Hz, 3H, H-14); 13C NMR (125 MHz, CDCl3) 
δ (ppm): 168.8 (C-7), 161.2 (C-9), 150.0 (C-5), 136.0 (C-16), 132.8 (C-18), 132.4 (C-17), 120.3 (q, 1J = 
319.9 Hz, C-Tf), 110.6 (C-15), 106.7 (C-10), 101.8 (C-12), 99.3 (C-6), 94.9 (C-8), 75.9 (C-4), 65.6 (C-2), 
38.9 (C-3), 35.4 (C-1), 25.25 (C-11a), 25.17 (C-11b), 24.7 (C-13a), 24.2 (C-13b), 11.5 (C-14); 19F NMR 
(376 MHz, CDCl3) δ: –79.2; HRMS-ESI (m/z) found [M–OTf]+ 499.0964, C22H28O5I requires 
499.0976; [α] 25D = –19.0 º (c = 0.5, MeCN). 
tert-butyl((4-methylocta-4,6-dien-1-yl)oxy)diphenylsilane 584 
 
n-Butyllithium (1.9 M in hexanes, 0.87 mL, 1.65 mmol) was added at 0 ºC to a solution of but-2-en-1-
yltriphenylphosphonium bromide 588 (5:1 E-:Z-, 596 mg, 1.50 mmol) in tetrahydrofuran (10 mL). The 
resulting mixture was stirred for 1 hour before undergoing the dropwise addition of a solution of 5-((tert-
butyldiphenylsilyl)oxy)pentan-2-one 586 (510 mg, 1.50 mmol) in tetrahydrofuran (5 mL). The resulting 
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solution was warmed to room temperature and was then stirred for a further 16 hours before pouring 
into hexanes (50 mL). The precipiated triphenylphosphine oxide was removed by filtration, with the 
filtrate taken and concentrated in vacuo. The resulting residues were purified by silica column 
chromatography, eluting with 100% petroleum ether 40–60, to furnish the title compound as a 
colourless viscous oil and as an inseparable complex mixture of four diastereoisomers (366 mg, 0.97 
mmol, 63%).  
RF 0.09 (100% pet. ether 40–60); IR νmax/cm-1 (film): 3071, 3026, 2956, 2931, 2857, 1473, 1428, 1187, 
1107, 1094; 1H NMR (400 MHz, CDCl3) δ (ppm): 7.76–7.69 (m, 4H, H-13), 7.53–7.36 (m. 6H, H-
12,14), 6.40–6.23 (m, 1H, H-6), 6.23–6.12 (m, 0.25H, H-5), 5.84 (d, J = 10.7 Hz, 0.75H, H-5’), 5.67–
5.55 (m, 0.75H, H-7), 5.52–5.37 (m, 0.25H, H-7’), 3.71 (m, 2H, H-1), 2.33–2.27 (m, 0.8H, H-3), 2.26–
2.20 (m, 0.3H, H-3’), 2.17–2.13 (m, 0.9H, H-3’’), 1.86–1.65 (m, 8H, H-2,8,15), 1.13–1.08 (m, 9H, H-
10); 13C NMR (100 MHz, CDCl3) δ (ppm): 138.6 (C-4), 138.2 (C-4’), 136.2 (C-4’’), 135.8 (C-4’’’), 135.7 
(C-13), 134.2 (C-11), 129.7 (C-14), 128.2 (C-6), 128.0 (C-6’). 127.7 (C-12), 126.9 (C-7), 126.7 (C-7’), 
125.8 (C-5), 125.5 (C-6’’), 124.9 (C-5’), 124.0 (C-7’’), 123.8 (C-7’’’), 120.7 (C-5’’), 120.1 (C-5’’’), 63.6 (C-
1), 36.6 (C-3), 36.1 (C-3’), 31.3 (C-2), 31.0 (C-2’), 28.63 (C-3’’), 28.56 (C-3’’’), 27.0 (C-10), 24.3 (C-15), 
23.7 (C-15’), 18.5 (C-8), 18.4 (C-8’), 16.6 (C-15’’), 16.5 (C-15’’’), 13.3 (C-8’’), 13.2 (C-8’’’); HRMS-ESI 
(m/z) found [M+H]+ 379.2448, C25H35OSi requires 379.2452. 
6-(((4S,5R,6S)-6-((S,E)-3-((4S,6S)-6-(3-((tert-butyldiphenylsilyl)oxy)propyl)-6-methyl-2-oxo-1,3-dioxan-4-yl)but-
1-en-1-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 559 
 
A solution of ((E)-2-((4R,5R,6S)-6-((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)-2,2,5-trimethyl-1,3-
dioxan-4-yl)vinyl)(phenyl)-iodonium trifluoromethanesulfonate 558 (52.7 mg, 81.6 μmol) and (S,E)-1-((tert-
butyldiphenylsilyl)oxy)-4-methyloct-6-en-4-yl dimethylcarbamate 470 (29.3 mg, 62.7 μmol) in dichloromethane 
(1 mL) was added to a sealed microwave vial charged with (CuOTf)2•PhH (4.7 mg, 9.4 μmol) and 4 Å 
molecular sieves (29.3 mg) under an atmosphere of nitrogen. Di-tert-butyl pyridine (14 μL, 63 μmol) was 
added and the resulting reaction mixture stirred for 21 hours at room temperature. The reaction was 
quenched with the addition of sat. aq. NaHCO3 solution (1 mL) and triethylamine (0.5 mL). The phases 
were separated and the aqueous phase was extracted with dichloromethane (3 x 2 mL). The organic 
fractions were combined, dried over anhydrous Na2SO4 and concentrated in vacuo. The crude residues 
were purified by five rounds of silica column chromatography, eluting in 0–5% ethyl acetate in 
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petroleum ether, then by a final round of silica column chromatography, eluting in 2% acetone in 
dichloromethane, to furnish the title compound as a colourless oil (1.0 mg, 1.3 μmol, 2%). 
RF 0.17 (40% EtOAc in pet. ether 40–60); 1H NMR (500 MHz, CDCl3) δ (ppm): 7.66–7.62 (m, 4H, H-
16), 7.46–7.35 (m, 6H, H-15,17), 5.74–5.56 (m, 2H, H-8,9), 5.32 (s, 1H, H-26), 4.42–4.18 (m, H-6,12), 
3.78–3.62 (m, 3H, H-1,10), 2.52–2.33 (m, 2H, H-7,13a), 2.28–2.21 (m, 1H, H-13b), 1.69 (s, 6H, H-29), 
1.36–1.34 (m, 6H, H-24), 1.06–1.03 (m, 9H, H-19), H-2,3,5,11,22,25 indistinguishable; HRMS-ESI 
(m/z) found [M+Na]+ 757.3728, C42H58O9SiNa requires 757.3742. Further characterisation data could 
not be obtained due to limited product availability. 
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vii Appendix 1 – Synthesis of Supporting Compounds 
((but-3-yn-2-yloxy)methyl)benzene 539195 
 
Adapted from a procedure reported by Nakai et al.197 Benzyl bromide (7.72 mL, 65.0 mmol) was added dropwise 
at 0 ºC to a vigorously stirred mixture of but-3-yn-2-ol (3.91 mL, 50.0 mmol), tetrabutylammonium 
iodide (920 mg, 2.50 mmol), NaOH (8.00 g, 200 mmol) and water (2.5 mL). The resulting reaction 
mixture was warmed to room temperature and was stirred for 16 hours before being quenched with sat. 
aq. NH4Cl solution (50 mL). The layers were separated and the aqueous layer extracted with diethyl 
ether (3 x 50 mL). The organic layers were combined, washed with brine (30 mL), dried over anhydrous 
MgSO4 and concentrated in vacuo. The crude residue was purified by alumina column chromatography, 
eluting with 0 to 1% diethyl ether in petroleum ether 40–60, to give the title compound as colourless oil 
(3.65 g, 22.8 mmol, 46%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.43–7.28 (m, 5H, H-7,8,9), 4.82 (d, J = 11.7 Hz, 1H, H-5a), 
4.53 (d, J = 11.7 Hz, 1H, H-5b), 4.24 (qd, J = 6.7, 2.0 Hz, 1H, H-2), 2.49 (d, J = 2.0 Hz, 1H, H-4), 
1.51 (d, J = 6.7 Hz, 3H, H-1); 13C NMR (100 MHz, CDCl3) δ (ppm): 137.9 (C-6), 128.5 (C-8), 128.1 
(C-7), 127.8 (C-9), 83.8 (C-3), 73.3 (C-4), 70.6 (C-5), 64.3 (C-2), 22.1 (C-1). Experimental data in 
agreement with previous literature report.195 
(but-3-yn-2-yloxy)triisopropylsilane 483a 
 
Triisopropylsilyl trifluoromethanesulfonate (2.78 mL, 15.2 mmol) was added dropwise at 0 ºC to a 
solution of but-3-yn-2-ol (1.00 mL, 12.7 mmol) and 2,6-lutidine (2.89 mL, 25.4 mmol) in 
dichloromethane (30 mL). The resulting solution was warmed to room temperature and was stirred for 
a further three hours before quenching with sat. aq. NaHCO3 solution (30 mL). The biphasic mixture 
was separated and the aqueous layer extracted with dichloromethane (3 x 30 mL). The organic layers 
were combined, washed with brine (60 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. 
The crude product was purified by silica column chromatography, eluting with 100% petroleum ether 
40–60, to furnish the title compound as a colourless oil (1.90 g, 8.40 mmol, 66%).  
RF 0.72 (2% Et2O in pet. ether 40–60); IR νmax/cm-1 (film): 3313 (sp C–H), 2944, 2866, 1464, 1250, 
1121, 1101, 1059, 974, 882; 1H NMR (400 MHz, CDCl3) δ (ppm): 4.60 (qd, J = 6.5, 2.0 Hz, 1H, H-2), 
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2.37 (d, J = 2.0 Hz, 1H, H-4), 1.46 (d, J = 6.5 Hz, 3H, H-1), 1.17–1.03 (m, 21H, H-5,6); 13C NMR (100 
MHz, CDCl3) δ (ppm): 86.8 (C-3), 71.2 (C-4), 58.9 (C-2), 25.7 (C-1), 18.1 (C-6), 12.3 (C-5). HRMS-ESI 
(m/z) found M+ 266.1754, C13H26OSi requires 266.1754. 
(E)-pent-3-en-1-yl dimethylcarbamate 317158 
 
Prepared according to a procedure adapted from Gaunt et al.158 Sodium metal (1.00 g, 43.5 mmol) was dissolved 
in liquid ammonia (50 mL, condensed into a Schlenk flask held at –78 ºC). A solution of 3-pentyn-1-ol 
(1.14 mL, 12.4 mmol) in dry diethyl ether (6 mL) was added dropwise to the resulting bright blue solution 
with this mixture stirred for a further four hours. The reaction was then opened to the atmosphere, solid 
ammonium chloride (1.19 g, 22.2 mmol) added in one portion, and the resulting mixture warmed to 
room temperature. Following evaporation of the ammonia, ice/water (150 mL) was added to the residue 
and mixture then extracted with diethyl ether (5 x 10 mL). The combined organic layers were then 
washed with water (10 mL) and brine (20 mL), dried over anhydrous MgSO4, and concentrated in vacuo 
(maintaining rotary evaporator bath at 0 ºC) to furnish the intermediate trans-3-penten-1-ol as a solution 
in diethyl ether (1.06 g, 40 wt%, 4.90 mmol, 40%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 5.66–5.54 (m, 1H, H-4), 5.46–5.34 (m, 1H, H-3), 3.63 (app. q, J 
= 5.5 Hz, 2H, H-1), 2.26 (app. q, J = 6.5 Hz, 2H, H-2), 1.69 (app. dq, J = 6.4, 0.9 Hz, 3H, H-5). 
Experimental data in agreement with previous literature report.224  
To a solution of trans-3-penten-1-ol (1.06 g, 40 wt% in Et2O, 4.90 mmol) in acetonitrile (10 mL) was 
added carbonyldiimidazole (3.00 g, 18.5 mmol) portion-wise against a counter-flow of nitrogen gas. The 
resulting solution was heated to 35 ºC for 30 minutes before re-cooling to room temperature. 
Dimethylamine (2.0 M in THF, 9.4 mL, 18.8 mmol) was added to the yellow solution with the reaction 
mixture then warmed to 30 ºC for a further 45 minutes. The resulting solution was concentrated in vacuo 
and the residue re-suspended in 1M aqueous HCl (10 mL) and dichloromethane (10 mL). The layers 
were separated and the aqueous extracted with further quantities of dichloromethane (3 x 10 mL). The 
organic fractions were combined, dried over anhydrous MgSO4, concentrated in vacuo. The resulting 
residue was purified by silica column chromatography, eluting in a gradient of 2.5–5% ethyl acetate in 
petroleum ether 40–60. The purified homoallylic carbamate was then further purified by kugelrohr 
distillation to furnish the title compound as a colourless oil (584 mg, 3.72 mmol, 76%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 5.58–5.48 (m, 1H, H-4), 5.46–5.36 (m, 1H, H-3), 4.05 (t, J = 6.8 
Hz, 2H, H-1), 2.89 (br. s, 6H, H-7,8), 2.30 (app. qt, J = 6.8, 1.1 Hz, 2H, H-2), 1.66 (app. dq, J = 6.3, 
1.1 Hz, 3H, H-5); 13C NMR (100 MHz, CDCl3) δ (ppm): 156.8 (C-6), 127.7 (C-4), 126.8 (C-3), 65.1 (C-
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1), 36.4 (C-7/8), 35.9 (C-7/8), 32.6 (C-2), 18.1 (C-5). Experimental data in agreement with previous 
literature report.158  
3-(triisopropylsilyl)prop-2-yn-1-o 3-(triisopropylsilyl)propiolaldehyde 494225 
 
Adapted from a procedure reported by Aponick et al.225 n-Butyllithum (1.8 mL, 2.5 M, 4.5 mmol) was added 
dropwise at –78 ºC to a stirred solution of triisopropylsilylacetylene (1.0 mL, 4.5 mmol) in 
tetrahydrofuran (12.5 mL). The resulting mixture was stirred at 0 ºC for 30 minutes before it was warmed 
to room temperature, stirred for ten minutes then cooled to –78 ºC. Dimethylformamide (0.70 mL, 9.0 
mmol) was added dropwise to the cold mixture and the reaction was stirred at –78 ºC for 10 minutes 
before warming to room temperature and stirring for a further 30 minutes. The reaction was quenched 
by pouring into a 0 ºC mixture of 10% aqueous NaH2PO4 (50 mL) and diethyl ether (50 mL) and was 
stirred for five minutes. The layers were separated and the organic phase was washed with water (25 
mL), dried over anhydrous MgSO4 and concentrated in vacuo. The crude residues were purified by silica 
column chromatography, eluting in a gradient of 1 to 2% diethyl ether in petroleum ether 40–60, to 
furnish the title compound as a colourless oil (0.876 g, 4.16 mmol, 92%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 9.19 (s, 1H, H-1), 1.14–1.06 (m, 21H, H-5,6); 13C NMR (100 
MHz, CDCl3) δ (ppm): 176.9 (C-2), 104.6 (C-4), 101.2 (C-3), 18.5 (C-5), 11.1 (C-6). Experimental data 
in agreement with previous literature report.225  
triisopropyl(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)silane 510a226 
 
Prepared according to a procedure reported by Barriault et al.227 n-BuLi (8.40 mL, 2.5 M, 21.0 mmol) was added 
dropwise at –40 ºC to a stirred solution of THP-protected proparyl alcohol (2.80 mL, 20.0 mmol) in 
tetrahydrofuran (10 mL). The resulting solution was maintained at this temperature for two hours before 
being cooled to –78 ºC and undergoing a dropwise addition of triisopropylsilyl chloride (5.10 mL, 24.0 
mmol). The resulting orange suspension was maintained at –78 ºC for a further hour before warming to 
room temperature and stirring for a further three hours. The reaction mixture was then quenched with 
sat. aq. NH4Cl solution (20 mL), separated, and the aqueous layer extracted with diethyl ether (3 x 20 
mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated in vacuo. The 
crude orange oil was purified by silica column chromatography, eluting with 0–10% ethyl acetate in 
petroleum ether 40–60, to furnish the title compound as a yellow oil (4.73 g, 15.9 mmol, 80%).  
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1H NMR (400 MHz, CDCl3) δ (ppm): 4.90 (app. t, J = 3.4 Hz, 1H, H-4), 4.33 (d, J = 16.1 Hz, 1H, H-
1a), 4.27 (d, J = 16.1 Hz, 1H, H-1b), 3.86 (ddd, J = 11.3, 8.5, 2.8 Hz, 1H, H-8ax), 3.57–3.46 (m, 1H, H-
8eq), 1.90–1.68 (m, 2H, H-5ax,6ax), 1.66–1.48 (m, 4H, H-5eq,6eq,7), 1.09–1.05 (m, 21H, H-9,10); 13C 
NMR (100 MHz, CDCl3) δ (ppm): 103.5 (C-2), 96.4 (C-4), 87.2 (C-3), 62.3 (C-8), 54.8 (C-1), 30.5 (C-5), 
25.6 (C-7), 19.3 (C-6), 18.7 (C-10), 11.3 (C-9). Experimental data in agreement with previous literature 
report.226  
3-(triisopropylsilyl)prop-2-yn-1-ol 510228 
 
Adapted from a procedure reported by Barriault et al.227 Para-toluenesulfonic acid (215 μL, 12 wt% in AcOH, 
0.15 mmol) was added to triisopropyl(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)silane 510a (4.44 g, 15.0 
mmol) in methanol (15 mL) and the mixture heated at reflux for 17 hours. The resulting solution was 
allowed to cool to room temperature and was concentrated in vacuo. The resulting residue was then re-
dissolved in a biphasic mixture of ethyl acetate (20 mL) and water (20 mL). The mixture was separated 
and the aqueous layer extracted with further portions of ethyl acetate (2 x 20 mL). The organics layers 
were combined, dried over anhydrous MgSO4 and concentrated in vacuo. The resulting residue (3:2 
desired product to starting material), was purified by silica column chromatography, eluting with a 
gradient of 2–10% ethyl acetate in petroleum ether 40–60, to furnish the title compound as a pale yellow 
oil (1.32 g, 6.20 mmol, 41%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 4.29 (s, 2H, H-1), 1.69 (br. s, 1H, H-4), 1.09–1.05 (m, 21H, H-
5,6); 13C NMR (100 MHz, CDCl3) δ (ppm): 105.8 (C-2), 86.9 (C-3), 51.9 (C-1), 18.7 (C-6), 11.3 (C-5). 
Experimental data in agreement with previous literature report.228  
4-cyano-3-nitrobenzoic acid  
 
Adapted from a procedure reported by Zambach et al.229 Periodic acid (4.92 g, 21.7 mmol) was suspended in 
acetonitrile (77 mL) under an atmosphere of argon gas and the resulting mixture vigorously stirred for 
fifteen minutes. Chromium (VI) oxide (250 mg, 25.0 mmol) and 4-methyl-2-nitrobenzonitrile (1.00 g, 
6.21 mmol) were then added and the resulting orange solution was stirred for 16 hours at room 
temperature before the mixture was filtered and the filtrate concentrated in vacuo. The residue was 
dissolved in dichloromethane (50 mL) and extracted with aqueous 1M Na2CO3 solution (3 x 25 mL). 
The combined aqueous layers were acidified with 3M HCl and then back extracted with 
HO
4
1
2
3 Si
5
Me
Me
Me
6
Me
Me
Me
6
5
4 3
2
1
7O OH8
9
NO2
N
Appendix 1 – Synthesis of Supporting Compounds 
 236 
dichloromethane (3 x 50 mL). The organic fractions were combined, washed with brine (25 mL), dried 
over anhydrous Na2SO4 and concentrated in vacuo. The resulting pale yellow solid was purified by silica 
column chromatography, flushing with 5% methanol in dichloromethane then eluting with a mixture 
of 1% acetic acid in 5% methanol in dichloromethane to give the title compound as an off-white 
crystalline solid (819 mg, 4.26 mmol, 69%).  
Tm 182–184 ºC; IR νmax/cm-1 (film): 3108 (br., O–H), 2254 (CºN), 1740 (C=O), 1727 (C=O), 1622, 
1564, 1542 (NO2 symm.), 1495, 1395, 1342 (NO2 antisymm.), 1231, 1221, 1116; 1H NMR (400 MHz, 
d6-DMSO) δ (ppm): 8.66 (d, J = 1.5 Hz, 1H, H-2), 8.40 (dd, J = 7.9, 1.5 Hz, 1H, H-6), 8.29 (d, J = 7.9 
Hz, 1H, H-5); 13C NMR (100 MHz, d6-DMSO) δ (ppm): 164.6 (C-4), 148.6 (C-3), 136.5 (C-5), 136.0 
(C-1), 134.7 (C-6), 125.6 (C-2), 115.2 (C-9), 110.3 (C-7); HRMS-ESI (m/z) found [M-H]– 191.0100, 
C8H3N2O4 requires 191.0098. 
((2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl)oxy)trimethylsilane 459230 
 
Adapted from a procedure reported by Gademann et al.199 n-BuLi (48.7 mL, 2.5 M in hexanes, 122 mmol) was 
added dropwise over ten minutes at 0 ºC to a stirred solution of freshly-distilled diisopropylamine (17.1 
mL, 122 mmol) in anhydrous tetrahydrofuran (62 mL). The resulting colourless solution was stirred 0 
ºC for a further 20 minutes before being cooled to –78 ºC and undergoing the dropwise addition of 
freshly distilled 2,2,6-trimethyl-4H-1,3-dioxin-4-one (13.3 mL, 100 mmol). The resulting yellow solution 
was stirred at –78 ºC for a further hour before undergoing the dropwise addition of trimethylsilyl 
chloride (18.1 mL, 142 mmol). The orange suspension was warmed to room temperature over 90 
minutes, filtered under a nitrogen atmosphere, and the clear filtrate concentrated in vacuo. The resulting 
orange residue was distilled under reduced pressure (care: substantial product decomposition is observed 
with heating over 50 ºC) to give the title compound as a colourless oil (17.1 g, 79.8 mmol, 80%).  
Tb 44–46 ºC (0.515 mbar); 1H NMR (400 MHz, CDCl3) δ (ppm): 4.64 (s, 1H, H-5), 4.06 (s, 1H, H-8a), 
3.87 (s, 1H, H-8b), 1.54 (s, 6H, H-7), 0.26 (s, 9H, H-9); 13C NMR (100 MHz, CDCl3) δ (ppm): 153.5 (C-
6), 151.9 (C-4), 102.6 (C-2), 85.1 (C-8), 76.7 (C-5), 24.6 (C-7), 0.4 (C-9). Experimental data in agreement 
with previous literature report.230 
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2-(benzyloxy)pyridine 522a 
 
Prepared according to a procedure reported by Dudley et al.201 A suspension of benzyl alcohol (1.92 mL, 18.5 
mmol), 2-chloropyridine (2.88 mL, 30.5 mmol), potassium hydroxide (3.42 g, 61.0 mmol), and 18-
crown-6 (25.0 mg, 0.9 mmol) in toluene (37 mL) was heated to reflux for one hour with the azeotropic 
removal of water. The resulting reaction mixture was cooled to room temperature, diluted with ethyl 
acetate (20 mL), washed successively with water (10 mL) and brine (10 mL), dried over anhydrous 
Na2SO4, and concentrated in vacuo. The crude residue was purified by silica column chromatography, 
eluting with 1% ethyl acetate in petroleum ether 40–60, to give the title compound as a colourless oil 
(3.21 g, 17.3 mmol, 94%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 8.18 (dd, J = 5.1, 1.8 Hz, H-5), 7.59 (ddd, J = 8.3, 7.1, 1.8 Hz, 
H-3), 7.50–7.44 (m, 2H, H-8), 7.41–7.35 (m, 2H, H-9), 7.34–7.29 (m, 1H, H-10), 6.89 (ddd, J = 7.1, 
5.1, 0.5 Hz, H-4), 6.81 (d, 8.3 Hz, H-2), 5.39 (s, 2H, H-6); 13C NMR (100 MHz, CDCl3) δ (ppm): 163.8 
(C-1), 147.0 (C-5), 138.7 (C-3), 137.5 (C-7), 128.6 (C-9), 128.1 (C-8), 127.9 (C-10), 117.0 (C-4), 111.5 
(C-2), 67.6 (C-6). Experimental data in agreement with previous literature report.231 
2-(benzyloxy)-1-methylpyridinium trifluoromethanesulfonate 522 
 
Prepared according to a procedure reported by Dudley et al.201 Methyl trifluoromethanesulfonate (0.64 mL, 5.7 
mmol) was added dropwise at 0 ºC to a solution of 2-(benzyloxy)pyridine X (1.00 g, 5.4 mmol) in toluene 
(5.4 mL). The reaction mixture was warmed to room temperature and was stirred for 40 minutes to 
result in product precipitation. The precipitate was collected by filtration and dried in vacuo to give the 
title compound as a colourless amorphous solid (1.85 g, 5.3 mmol, 98%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.45 (dd, J = 6.5, 1.5 Hz, H-5), 8.29 (ddd, J = 9.0, 7.4, 1.5 Hz, 
H-3), 7.65 (d, J = 9.0 Hz, H-2) 7.50–7.43 (m, 2H, H-9), 7.42–7.31 (m, 4H, H-4,10,11), 5.51 (s, 2H, H-
7), 4.01 (s, 3H, H-6); 13C NMR (100 MHz, CDCl3) δ (ppm): 159.6 (C-1), 148.2 (C-5), 143.9 (C-3), 132.6 
(C-8), 129.7 (C-11), 128.1 (C-9), 127.9 (C-10), 119.4 (C-4), 112.2 (C-2), 74.6 (C-6), 42.0 (C-6). 
Experimental data in agreement with previous literature report.201 
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2,4,6-tris(benzyloxy)-1,3,5-triazine (TriBOT) 523 
 
Prepared according to a procedure reported by Kunishima et al.202 Powdered sodium hydroxide (668 mg, 16.5 
mmol) was added at room temperature to neat benzyl alcohol (4.70 mL, 45.0 mmol) and the resulting 
suspension cooled to 0 ºC. Cyanuric chloride (920 mg, 5.0 mmol) was added portion-wise to the cooled 
reaction mixture and the resulting mixture stirred for 30 minutes then heated to 50 ºC for a further two 
hours. The reaction mixture was then cooled to room temperature and passed through a plug of silica 
gel, eluting with diethyl ether. The crude residue was concentrated and the residual benzyl alcohol 
removed with heating in vacuo. The resulting white solid was purified by silica column chromatography, 
eluting with 1% methanol in dichloromethane, to give the title compound as a colourless amorphous 
solid (1.33 g, 3.33 mmol, 66%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.49–7.43 (m, 6H, H-5), 7.42–7.30 (m, 9H, H-6,4), 5.47 (s, 6H, 
H-2); 13C NMR (100 MHz, CDCl3) δ (ppm): 173.1 (C-1), 135.4 (C-3), 128.6 (C-5), 128.5 (C-6), 128.4 
(C-4), 70.0 (C-2). Experimental data in agreement with previous literature report.202 
(but-3-yn-2-yloxy)triethylsilane 532 
 
Triethylsilyl trifluoromethanesulfonate (2.26 mL, 10.0 mmol) was added dropwise at –78 ºC to a stirred 
solution of but-3-yn-2-ol (787 μL, 10.0 mmol) and 2,6-lutidine (2.33 mL, 20.0 mmol) in dichloromethane 
(50 mL). The resulting suspension was warmed to room temperature and stirred twelve hours. The 
reaction mixture was quenched on the addition of sat. aq. NaHCO3 solution (50 mL) and the resulting 
biphasic mixture was separated and the aqueous layer extracted with further portions of 
dichloromethane (3 x 25 mL). The organic fractions were combined, washed with brine (25 mL), dried 
over anhydrous MgSO4 and concentrated in vacuo. The residue was purified by silica column 
chromatography, eluting in 100% petroleum ether 40–60, to furnish the title compound as a colourless 
oil (1.02 g, 5.54 mmol, 55%).  
RF 0.26 (100% pet. ether 40–60); IR νmax/cm-1 (film): 3313 (sp C–H), 2956, 2878, 1459, 1415, 1370, 
1315, 1239, 1120, 1101, 1005, 971; 1H NMR (400 MHz, CDCl3) δ (ppm): 4.51 (dq, J = 6.5, 2.0 Hz, 
1H, H-2), 2.36 (d, J = 2.0 Hz, 1H, H-4), 1.43 (d, J = 6.5 Hz, 3H, H-1), 0.97 (t, J = 7.7 Hz, 9H, H-6), 
0.65 (q, J = 7.7 Hz, 6H, H-5); 13C NMR (100 MHz, CDCl3) δ (ppm): 86.5 (C-3), 71.3 (C-4), 58.6 (C-2), 
N
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25.6 (C-1), 6.9 (C-6), 4.8 (C-5); HRMS-APCI (m/z) found [M–Et]+ 155.0894, C8H15OSi requires 
155.0892. 
cyano(phenyl)iodonium trifluoromethanesulfonate 535158 
 
Prepared according to a procedure reported by Holt et al.158 Trimethylsilyltrifluoromethanesulfonate (1.80 mL, 
9.90 mmol) was added to a stirred solution of bis(trifluoroacetoxy)iodobenzene (4.0 g, 9.00 mmol) in 
dichloromethane (18 mL) held at –20 ºC. The mixture was warmed to room temperature over 20 
minutes, with the colour changing from colourless to a vivid yellow. The reaction mixture was re-cooled 
to –30 ºC and trimethylsilylcyanide (1.30 mL, 9.90 mmol) was added dropwise. The resulting suspension 
was warmed to room temperature and filtered. The precipitate was washed with cold diethyl ether (80 
mL) and collected to furnish the title compound as an off-white solid (3.17 g, 8.30 mmol, 93%).  
1H NMR (400 MHz, d3-MeCN) δ (ppm): 8.34 (d, J = 8.0 Hz, 2H, H-2), 7.85 (t, J = 7.4, 1H, H-4), 7.69 
(app. t, J = 7.9); 13C NMR (100 MHz, d3-MeCN) δ (ppm): 136.7 (C-2), 135.2 (C-4), 134.2 (C-3), 120.9 
(q, 1J = 318.9 Hz, C-Tf), 119.1 (C-1), 68.8 (C-5). Experimental data in agreement with previous 
literature report.158  
tert-butyldimethyl(prop-2-yn-1-yloxy)silane 561a232 
 
Prepared according to a procedure reported by Sakaguchi and Ohfune et al.232 (Tert-butyl)dimethylsilyl chloride (4.00 
g, 26.8 mmol) was added in one portion at 0 ºC to a solution of propargyl alcohol (1.00 g, 17.8 mmol) 
and imidazole (1.80 g, 26.8 mmol) in dichloromethane (50 mL). The resulting suspension was warmed 
to room temperature and stirred for a further two hours before being quenched by the addition of sat. 
aq. NH4Cl solution. The phases were separated and the aqueous layer was extracted with further 
portions of dichloromethane (2 x 25 mL). The combined organic layers were washed with brine (50 mL), 
dried over anhydrous MgSO4 and concentrated in vacuo. The resulting residues were purified by silica 
column chromatography, eluting with 100% petroleum ether 40–60, to furnish the title compound as a 
colourless oil (1.72 g, 10.0 mmol, 56%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 4.31 (d, J = 2.4 Hz, 2H, H-1), 2.38 (t, J = 2.4 Hz, 1H, H-3), 0.91 
(s, 9H, H-6), 0.12 (s, 6H, H-4); 13C NMR (100 MHz, CDCl3) δ (ppm): 82.6 (C-2), 73.0 (C-3), 51.7 (C-1), 
25.9 (C-6), 18.4 (C-5), –5.1 (C-4). Experimental data in agreement with previous literature report.232  
 
 
3
4
1
2 I C
5
OTf
N
3 2
1
O SiMe 4
5
Me
Me Me
6Me
Appendix 1 – Synthesis of Supporting Compounds 
 240 
(E)-3-(tributylstannyl)prop-2-en-1-ol 561233 
 
Prepared according to a procedure reported by Menche et al.233 A flask was charged with tert-butyldimethyl(prop-2-yn-
1-yloxy)silane 561a (1.53 g, 8.96 mmol), tributyltin hydride (2.90 mL, 10.7 mmol) and 
azobisisobutyronitrile (44.3 mg, 0.27 mmol), evacuated and back-filled with nitrogen. The resulting 
mixture was heated at 80 ºC for two hours before being cooled to room temperature and diluted with 
tetrahydrofuran (18 mL). The crude stannylated solution was cooled to 0 ºC then underwent the addition 
of tetrabutylammonium fluoride solution (18 mL, 1.0 M in THF, 18.0 mmol). The resulting orange 
mixture was warmed to room temperature and stirred for a further two hours before being quenched 
by the addition of sat. aq. NH4Cl solution (25 mL). The phases were then separated and the aqueous 
layer extracted with diethyl ether (2 x 15 mL). The combined organic fractions were washed with brine 
(15 mL), dried over anhydrous MgSO4, and concentrated in vacuo. The resulting residues were purified 
by silica column chromatography, eluting in a gradient of 5–10% diethyl ether in petroleum ether 40–
60, to furnish the title product as a colourless oil (395 mg, 1.14 mmol, 13%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.29 (m, 2H, H-2,3), 4.17 (dd, J = 6.0, 3.5 Hz. 2H, H-1), 1.57–
1.40 (m, 7H, H-5,O–H), 1.30 (app. sx, J = 7.3 Hz, 6H, H-6), 0.92–0.86 (m, 15H, H-4,7); 13C NMR (100 
MHz, CDCl3) δ (ppm): 147.2 (C-2), 128.5 ([d+d], [1JC–119Sn = 372.8 Hz], [1JC–117Sn = 355.9 Hz], C-3), 
66.5 ([d+d], [2JC–119Sn = 65.9 Hz], [2JC–117Sn = 62.9 Hz], C-1), 29.2 ([d], [3JC–[Sn] = 20.4 Hz], C-6), 27.4 
([d+d], [2JC–119Sn = 55.9 Hz], [2JC–117Sn = 53.8 Hz], C-5), 13.8 (C-7), 9.6 ([d+d], [1JC–119Sn = 345.1 Hz], 
[1JC–117Sn = 329.9 Hz], C-4). Experimental data in agreement with previous literature report.233 
5-((tert-butyldiphenylsilyl)oxy)pentan-2-one 586234 
 
Tert-butyl(chloro)diphenyl silane (1.43 mL, 5.50 mmol) was added dropwise at 0 ºC to a stirred 
suspension of 5-hydroxypentan-2-one (506 μL, 5.00 mmol), imidazole (680 mg, 10.0 mmol) and 4-
dimethylaminopyridine (61.1 mg, 0.50 mmol) in dichloromethane (25 mL). The resulting suspension 
was warmed to room temperature and stirred for 24 hours before quenching with sat. aq. NH4Cl 
solution (25 mL). The phases were separated and the aqueous layer extracted with dichloromethane (2 
x 15 mL). The combined organic fractions were washed with brine (25 mL), dried over anhydrous 
MgSO4, and concentrated in vacuo. The resulting residues were purified by silica column 
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chromatography, eluting in a gradient of 3 to 5% ethyl acetate in petroleum ether 40–60, and then by 
kugelrohr distillation to furnish the title compound as a colourless oil (566 mg, 1.66 mmol, 33%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.68–7.64 (m, 4H, H-10), 7.45–7.36 (m, 6H, H-9,11), 3.67 (t, J 
= 6.1 Hz, 2H, H-5), 2.55 (t, J = 7.3 Hz, 2H, H-3), 2.13 (s, 3H, H-1), 1.83 (app. qn, J = 6.7 Hz, 2H, H-
4), 1.06 (s, 9H, H-7); 13C NMR (100 MHz, CDCl3) δ (ppm): 209.1 (C-2), 135.7 (C-10), 133.9 (C-8), 129.8 
(C-11), 127.8 (C-9), 63.1 (C-5), 40.3 (C-3), 30.1 (C-1), 27.0 (C-7), 26.8 (C-1), 19.4 (C-6). Experimental 
data in agreement with previous literature report.234  
(E)-but-2-en-1-yltriphenylphosphonium bromide 588235 
 
Prepared according to a procedure reported by Orfanopoulos et al.235 A microwave tube was charged with crotyl 
bromide (6:1 E- to Z-, 400 μL, 3.80 mmol) and triphenylphosphine (1.02 g, 3.80 mmol), sealed, flushed 
with nitrogen and then heated at 80 ºC for 12 hours. The resulting white solid was collected by filtration 
and washed with hot toluene to furnish the title compound as a white powder in a 5:1 E- to Z- 
diasteroisomeric mixture (1.30 g, 3.27 mmol, 84%).  
E-isomer: 1H NMR (400 MHz, CDCl3) δ (ppm): 7.79–7.72 (m, 9H, H-6,8), 7.67–7.60 (m, 6H, H-7), 
5.97–5.85 (m, 1H, H-2), 5.29–5.18 (m, 1H, H-3), 4.59 (dd, JP–H = 14.5 Hz, J = 7.2 Hz, 2H, H-1), 1.56 
(app. t, J = 5.9 Hz, 3H, H-4); 13C NMR (100 MHz, CDCl3) δ (ppm): 137.8 (d, J = 13.5 Hz, C-2), 135.0 
(d, J = 3.0 Hz, C-8), 133.9 (d, J = 9.7 Hz, C-6), 130.3 (d, JP–C = 12.5 Hz, C-7), 118.1 (d, JP–C = 85.7 
Hz, C-5), 114.8 (d, JP–C = 9.8 Hz, C-3), 27.9 (d, JP–C = 49.5, C-1), 18.4 (d, JP–C = 2.6 Hz, C-4); Z-isomer: 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.85–7.71 (m, 9H, H-6,8), 7.67–7.60 (m, 6H, H-7), 5.85–5.75 (m, 
1H, H-2), 5.41–5.30 (m, 1H, H-3), 4.56 (dd, JH–P = 14.5 Hz, J = 8.0 Hz, 2H, H-1), 1.32 (app. t, J = 6.6 
Hz, 3H, H-4); 13C NMR (100 MHz, CDCl3) δ (ppm): 135.1 (2C, C-2,8), 133.9 (d, JP–C = 9.7 Hz, C-6), 
130.4 (d, JP–C = 12.6 Hz, C-7), 118.1 (d, JP–C = 85.7 Hz, C-5), 114.6 (d, JP–C = 9.1 Hz, C-3), 23.6 (d, JP–
C = 50.3, C-1), 13.7 (d, JP–C = 3.0 Hz, C-4). Experimental data in agreement with previous literature 
report.235  
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viii Appendix 2 – NMR Spectra 
viii.1 The Enantioselective and Regiodivergent Copper-Catalysed Arylation of 
Allylic Amides with Diaryliodonium Salts 
viii.1.1  Substrate synthesis 
(Z)-3-phenylallyl pivalate 349 
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(Z)-1,1-dimethyl-3-(3-phenylallyl)urea 350 
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(Z)-2-(3-phenylallyl)isoindoline-1,3-dione 352 
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(Z)-N-(3-(4-chlorophenyl)allyl)pivalamide 356 
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(Z)-N-(3-(naphthalen-2-yl)allyl)pivalamide 362 
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(Z)-N-(3-(1-(phenylsulfonyl)-1H-indol-3-yl)allyl)pivalamide 364 
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(Z)-N-(3-(benzo[d][1,3]dioxol-5-yl)allyl)pivalamide 365 
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(Z)-N-(3-(thiophen-2-yl)allyl)pivalamide 366 
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viii.1.2 Enamide products 
(R)-N-[(1Z)-3-(3-bromophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 332 
 
 
 
-100102030405060708090100110120130140150160170180190200210220230240
f1 (ppm)
27
.1
5
38
.8
2
49
.0
7
11
1.
85
12
3.
14
12
3.
22
12
6.
94
12
7.
37
12
9.
33
14
2.
74
14
6.
12
17
5.
56
NH
O
Br
126127128129130131
f1 (ppm)
12
6.
94
12
7.
37
12
8.
34
12
9.
33
13
0.
11
13
0.
60
13
1.
29
CDCl3
125 MHz
Appendix 2 – NMR Spectra 
 251 
(R)-N-[(1Z)-3-(3-bromophenyl)-3-(4-chlorophenyl)prop-1-en-1-yl]-2,2-dimethylpropanamide 378 
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(S)-N-[(1Z)-3-(3-bromophenyl)-3-(2-fluorophenyl)prop-1-en-1-yl]-2,2-dimethylpropanamide 379 
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(S)-N-[(1Z)-3-(3-bromophenyl)-3-(2-methylphenyl)prop-1-en-1-yl]-2,2-dimethylpropanamide 380 
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(R)-2,2-dimethyl-N-[(1Z)-3-phenyl-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 383 
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(R)-2,2-dimethyl-N-[(1Z)-3-(2-methylphenyl)-3-phenylprop-1-en-1-yl]propanamide 384 
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(R)-N-[(1Z)-3-(2-fluorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 385 
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(R)-N-[(1Z)-3-(3,4-dichlorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 389 
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(S)-2,2-dimethyl-N-[(1Z)-3-(naphthalen-2-yl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 396 
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(S)-N-[(1Z)-3-(4-chlorophenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]-2,2-dimethylpropanamide 398 
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(S)-N-[(1Z)-3-(4-bromophenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]-2,2-dimethylpropanamide 399 
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(S)-2,2-dimethyl-N-[(1Z)-3-(2-methylphenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 403 
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(S,Z)-N-(3-phenyl-3-(p-tolyl)prop-1-en-1-yl)pivalamide 407 
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viii.1.3  Oxazine products 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(4-methoxyphenyl)-5,6-dihydro-4H-1,3-oxazine 410 
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(E)-N-(2,3-bis(4-methoxyphenyl)allyl)pivalamide 413a  
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(Z)-N-(2,3-bis(4-methoxyphenyl)allyl)pivalamide 413b  
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(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(4-bromophenyl)-5,6-dihydro-4H-1,3-oxazine 412 
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 (5S,6S)-6-(benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)-5-(4-methoxyphenyl)-5,6-dihydro-4H-1,3-oxazine 414 
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(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(1-(phenylsulfonyl)-1H-indol-3-yl)-5,6-dihydro-4H-1,3-oxazine 415 
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(5S,6S)-2-(tert-butyl)-5-(naphthalen-2-yl)-6-phenyl-5,6-dihydro-4H-1,3-oxazine 423 
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(5S,6S)-2-(tert-butyl)-6-phenyl-5-(thiophen-3-yl)-5,6-dihydro-4H-1,3-oxazine 424 
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(5S,6S)-2-(tert-butyl)-6-(4-methoxyphenyl)-5-(naphthalen-2-yl)-5,6-dihydro-4H-1,3-oxazine 425 
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(5S,6S)-2-(tert-butyl)-6-(4-methoxyphenyl)-5-(thiophen-3-yl)-5,6-dihydro-4H-1,3-oxazine 426 
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viii.2 Studies Towards the Total Synthesis of (–)-Lyngbyaloside B 
viii.2.1 Model coupling 
 (E)-(3-(benzyloxy)but-1-en-1-yl)(mesityl)iodonium trifluoromethanesulfonate 481 
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(E)-(3-(benzyloxy)but-1-en-1-yl)(o-tolyl)iodonium trifluoromethanesulfonate 482 
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(E)-(3-((triisopropylsilyl)oxy)but-1-en-1-yl)(mesityl)iodonium trifluoromethanesulfonate 483 
 
 
Appendix 2 – NMR Spectra 
 276 
(E)-4-(hexa-3,5-dien-2-yl)-1,3-dioxan-2-one 484 
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(E)-4-(5-(benzyloxy)hex-3-en-2-yl)-1,3-dioxan-2-one 478 
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viii.2.2 First generation 
(3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-ol 511 
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(3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-yl (S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 511a 
 
(3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-yl (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 511b 
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 (3R,4R)-4-methylhex-5-en-1-yn-3-ol 514 
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((((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)methyl)benzene 517 
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(2S,3R)-3-(benzyloxy)-2-methylpent-4-ynal 518 
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6-((2S,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 520 
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6-((2R,3R,4R)-4-(benzyloxy)-2-hydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one epi-520 
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6-((2S,3R,4R)-2,4-bis(benzyloxy)-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 521 
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6-(((2S,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 525 
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6-(((2R,4S,5R,6R)-6-ethynyl-5-methyl-2-phenyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 524 
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6-((2S,3S,4R)-4-(benzyloxy)-2-((tert-butyldimethylsilyl)oxy)-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-
4-one 526 
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6-((2S,3S,4R)-4-(benzyloxy)-3-methyl-2-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 527 
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viii.2.3 Second generation 
6-((2S,3S,4R,E)-4-(benzyloxy)-3-methyl-6-(tributylstannyl)-2-((triethylsilyl)oxy)hex-5-en-1-yl)-2,2-dimethyl-4H-
1,3-dioxin-4-one 534 
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(E)-(3-(benzyloxy)but-1-en-1-yl)tributylstannane 540 
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(E)-(3-(benzyloxy)but-1-en-1-yl)(phenyl)iodonium trifluoromethanesulfonate 541 
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(E)-triethyl((4-(tributylstannyl)but-3-en-2-yl)oxy)silane 542 
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 (E)-(3-((triethylsilyl)oxy)but-1-en-1-yl)(phenyl)iodonium trifluoromethanesulfonate 543 
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((3R,4S,5S,E)-3-(benzyloxy)-6-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-4-methyl-5-((triethylsilyl)oxy)hex-1-en-1-
yl)(phenyl)-iodonium trifluoromethanesulfonate 536 
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triethyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 550 
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(2S,3R)-2-methyl-3-((triethylsilyl)oxy)pent-4-ynal 549 
 
 
Appendix 2 – NMR Spectra 
 298 
6-((2S,3R,4R)-2-hydroxy-3-methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 548 
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6-((2R,3R,4R)-2-hydroxy-3-methyl-4-((triethylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one epi-548 
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2,2-dimethyl-6-((2S,3R,4R)-3-methyl-2,4-bis((triethylsilyl)oxy)hex-5-yn-1-yl)-4H-1,3-dioxin-4-one 547 
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2,2-dimethyl-6-((2S,3R,4R,E)-3-methyl-6-(tributylstannyl)-2,4-bis((triethylsilyl)oxy)hex-5-en-1-yl)-4H-1,3-dioxin-
4-one 546 
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((3R,4R,5S,E)-6-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-4-methyl-3,5-bis((triethylsilyl)oxy)hex-1-en-1-
yl)(phenyl)iodonium trifluoromethanesulfonate 531 
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(5S,8S,9S)-2,2,8-trimethyl-5,8,9,10-tetrahydro-4H-5,9-epoxycycloocta[d][1,3]dioxin-4-one 552 
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viii.2.4 Third generation 
(3R,4R,E)-4-methyl-1-(tributylstannyl)hexa-1,5-dien-3-ol 563 
 
 
Appendix 2 – NMR Spectra 
 305 
triethyl(((3R,4R,E)-4-methyl-1-(tributylstannyl)hexa-1,5-dien-3-yl)oxy)silane 563 
 
 
 
Appendix 2 – NMR Spectra 
 306 
triisopropyl(((3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-yl)oxy)silane 565 
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triisopropyl(((3R,4R)-4-methylhex-5-en-1-yn-3-yl)oxy)silane 566 
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(2S,3R)-2-methyl-3-((triisopropylsilyl)oxy)pent-4-ynal 567 
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6-((2S,3R,4R)-2-hydroxy-3-methyl-4-((triisopropylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 568 
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triisopropyl(((3R,4R)-4-methyl-1-(triisopropylsilyl)hex-5-en-1-yn-3-yl)oxy)silane 569 
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(2S,3R)-2-methyl-5-(triisopropylsilyl)-3-((triisopropylsilyl)oxy)pent-4-ynal 570 
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6-((2S,3R,4R)-2-hydroxy-3-methyl-6-(triisopropylsilyl)-4-((triisopropylsilyl)oxy)hex-5-yn-1-yl)-2,2-dimethyl-4H-
1,3-dioxin-4-one 571 
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6-((2S,3R,4R)-2,4-dihydroxy-3-methyl-6-(triisopropylsilyl)hex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 573 
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6-((2S,3R,4R)-2,4-dihydroxy-3-methylhex-5-yn-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one 572 
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6-(((4S,5R,6R)-6-ethynyl-2,2,5-trimethyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 574 
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2,2-dimethyl-6-(((4S,5R,6R)-2,2,5-trimethyl-6-((E)-2-(tributylstannyl)vinyl)-1,3-dioxan-4-yl)methyl)-4H-1,3-
dioxin-4-one 560 
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6,6'-(((4S,4'S,5R,5'R,6S,6'S)-((1E,3E)-buta-1,3-diene-1,4-diyl)bis(2,2,5-trimethyl-1,3-dioxane-6,4-
diyl))bis(methylene))bis(2,2-dimethyl-4H-1,3-dioxin-4-one) 575 
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((E)-2-((4R,5R,6S)-6-((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)-2,2,5-trimethyl-1,3-dioxan-4-yl)vinyl)(o-
tolyl)-iodonium trifluoromethanesulfonate 577 
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 319 
((E)-2-((4R,5R,6S)-6-((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)-2,2,5-trimethyl-1,3-dioxan-4-
yl)vinyl)(phenyl)-iodonium trifluoromethanesulfonate 558 
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tert-butyl(((4E,6E)-4-methylocta-4,6-dien-1-yl)oxy)diphenylsilane 584 
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 321 
6-(((4S,5R,6S)-6-((S,E)-3-((4S,6S)-6-(3-((tert-butyldiphenylsilyl)oxy)propyl)-6-methyl-2-oxo-1,3-dioxan-4-yl)but-
1-en-1-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)methyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 591 
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ix Appendix 3 – Chiral HPLC and GC-FID Traces 
viii.1 The Enantioselective and Regiodivergent Copper-Catalysed Arylation of 
Allylic Amides with Diaryliodonium Salts 
viii.1.1 Enamide products and derivatives 
(R)-N-[(1Z)-3-(3-bromophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 332 
 
 
 
  
 
  
N
H
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(R,Z)-N-(3-(3-bromophenyl)-3-(4-chlorophenyl)prop-1-en-1-yl)pivalamide 378 
 
 
 
  
 
 
 
 
 
(S,Z)-N-(3-(3-bromophenyl)-3-(2-fluorophenyl)prop-1-en-1-yl)pivalamide 379 
 
 
 
  
Me3C NH
O
Br
Cl
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(S,Z)-N-(3-(3-bromophenyl)-3-(o-tolyl)prop-1-en-1-yl)pivalamide 380 
 
 
 
  
 
 
 
 
(R)-2,2-dimethyl-N-[(1Z)-3-phenyl-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 383 
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(R)-2,2-dimethyl-N-[(1Z)-3-(2-methylphenyl)-3-phenylprop-1-en-1-yl]propanamide 384 
 
 
 
  
 
 
 
(R)-N-[(1Z)-3-(2-fluorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 385 
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(R)-N-[(1Z)-3-(3,4-dichlorophenyl)-3-phenylprop-1-en-1-yl]-2,2-dimethylpropanamide 389 
 
 
 
  
 
 
 
 
 
 (R)-3-(3,4-dichlorophenyl)-3-phenylpropanal 436 via reduction to (R)-3-(3,4-dichlorophenyl)-3-phenylpropan-1-ol 
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(S)-2,2-dimethyl-N-[(1Z)-3-(naphthalen-2-yl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 396 
 
 
 
  
 
 
 
(S)-N-[(1Z)-3-(4-bromophenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]-2,2-dimethylpropanamide 398 
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(S)-N-[(1Z)-3-(4-bromophenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]-2,2-dimethylpropanamide 399 
 
 
 
  
 
 
 
(S)-2,2-dimethyl-N-[(1Z)-3-(2-methylphenyl)-3-[4-(trifluoromethyl)phenyl]prop-1-en-1-yl]propanamide 403 
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(S,Z)-N-(3-phenyl-3-(p-tolyl)prop-1-en-1-yl)pivalamide 407 
 
 
 
  
 
 
 
viii.1.2 Oxazine products 
(5R,6R)-2-(tert-butyl)-5-phenyl-6-(4-tolyl)-5,6-dihydro-4H-1,3-oxazine 407 
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 330 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(4-methoxyphenyl)-5,6-dihydro-4H-1,3-oxazine 410 
 
 
 
  
 
 
 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(4-bromophenyl)-5,6-dihydro-4H-1,3-oxazine 412 
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 331 
(5S,6S)-6-(benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)-5-(4-methoxyphenyl)-5,6-dihydro-4H-1,3-oxazine 414 
 
 
 
  
 
 
(5S,6S)-2-(tert-butyl)-5-(4-methoxyphenyl)-6-(1-(phenylsulfonyl)-1H-indol-3-yl)-5,6-dihydro-4H-1,3-oxazine 415 
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 332 
(5S,6S)-2-(tert-butyl)-5-(naphthalen-2-yl)-6-phenyl-5,6-dihydro-4H-1,3-oxazine 423 
 
 
  
 
 
 
 
 
(5S,6S)-2-(tert-butyl)-6-phenyl-5-(thiophen-3-yl)-5,6-dihydro-4H-1,3-oxazine 424 
 
 
 
  
 
N
OMe3C
N
OMe3C
S
Appendix 3 – Chiral HPLC and GC-FID Traces 
 333 
(5S,6S)-2-(tert-butyl)-6-(4-methoxyphenyl)-5-(naphthalen-2-yl)-5,6-dihydro-4H-1,3-oxazine 425 
 
 
  
 
 
 
 
(5S,6S)-2-(tert-butyl)-6-(4-methoxyphenyl)-5-(thiophen-3-yl)-5,6-dihydro-4H-1,3-oxazine 426 
 
 
 
  
N
OMe3C
OMe
N
OMe3C
OMe
S
Appendix 3 – Chiral HPLC and GC-FID Traces 
 334 
viii.2 Studies Towards the Total Synthesis of (–)-Lyngbyaloside B 
(3R,4R)-4-methyl-1-(trimethylsilyl)hex-5-en-1-yn-3-ol 511 
 
Racemate (Diasteroisomeric mixture): 
 
 
Enantioenriched (Brown Crotylation – Method 1) – 93% e.e.: 
 
 
Enantioenriched (Roush Crotylation – Method 2) – 75% e.e.: 
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(3R,4R,E)-4-methyl-1-(tributylstannyl)hexa-1,5-dien-3-ol 562 
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x Appendix 4 – Computational Experimental  
i.1 General Comments 
Gaussian 09 version D.011 was used for DFT calculations at the BP862,3 level. All calculations were 
carried out with dichloromethane as solvent with the IEFPCM (SCRF) model.4–7 Calculations employed 
either the quadruple-ξ valence polarised def2-QZVP basis set on Cu and I with the SDD ECP and the 
6-311+G(2d,p) basis set on other atoms or the single-ξ valence polarised def2-SVP basis set on Cu and I 
with the SDD ECP and the 6-31+G(d,p) basis set on other atoms (as stated).8 All thermodynamic data 
were calculated at the standard state (298.15 K and 1 atm). All transition structures contained one 
imaginary frequency. The nature of transition structures was confirmed by vibrational frequency 
calculations or by intrinsic reaction coordinate (IRC) calculations. 
i.2 Calculated Intermediates and Transition States 
i.2.1 Oxidative addition of copper(I) triflate into diphenyliodonium triflate 
Pathway elaborated as below (Scheme 135). 
 
Scheme 135 – Oxidative addition of copper(I) triflate 592 into diphenyliodonium triflate 168 (Gaussian 09 - 
BP86 functional, Def2SVP (SDD) [Cu,I], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Diphenyliodonium triflate (168): 
Energies (Hartree): 
Zero-point correction 0.201118 
Thermal correction to Energy 0.222647 
Thermal correction to Enthalpy 0.223591 
Thermal correction to Gibbs Free Energy 0.144109 
Sum of electronic and zero-point Energies -1435.851272 
Sum of electronic and thermal Energies -1435.829742 
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Sum of electronic and thermal Enthalpies -1435.828798 
Sum of electronic and thermal Free Energies -1435.908280 
E(RB-P86)  -1436.052389 
Structure: 
 
Coordinates: 
 
C -3.902949 -0.491297 0.820392  C 1.036628 1.658914 -0.009944 
F -4.889109 -1.422709 0.765114  C 1.076485 2.192492 1.284977 
F -3.080568 -0.807549 1.856089  C 1.292270 2.413147 -1.162667 
F -4.470766 0.713144 1.084704  C 1.398424 3.555440 1.422319 
S -2.937745 -0.444225 -0.816752  H 0.860803 1.580537 2.164382 
O -2.352307 -1.818836 -0.929472  C 1.609731 3.774281 -0.998169 
O -3.963353 -0.060845 -1.827474  H 1.241543 1.970445 -2.160514 
C 2.607728 -1.149201 0.026278  C 1.664576 4.340975 0.287110 
C 3.448813 -1.242212 -1.094526  H 1.435110 3.996656 2.423139 
C 3.018339 -1.539811 1.311171  H 1.811353 4.385560 -1.883222 
C 4.753689 -1.734668 -0.910426  H 1.911869 5.400507 0.404441 
C 4.326950 -2.030638 1.473623  O -1.889021 0.626128 -0.551533 
C 5.190468 -2.125825 0.367938  H 3.106125 -0.944830 -2.089679 
H 5.424111 -1.813466 -1.771984  H 6.206065 -2.511118 0.501899 
H 4.665006 -2.339211 2.467851  H 2.343812 -1.469196 2.169238 
I 0.574956 -0.437649 -0.244364      
 
Copper(I) triflate (592): 
Energies (Hartree): 
Zero-point correction 0.025739 
Thermal correction to Energy 0.035478 
Thermal correction to Enthalpy 0.036422 
Thermal correction to Gibbs Free Energy -0.012422 
Sum of electronic and zero-point Energies -1157.145744 
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Sum of electronic and thermal Energies -1157.136005 
Sum of electronic and thermal Enthalpies -1157.135061 
Sum of electronic and thermal Free Energies -1157.183905 
E(RB-P86)  -1158.156448 
Structure: 
 
Coordinates: 
 
O 0.610714 0.313327 -1.236083  S -0.187349 0.725456 -0.000033 
C -1.671326 -0.457671 0.000034  O -0.767830 2.087679 0.000317 
F -2.429000 -0.249358 1.100536  O 0.611231 0.313042 1.235644 
F -2.429376 -0.248854 -1.100112  Cu 2.218468 -0.358904 0.000016 
F -1.246398 -1.742393 -0.000333  
    
 
Diphenyliodonium cation (179): 
Energies (Hartree): 
Zero-point correction 0.175197 
Thermal correction to Energy 0.187115 
Thermal correction to Enthalpy 0.188059 
Thermal correction to Gibbs Free Energy 0.134038 
Sum of electronic and zero-point Energies -474.184977 
Sum of electronic and thermal Energies -474.173059 
Sum of electronic and thermal Enthalpies -474.172115 
Sum of electronic and thermal Free Energies -474.226136 
E(RB-P86)  -474.360174 
Structure: 
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Coordinates: 
 
C -1.665489 0.000701 -0.027141  C 3.401114 1.158584 -1.158191 
C -2.303496 0.278468 1.189904  H 1.970788 -0.164218 -2.131689 
C -2.063480 0.536775 -1.259600  C 3.162651 1.414300 1.258465 
C -3.401226 1.158273 1.158325  H 1.548581 0.286781 2.190504 
C -3.162568 1.414612 -1.258241  C 3.825711 1.722906 0.057295 
C -3.825773 1.722852 -0.057055  H 3.919403 1.396292 -2.092015 
H -3.919601 1.395702 2.092172  H 3.496256 1.850650 2.204777 
H -3.496122 1.851174 -2.204474  H 4.681873 2.404001 0.069757 
I -0.000009 -1.375208 -0.000091  H -1.970866 -0.164633 2.131614 
C 1.665563 0.000602 0.027124  H -1.548351 0.287456 -2.190444 
C 2.303459 0.278694 -1.189904  H -4.682000 2.403866 -0.069433 
C 2.063620 0.536390 1.259690  
    
 
Copper(I) triflate anion (178): 
Energies (Hartree): 
Zero-point correction 0.052707 
Thermal correction to Energy 0.071526 
Thermal correction to Enthalpy 0.072471 
Thermal correction to Gibbs Free Energy -0.000653 
Sum of electronic and zero-point Energies -2118.852201 
Sum of electronic and thermal Energies -2118.833382 
Sum of electronic and thermal Enthalpies -2118.832438 
Sum of electronic and thermal Free Energies -2118.905561 
E(RB-P86)  -2118.904908 
Structure: 
 
Coordinates: 
 
O -1.580651 -1.162686 0.407494  O 1.613696 0.134352 -1.203172 
C -3.247010 0.940207 0.397797  S 2.690314 0.874788 -0.374913 
F -4.446838 1.397684 -0.035370  C 3.534622 -0.568445 0.529676 
F -3.222354 1.006705 1.750458  O 2.137881 1.725736 0.714335 
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F -2.275167 1.753533 -0.089360  O 3.742691 1.444021 -1.254710 
S -2.969836 -0.844791 -0.195074  F 4.554340 -0.109833 1.295410 
O -4.032599 -1.642154 0.468434  F 2.645788 -1.206036 1.334322 
O -2.977699 -0.749663 -1.680732  F 4.029935 -1.467140 -0.354974 
Cu -0.001766 -0.451089 -0.384917  
    
 
Copper(I) triflate anion – diphenyliodonium cation adduct (Int-1): 
Energies (Hartree): 
Zero-point correction 0.228549 
Thermal correction to Energy 0.261557 
Thermal correction to Enthalpy 0.262501 
Thermal correction to Gibbs Free Energy 0.152517 
Sum of electronic and zero-point Energies -2593.057248 
Sum of electronic and thermal Energies -2593.024240 
Sum of electronic and thermal Enthalpies -2593.023296 
Sum of electronic and thermal Free Energies -2593.133280 
E(RB-P86)  -2593.285797 
Structure: 
 
Coordinates: 
 
C -4.581902 -0.354296 0.117242  O 0.098435 1.171809 -0.465814 
C -5.364768 -0.678035 -1.001822  Cu 1.456153 -0.174989 -0.431298 
C -5.046300 -0.477436 1.436094  S 0.325693 2.679956 -0.808213 
C -6.669083 -1.155645 -0.778949  C 0.904473 3.358721 0.873670 
C -6.353946 -0.956889 1.633321  O -0.986015 3.329300 -1.062039 
C -7.159675 -1.295095 0.531501  O 1.450527 2.908804 -1.745372 
H -7.297639 -1.415339 -1.636298  F 1.075376 4.697005 0.789652 
H -6.737415 -1.061752 2.652893  F -0.022080 3.093976 1.824510 
I -2.587896 0.420066 -0.202620  F 2.074656 2.787590 1.235771 
C -1.537923 -1.465589 -0.149775  O 2.752096 -1.569198 -0.490532 
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C -1.039841 -1.911929 1.082786  S 3.857089 -1.687421 0.586774 
C -1.423675 -2.195211 -1.341800  O 4.374313 -3.076426 0.678008 
C -0.395045 -3.162500 1.111810  O 3.546149 -0.959666 1.847925 
H -1.136209 -1.313540 1.992127  C 5.264475 -0.695004 -0.216579 
C -0.773288 -3.441554 -1.282846  F 6.368097 -0.732543 0.569207 
H -1.815418 -1.815681 -2.288829  F 5.579687 -1.210887 -1.428796 
C -0.266964 -3.923139 -0.063053  F 4.897416 0.599291 -0.382784 
H 0.011211 -3.530592 2.058689  H -4.419139 -0.208852 2.290269 
H -0.663531 -4.028772 -2.199582  H -8.176569 -1.664882 0.694880 
H 0.240707 -4.891702 -0.030257  H -4.982117 -0.563571 -2.019466 
 
Copper(I) triflate anion – diphenyliodonium cation adduct – TS to oxidative addition 
intermediate (TS-1): 
Energies (Hartree): 
Zero-point correction 0.227643 
Thermal correction to Energy 0.259787 
Thermal correction to Enthalpy 0.260731 
Thermal correction to Gibbs Free Energy 0.155044 
Sum of electronic and zero-point Energies -2593.057820 
Sum of electronic and thermal Energies -2593.025676 
Sum of electronic and thermal Enthalpies -2593.024732 
Sum of electronic and thermal Free Energies -2593.130419 
E(RB-P86)  -2593.285463 
Structure: 
 
Coordinates: 
 
C -4.317769 -0.645290 0.070314  O 0.068286 1.372350 -0.355477 
C -4.854019 -1.285817 -1.058849  Cu 1.080512 -0.478322 -0.355231 
C -4.972085 -0.618899 1.312733  S 0.280766 2.836092 -0.808600 
C -6.088219 -1.945012 -0.921220  C 0.758148 3.672340 0.831477 
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C -6.207193 -1.283515 1.425340  O -1.010040 3.471545 -1.195533 
C -6.760777 -1.943659 0.314531  O 1.456836 3.013146 -1.695259 
H -6.523140 -2.453511 -1.787213  F 0.978153 4.993104 0.627151 
H -6.732943 -1.277923 2.385075  F -0.243820 3.537142 1.736659 
I -2.455736 0.436367 -0.122937  F 1.879291 3.118568 1.344364 
C -1.141573 -1.290397 -0.018542  H -4.540934 -0.101077 2.173967 
C -1.193206 -2.107166 1.123138  H -4.335467 -1.276657 -2.021338 
C -0.410726 -1.630103 -1.193940  H -7.723191 -2.455721 0.409919 
C -0.446765 -3.300499 1.117278  O 3.125284 -0.536114 -1.348400 
H -1.777405 -1.822849 2.001591  S 3.783888 -0.396520 0.010717 
C 0.382623 -2.814087 -1.130421  O 2.689630 -0.413166 1.074184 
H -0.572563 -1.116622 -2.148059  O 4.838415 0.634022 0.158776 
C 0.345616 -3.642476 0.006496  C 4.695467 -2.041496 0.274019 
H -0.474120 -3.948325 1.998270  F 5.265687 -2.066703 1.502123 
H 0.960434 -3.105901 -2.012173  F 3.840283 -3.087397 0.174257 
H 0.939663 -4.560348 0.023092  F 5.667069 -2.188955 -0.657896 
 
Oxidative addition intermediate (Int-2): 
Energies (Hartree): 
Zero-point correction 0.227585 
Thermal correction to Energy 0.260600 
Thermal correction to Enthalpy 0.261544 
Thermal correction to Gibbs Free Energy 0.153295 
Sum of electronic and zero-point Energies -2593.060615 
Sum of electronic and thermal Energies -2593.027600 
Sum of electronic and thermal Enthalpies -2593.026656 
Sum of electronic and thermal Free Energies -2593.134905 
E(RB-P86)  -2593.288200 
Structure: 
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Coordinates: 
 
C -4.170792 -0.474433 0.146519  O 0.247153 1.523785 -0.103528 
C -4.826266 -0.811286 -1.049862  Cu 0.858143 -0.443720 -0.432971 
C -4.718379 -0.741595 1.412724  S 0.436935 2.913426 -0.759349 
C -6.068977 -1.463643 -0.964720  C 1.285768 3.861190 0.652465 
C -5.962111 -1.395463 1.473057  O -0.872752 3.597578 -0.951001 
C -6.633352 -1.754049 0.290490  O 1.408482 2.916250 -1.880685 
H -6.594682 -1.737409 -1.884637  F 1.518332 5.139953 0.270770 
H -6.404650 -1.616166 2.449281  F 0.493825 3.875747 1.752377 
I -2.309005 0.605328 0.035159  F 2.463292 3.280908 0.972135 
C -0.994217 -1.184957 -0.050476  H -4.197239 -0.454934 2.330280 
C -0.899593 -1.956918 1.140389  H -4.389751 -0.577278 -2.024640 
C -0.700717 -1.745481 -1.334206  H -7.603100 -2.257984 0.347155 
C -0.489181 -3.292088 1.036141  O 2.781561 -0.628957 -1.154482 
H -1.127404 -1.516430 2.114274  S 3.558753 -0.675682 0.168639 
C -0.294358 -3.104182 -1.391481  O 2.577852 -0.643970 1.311931 
H -0.910269 -1.195792 -2.257486  O 4.748824 0.204488 0.240732 
C -0.206286 -3.868625 -0.222187  C 4.272505 -2.435866 0.184622 
H -0.391833 -3.888226 1.948494  F 4.942271 -2.651318 1.342215 
H -0.076583 -3.547243 -2.367798  F 3.283561 -3.356344 0.082080 
H 0.089274 -4.919965 -0.281447  F 5.129064 -2.606278 -0.850019 
 
Oxidative addition transition state (TS-2): 
Energies (Hartree): 
Zero-point correction 0.227389 
Thermal correction to Energy 0.259620 
Thermal correction to Enthalpy 0.260564 
Thermal correction to Gibbs Free Energy 0.155980 
Sum of electronic and zero-point Energies -2593.050441 
Sum of electronic and thermal Energies -2593.018210 
Sum of electronic and thermal Enthalpies -2593.017266 
Sum of electronic and thermal Free Energies -2593.121850 
E(RB-P86)  -2593.277830 
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Structure: 
 
Coordinates: 
 
C -3.454037 -0.997129 -0.748213  O 1.500781 -1.323266 -0.732228 
C -4.297502 -1.78987 0.048668  Cu 0.393698 0.317978 0.056805 
C -3.924235 0.070664 -1.532168  S 2.515351 -2.410501 -0.347386 
C -5.668325 -1.481096 0.066066  C 4.116356 -1.398018 -0.189045 
C -5.300295 0.357642 -1.498477  O 2.768964 -3.366398 -1.457457 
C -6.166539 -0.412751 -0.702639  O 2.291134 -2.982408 1.012922 
H -6.344315 -2.083188 0.68076  F 5.146617 -2.215281 0.138505 
H -5.688688 1.185331 -2.099581  F 4.40632 -0.782393 -1.358857 
I -1.37364 -1.498664 -0.863834  F 3.989304 -0.456178 0.776823 
C -0.838852 -0.482296 1.396001  H -3.246947 0.662091 -2.153905 
C -1.773807 0.499015 1.763215  H -3.907171 -2.619921 0.643265 
C -0.19246 -1.337329 2.30214  H -7.236172 -0.182695 -0.684135 
C -1.966888 0.717436 3.141353  O 1.292604 2.079915 1.081768 
H -2.32214 1.095196 1.028302  S 1.521937 2.758724 -0.25995 
C -0.410387 -1.090185 3.670859  O 1.016033 1.798928 -1.338046 
H 0.496449 -2.122283 1.971622  O 2.834397 3.397642 -0.494567 
C -1.292831 -0.07538 4.085707  C 0.26802 4.18624 -0.294686 
H -2.654751 1.50667 3.460227  F 0.306618 4.805891 -1.495524 
H 0.112359 -1.709764 4.406372  F -0.98612 3.717907 -0.08701 
H -1.468947 0.086486 5.1535  F 0.562683 5.08354 0.672173 
 
Copper(III)-Ph-IPh-Κ2OTf-ApicalOTf (Int-3): 
Energies (Hartree): 
Zero-point correction 0.227238 
Thermal correction to Energy 0.260289 
Thermal correction to Enthalpy 0.261233 
Thermal correction to Gibbs Free Energy 0.153098 
Sum of electronic and zero-point Energies -2593.051908 
Sum of electronic and thermal Energies -2593.018857 
Sum of electronic and thermal Enthalpies -2593.017913 
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Sum of electronic and thermal Free Energies -2593.126049 
E(RB-P86)  -2593.279147 
Structure: 
 
Coordinates: 
 
C -3.171476 -1.135532 -0.984623  O 1.744581 -1.012524 -0.649940 
C -3.988618 -2.050072 -0.296611  Cu 0.212361 0.255770 0.193493 
C -3.684761 0.002339 -1.632862  S 2.990758 -1.867895 -0.404697 
C -5.370433 -1.798306 -0.249114  C 4.364993 -0.555439 -0.410829 
C -5.069250 0.234198 -1.568659  O 3.308756 -2.760913 -1.550864 
C -5.907915 -0.661486 -0.880267  O 3.043751 -2.464966 0.963032 
H -6.023725 -2.497038 0.282212  F 5.570340 -1.143050 -0.211801 
H -5.487645 1.115690 -2.063899  F 4.392925 0.095136 -1.598139 
I -1.080136 -1.547543 -1.148829  F 4.160548 0.352066 0.574767 
C -0.605243 -0.746036 1.667688  H -3.030477 0.690231 -2.174733 
C -1.821483 -0.243948 2.127681  H -3.567517 -2.931301 0.194487 
C 0.225976 -1.618530 2.363019  H -6.985262 -0.474452 -0.838159 
C -2.166944 -0.553722 3.461680  O 0.739365 1.975297 1.281071 
H -2.479340 0.384480 1.519887  S 0.917545 2.821603 0.011264 
C -0.151879 -1.911309 3.694216  O 0.658397 1.867656 -1.151637 
H 1.147880 -2.034761 1.938964  O 2.105093 3.692698 -0.055853 
C -1.337669 -1.385322 4.233150  C -0.573819 4.004506 0.017456 
H -3.093181 -0.141003 3.874500  F -0.580628 4.725302 -1.123467 
H 0.495142 -2.564704 4.288606  F -1.728026 3.305062 0.103155 
H -1.629697 -1.642822 5.256216  F -0.486123 4.840236 1.072756 
 
Copper(III)-Ph-Κ2OTf-OTf (Int-4): 
Energies (Hartree): 
Zero-point correction 0.139342 
Thermal correction to Energy 0.163975 
Thermal correction to Enthalpy 0.164919 
Thermal correction to Gibbs Free Energy 0.078570 
Sum of electronic and zero-point Energies -2350.184093 
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Sum of electronic and thermal Energies -2350.159460 
Sum of electronic and thermal Enthalpies -2350.158516 
Sum of electronic and thermal Free Energies -2350.244864 
E(RB-P86)  -2350.323435 
Structure: 
 
Coordinates: 
 
O -1.235468 -1.619700 -0.179275  F -4.813364 -0.141593 0.222664 
C 0.287403 2.162210 0.042614  F -4.173855 -2.165787 0.806370 
C 0.415346 2.779861 -1.191027  F -3.267775 -0.405715 1.765386 
C 0.362924 2.749939 1.294964  S -2.434300 -0.873790 -0.746400 
C 0.591720 4.185218 -1.145453  O -3.085591 -1.372274 -1.966260 
H 0.370081 2.254404 -2.148043  O -1.958382 0.613698 -0.790581 
C 0.530630 4.156626 1.293604  O 1.458365 -0.142382 0.824152 
H 0.308194 2.193271 2.233827  S 2.724423 -0.343118 -0.105708 
C 0.645747 4.859681 0.084228  O 3.903938 0.350269 0.452479 
H 0.680594 4.726037 -2.093441  O 2.370987 -0.194751 -1.538943 
H 0.584152 4.674075 2.257070  F 3.234568 -2.440389 1.498463 
H 0.792663 5.944141 0.100277  C 3.035331 -2.201678 0.185626 
Cu -0.187773 0.263886 -0.004212  F 4.135307 -2.571971 -0.504590 
C -3.770925 -0.895856 0.616362  F 1.979327 -2.922210 -0.242949 
 
Iodobenzene: 
Energies (Hartree): 
Zero-point correction 0.087425 
Thermal correction to Energy 0.093474 
Thermal correction to Enthalpy 0.094418 
Thermal correction to Gibbs Free Energy 0.055527 
Sum of electronic and zero-point Energies -242.863274 
Sum of electronic and thermal Energies -242.857224 
Sum of electronic and thermal Enthalpies -242.856280 
Sum of electronic and thermal Free Energies -242.895172 
E(RB-P86)  -242.950698 
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Structure: 
 
Coordinates: 
 
I -1.570945 0.000000 -0.000144  C 2.670832 -1.216353 0.000305 
C 0.578320 -0.000039 0.000057  H 0.718087 -2.174079 0.000180 
C 1.263070 1.226055 0.000052  C 3.375829 0.000024 0.000304 
C 1.263109 -1.226080 0.000181  H 3.211008 2.168848 0.000184 
C 2.670768 1.216391 0.000185  H 3.211070 -2.168812 0.000401 
H 0.717957 2.174001 -0.000043  H 4.470393 0.000071 0.000401 
i.2.2 Styrene functionalisation towards stilbene 
Pathway elaborated as below (Scheme 138). 
 
Scheme 138 – Association of styrene 35 to key κ2-bound copper(III) species Int-4 and reaction towards trans-
stilbene production (Gaussian 09 - BP86 functional, Def2QZVP (SDD) [Cu], 6-311G+(2d,p) [C,H,O,F,S,N]); 
energies given as ΔG (kcal mol-1) 
Copper(III)-Ph-Κ2OTf-OTf (Int-5): 
Energies (Hartree): 
Zero-point correction 0.139508 
Thermal correction to Energy 0.163932 
Thermal correction to Enthalpy 0.164876 
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Thermal correction to Gibbs Free Energy 0.079374 
Sum of electronic and zero-point Energies -2351.442866 
Sum of electronic and thermal Energies -2351.418443 
Sum of electronic and thermal Enthalpies -2351.417499 
Sum of electronic and thermal Free Energies -2351.503000 
E(RB-P86)  -2351.582374 
Structure: 
 
Coordinates: 
 
O -1.120879 -1.698428 -0.265292  F -4.674137 -0.315938 0.297984 
C 0.128937 2.169158 0.034240  F -3.939456 -2.294547 0.891730 
C 0.339372 2.800317 -1.172389  F -3.026324 -0.487570 1.735178 
C 0.038557 2.752236 1.279420  S -2.337927 -0.998759 -0.786523 
C 0.419253 4.207616 -1.112434  O -3.027853 -1.515992 -1.952440 
H 0.428552 2.279225 -2.126049  O -1.926806 0.487875 -0.871439 
C 0.115444 4.160325 1.296232  O 1.443737 -0.049899 0.809215 
H -0.083601 2.190745 2.206327  S 2.697762 -0.239496 -0.109954 
C 0.306838 4.873103 0.110291  O 3.840367 0.492027 0.422606 
H 0.571235 4.757217 -2.044297  O 2.341175 -0.139971 -1.526696 
H 0.036488 4.672788 2.257764  F 3.266223 -2.268245 1.542303 
H 0.379528 5.962394 0.140637  C 3.073196 -2.070429 0.226709 
Cu -0.184734 0.265292 -0.045519  F 4.191499 -2.409458 -0.440629 
C -3.588713 -1.024993 0.639225  F 2.056918 -2.841204 -0.193910 
 
Styrene (35): 
Energies (Hartree): 
Zero-point correction 0.128916 
Thermal correction to Energy 0.135878 
Thermal correction to Enthalpy 0.136822 
Thermal correction to Gibbs Free Energy 0.097514 
Sum of electronic and zero-point Energies -309.598053 
Sum of electronic and thermal Energies -309.591091 
Sum of electronic and thermal Enthalpies -309.590147 
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Sum of electronic and thermal Free Energies -309.629455 
E(RB-P86)  -309.726969 
Structure: 
 
Coordinates: 
 
C -2.270205 0.263992 -0.000003  H -0.034149 -2.314717 -0.000005 
C -1.786044 -1.048656 -0.000005  H 0.700105 1.943998 0.000011 
C -0.407950 -1.286508 -0.000005  H -1.733282 2.362686 -0.000004 
C 0.517805 -0.222176 0.000010  C 1.957332 -0.533089 0.000009 
C 0.011464 1.095703 0.000007  C 2.982662 0.337287 -0.000014 
C -1.363179 1.334380 0.000004  H 2.190701 -1.604798 0.000043 
H -3.345909 0.454935 -0.000007  H 4.014856 -0.017927 -0.000008 
H -2.482600 -1.890653 -0.000014  H 2.838967 1.420879 -0.000036 
 
Copper(III)-styrene-Ph-Κ2OTf-apicalOTf – towards stilbene (Int-5): 
Energies (Hartree): 
Zero-point correction 0.270786 
Thermal correction to Energy 0.303617 
Thermal correction to Enthalpy 0.304561 
Thermal correction to Gibbs Free Energy 0.200194 
Sum of electronic and zero-point Energies -2661.051018 
Sum of electronic and thermal Energies -2661.018187 
Sum of electronic and thermal Enthalpies -2661.017243 
Sum of electronic and thermal Free Energies -2661.121610 
E(RB-P86)  -2661.321803 
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Structure: 
 
Coordinates: 
 
C 0.725433 2.224536 -1.040272  H -0.212214 -2.676355 -1.315497 
C -0.197230 3.165312 -1.476413  C -3.452657 -3.685596 -1.659088 
C 2.087862 2.452902 -0.918433  H -5.109929 -2.455652 -2.324484 
C 0.281319 4.467669 -1.706767  H -1.635447 -4.680777 -1.021831 
H -1.258926 2.947874 -1.599380  O -1.285822 -0.668901 0.894429 
C 2.537302 3.764064 -1.157450  S -1.527985 0.398390 1.928884 
H 2.783055 1.667503 -0.622463  O -0.684862 1.583887 1.525325 
C 1.639229 4.760842 -1.550275  O -1.503749 0.004565 3.330079 
H -0.427216 5.241504 -2.011256  C -3.306767 0.966370 1.611336 
H 3.600990 3.983834 -1.039602  F -4.156584 -0.054983 1.826080 
H 2.002517 5.771284 -1.749809  F -3.617574 1.979948 2.440125 
Cu 0.029736 0.612898 -0.243867  F -3.444679 1.387855 0.336467 
C 0.315133 -0.091567 -2.151594  H -4.071784 -4.575246 -1.523572 
C -1.082457 -0.234356 -2.264228  H 0.951326 -0.939972 -1.868856 
H 0.782081 0.672921 -2.774918  O 1.784252 -0.230305 0.762857 
C -1.857539 -1.408900 -2.007156  S 2.367430 -1.614288 0.675529 
H -1.638689 0.621666 -2.663588  O 2.016307 -2.334239 -0.568120 
C -3.253091 -1.361772 -2.280227  O 2.295426 -2.380980 1.924663 
C -1.278713 -2.625702 -1.546066  C 4.207504 -1.230321 0.469681 
C -4.040515 -2.492576 -2.110331  F 4.916516 -2.373687 0.340867 
H -3.695508 -0.427061 -2.632968  F 4.417557 -0.476083 -0.638235 
C -2.076310 -3.747851 -1.377162  F 4.681746 -0.552130 1.537207 
 
Copper(III)-styrene-Ph-Κ2OTf-apicalOTf – TS – towards stilbene (TS-3): 
Energies (Hartree): 
Zero-point correction 0.270736 
Thermal correction to Energy 0.302747 
Thermal correction to Enthalpy 0.303691 
Thermal correction to Gibbs Free Energy 0.202851 
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Sum of electronic and zero-point Energies -2661.050188 
Sum of electronic and thermal Energies -2661.018178 
Sum of electronic and thermal Enthalpies -2661.017234 
Sum of electronic and thermal Free Energies -2661.118073 
E(RB-P86)  -2661.320924 
Structure: 
 
Coordinates: 
 
C 0.649991 2.026403 -1.335466  H 0.241651 -2.684758 -1.425903 
C -0.299992 2.960416 -1.742521  C -2.835095 -4.159124 -1.449629 
C 2.003998 2.308366 -1.187812  H -4.717213 -3.180652 -1.89945 
C 0.123133 4.291558 -1.880339  H -0.83305 -4.87905 -1.035579 
H -1.346611 2.703695 -1.912666  O -1.393799 -0.57295 0.875637 
C 2.400013 3.646414 -1.339533  S -1.658325 0.533705 1.873937 
H 2.72616 1.53911 -0.917981  O -0.836355 1.712964 1.458479 
C 1.466032 4.629529 -1.683522  O -1.663918 0.155313 3.281913 
H -0.610129 5.053703 -2.153008  C -3.442133 1.044222 1.503061 
H 3.450897 3.904575 -1.190562  F -4.283033 0.029175 1.780852 
H 1.790061 5.664087 -1.81433  F -3.781394 2.111047 2.252447 
Cu -0.059822 0.530463 -0.325107  F -3.574405 1.371416 0.198889 
C 0.286514 -0.023465 -2.305468  H -3.298618 -5.131945 -1.271143 
C -1.083969 -0.386916 -2.222014  H 1.075737 -0.749528 -2.073276 
H 0.53974 0.705223 -3.077095  O 1.678552 -0.131594 0.772385 
C -1.63674 -1.668644 -1.908873  S 2.393174 -1.452091 0.655358 
H -1.808412 0.367511 -2.550475  O 2.325529 -2.043074 -0.699115 
C -3.046265 -1.82601 -2.0274  O 2.179509 -2.361974 1.786267 
C -0.839207 -2.789594 -1.543277  C 4.198137 -0.913699 0.822905 
C -3.636653 -3.06222 -1.803863  F 5.013726 -1.988872 0.756478 
H -3.656591 -0.963352 -2.3042  F 4.540443 -0.062503 -0.176733 
C -1.441975 -4.018691 -1.318248  F 4.408304 -0.289002 2.000564 
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Copper-OTf2-stilbenium adduct (Int-6): 
Energies (Hartree): 
Zero-point correction 0.273378 
Thermal correction to Energy 0.305598 
Thermal correction to Enthalpy 0.306543 
Thermal correction to Gibbs Free Energy 0.203930 
Sum of electronic and zero-point Energies -2661.100062 
Sum of electronic and thermal Energies -2661.067841 
Sum of electronic and thermal Enthalpies -2661.066897 
Sum of electronic and thermal Free Energies -2661.169509 
E(RB-P86)  -2661.373439 
Structure: 
 
Coordinates: 
 
O -1.139408 0.800617 -0.749370  O 2.411074 -3.041299 -0.256889 
C 0.451468 0.011096 2.868063  O 2.008197 -0.546703 -0.326835 
C 1.366615 -1.039999 3.121640  F 0.786903 -3.201312 -2.832634 
C -0.933436 -0.295503 2.718611  C 1.348228 -2.027222 -2.476012 
C 0.907333 -2.343905 3.271761  F 2.571038 -1.943067 -3.042910 
H 2.429552 -0.814037 3.228007  F 0.585855 -1.021306 -2.941586 
C -1.375865 -1.622503 2.863001  C 0.911539 1.476039 2.866618 
H -1.662436 0.509677 2.591757  C 0.629954 1.990888 1.481844 
C -0.462579 -2.636532 3.143496  C 1.615331 2.415266 0.540422 
H 1.616825 -3.144112 3.490552  H -0.393943 2.343953 1.305067 
H -2.439199 -1.847097 2.766971  C 1.180254 3.100680 -0.635558 
H -0.809722 -3.664849 3.261922  C 3.014330 2.232568 0.748746 
Cu 0.100706 0.051040 0.680541  C 2.103648 3.611891 -1.534138 
C -3.669785 -0.049719 -0.838843  H 0.110874 3.222081 -0.814194 
F -4.953821 0.348504 -0.704063  C 3.927580 2.741544 -0.161188 
F -3.500643 -0.547345 -2.080341  H 3.373143 1.696846 1.627594 
F -3.431223 -1.033595 0.055432  C 3.477387 3.432458 -1.300308 
S -2.511458 1.417050 -0.545525  H 1.764626 4.146301 -2.423032 
O -2.850860 2.366228 -1.609843  H 4.997384 2.604731 0.005122 
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O -2.766610 1.826463 0.847341  H 4.204044 3.829501 -2.012592 
O 0.101927 -2.030200 -0.084122  H 1.974056 1.532782 3.129403 
S 1.510474 -1.939059 -0.593007  H 0.340508 2.056158 3.608003 
 
Pyridine: 
Energies (Hartree): 
Zero-point correction 0.085831 
Thermal correction to Energy 0.090249 
Thermal correction to Enthalpy 0.091193 
Thermal correction to Gibbs Free Energy 0.058348 
Sum of electronic and zero-point Energies -248.270502 
Sum of electronic and thermal Energies -248.266084 
Sum of electronic and thermal Enthalpies -248.265139 
Sum of electronic and thermal Free Energies -248.297985 
E(RB-P86)  -248.356332 
Structure: 
 
Coordinates: 
 
C 1.201554 0.674943 0.000000  H -0.000283 2.481559 0.000001 
C -0.000192 1.389116 -0.000017  H -2.165819 1.187449 0.000037 
C -1.201720 0.674672 0.000008  H -2.072774 -1.310927 0.000037 
C -1.148797 -0.723058 -0.000003  H 2.073089 -1.310440 0.000026 
C 1.149007 -0.722746 0.000018  N 0.000169 -1.427605 -0.000021 
H 2.165487 1.188035 0.000005  
    
 
Copper-OTf2-stilbenium adduct – TS – elimination with pyridine (TS-4): 
Energies (Hartree): 
Zero-point correction 0.356687 
Thermal correction to Energy 0.394838 
Thermal correction to Enthalpy 0.395782 
Thermal correction to Gibbs Free Energy 0.275201 
Sum of electronic and zero-point Energies -2909.372429 
Sum of electronic and thermal Energies -2909.334277 
Sum of electronic and thermal Enthalpies -2909.333333 
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Sum of electronic and thermal Free Energies -2909.453914 
E(RB-P86)  -2909.729116 
Structure: 
 
Coordinates: 
 
O 1.654614 1.261802 0.641712  C -1.860623 -0.749190 -0.110442 
C -1.365947 -0.387815 -1.509837  C -1.286265 0.014714 0.977449 
C -1.313540 -1.393094 -2.500617  C -1.090305 -0.455491 2.319884 
C -1.009681 0.937471 -1.865979  H -1.245903 1.107093 0.868041 
C -0.920074 -1.088638 -3.802345  C -0.865191 0.507752 3.342031 
H -1.579094 -2.419460 -2.236094  C -1.131798 -1.831901 2.671256 
C -0.601923 1.227290 -3.181032  C -0.719167 0.112903 4.666226 
H -1.115695 1.761989 -1.156229  H -0.819839 1.565182 3.071643 
C -0.558337 0.222864 -4.146582  C -0.982002 -2.217881 3.996939 
H -0.887093 -1.880505 -4.553880  H -1.264006 -2.590488 1.899019 
H -0.332622 2.252504 -3.441558  C -0.777692 -1.249800 4.995089 
H -0.242602 0.454741 -5.165858  H -0.553352 0.858674 5.445659 
Cu 0.555372 -0.086575 -0.324096  H -1.011544 -3.276083 4.263221 
C 2.297047 3.586949 -0.508281  H -0.654508 -1.562883 6.034332 
F 2.153360 4.926352 -0.397382  H -1.830385 -1.836129 0.048149 
F 3.611426 3.289696 -0.459037  H -3.057765 -0.503336 -0.100960 
F 1.814494 3.204886 -1.710750  N -4.643355 -0.293143 -0.256185 
S 1.367695 2.729360 0.899846  C -5.188845 0.857688 0.173205 
O 2.031954 3.214577 2.112491  C -5.428799 -1.244749 -0.790409 
O -0.045005 3.099912 0.695912  C -6.559651 1.104067 0.081463 
O 2.226436 -1.039141 -1.616457  H -4.502442 1.595122 0.598094 
S 2.049439 -2.341185 -0.909297  C -6.808395 -1.075990 -0.917843 
O 1.952566 -3.549373 -1.731217  H -4.931439 -2.159852 -1.121300 
O 0.999631 -2.181035 0.158598  C -7.381933 0.119323 -0.474097 
F 4.703676 -2.633775 -0.768834  H -6.967825 2.050274 0.439695 
C 3.648907 -2.574562 0.072361  H -7.415135 -1.869253 -1.357004 
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F 3.595245 -3.727672 0.775164  H -8.458188 0.281840 -0.560298 
F 3.839213 -1.555372 0.933025      
 
Pyridium ion: 
Energies (Hartree): 
Zero-point correction 0.100056 
Thermal correction to Energy 0.104552 
Thermal correction to Enthalpy 0.105496 
Thermal correction to Gibbs Free Energy 0.072495 
Sum of electronic and zero-point Energies -248.693424 
Sum of electronic and thermal Energies -248.688928 
Sum of electronic and thermal Enthalpies -248.687984 
Sum of electronic and thermal Free Energies -248.720985 
E(RB-P86)  -248.793480 
Structure: 
 
Coordinates: 
 
C -0.718309 1.211580 -0.000001  H -2.509828 0.000036 0.000011 
C -1.418808 0.000017 0.000006  H -1.236387 -2.169796 0.000013 
C -0.718344 -1.211560 0.000008  H 1.291825 -2.082381 0.000001 
C 0.667833 -1.190574 0.000001  H 1.291886 2.082345 -0.000012 
C 0.667863 1.190560 -0.000007  N 1.311696 -0.000019 -0.000006 
H -1.236334 2.169826 -0.000001  H 2.335553 -0.000031 -0.000013 
 
Copper-(I)-OTf2-anion-stilbene adduct (Int-7): 
Energies (Hartree): 
Zero-point correction 0.261709 
Thermal correction to Energy 0.293747 
Thermal correction to Enthalpy 0.294691 
Thermal correction to Gibbs Free Energy 0.190259 
Sum of electronic and zero-point Energies -2660.717101 
Sum of electronic and thermal Energies -2660.685063 
Sum of electronic and thermal Enthalpies -2660.684119 
Sum of electronic and thermal Free Energies -2660.788551 
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E(RB-P86)  -2660.978810 
Structure: 
 
Coordinates: 
 
O -0.053282 -0.367751 -1.654447  O 3.065022 -2.085384 2.343818 
C -1.910623 0.605153 2.420796  O 1.387378 -0.568311 1.347754 
C -1.682441 0.430518 3.802203  F 4.866323 -1.396586 -0.041641 
C -3.000035 -0.074505 1.830738  C 3.815217 -0.602123 0.270602 
C -2.520658 -0.378349 4.573657  F 4.257597 0.373514 1.100392 
H -0.837944 0.942580 4.271628  F 3.375687 -0.016852 -0.866819 
C -3.834942 -0.881477 2.603822  C -1.014971 1.503320 1.666351 
H -3.185826 0.013622 0.757417  C -1.266852 2.013086 0.387965 
C -3.602923 -1.036578 3.978458  C -0.546476 3.133965 -0.246639 
H -2.326046 -0.496669 5.642330  H -2.190440 1.718564 -0.120445 
H -4.670740 -1.401603 2.129488  C -1.061791 3.669604 -1.446324 
H -4.258699 -1.672156 4.578046  C 0.622996 3.713332 0.293516 
Cu -0.063887 0.338535 0.243718  C -0.443174 4.751918 -2.076814 
C -1.425040 -2.582778 -2.177450  H -1.961174 3.226770 -1.882450 
F -2.513495 -3.068651 -2.822455  C 1.239722 4.793574 -0.337788 
F -0.330811 -3.202598 -2.668588  H 1.059550 3.319035 1.214162 
F -1.539699 -2.892166 -0.866228  C 0.710985 5.319898 -1.525387 
S -1.310083 -0.711064 -2.420506  H -0.862436 5.150377 -3.003793 
O -1.149492 -0.546037 -3.871064  H 2.143050 5.227999 0.097300 
O -2.551109 -0.198962 -1.812848  H 1.198698 6.164862 -2.016882 
O 2.086380 -2.630660 0.095760  H -0.216155 1.956332 2.263747 
S 2.445541 -1.615915 1.094985  
    
 
Stilbene (37): 
Energies (Hartree): 
Zero-point correction 0.207552 
Thermal correction to Energy 0.219237 
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Thermal correction to Enthalpy 0.220181 
Thermal correction to Gibbs Free Energy 0.167767 
Sum of electronic and zero-point Energies -540.637849 
Sum of electronic and thermal Energies -540.626165 
Sum of electronic and thermal Enthalpies -540.625220 
Sum of electronic and thermal Free Energies -540.677635 
E(RB-P86)  -540.845401 
Structure: 
 
Coordinates: 
 
C -4.747643 0.204452 0.000000  C 0.500221 0.457237 0.000000 
C -4.218355 -1.091167 0.000000  H 0.242121 1.522654 0.000000 
C -2.834213 -1.282778 0.000000  C 1.940516 0.187930 0.000000 
C -1.940516 -0.187930 0.000000  C 2.494713 -1.113371 0.000000 
C -2.494713 1.113371 0.000000  C 3.876212 -1.304254 0.000000 
C -3.876212 1.304254 0.000000  C 4.747643 -0.204452 0.000000 
H -5.829124 0.359204 0.000000  C 4.218355 1.091167 0.000000 
H -4.885764 -1.956563 0.000000  C 2.834213 1.282778 0.000000 
H -2.427645 -2.298402 0.000000  H 1.838824 -1.987102 0.000001 
H -1.838824 1.987102 0.000001  H 4.280257 -2.319786 0.000000 
H -4.280257 2.319786 0.000000  H 5.829124 -0.359204 0.000000 
C -0.500221 -0.457237 0.000000  H 4.885764 1.956563 0.000000 
H -0.242121 -1.522654 0.000000  H 2.427645 2.298402 0.000000 
 
Copper(I) triflate anion (178): 
Energies (Hartree): 
Zero-point correction 0.207552 
Thermal correction to Energy 0.219237 
Thermal correction to Enthalpy 0.220181 
Thermal correction to Gibbs Free Energy 0.167767 
Sum of electronic and zero-point Energies -540.637849 
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Sum of electronic and thermal Energies -540.626165 
Sum of electronic and thermal Enthalpies -540.625220 
Sum of electronic and thermal Free Energies -540.677635 
E(RB-P86)  -540.845401 
Structure: 
 
Coordinates: 
 
O -1.631481 -1.035154 0.609335  O 1.682664 -0.468813 -1.093487 
C -3.328998 0.995927 0.333237  S 2.612861 0.653632 -0.630711 
F -4.476060 1.392668 -0.262165  C 3.651078 -0.224044 0.685532 
F -3.478333 1.114180 1.670179  O 1.930358 1.731549 0.095791 
F -2.334876 1.820935 -0.061878  O 3.573674 1.007975 -1.678543 
S -2.940057 -0.792968 -0.145037  F 4.563109 0.631969 1.197798 
O -4.036419 -1.575726 0.431458  F 2.869013 -0.668097 1.695387 
O -2.787123 -0.761513 -1.605338  F 4.305784 -1.280129 0.156455 
Cu 0.014191 -0.713524 -0.252978  
    
 
Stilbenium cation (601): 
Energies (Hartree): 
Zero-point correction 0.219575 
Thermal correction to Energy 0.231406 
Thermal correction to Enthalpy 0.232350 
Thermal correction to Gibbs Free Energy 0.180294 
Sum of electronic and zero-point Energies -541.015593 
Sum of electronic and thermal Energies -541.003762 
Sum of electronic and thermal Enthalpies -541.002818 
Sum of electronic and thermal Free Energies -541.054874 
E(RB-P86)  -541.235168 
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Structure: 
 
 
Coordinates: 
 
C 1.728979 -0.390503 0.560687  H -0.080580 -1.938190 -0.599523 
C 1.667915 1.012234 0.462999  C -2.294122 -0.750309 -1.166635 
C 2.792373 -1.088183 -0.042685  C -2.099147 0.319600 1.047783 
C 2.694755 1.713203 -0.172223  C -3.511497 -0.119334 -1.362877 
H 0.828907 1.556975 0.902638  H -1.878434 -1.410557 -1.930819 
C 3.812391 -0.382829 -0.681819  C -3.315899 0.944907 0.837649 
H 2.834051 -2.178506 0.017692  H -1.560213 0.480850 1.982161 
C 3.765445 1.017380 -0.747772  C -4.019773 0.727566 -0.362996 
H 2.655970 2.803060 -0.223906  H -4.072836 -0.275710 -2.284961 
H 4.649843 -0.924671 -1.125990  H -3.734108 1.602766 1.600777 
H 4.562850 1.565786 -1.253757  H -4.979497 1.225647 -0.517798 
C 0.618679 -1.156187 1.307739  H 0.267085 -0.611235 2.190545 
C -0.359500 -1.258873 0.214469  H 0.987922 -2.147928 1.604748 
C -1.560759 -0.546720 0.045380  
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i.2.3 Styrene functionalisation towards 1,1-diphenylethylene 
Pathway elaborated as below (Scheme 140). 
 
Scheme 140 – Association of styrene 35 to key κ2-bound copper(III) species Int-4 and reactions towards 1,1-
diphenylethylene production (Gaussian 09 - BP86 functional, Def2QZVP (SDD) [Cu], 6-311G+(2d,p) 
[C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Copper(III)-Ph-Κ2OTf-OTf (Int-4): 
See section 1.2.2 
Styrene (35): 
See section 1.2.2 
Copper(III)-styrene-Ph-OTf2 – towards 1,1-diphenylethylene (Int-8): 
Energies (Hartree): 
Zero-point correction 0.270827 
Thermal correction to Energy 0.303587 
Thermal correction to Enthalpy 0.304531 
Thermal correction to Gibbs Free Energy 0.198982 
Sum of electronic and zero-point Energies -2661.049935 
Sum of electronic and thermal Energies -2661.017175 
Sum of electronic and thermal Enthalpies -2661.016231 
Sum of electronic and thermal Free Energies -2661.121780 
E(RB-P86)  -2661.320762 
 
 
 
 
 
 
0.0
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Structure: 
 
Coordinates: 
 
C -0.112144 -1.992931 0.175057  H 3.557589 0.745293 -1.327252 
C 0.428268 -2.076122 1.451180  C 6.118102 -0.763859 0.338100 
C -0.809568 -3.010039 -0.454805  H 6.186721 -2.835200 0.974590 
C 0.178764 -3.256862 2.174634  H 5.792186 1.247130 -0.403393 
H 1.006723 -1.264019 1.896945  O 0.444557 1.737998 -1.070111 
C -1.036853 -4.182343 0.288388  S 1.185925 2.322190 0.122749 
H -1.216010 -2.905462 -1.461602  C 0.016785 3.669451 0.760777 
C -0.542168 -4.302859 1.591197  O 2.401448 3.052410 -0.244637 
H 0.568185 -3.343318 3.191794  O 1.271559 1.322367 1.211278 
H -1.609439 -4.993255 -0.168025  F 0.636364 4.360402 1.742988 
H -0.713692 -5.223160 2.153914  F -0.294945 4.522071 -0.236648 
Cu 0.017962 -0.215063 -0.563351  F -1.114294 3.140195 1.254244 
C 1.389904 -0.922203 -1.923719  O -1.777896 0.281940 0.161596 
C 2.310637 -1.728385 -1.229215  S -2.960646 0.203429 -0.805778 
H 0.651293 -1.445831 -2.541548  O -2.702261 -0.687613 -1.946894 
C 3.582523 -1.352662 -0.701930  O -3.565243 1.511186 -1.066375 
H 2.040485 -2.779680 -1.092427  C -4.238741 -0.690340 0.265822 
C 4.346833 -2.356575 -0.042165  F -5.392770 -0.814118 -0.425433 
C 4.123417 -0.042107 -0.827301  F -3.809786 -1.921341 0.608197 
C 5.603323 -2.062944 0.470671  F -4.483200 0.010837 1.391479 
H 3.930710 -3.362075 0.054159  H 7.105676 -0.529958 0.741946 
C 5.378130 0.242025 -0.309652  H 1.701294 0.060265 -2.288017 
 
Copper(III)-styrene-Ph-OTf2 – TS – towards 1,1-diphenylethylene (TS-9): 
Energies (Hartree): 
Zero-point correction 0.270803 
Thermal correction to Energy 0.302735 
Thermal correction to Enthalpy 0.303679 
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Thermal correction to Gibbs Free Energy 0.201471 
Sum of electronic and zero-point Energies -2661.048329 
Sum of electronic and thermal Energies -2661.016397 
Sum of electronic and thermal Enthalpies -2661.015453 
Sum of electronic and thermal Free Energies -2661.117661 
E(RB-P86)  -2661.319132 
Structure: 
 
Coordinates: 
 
C 0.747983 -1.707269 -0.233481  H 3.328195 1.046078 0.118433 
C 1.161323 -1.759057 1.107292  C 6.049118 -0.870637 0.862390 
C 0.185158 -2.807546 -0.901255  H 6.408431 -2.888729 0.159910 
C 0.927963 -2.935428 1.820685  H 5.439775 1.137588 1.401084 
H 1.654206 -0.910302 1.586154  O -0.535673 1.917278 -1.060517 
C -0.018868 -3.980551 -0.171101  S 0.215696 3.174314 -0.649775 
H -0.101325 -2.751121 -1.952516  C -0.286352 3.386317 1.161272 
C 0.348784 -4.040863 1.180078  O -0.307618 4.359018 -1.329047 
H 1.215385 -2.991627 2.872319  O 1.677915 2.994879 -0.594614 
H -0.463162 -4.847895 -0.663031  F 0.312389 4.483042 1.673512 
H 0.196192 -4.966684 1.738641  F -1.618766 3.524537 1.280646 
Cu -0.039753 0.027653 -0.637774  F 0.104805 2.309847 1.884084 
C 1.607337 0.007561 -1.754627  O -1.744221 -0.224584 0.460044 
C 2.453939 -1.095056 -1.400176  S -3.015774 -0.276069 -0.373613 
H 1.062031 -0.092014 -2.702471  O -2.745238 -0.647594 -1.773927 
C 3.654649 -0.993670 -0.592869  O -3.939750 0.831321 -0.116503 
H 2.393653 -1.987981 -2.026026  C -3.888725 -1.775773 0.377825 
C 4.537051 -2.099907 -0.567519  F -5.092130 -1.945226 -0.213503 
C 3.991120 0.177558 0.128452  F -3.165244 -2.902955 0.198033 
C 5.728209 -2.035053 0.150730  F -4.083560 -1.600240 1.702702 
H 4.277847 -3.004693 -1.123048  H 6.981790 -0.819340 1.428485 
C 5.180795 0.232205 0.848992  H 1.923399 1.022307 -1.481163 
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1,1-diphenylethyl-Copper(III)-OTf2 (Int-9): 
Energies (Hartree): 
Zero-point correction 0.272424 
Thermal correction to Energy 0.304487 
Thermal correction to Enthalpy 0.305431 
Thermal correction to Gibbs Free Energy 0.202795 
Sum of electronic and zero-point Energies -2661.070248 
Sum of electronic and thermal Energies -2661.038185 
Sum of electronic and thermal Enthalpies -2661.037241 
Sum of electronic and thermal Free Energies -2661.139877 
E(RB-P86)  -2661.342672 
Structure: 
 
Coordinates: 
 
C 1.110231 -1.577769 0.476508  H 3.594423 0.646698 -0.383324 
C 1.208132 -0.459799 1.371525  C 6.246668 -1.480197 -0.149024 
C 0.323371 -2.700198 0.855697  H 6.150136 -3.631899 -0.382626 
C 0.572104 -0.509034 2.622405  H 6.023864 0.666570 0.015970 
H 1.856460 0.385385 1.128315  O -0.445692 1.800279 -1.013733 
C -0.274616 -2.734233 2.106340  S 0.477142 2.961044 -0.656581 
H 0.233923 -3.545738 0.171514  C -0.436651 3.776769 0.787695 
C -0.153201 -1.640978 2.989136  O 0.492555 3.982309 -1.704505 
H 0.662118 0.337357 3.304368  O 1.763675 2.522929 -0.087231 
H -0.841405 -3.615696 2.410626  F 0.261657 4.850299 1.214489 
H -0.634568 -1.683825 3.967986  F -1.662150 4.180719 0.403184 
Cu -0.251418 -0.090935 -0.333101  F -0.568206 2.913484 1.817839 
C 1.315709 -0.473562 -1.548840  O -2.131167 -0.194238 0.623832 
C 1.965578 -1.604091 -0.819708  S -2.913298 -0.539971 -0.624177 
H 0.655312 -0.711532 -2.391131  O -1.920975 -0.799454 -1.717589 
C 3.467867 -1.519254 -0.595395  O -4.057382 0.311115 -0.930185 
H 1.729496 -2.551126 -1.326995  C -3.680697 -2.230941 -0.250465 
Appendix 4 – Computational Experimental 
 364 
C 4.209015 -2.712728 -0.602749  F -4.495645 -2.588234 -1.261319 
C 4.135377 -0.303241 -0.374016  F -2.726197 -3.173194 -0.111997 
C 5.588608 -2.694906 -0.376480  F -4.397065 -2.166544 0.888461 
H 3.701660 -3.664173 -0.785528  H 7.325455 -1.463854 0.021272 
C 5.517419 -0.286662 -0.150930  H 1.803619 0.504440 -1.569236 
i.2.4 Functionalisation of allylic amide 315 towards oxazine formation 
Pathway elaborated as below (Scheme 142). 
 
Scheme 142 – Reaction of amide 315 with Int-4 towards oxazine formation (Gaussian 09 - BP86 functional, 
Def2SVP (SDD) [Cu], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Copper(III)-Ph-Κ2OTf-OTf (Int-4): 
See section 1.2.1 
Allylic amide substrate (315): 
Energies (Hartree): 
Zero-point correction 0.292655 
Thermal correction to Energy 0.309583 
Thermal correction to Enthalpy 0.310528 
Thermal correction to Gibbs Free Energy 0.246166 
Sum of electronic and zero-point Energies -674.661591 
Sum of electronic and thermal Energies -674.644663 
Sum of electronic and thermal Enthalpies -674.643719 
Sum of electronic and thermal Free Energies -674.708081 
E(RB-P86)  -674.954247 
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Structure: 
 
Coordinates: 
 
C -3.042341 -0.543255 -0.309821  O 2.617029 1.146544 -1.341943 
C -4.153580 -1.175270 0.306478  C 3.881970 -0.013731 0.393696 
C -5.229838 -0.427930 0.806416  C 4.814741 -0.688429 -0.644319 
C -5.232256 0.974540 0.686459  H 4.989771 -0.019265 -1.501827 
C -4.154684 1.616131 0.050628  H 5.786724 -0.922960 -0.176090 
C -3.074376 0.868121 -0.446263  H 4.379950 -1.631072 -1.021095 
H -4.160225 -2.267482 0.399806  C 4.534854 1.296879 0.903132 
H -6.070753 -0.940048 1.286027  H 3.897280 1.796604 1.653742 
H -4.159585 2.704347 -0.072626  H 5.506484 1.070588 1.376314 
H -2.271683 1.382530 -0.982412  H 4.704942 1.997333 0.069888 
C -1.935384 -1.385205 -0.804264  C 3.663187 -0.972414 1.585163 
H -2.232938 -2.399815 -1.102976  H 4.637125 -1.203448 2.049952 
C -0.613277 -1.090460 -0.906092  H 3.030924 -0.524208 2.372979 
H 0.047494 -1.866249 -1.315685  H 3.220840 -1.935316 1.271868 
C 0.096934 0.172025 -0.482295  N 1.400932 -0.129615 0.116492 
H 0.312692 0.827834 -1.346131  H 1.416239 -0.736507 0.934451 
H -0.512308 0.753893 0.232981  H -6.074023 1.559889 1.070586 
C 2.578764 0.383716 -0.352194  
    
 
Cu(III)-OTf-bidentatesubstrate-cation (Int-10): 
Energies (Hartree): 
Zero-point correction 0.410544 
Thermal correction to Energy 0.443545 
Thermal correction to Enthalpy 0.444489 
Thermal correction to Gibbs Free Energy 0.342520 
Sum of electronic and zero-point Energies -2063.187774 
Sum of electronic and thermal Energies -2063.154774 
Sum of electronic and thermal Enthalpies -2063.153830 
Sum of electronic and thermal Free Energies -2063.255799 
E(RB-P86)  -2063.598319 
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Structure: 
 
Coordinates: 
 
C -1.460330 1.854180 0.476812  H 1.420773 -4.212634 1.355941 
C -1.620738 2.728838 -0.597416  H 0.794102 -3.845857 -0.281942 
C -2.195599 1.916218 1.659313  C 1.128546 1.195189 1.669464 
C -2.587720 3.750917 -0.458808  H 2.504256 0.547741 3.156185 
H -1.054156 2.638353 -1.529353  H 0.974269 -0.341332 3.136674 
C -3.157512 2.947493 1.768931  C 1.618764 1.992368 0.603752 
H -2.069046 1.201207 2.477270  H 0.374183 1.722975 2.269470 
C -3.345543 3.859031 0.718624  C 2.805458 1.960079 -0.212910 
H -2.739209 4.447579 -1.290006  H 0.955722 2.838079 0.377643 
H -3.749820 3.017629 2.687350  C 2.823065 2.833900 -1.345152 
H -4.091154 4.654600 0.814868  C 3.981392 1.212278 0.092345 
Cu -0.184098 0.365764 0.263859  C 3.951643 2.922298 -2.160967 
O 1.037078 -1.169826 -0.013976  H 1.934368 3.432248 -1.570828 
C 2.017995 -1.616364 0.660215  C 5.114007 1.323229 -0.715629 
C 2.729220 -2.886456 0.163579  H 4.009115 0.571109 0.973739 
N 2.440296 -1.015199 1.787780  C 5.099058 2.165823 -1.847581 
C 3.087882 -2.680562 -1.331090  H 3.949111 3.583750 -3.031808 
C 4.003966 -3.215720 0.970596  H 6.017923 0.760249 -0.466178 
C 1.705004 -4.048594 0.302290  O -1.477151 -0.463692 -0.966941 
C 1.759360 0.081230 2.483901  S -2.275871 -1.684746 -0.411045 
H 3.193529 -1.472999 2.303983  O -2.186873 -1.769929 1.071954 
H 3.811446 -1.858079 -1.462422  O -2.058769 -2.904173 -1.224623 
H 3.545190 -3.604858 -1.721529  C -4.059392 -1.152905 -0.805199 
H 2.188796 -2.456597 -1.925512  F -4.909598 -2.130954 -0.417171 
H 3.788819 -3.442446 2.030541  F -4.373214 -0.015157 -0.149259 
H 4.465233 -4.122482 0.546397  F -4.202864 -0.948527 -2.133495 
H 4.756936 -2.410385 0.912770  H 5.989825 2.241439 -2.478960 
H 2.166136 -4.976247 -0.076340      
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OTf-anion: 
Energies (Hartree): 
Zero-point correction 0.025017 
Thermal correction to Energy 0.032531 
Thermal correction to Enthalpy 0.033476 
Thermal correction to Gibbs Free Energy -0.007799 
Sum of electronic and zero-point Energies -961.652226 
Sum of electronic and thermal Energies -961.644712 
Sum of electronic and thermal Enthalpies -961.643768 
Sum of electronic and thermal Free Energies -961.685042 
E(RB-P86)  -961.677243 
Structure: 
 
Coordinates: 
 
C -0.970231 -0.000043 0.000289  S 0.933938 0.000092 -0.000123 
F -1.465715 0.951635 0.841286  O 1.267916 1.387948 -0.462747 
F -1.465164 0.252599 -1.244569  O 1.269558 -0.293086 1.432696 
F -1.465334 -1.204556 0.403676  O 1.268064 -1.094650 -0.970361 
 
Cu(III)-OTf-bidentatesubstrate-cation – TS – towards oxazine (TS-6): 
Energies (Hartree): 
Zero-point correction 0.409431 
Thermal correction to Energy 0.441760 
Thermal correction to Enthalpy 0.442704 
Thermal correction to Gibbs Free Energy 0.344213 
Sum of electronic and zero-point Energies -2063.180054 
Sum of electronic and thermal Energies -2063.147726 
Sum of electronic and thermal Enthalpies -2063.146781 
Sum of electronic and thermal Free Energies -2063.245272 
E(RB-P86)  -2063.589485 
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Structure: 
 
Coordinates: 
 
C -0.891897 2.215192 -1.151408  H 3.692802 2.919867 2.31286 
C -2.063645 2.14184 -1.916206  H 2.351915 2.10452 3.177786 
C -0.459499 3.373775 -0.497707  C 0.746037 0.97317 -2.048537 
C -2.895423 3.279181 -1.943245  H 2.741913 1.332745 -2.623406 
H -2.352972 1.242613 -2.468032  H 2.020571 2.624216 -1.658291 
C -1.309201 4.498048 -0.547562  C 0.256126 -0.376255 -2.170259 
H 0.466986 3.404145 0.080272  H 0.306879 1.6069 -2.830742 
C -2.516145 4.45073 -1.266063  C 0.857533 -1.677853 -2.024842 
H -3.831141 3.237634 -2.509496  H -0.736113 -0.416578 -2.642555 
H -1.013271 5.405978 -0.012395  C 0.035947 -2.793278 -2.386117 
H -3.158348 5.335603 -1.309094  C 2.208584 -1.922296 -1.635997 
Cu -0.367723 0.539923 -0.248144  C 0.544415 -4.091718 -2.361769 
O 1.242937 1.161259 0.992094  H -1.001415 -2.617284 -2.688711 
C 2.464863 1.014144 0.713379  C 2.709236 -3.224184 -1.617635 
C 3.483477 0.770402 1.843236  H 2.851278 -1.090143 -1.346052 
N 2.901401 1.044098 -0.573676  C 1.882708 -4.31026 -1.976903 
C 3.048789 -0.522093 2.584351  H -0.093314 -4.935173 -2.640629 
C 4.937517 0.621962 1.34474  H 3.747351 -3.402682 -1.323005 
C 3.382102 1.983359 2.807879  O -0.562183 -1.313206 0.671879 
C 2.12746 1.527096 -1.724904  S -1.603758 -0.857762 1.709635 
H 3.911373 1.009445 -0.718263  O -1.865598 0.609943 1.425873 
H 3.104022 -1.402595 1.921552  O -1.369246 -1.27567 3.10628 
H 3.723031 -0.691938 3.440637  C -3.196595 -1.754881 1.182269 
H 2.018354 -0.43272 2.961608  F -4.222092 -1.354652 1.963205 
H 5.303842 1.532125 0.835863  F -3.488585 -1.469228 -0.107862 
H 5.597064 0.458944 2.213284  F -3.035831 -3.089448 1.309578 
H 5.067618 -0.249189 0.677546  H 2.284474 -5.328074 -1.956993 
H 4.04836 1.81425 3.670541      
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Cu(I)-OTf-anion-arylatedallylicamide-cation-adduct – towards oxazine (Int-11): 
Energies (Hartree): 
Zero-point correction 0.412258 
Thermal correction to Energy 0.444645 
Thermal correction to Enthalpy 0.445589 
Thermal correction to Gibbs Free Energy 0.346118 
Sum of electronic and zero-point Energies -2063.218800 
Sum of electronic and thermal Energies -2063.186413 
Sum of electronic and thermal Enthalpies -2063.185469 
Sum of electronic and thermal Free Energies -2063.284940 
E(RB-P86)  -2063.631058 
Structure: 
 
Coordinates: 
 
C 0.784228 2.112225 -1.488945  H 3.937763 1.609069 2.512371 
C -0.396012 2.703988 -1.991678  H 2.798629 0.450404 3.265536 
C 1.594483 2.857254 -0.606266  C 1.149833 0.687161 -1.952760 
C -0.770284 3.999773 -1.606007  H 2.825231 -0.553851 -2.541252 
H -1.027092 2.155320 -2.700640  H 3.178108 1.170699 -2.406806 
C 1.219139 4.158431 -0.221836  C 0.111370 -0.317933 -1.479444 
H 2.530457 2.444401 -0.220074  H 0.947278 0.684576 -3.051397 
C 0.036296 4.730904 -0.715013  C 0.147081 -1.760357 -1.489405 
H -1.688549 4.439596 -2.007382  H -0.910047 0.074687 -1.627269 
H 1.860509 4.721756 0.463315  C -1.125298 -2.416473 -1.619422 
H -0.253392 5.742467 -0.413758  C 1.325940 -2.570991 -1.420034 
Cu -0.004655 0.174788 0.551627  C -1.203988 -3.803823 -1.734651 
O 1.763275 -0.261765 0.998839  H -2.031206 -1.802795 -1.646894 
C 2.977608 -0.173789 0.614384  C 1.233452 -3.955836 -1.531663 
C 4.054471 -0.437539 1.687036  H 2.305910 -2.121341 -1.258225 
N 3.363463 0.120808 -0.634388  C -0.026606 -4.576612 -1.694493 
C 3.842311 -1.891817 2.190821  H -2.177163 -4.288405 -1.852732 
C 5.495466 -0.278658 1.155833  H 2.139106 -4.566770 -1.482033 
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C 3.810636 0.565158 2.847403  O -1.730527 0.874354 0.919224 
C 2.649735 0.337696 -1.914655  S -3.155441 0.678790 0.333802 
H 4.378596 0.138927 -0.758762  O -3.134343 0.178642 -1.068472 
H 4.005215 -2.624554 1.381480  O -4.023765 1.825839 0.674240 
H 4.567754 -2.102951 2.993884  C -3.801186 -0.771525 1.383732 
H 2.826502 -2.028406 2.592973  F -5.055782 -1.087825 0.996140 
H 5.704550 0.745757 0.799689  F -3.006233 -1.857682 1.221898 
H 6.197619 -0.476368 1.982127  F -3.813584 -0.433262 2.690878 
H 5.736556 -1.004120 0.357999  H -0.086030 -5.666265 -1.776893 
H 4.542734 0.371957 3.648928      
 
i.2.5 Functionalisation of allylic amide 315 towards enamide formation 
Pathway elaborated as below (Scheme 144). 
 
Scheme 144 – Reaction of amide 315 with Int-4 towards enamide formation (Gaussian 09 - BP86 functional, 
Def2SVP (SDD) [Cu], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Copper(III)-Ph-Κ2OTf-OTf (Int-4): 
See section 1.2.1 
Allylic amide substrate (315): 
See section 1.2.4 
OTf-anion: 
See section 1.2.4 
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Cu(III)-OTf-arylatedallylicamideadduct-cation – towards enamide (Int-12): 
Energies (Hartree): 
Zero-point correction 0.411537 
Thermal correction to Energy 0.44392 
Thermal correction to Enthalpy 0.444864 
Thermal correction to Gibbs Free Energy 0.344351 
Sum of electronic and zero-point Energies -2063.222241 
Sum of electronic and thermal Energies -2063.189859 
Sum of electronic and thermal Enthalpies -2063.188915 
Sum of electronic and thermal Free Energies -2063.289427 
E(RB-P86)  -2063.633778 
Structure: 
 
Coordinates: 
 
O -1.833488 -1.370850 0.880143  H 1.022408 3.908556 -0.199613 
C 1.600256 -1.506887 0.290469  H -1.399972 3.738431 2.723059 
C 1.428297 -1.021323 1.632571  H -2.853136 4.556585 2.085135 
C 1.275542 -2.863614 0.005735  H -2.701214 2.779285 1.953085 
C 0.964335 -1.886400 2.645986  H -0.286205 5.494410 -0.496096 
H 1.760765 -0.014871 1.908249  H -1.445655 6.082007 0.701051 
C 0.825659 -3.706945 1.023236  H 0.060623 5.334967 1.267946 
H 1.397073 -3.240830 -1.014307  H -3.260436 4.724965 -0.430501 
C 0.664289 -3.219819 2.341189  H -2.101942 4.020504 -1.593189 
H 0.850254 -1.509067 3.665867  H -3.116680 2.948961 -0.577593 
H 0.591756 -4.750953 0.795923  C 1.297001 0.618686 -0.842781 
H 0.303838 -3.890768 3.126451  H 2.300600 1.773105 0.700295 
Cu -0.216217 -0.213301 0.224661  H 2.512243 2.329282 -0.958438 
C -3.994439 -1.018272 -0.740907  C 2.214121 -0.605321 -0.800968 
F -4.476604 -1.320871 -1.966118  H 0.669631 0.716352 -1.744828 
F -4.849865 -1.478024 0.197595  C 3.707991 -0.304659 -0.683645 
F -3.894771 0.323287 -0.626670  H 2.051632 -1.134858 -1.756000 
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S -2.293354 -1.836108 -0.509621  C 4.367348 0.169540 -1.842318 
O -2.548325 -3.283948 -0.661270  C 4.450049 -0.482329 0.501355 
O -1.383029 -1.166706 -1.523703  C 5.738296 0.464335 -1.813119 
O -1.023483 1.554369 0.455596  H 3.803400 0.290234 -2.774603 
C -0.543858 2.722313 0.283794  C 5.826683 -0.194540 0.527081 
C -1.475956 3.925278 0.525281  H 3.970235 -0.862051 1.408424 
N 0.719736 2.937025 -0.118104  C 6.472198 0.285547 -0.625087 
C -2.146241 3.728850 1.910370  H 6.235975 0.823495 -2.719537 
C -0.724777 5.274291 0.493953  H 6.392404 -0.346880 1.451642 
C -2.553546 3.894436 -0.594469  H 7.542584 0.513093 -0.600843 
C 1.760649 1.916479 -0.255307      
 
i.2.6 Functionalisation of allylic amide 361 towards enamide formation 
Pathway elaborated as below (Scheme 145). 
 
Scheme 145 – Reactivity of amide 361 with Int-4 towards enamide formation (Gaussian 09 - BP86 functional, 
Def2QZVP (SDD) [Cu], 6-311G+(2d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Copper(III)-Ph-Κ2OTf-OTf (Int-4): 
See section 1.2.2 
Allylic amide substrate (361): 
Energies (Hartree): 
Zero-point correction 0.317955 
Thermal correction to Energy 0.336839 
Thermal correction to Enthalpy 0.337783 
Thermal correction to Gibbs Free Energy 0.268364 
Sum of electronic and zero-point Energies -714.113647 
Sum of electronic and thermal Energies -714.094764 
Sum of electronic and thermal Enthalpies -714.093819 
Sum of electronic and thermal Free Energies -714.163238 
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E(RB-P86)  -714.4316021 
Structure: 
 
Coordinates: 
 
C 2.542929 0.903900 -0.259240  C -4.251502 -0.236757 0.450598 
C 3.613481 1.404747 0.514351  C -5.209702 0.798828 -0.183009 
C 4.745953 0.633061 0.773583  H -5.436887 0.532266 -1.224782 
C 4.873071 -0.669579 0.257291  H -6.153337 0.831146 0.384466 
C 3.827512 -1.157041 -0.544485  H -4.769893 1.808855 -0.170824 
C 2.686767 -0.390920 -0.801398  C -4.907284 -1.636191 0.421147 
H 3.545883 2.417448 0.922682  H -4.253417 -2.393302 0.882686 
H 5.553171 1.051342 1.382291  H -5.855249 -1.616577 0.981845 
H 3.913235 -2.152469 -0.990377  H -5.117384 -1.944121 -0.612569 
H 1.921211 -0.789531 -1.469889  C -3.961666 0.161255 1.911030 
C 1.368613 1.762654 -0.483650  H -4.904024 0.172296 2.480118 
H 1.584747 2.837725 -0.476220  H -3.291344 -0.556199 2.411884 
C 0.075648 1.412632 -0.657126  H -3.528189 1.171807 1.990296 
H -0.650143 2.218512 -0.814237  N -1.798662 0.035487 0.117319 
C -0.528601 0.034389 -0.611799  H -1.782724 0.315911 1.094404 
H -0.766721 -0.335061 -1.623334  C 6.088382 -1.513264 0.559335 
H 0.159263 -0.688952 -0.145421  H 6.256634 -2.270558 -0.220361 
C -2.991062 -0.300919 -0.451446  H 6.995398 -0.896291 0.645381 
O -3.079096 -0.644297 -1.642125  H 5.967948 -2.049043 1.516616 
 
Cu(III)-OTf2-bidentateallylicamideadduct – towards enamide (Int-13): 
Energies (Hartree): 
Zero-point correction 0.460277 
Thermal correction to Energy 0.504995 
Thermal correction to Enthalpy 0.505939 
Thermal correction to Gibbs Free Energy 0.375937 
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Sum of electronic and zero-point Energies -3065.569251 
Sum of electronic and thermal Energies -3065.524533 
Sum of electronic and thermal Enthalpies -3065.523589 
Sum of electronic and thermal Free Energies -3065.653591 
E(RB-P86)  -3066.029528 
Structure: 
 
Coordinates: 
 
O 0.467266 0.473531 1.123759  H -2.813600 5.768969 -2.219419 
C 0.400020 -1.847958 -1.070948  H -1.358477 5.537356 -1.238362 
C 1.144551 -2.307656 0.006734  H -4.147959 3.806228 -3.094867 
C 0.014694 -2.648930 -2.143585  H -2.691210 3.064855 -3.805751 
C 1.436631 -3.681244 0.053595  H -3.697948 2.135669 -2.657063 
H 1.459593 -1.639728 0.809754  C 0.889958 0.835790 -2.038198 
C 0.322725 -4.016689 -2.078023  H 1.218012 2.088437 -0.289532 
H -0.533446 -2.252580 -3.000768  H 1.954149 2.684436 -1.800647 
C 1.031659 -4.527243 -0.984521  C 1.925710 -0.120269 -2.194536 
H 1.984449 -4.076059 0.912560  H 0.201874 0.848346 -2.896825 
H 0.009189 -4.671284 -2.894696  C 3.230218 -0.211931 -1.612172 
H 1.282319 -5.589847 -0.948541  H 1.757939 -0.824255 -3.012749 
Cu -0.527615 -0.127587 -0.868476  C 4.141471 -1.115454 -2.225731 
C 1.819494 1.531646 3.115329  C 3.687744 0.543495 -0.497995 
F 1.726517 2.086643 4.344986  C 5.447742 -1.231853 -1.772850 
F 2.655467 0.468815 3.196063  H 3.803812 -1.716360 -3.073721 
F 2.393222 2.448619 2.288010  C 4.990570 0.408257 -0.046695 
S 0.112227 1.020694 2.478906  H 3.011108 1.209115 0.034856 
O -0.321926 0.005315 3.448807  C 5.900213 -0.472788 -0.675371 
O -0.635542 2.287646 2.446778  H 6.132499 -1.925649 -2.265954 
O -1.651394 1.524468 -1.050904  H 5.321698 0.988578 0.817764 
C -1.350060 2.690256 -1.431048  C 7.310240 -0.593251 -0.172685 
C -2.478755 3.694901 -1.705303  H 7.844101 0.364839 -0.288904 
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N -0.076565 3.059713 -1.634317  H 7.322240 -0.830316 0.903268 
C -3.362988 3.765485 -0.438484  H 7.871155 -1.368811 -0.710434 
C -1.955323 5.100998 -2.055189  O -2.249668 -1.208251 -0.745790 
C -3.301562 3.133021 -2.891473  S -3.436540 -1.136060 0.203009 
C 1.067110 2.188127 -1.374605  C -3.362947 -2.848855 1.003040 
H 0.109080 4.020229 -1.912490  O -4.710427 -1.146035 -0.529916 
H -2.800320 4.160874 0.420361  O -3.281728 -0.198200 1.316354 
H -4.214626 4.435519 -0.630989  F -4.384596 -2.991614 1.878878 
H -3.749030 2.772927 -0.172294  F -3.467201 -3.822623 0.069244 
H -1.362400 5.111098 -2.984754  F -2.202934 -3.022018 1.670281 
 
OTf-anion: 
Energies (Hartree): 
Zero-point correction 0.025114 
Thermal correction to Energy 0.032588 
Thermal correction to Enthalpy 0.033532 
Thermal correction to Gibbs Free Energy -0.007672 
Sum of electronic and zero-point Energies -961.876919 
Sum of electronic and thermal Energies -961.869445 
Sum of electronic and thermal Enthalpies -961.868501 
Sum of electronic and thermal Free Energies -961.909705 
E(RB-P86)  -961.902033 
Structure: 
 
Coordinates: 
 
C 0.962162 0.000063 -0.000023  S -0.930667 0.000049 0.000043 
F 1.457249 0.846719 0.940631  O -1.259053 -0.443147 1.373792 
F 1.456744 -1.238106 0.262916  O -1.259343 1.411300 -0.303057 
F 1.456937 0.391249 -1.203709  O -1.259187 -0.968143 -1.070622 
 
Cu(III)-OTf-bidentateallylicamideadduct-cation – towards enamide (Int-14): 
Energies (Hartree): 
Zero-point correction 0.434613 
Thermal correction to Energy 0.469737 
Thermal correction to Enthalpy 0.470682 
Thermal correction to Gibbs Free Energy 0.362896 
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Sum of electronic and zero-point Energies -2103.678829 
Sum of electronic and thermal Energies -2103.643705 
Sum of electronic and thermal Enthalpies -2103.642761 
Sum of electronic and thermal Free Energies -2103.750546 
E(RB-P86)  -2104.113442 
Structure: 
 
Coordinates: 
 
O 1.587513 -1.218187 -0.807101  H 3.045583 3.574798 -2.055011 
C -1.045891 -1.408331 0.206919  H 4.452756 3.959320 -1.031445 
C -1.698155 -1.702417 -0.988816  H 3.840026 2.284517 -1.109071 
C -1.052387 -2.255738 1.313873  H 1.598352 5.417310 0.949006 
C -2.314534 -2.955391 -1.107083  H 3.142852 5.752379 0.156732 
H -1.716718 -1.001448 -1.827182  H 1.722325 5.429497 -0.845325 
C -1.681210 -3.502970 1.175198  H 4.263989 3.941868 1.503823 
H -0.562588 -1.992060 2.252404  H 2.725625 3.528388 2.302117 
C -2.310250 -3.846401 -0.025980  H 3.660637 2.262910 1.455379 
H -2.799506 -3.224930 -2.047924  C -1.092922 1.302681 0.800322 
H -1.677550 -4.195948 2.019477  H -1.099335 2.069915 -1.254027 
H -2.812811 -4.811625 -0.117986  H -1.878259 3.118250 -0.053420 
Cu 0.276775 0.002250 0.097125  C -2.300228 0.594298 1.109797 
C 4.195440 -1.638736 -0.490600  H -0.507718 1.499958 1.713331 
F 5.097851 -2.425250 0.134113  C -3.589743 0.603095 0.507028 
F 4.307320 -1.827295 -1.822204  H -2.263543 0.071383 2.069090 
F 4.482995 -0.351899 -0.210532  C -4.641786 -0.016416 1.245756 
S 2.454010 -2.094152 0.099047  C -3.916504 1.201110 -0.744569 
O 2.337565 -3.520701 -0.211200  C -5.944014 -0.011436 0.776382 
O 2.390744 -1.671380 1.506743  H -4.409247 -0.486976 2.203943 
O 1.607846 1.465695 -0.008208  C -5.220447 1.189051 -1.207592 
C 1.416165 2.717491 0.006927  H -3.146803 1.655570 -1.366263 
C 2.626303 3.653252 0.105757  C -6.261706 0.588171 -0.461338 
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N 0.182284 3.235909 -0.056053  H -6.735370 -0.478096 1.367062 
C 3.544784 3.341921 -1.101851  H -5.453702 1.652034 -2.169001 
C 2.230697 5.142043 0.089323  C -7.664291 0.564870 -0.989433 
C 3.360530 3.318818 1.427432  H -7.866845 1.427793 -1.639077 
C -1.029006 2.435923 -0.215096  H -7.817147 -0.343739 -1.599062 
H 0.082996 4.248710 -0.058910  H -8.402534 0.537290 -0.176059 
 
Cu(III)-OTf-bidentateallylicamideadduct-cation – TS – towards enamide (TS-7): 
Energies (Hartree): 
Zero-point correction 0.435307 
Thermal correction to Energy 0.469461 
Thermal correction to Enthalpy 0.470406 
Thermal correction to Gibbs Free Energy 0.365591 
Sum of electronic and zero-point Energies -2103.677504 
Sum of electronic and thermal Energies -2103.643350 
Sum of electronic and thermal Enthalpies -2103.642405 
Sum of electronic and thermal Free Energies -2103.747220 
E(RB-P86)  -2104.112811 
Structure: 
 
Coordinates: 
 
O 1.561893 -1.254890 -0.808468  H 2.889057 3.806954 -2.032334 
C -1.139776 -1.309683 0.304541  H 4.313709 4.149645 -1.017804 
C -1.707791 -1.712203 -0.910791  H 3.743954 2.469647 -1.211955 
C -1.010505 -2.166509 1.406783  H 1.475473 5.361165 1.147535 
C -2.094269 -3.047704 -1.044644  H 2.989371 5.806559 0.349320 
H -1.840213 -1.016356 -1.742045  H 1.552825 5.525715 -0.641843 
C -1.413886 -3.496849 1.253059  H 4.198048 3.931625 1.509919 
H -0.590891 -1.821482 2.353615  H 2.696165 3.410984 2.314912 
C -1.952864 -3.931438 0.035379  H 3.641010 2.243805 1.346715 
H -2.513937 -3.392786 -1.991759  C -1.116426 1.258635 0.792800 
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H -1.309446 -4.188168 2.091630  H -1.171146 2.069728 -1.241638 
H -2.278515 -4.968271 -0.070795  H -1.965531 3.062526 -0.006032 
Cu 0.267393 0.026231 0.072449  C -2.282942 0.444707 1.050833 
C 4.189283 -1.590710 -0.549683  H -0.556085 1.466047 1.718554 
F 5.131882 -2.313481 0.093411  C -3.594005 0.469184 0.449880 
F 4.271983 -1.854925 -1.871332  H -2.277673 0.003473 2.049412 
F 4.448895 -0.281712 -0.355554  C -4.646388 -0.116307 1.202881 
S 2.477434 -2.053901 0.112372  C -3.917619 1.050134 -0.803531 
O 2.393229 -3.499453 -0.112128  C -5.955724 -0.093066 0.742557 
O 2.445372 -1.557950 1.498413  H -4.417875 -0.582791 2.164489 
O 1.564183 1.500986 -0.087450  C -5.228527 1.059084 -1.258245 
C 1.341938 2.746042 -0.000496  H -3.145232 1.478884 -1.441002 
C 2.529706 3.704268 0.138937  C -6.275693 0.496829 -0.496186 
N 0.095497 3.236700 -0.023508  H -6.747805 -0.542720 1.345808 
C 3.420634 3.514388 -1.113848  H -5.454901 1.506900 -2.228861 
C 2.092930 5.177097 0.253325  C -7.694267 0.547556 -0.988125 
C 3.310859 3.288989 1.409739  H -8.152724 1.515002 -0.718251 
C -1.096541 2.412051 -0.195710  H -7.743603 0.462495 -2.083230 
H -0.028462 4.244884 0.040240  H -8.308424 -0.244089 -0.537413 
 
Cu(III)-OTf-arylatedallylicamideadduct-cation – towards enamide (Int-15): 
Energies (Hartree): 
Zero-point correction 0.435980 
Thermal correction to Energy 0.470420 
Thermal correction to Enthalpy 0.471365 
Thermal correction to Gibbs Free Energy 0.365779 
Sum of electronic and zero-point Energies -2103.708675 
Sum of electronic and thermal Energies -2103.674234 
Sum of electronic and thermal Enthalpies -2103.673290 
Sum of electronic and thermal Free Energies -2103.778876 
E(RB-P86)  -2104.144655 
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Structure: 
 
Coordinates: 
 
O -2.134859 -1.324615 0.856774  H -1.507188 3.783813 2.723296 
C 1.304370 -1.539932 0.348416  H -2.961226 4.615544 2.117233 
C 1.127608 -1.033112 1.675753  H -2.845319 2.838509 2.011020 
C 0.948340 -2.885357 0.079413  H -0.454334 5.455086 -0.545255 
C 0.622299 -1.865582 2.688347  H -1.570987 6.089013 0.664012 
H 1.482488 -0.034436 1.939894  H -0.069616 5.325951 1.208229 
C 0.460625 -3.696229 1.096309  H -3.431456 4.758636 -0.390047 
H 1.072463 -3.278907 -0.931240  H -2.323911 4.004340 -1.564551 
C 0.291254 -3.187372 2.398397  H -3.334392 2.980876 -0.504406 
H 0.502224 -1.471902 3.698745  C 1.062885 0.571745 -0.806606 
H 0.201970 -4.734506 0.881537  H 2.078028 1.726716 0.721672 
H -0.100726 -3.834867 3.184957  H 2.298418 2.257241 -0.938226 
Cu -0.464170 -0.205874 0.251686  C 1.949051 -0.668143 -0.743981 
C -4.202057 -0.953092 -0.837295  H 0.437628 0.663971 -1.706826 
F -4.646155 -1.274880 -2.067532  C 3.444038 -0.405954 -0.611482 
F -5.099504 -1.368636 0.076354  H 1.788692 -1.203374 -1.693597 
F -4.081124 0.385337 -0.753802  C 4.129622 0.073473 -1.746366 
S -2.537827 -1.798219 -0.524090  C 4.176123 -0.635288 0.561147 
O -2.823643 -3.222685 -0.656435  C 5.499914 0.319696 -1.700400 
O -1.592067 -1.183327 -1.509408  H 3.583910 0.236768 -2.680496 
O -1.255791 1.563175 0.449370  C 5.554577 -0.394307 0.598485 
C -0.746590 2.712445 0.284686  H 3.686432 -1.021369 1.457674 
C -1.646363 3.935602 0.531193  C 6.241626 0.092725 -0.523937 
N 0.517616 2.900680 -0.110089  H 6.009480 0.682823 -2.597211 
C -2.276223 3.774435 1.935656  H 6.105414 -0.591119 1.522023 
C -0.872844 5.265300 0.456504  C 7.725441 0.359775 -0.482673 
C -2.751411 3.909638 -0.554662  H 8.150288 0.117751 0.501225 
C 1.540813 1.864409 -0.233223  H 8.255145 -0.238335 -1.241488 
H 0.839040 3.865121 -0.180456  H 7.943706 1.417742 -0.700203 
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i.2.7 CuTC activation 
It has been previously observed that reactions employing copper(I) thiophene-2-carboxylate (CuTC, 
341) give near catalyst-equimolar quantities of thiophene-coupled product 611. It is thought that the 
active catalyst for these alkene functionalisation process is in fact copper(I) triflate rather than the more 
stable copper TC adduct. It is proposed that the following process to generate copper(I) triflate occurs 
in the early stages of these copper-catalysed reactions (Scheme 147).  
 
Scheme 147 – Proposed generation of CuOTf from CuTC (341) 
To assess the viability of this process, the following energy profile for the oxidative addition of CuTC 
(341) into phenyl(mesityl)iodonium triflate (247) was computed (Scheme 148). 
 
Scheme 148 – Oxidative addition of CuTC 341 with mesityl(phenyl)iodonium triflate 247 (Gaussian 09 - BP86 
functional, Def2SVP (SDD) [Cu,I], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
Formation of the pre-oxidative addition complex Int-17 is observed to be thermodynamically downhill 
relative to all previous intermediate adducts. The energetic barrier to oxidative addition is computed to 
+
247
TfO
I Me
Me
Me
O Cu
S
O
341
O
O
S
Cu OTf+ +
I
Me Me
Me
611
CuTC activation
Appendix 4 – Computational Experimental 
 381 
be only 5 kcal mol-1, proceeding through transition state TS-9 to give the apical mesityl-iodide-bound 
aryl copper(III) species Int-18. Simple dissociation of the aryl iodide gives κ2-TC bound Cu(III) 
intermediate Int-19. 
Attention was next turned towards the reductive elimination process (Scheme 149). It is computed that 
κ2-TC-bound species Int-19 lies in equilibrium with the corresponding κ2-triflate-bound adduct Int-20. 
Reductive elimination of this species is calculated to proceed with a barrier of 4.5 kcal mol-1 through 
transition structure TS-10 to give the ester-bound copper(I) species Int-21. Dissociation of the coupled 
product and association of a triflate anion is computed to be thermodynamically favourable, giving 
copper(I) triflate anion 178 ready for a subsequent oxidative addition. 
 
Scheme 149 – Reductive elimination of thiophene carboxylate-bound Cu(III) species Int-19 to ultimately 
furnish copper(I) triflate anion 178 as the active catalyst for the alkene arylation procedure (Gaussian 09 - BP86 
functional, Def2SVP (SDD) [Cu,I], 6-31G+(d,p) [C,H,O,F,S]); energies given as ΔG (kcal mol-1) 
This overall process is computed to be highly exergonic, giving a net free energy change of –76.0 kcal 
mol-1 over the course of the reaction. This reaction scheme therefore represents a plausible mechanism 
by which these highly reactive copper(I) adducts may be generated in situ from bench-stable copper(I) 
sources. We anticipate that analogous mechanisms are followed to activate other commonly employed 
copper(I) salts such as copper(I) chloride and copper(I) iodide. 
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Phenyl(mesityl)iodonium triflate (247): 
Energies (Hartree): 
Zero-point correction 0.281520 
Thermal correction to Energy 0.308191 
Thermal correction to Enthalpy 0.309135 
Thermal correction to Gibbs Free Energy 0.219043 
Sum of electronic and zero-point Energies -1553.724109 
Sum of electronic and thermal Energies -1553.697438 
Sum of electronic and thermal Enthalpies -1553.696494 
Sum of electronic and thermal Free Energies -1553.786587 
E(RB-P86)  -1554.005629 
Structure: 
 
Coordinates: 
 
C -4.263199 -0.778468 0.869399  H -1.603237 2.325780 0.382679 
F -5.060348 -1.872989 0.967602  C 1.918664 3.900346 -0.318770 
F -3.422446 -0.770437 1.938128  H 2.603769 1.860018 -0.651259 
F -5.048538 0.327075 0.942516  C 0.830867 4.726367 0.012301 
S -3.285286 -0.810003 -0.761016  H -1.281537 4.800683 0.527684 
O -2.452592 -2.051939 -0.655651  H 2.903909 4.332201 -0.520965 
O -4.340587 -0.794503 -1.813046  H 0.966782 5.810707 0.069423 
C 2.279651 -0.699211 0.021985  C 1.970273 -0.319253 2.556597 
C 3.036763 -1.071397 -1.113743  H 1.618452 0.725137 2.484158 
C 2.785001 -0.716827 1.346089  H 1.077795 -0.958161 2.675559 
C 4.376262 -1.451248 -0.880493  H 2.574544 -0.407621 3.472354 
C 4.129020 -1.106108 1.502728  C 2.495436 -1.081125 -2.527781 
C 4.937742 -1.479511 0.409459  H 1.690109 -1.826252 -2.651054 
H 4.991704 -1.737416 -1.741051  H 2.081111 -0.100534 -2.819629 
H 4.552099 -1.119757 2.513996  H 3.295784 -1.333412 -3.240153 
I 0.194886 -0.190264 -0.273101  C 6.372698 -1.905116 0.627212 
C 0.485986 1.982468 -0.134888  H 6.419120 -2.853812 1.191541 
C -0.621796 2.768777 0.198877  H 6.900284 -2.052399 -0.328185 
C 1.756172 2.503617 -0.398700  H 6.925380 -1.153008 1.216520 
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C -0.430687 4.162837 0.268322  O -2.463269 0.466707 -0.680901 
 
Copper(I) thiophenecarboxylate (341): 
Energies (Hartree): 
Zero-point correction 0.067752 
Thermal correction to Energy 0.076359 
Thermal correction to Enthalpy 0.077304 
Thermal correction to Gibbs Free Energy 0.032530 
Sum of electronic and zero-point Energies -936.632159 
Sum of electronic and thermal Energies -936.623552 
Sum of electronic and thermal Enthalpies -936.622607 
Sum of electronic and thermal Free Energies -936.667381 
E(RB-P86)  -936.699911 
Structure: 
 
Coordinates: 
 
O -1.795380 0.867956 0.108693  S 0.666036 -0.934099 0.620901 
Cu -1.426582 -1.014528 -0.268965  C 2.803399 0.083543 -0.429192 
C -0.676108 1.560432 0.148379  H 2.025292 2.155570 -0.777806 
O -0.620128 2.806883 0.190829  C 2.314458 -1.113306 0.051865 
C 0.612278 0.768672 0.107264  H 3.826203 0.199877 -0.797576 
C 1.838408 1.146622 -0.402441  H 2.832254 -2.063033 0.189519 
 
Phenyl(mesityl)iodonium cation (154): 
Energies (Hartree): 
Zero-point correction 0.255672 
Thermal correction to Energy 0.272667 
Thermal correction to Enthalpy 0.273611 
Thermal correction to Gibbs Free Energy 0.209533 
Sum of electronic and zero-point Energies -592.059802 
Sum of electronic and thermal Energies -592.042807 
Sum of electronic and thermal Enthalpies -592.041863 
Sum of electronic and thermal Free Energies -592.105941 
E(RB-P86)  -592.315474 
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Structure: 
 
Coordinates: 
 
C -1.241384 -0.232982 -0.192247  C 4.059153 1.806191 1.131753 
C -2.075324 -0.776277 0.810329  H 4.607346 2.092473 -0.954412 
C -1.533130 0.917268 -0.958832  H 3.295504 1.321933 3.111624 
C -3.282478 -0.083755 1.039669  H 4.833547 2.480426 1.509565 
C -2.757463 1.552444 -0.665331  C -0.629331 1.478496 -2.031196 
C -3.642382 1.071513 0.319224  H 0.320149 1.851472 -1.608765 
H -3.960398 -0.474131 1.806953  H -0.381112 0.719270 -2.793828 
H -3.019090 2.452369 -1.233231  H -1.118987 2.321185 -2.541857 
I 0.618893 -1.279744 -0.595083  C -1.768794 -2.028000 1.602599 
C 2.100725 0.104002 0.178949  H -1.671632 -2.912567 0.949189 
C 2.943696 0.726077 -0.752061  H -0.833078 -1.932958 2.180183 
C 2.199450 0.284257 1.564577  H -2.581037 -2.231450 2.316414 
C 3.936096 1.590024 -0.251437  C -4.960946 1.763842 0.578013 
H 2.841433 0.559657 -1.827320  H -5.743141 1.366904 -0.095002 
C 3.196473 1.158832 2.034198  H -5.304455 1.603015 1.612382 
H 1.537239 -0.230723 2.264123  H -4.889811 2.847944 0.394148 
 
Copper(I)(triflate)thiophenecarboxylate anion (612): 
Energies (Hartree): 
Zero-point correction 0.255672 
Thermal correction to Energy 0.272667 
Thermal correction to Enthalpy 0.273611 
Thermal correction to Gibbs Free Energy 0.209533 
Sum of electronic and zero-point Energies -592.059802 
Sum of electronic and thermal Energies -592.042807 
Sum of electronic and thermal Enthalpies -592.041863 
Sum of electronic and thermal Free Energies -592.105941 
E(RB-P86)  -592.315474 
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Structure: 
 
Coordinates: 
 
Cu -0.300686 -0.709904 -0.556266  C 2.173705 0.369872 -0.463445 
O -2.150201 -0.860936 -1.017943  O 1.655815 1.378185 -1.004611 
S -3.260826 -0.748783 0.047354  C 3.623137 0.364332 -0.120910 
C -3.266183 1.116762 0.415023  C 4.557130 1.370620 -0.332119 
O -2.925063 -1.382440 1.352670  S 4.368620 -1.026257 0.647158 
O -4.597797 -1.024715 -0.541435  C 5.866489 1.026248 0.122030 
F -4.237650 1.415069 1.313939  H 4.288763 2.320448 -0.800737 
F -2.071972 1.502087 0.931335  C 5.919431 -0.243505 0.676088 
F -3.493992 1.829872 -0.714889  H 6.736299 1.683916 0.045238 
O 1.539446 -0.735889 -0.148387  H 6.782773 -0.759386 1.099213 
 
Copper(I)(triflate)thiophenecarboxylate – phenyl(mesityl)iodonium adduct (Int-16): 
Energies (Hartree): 
Zero-point correction 0.350511 
Thermal correction to Energy 0.387893 
Thermal correction to Enthalpy 0.388837 
Thermal correction to Gibbs Free Energy 0.269901 
Sum of electronic and zero-point Energies -2490.411851 
Sum of electronic and thermal Energies -2490.374469 
Sum of electronic and thermal Enthalpies -2490.373525 
Sum of electronic and thermal Free Energies -2490.492461 
E(RB-P86)  -2490.762362 
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Structure: 
 
Coordinates: 
 
C -3.784968 -0.955902 -0.208250  H -2.487037 -1.639336 -2.731817 
C -4.230739 -1.532936 -1.420709  H -4.048551 -1.943148 -3.531028 
C -4.445351 -1.106602 1.033641  C -7.364057 -3.345458 -0.104765 
C -5.397166 -2.322030 -1.343048  H -8.244210 -2.710929 -0.317465 
C -5.602571 -1.911812 1.032997  H -7.344874 -4.143551 -0.864595 
C -6.096657 -2.520692 -0.136816  H -7.521775 -3.805228 0.884215 
H -5.767723 -2.789203 -2.262704  O 0.375316 1.797340 -0.262363 
H -6.131815 -2.058918 1.981483  Cu 1.983197 0.757701 -0.073414 
I -2.025470 0.314612 -0.289313  S 0.257859 3.217487 -0.890563 
C -0.671969 -0.968831 0.824965  C 0.423249 4.313744 0.655086 
C -0.081138 -0.439908 1.981526  O -1.128582 3.443935 -1.377220 
C -0.439249 -2.268989 0.362734  O 1.402102 3.581972 -1.760160 
C 0.782290 -1.276278 2.715156  F 0.261248 5.613049 0.314391 
H -0.282346 0.581256 2.314551  F -0.520875 3.982592 1.568808 
C 0.428264 -3.082551 1.115317  F 1.643132 4.158752 1.219198 
H -0.901520 -2.651912 -0.550068  O 3.587953 -0.215777 0.185955 
C 1.033021 -2.589970 2.284921  C 3.763242 -1.120620 -0.749933 
H 1.256187 -0.887141 3.621387  O 2.969034 -1.343295 -1.698581 
H 0.631569 -4.101567 0.772289  C 5.017538 -1.910702 -0.619004 
H 1.708274 -3.231406 2.859155  C 5.488319 -2.915442 -1.455234 
C -3.968256 -0.477004 2.322031  S 6.128485 -1.637185 0.711916 
H -2.980816 -0.868702 2.623423  C 6.735092 -3.464236 -1.027425 
H -3.873122 0.619383 2.229212  H 4.940058 -3.233467 -2.345063 
H -4.675763 -0.687720 3.138318  C 7.205084 -2.871648 0.134373 
C -3.548498 -1.339498 -2.758353  H 7.267401 -4.262208 -1.551532 
H -3.583321 -0.285619 -3.086459  H 8.124059 -3.091934 0.679753 
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TS to oxidative addition pre-complex (TS-8): 
Energies (Hartree): 
Zero-point correction 0.349647 
Thermal correction to Energy 0.386084 
Thermal correction to Enthalpy 0.387029 
Thermal correction to Gibbs Free Energy 0.272842 
Sum of electronic and zero-point Energies -2490.415751 
Sum of electronic and thermal Energies -2490.379314 
Sum of electronic and thermal Enthalpies -2490.378370 
Sum of electronic and thermal Free Energies -2490.492557 
E(RB-P86)  -2490.765399 
Structure: 
 
Coordinates: 
 
C -4.090410 -0.156269 0.212063  H -4.892490 -1.378387 -2.939304 
C -4.766207 -0.762985 -0.874080  H -3.829008 0.027665 -2.673845 
C -4.657133 0.022391 1.495445  C -8.073806 -1.650055 0.881613 
C -6.067534 -1.237577 -0.617607  H -8.536362 -1.202093 1.775424 
C -5.964912 -0.475301 1.677061  H -8.731385 -1.463924 0.016110 
C -6.683304 -1.105215 0.643291  H -8.041092 -2.744316 1.035370 
H -6.614960 -1.718395 -1.436590  O 0.550386 1.242423 -0.540454 
H -6.432602 -0.353928 2.660694  Cu 1.374355 -0.720985 -0.584807 
I -2.102204 0.649230 -0.132108  S 0.891021 2.682821 -0.967644 
C -1.050273 -1.243733 -0.283744  C 1.719752 3.367772 0.600781 
C -1.214990 -2.191981 0.734774  O -0.341728 3.506772 -1.129247 
C -0.311107 -1.484280 -1.476690  O 1.934707 2.764642 -2.021494 
C -0.569957 -3.437247 0.591965  F 2.039372 4.673320 0.421491 
H -1.810418 -1.977015 1.625650  F 0.877691 3.274173 1.660952 
C 0.392617 -2.726653 -1.541424  F 2.849875 2.682170 0.887658 
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H -0.406742 -0.843475 -2.359702  O 2.933472 -0.963784 0.786886 
C 0.245931 -3.691669 -0.523354  C 3.787203 -1.097404 -0.175391 
H -0.689424 -4.191006 1.375729  O 3.424223 -1.036976 -1.402070 
H 0.968049 -2.956802 -2.442834  C 5.209059 -1.330510 0.162342 
H 0.772276 -4.646607 -0.609340  C 6.286336 -1.496423 -0.700184 
C -3.956531 0.712708 2.646780  S 5.725618 -1.426856 1.835773 
H -2.978711 0.253626 2.872950  C 7.522383 -1.701532 -0.017290 
H -3.776014 1.781086 2.433702  H 6.171536 -1.466424 -1.786089 
H -4.573302 0.655646 3.556708  C 7.374934 -1.689489 1.361417 
C -4.159383 -0.936063 -2.247728  H 8.483172 -1.851139 -0.516292 
H -3.280164 -1.603950 -2.220765  H 8.144961 -1.819146 2.123357 
 
Oxidative addition pre-complex (Int-17): 
Energies (Hartree): 
Zero-point correction 0.349636 
Thermal correction to Energy 0.386883 
Thermal correction to Enthalpy 0.387827 
Thermal correction to Gibbs Free Energy 0.270273 
Sum of electronic and zero-point Energies -2490.420800 
Sum of electronic and thermal Energies -2490.383553 
Sum of electronic and thermal Enthalpies -2490.382609 
Sum of electronic and thermal Free Energies -2490.500162 
E(RB-P86)  -2490.770436 
Structure: 
 
Coordinates: 
 
C -3.742047 -0.080555 0.552517  H -5.326509 0.097275 -2.533746 
C -4.691618 -0.198972 -0.492088  H -4.122911 1.289719 -1.976227 
C -3.991695 -0.473537 1.890545  C -7.574141 -1.824940 1.472831 
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C -5.934176 -0.770601 -0.154209  H -7.853025 -1.672366 2.527946 
C -5.257983 -1.034800 2.154967  H -8.374806 -1.416266 0.834973 
C -6.237832 -1.192206 1.155505  H -7.538341 -2.915834 1.295484 
H -6.687871 -0.879040 -0.942668  O 0.696045 1.530300 -0.558164 
H -5.481748 -1.349342 3.180869  Cu 1.064876 -0.592866 -0.882339 
I -1.844678 0.857208 0.115591  S 1.246322 2.946801 -0.792196 
C -0.935603 -0.888208 -0.980306  C 2.285093 3.219850 0.776724 
C -1.275234 -2.173038 -0.478289  O 0.181151 3.986620 -0.718578 
C -0.521710 -0.692748 -2.337784  O 2.220377 3.023649 -1.913350 
C -1.139964 -3.276649 -1.328622  F 2.841054 4.457046 0.755080 
H -1.618426 -2.303137 0.551387  F 1.506521 3.119716 1.883936 
C -0.403905 -1.844863 -3.165837  F 3.277822 2.304303 0.866392 
H -0.447536 0.307544 -2.775087  O 2.249238 -1.281420 0.768316 
C -0.711049 -3.114356 -2.667218  C 3.218249 -1.386886 -0.073738 
H -1.366515 -4.274502 -0.940647  O 3.039204 -1.081640 -1.315471 
H -0.099077 -1.711706 -4.208323  C 4.540778 -1.859642 0.375058 
H -0.629476 -3.989045 -3.319086  C 5.699032 -2.023554 -0.376814 
C -2.998947 -0.311783 3.022319  S 4.809964 -2.299375 2.050993 
H -2.029735 -0.789826 2.798779  C 6.798815 -2.503195 0.393976 
H -2.794959 0.752042 3.237561  H 5.737442 -1.799070 -1.445081 
H -3.394360 -0.767772 3.942787  C 6.466880 -2.699617 1.726120 
C -4.424384 0.229266 -1.917056  H 7.795614 -2.695810 -0.010345 
H -3.616138 -0.368051 -2.375141  H 7.106271 -3.056008 2.535006 
 
Oxidative addition TS (TS-9): 
Energies (Hartree): 
Zero-point correction 0.349183 
Thermal correction to Energy 0.385781 
Thermal correction to Enthalpy 0.386725 
Thermal correction to Gibbs Free Energy 0.271258 
Sum of electronic and zero-point Energies -2490.414309 
Sum of electronic and thermal Energies -2490.377711 
Sum of electronic and thermal Enthalpies -2490.376767 
Sum of electronic and thermal Free Energies -2490.492233 
E(RB-P86)  -2490.763492 
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Structure: 
 
Coordinates: 
 
C -3.146877 0.018757 -0.860343  H -5.593790 -1.827291 0.776946 
C -4.380835 -0.410791 -0.309339  H -4.309691 -2.581707 -0.205270 
C -2.987530 1.232436 -1.576090  C -6.591216 2.570440 -1.328516 
C -5.485085 0.444170 -0.488617  H -6.707524 3.208764 -0.432992 
C -4.136571 2.038104 -1.713972  H -6.493164 3.238711 -2.199136 
C -5.387333 1.666990 -1.183982  H -7.521343 1.988174 -1.435634 
H -6.452523 0.136893 -0.074793  O 1.224010 -2.016757 0.333739 
H -4.044779 2.981842 -2.263884  Cu 1.007731 -0.071524 0.992744 
I -1.437417 -1.253914 -0.647115  S 2.413942 -2.967108 0.082881 
C -0.786331 -0.410903 1.739633  C 2.849916 -2.578616 -1.728418 
C -1.460173 0.787640 2.037252  O 1.978618 -4.389325 0.056953 
C -0.634722 -1.459764 2.668490  O 3.630282 -2.615458 0.860752 
C -1.870377 0.992648 3.367301  F 3.899519 -3.339206 -2.124604 
H -1.614091 1.561993 1.280942  F 1.793969 -2.849940 -2.536872 
C -1.050801 -1.221569 3.993947  F 3.180350 -1.274507 -1.881910 
H -0.181164 -2.411202 2.380261  O 0.940722 1.946214 0.329043 
C -1.670554 -0.007506 4.338103  C 2.227596 1.968306 0.457950 
H -2.351517 1.939335 3.633869  O 2.834619 0.907199 0.867342 
H -0.905350 -2.006173 4.743585  C 2.987577 3.186146 0.150374 
H -2.013260 0.156229 5.364510  C 4.365667 3.370021 0.206853 
C -1.678370 1.681744 -2.184611  S 2.174356 4.649754 -0.370666 
H -0.874413 1.751467 -1.430047  C 4.763808 4.685843 -0.167727 
H -1.333355 0.977267 -2.962473  H 5.048865 2.572605 0.507273 
H -1.794595 2.671605 -2.652488  C 3.685275 5.490234 -0.505427 
C -4.553427 -1.715317 0.434723  H 5.799857 5.032011 -0.189878 
H -3.896498 -1.770112 1.320377  H 3.696117 6.532683 -0.826742 
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Copper(III)-K2-TC-OTf-Ph-apicalMesI (Int-18): 
Energies (Hartree): 
Zero-point correction 0.349719 
Thermal correction to Energy 0.386947 
Thermal correction to Enthalpy 0.387891 
Thermal correction to Gibbs Free Energy 0.269128 
Sum of electronic and zero-point Energies -2490.425265 
Sum of electronic and thermal Energies -2490.388038 
Sum of electronic and thermal Enthalpies -2490.387093 
Sum of electronic and thermal Free Energies -2490.505856 
E(RB-P86)  -2490.774984 
Structure: 
 
Coordinates: 
 
C -2.429221 -1.109712 -1.355033  H -2.996295 -3.320822 1.259921 
C -3.047331 -1.850099 -0.322188  H -1.948311 -3.715055 -0.133390 
C -3.106473 -0.140341 -2.128385  C -6.592722 -0.347514 -0.495174 
C -4.409980 -1.580301 -0.072023  H -7.131923 0.025410 -1.381533 
C -4.468056 0.078326 -1.825955  H -7.107635 -1.251819 -0.130398 
C -5.138086 -0.627212 -0.808979  H -6.684387 0.421989 0.293626 
H -4.911505 -2.144573 0.723545  O 2.619951 0.020180 -0.545735 
H -5.016421 0.822000 -2.416620  Cu 1.049325 0.022811 0.572781 
I -0.363566 -1.539839 -1.830263  S 3.931068 0.728688 -0.058419 
C 1.660028 -1.569766 1.550458  C 4.032766 2.151622 -1.319140 
C 1.357812 -1.568494 2.908619  O 5.126319 -0.104220 -0.327344 
C 2.342515 -2.584000 0.884182  O 3.765498 1.371509 1.269865 
C 1.774542 -2.694772 3.657033  F 5.164295 2.860112 -1.096848 
H 0.810547 -0.754336 3.391210  F 4.063764 1.663413 -2.579416 
C 2.734826 -3.700978 1.656999  F 2.969839 2.974476 -1.192270 
H 2.587919 -2.532477 -0.178526  O -0.493745 0.363140 1.705250 
C 2.454600 -3.751872 3.032207  C -0.785753 1.456071 1.033354 
H 1.549488 -2.724604 4.728523  O -0.006558 1.743399 0.054230 
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H 3.271531 -4.517338 1.161875  C -1.927823 2.271289 1.406281 
H 2.772130 -4.618678 3.620793  C -2.322479 3.473606 0.820565 
C -2.455081 0.627964 -3.255368  S -2.989092 1.822826 2.728156 
H -1.575794 1.195181 -2.902935  C -3.477954 4.026528 1.436209 
H -2.100953 -0.050891 -4.051720  H -1.785733 3.922538 -0.017898 
H -3.167609 1.338835 -3.702576  C -3.947837 3.242697 2.481709 
C -2.324671 -2.891654 0.499905  H -3.950743 4.961930 1.129103 
H -1.450353 -2.457222 1.016303  H -4.811540 3.423277 3.123220 
 
Mesityl iodide: 
Energies (Hartree): 
Zero-point correction 0.167168 
Thermal correction to Energy 0.178604 
Thermal correction to Enthalpy 0.179548 
Thermal correction to Gibbs Free Energy 0.127293 
Sum of electronic and zero-point Energies -360.736878 
Sum of electronic and thermal Energies -360.725442 
Sum of electronic and thermal Enthalpies -360.724497 
Sum of electronic and thermal Free Energies -360.776753 
E(RB-P86)  -360.904046 
Structure: 
 
Coordinates: 
 
C -0.180789 -0.000004 -0.000446  H 0.508950 -2.685094 0.881077 
C -0.854250 1.242204 -0.004738  H -0.862885 -3.403716 -0.010961 
C -0.854239 -1.242209 -0.005055  C -0.138587 2.573803 -0.006394 
C -2.266082 1.206496 -0.009983  H 0.508979 2.684847 0.881727 
C -2.266078 -1.206507 -0.010292  H 0.513658 2.680820 -0.891583 
C -2.990490 -0.000010 -0.009497  H -0.862899 3.403712 -0.010052 
H -2.808546 2.159792 -0.016529  C -4.505130 0.000001 0.018618 
H -2.808537 -2.159804 -0.017083  H -4.880788 0.000769 1.058765 
I 1.984515 0.000003 0.003431  H -4.917808 0.893517 -0.478646 
C -0.138574 -2.573807 -0.007044  H -4.917794 -0.894234 -0.477355 
H 0.513713 -2.680580 -0.892232  
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Copper(III)-K2-TC-OTf-Ph (Int-19): 
Energies (Hartree): 
Zero-point correction 0.182282 
Thermal correction to Energy 0.205669 
Thermal correction to Enthalpy 0.206613 
Thermal correction to Gibbs Free Energy 0.124002 
Sum of electronic and zero-point Energies -2129.681909 
Sum of electronic and thermal Energies -2129.658522 
Sum of electronic and thermal Enthalpies -2129.657578 
Sum of electronic and thermal Free Energies -2129.740189 
E(RB-P86)  -2129.864191 
Structure: 
 
Coordinates: 
 
C -0.649244 2.446595 -0.099710  O -1.668428 -1.479879 1.730300 
C 0.235990 3.283311 -0.771704  F -3.155800 -3.625151 0.088809 
C -1.803653 2.857448 0.559425  F -3.525798 -2.244444 -1.584592 
C -0.083686 4.661786 -0.788896  F -1.467551 -2.817338 -1.066765 
H 1.148386 2.919754 -1.251834  O 1.733583 0.894299 -0.016377 
C -2.083694 4.243894 0.538668  C 2.016064 -0.394749 -0.024160 
H -2.482646 2.162901 1.056431  O 1.011150 -1.188672 -0.090878 
C -1.232019 5.134524 -0.134125  C 3.392896 -0.842485 0.042752 
H 0.589931 5.349053 -1.311857  C 3.846698 -2.161543 0.017576 
H -2.983565 4.602793 1.049557  S 4.723800 0.292838 0.171812 
H -1.464572 6.204231 -0.148176  C 5.262080 -2.251032 0.102156 
O -1.996302 0.048546 -0.275343  H 3.169759 -3.015181 -0.057861 
Cu -0.154584 0.539149 -0.092700  C 5.868144 -1.004482 0.189770 
S -2.596760 -1.071827 0.648109  H 5.820288 -3.189657 0.100290 
C -2.688284 -2.537443 -0.565057  H 6.932541 -0.777639 0.265741 
O -4.008158 -0.756830 0.968556  
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Copper(III)-K2-OTf-TC-Ph (Int-20): 
Energies (Hartree): 
Zero-point correction 0.181862 
Thermal correction to Energy 0.205408 
Thermal correction to Enthalpy 0.206353 
Thermal correction to Gibbs Free Energy 0.123141 
Sum of electronic and zero-point Energies -2129.681581 
Sum of electronic and thermal Energies -2129.658034 
Sum of electronic and thermal Enthalpies -2129.657090 
Sum of electronic and thermal Free Energies -2129.740302 
E(RB-P86)  -2129.863443 
Structure: 
 
Coordinates: 
 
C -0.274124 2.090353 0.036179  O 1.561089 -1.346859 -1.137414 
C -0.349705 2.371645 1.394795  F 3.952698 -2.672701 0.399725 
C -0.498229 2.986668 -1.002279  F 4.658952 -0.719836 1.131093 
C -0.618488 3.718794 1.735045  F 2.670587 -1.459502 1.711807 
H -0.202735 1.614273 2.168665  O -1.405206 -0.103396 -0.793332 
C -0.763469 4.323559 -0.624286  C -1.786599 -0.754327 0.308818 
H -0.471664 2.700577 -2.057253  O -1.024234 -0.921087 1.285805 
C -0.822417 4.681443 0.732972  C -3.166450 -1.264680 0.263212 
H -0.666800 3.990983 2.794690  C -3.779592 -2.091658 1.200500 
H -0.929340 5.068064 -1.409948  S -4.255361 -0.888270 -1.059607 
H -1.042628 5.716728 1.011878  C -5.123656 -2.410693 0.857012 
O 2.344012 0.800376 -0.313217  H -3.263000 -2.441835 2.096800 
Cu 0.398229 0.346230 -0.473865  C -5.518629 -1.830400 -0.340489 
S 2.838356 -0.579661 -0.822581  H -5.780097 -3.038788 1.463688 
C 3.580871 -1.417367 0.720817  H -6.487487 -1.902841 -0.836687 
O 3.918088 -0.555608 -1.823360  
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Copper(III)-K2-TC-OTf-Ph – TS – Reductive elimination (TS-10): 
Energies (Hartree): 
Zero-point correction 0.181334 
Thermal correction to Energy 0.204314 
Thermal correction to Enthalpy 0.205258 
Thermal correction to Gibbs Free Energy 0.123886 
Sum of electronic and zero-point Energies -2129.675712 
Sum of electronic and thermal Energies -2129.652733 
Sum of electronic and thermal Enthalpies -2129.651788 
Sum of electronic and thermal Free Energies -2129.733160 
E(RB-P86)  -2129.857046 
Structure: 
 
Coordinates: 
 
C -0.729412 1.828283 0.037197  O 1.765907 -1.218089 -1.164370 
C -0.865743 2.074409 1.404586  F 4.227588 -2.474177 0.279420 
C -0.824815 2.787107 -0.973207  F 4.820510 -0.533933 1.132855 
C -0.991782 3.428016 1.782527  F 2.879060 -1.421927 1.662892 
H -0.843292 1.273493 2.147352  O -1.523243 0.148005 -0.692186 
C -0.944679 4.127983 -0.556767  C -1.798828 -0.768548 0.264174 
H -0.800373 2.520139 -2.033028  O -0.939636 -1.094296 1.109366 
C -1.028319 4.444782 0.811681  C -3.147927 -1.326140 0.195174 
H -1.060738 3.670732 2.847854  C -3.652035 -2.376091 0.962206 
H -0.988124 4.915516 -1.315789  S -4.351859 -0.723875 -0.930051 
H -1.143826 5.487625 1.121980  C -5.003864 -2.682665 0.648781 
O 2.421848 0.928696 -0.205096  H -3.052290 -2.888828 1.717294 
Cu 0.438065 0.312416 -0.412272  C -5.513745 -1.870391 -0.356345 
S 2.980009 -0.369535 -0.806251  H -5.586131 -3.466367 1.138456 
C 3.780179 -1.261199 0.670618  H -6.515519 -1.884119 -0.788128 
O 4.052301 -0.233899 -1.812654      
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Copper(I)-OTf-phenolic ester adduct (Int-21): 
Energies (Hartree): 
Zero-point correction 0.183848 
Thermal correction to Energy 0.207112 
Thermal correction to Enthalpy 0.208056 
Thermal correction to Gibbs Free Energy 0.123641 
Sum of electronic and zero-point Energies -2129.729106 
Sum of electronic and thermal Energies -2129.705842 
Sum of electronic and thermal Enthalpies -2129.704898 
Sum of electronic and thermal Free Energies -2129.789313 
E(RB-P86)  -2129.912955 
Structure: 
 
Coordinates: 
 
C 1.579809 2.058293 0.103819  O -2.430022 0.626760 -0.344620 
C 1.523182 3.003651 -0.927794  F -4.385440 -0.844353 1.414041 
C 0.712944 2.112715 1.231286  F -4.197001 -2.740273 0.313383 
C 0.571071 4.040131 -0.847243  F -2.454022 -1.894364 1.356950 
H 2.213693 2.924038 -1.771693  O 2.581530 1.074001 0.043573 
C -0.282688 3.130258 1.250555  C 2.185871 -0.247234 0.058262 
H 0.919956 1.509576 2.123210  O 0.991233 -0.596885 0.108756 
C -0.340489 4.091931 0.220508  C 3.299624 -1.169930 0.000981 
H 0.533171 4.794119 -1.638941  C 3.202170 -2.563198 -0.004270 
H -0.951025 3.202272 2.113622  S 4.973140 -0.643163 -0.073460 
H -1.096128 4.881591 0.259547  C 4.469919 -3.196770 -0.067207 
O -2.138858 -1.529864 -1.656460  H 2.242950 -3.083490 0.035514 
Cu -0.556675 0.822655 0.202056  C 5.516931 -2.283736 -0.108838 
S -3.086605 -0.632219 -0.940305  H 4.617463 -4.278549 -0.081411 
C -3.561878 -1.586549 0.633372  H 6.586947 -2.490918 -0.157882 
O -4.383711 -0.316009 -1.593914      
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Copper(I)-OTf2 anion (178): 
See section 1.2.2 
Thiophenyl phenolic ester (611): 
Energies (Hartree): 
Zero-point correction 0.156431 
Thermal correction to Energy 0.168422 
Thermal correction to Enthalpy 0.169366 
Thermal correction to Gibbs Free Energy 0.115114 
Sum of electronic and zero-point Energies -972.531515 
Sum of electronic and thermal Energies -972.519524 
Sum of electronic and thermal Enthalpies -972.518579 
Sum of electronic and thermal Free Energies -972.572832 
E(RB-P86)  -972.687946 
Structure: 
 
Coordinates: 
 
C -3.781988 0.606114 1.048653  O -0.343894 -0.399852 0.077219 
C -2.378927 0.526030 1.051978  C 0.453896 0.685493 -0.249203 
C -1.745149 -0.228980 0.054866  O 0.013239 1.775953 -0.603380 
C -2.470927 -0.908185 -0.932361  C 1.875578 0.349099 -0.124036 
C -3.874532 -0.822708 -0.921474  C 2.940663 1.201719 -0.402342 
C -4.531015 -0.065882 0.065322  S 2.445785 -1.223679 0.408949 
H -4.288906 1.193712 1.820691  C 4.207557 0.591190 -0.187455 
H -1.784682 1.037153 1.814438  H 2.792339 2.226839 -0.748495 
H -1.940684 -1.492112 -1.690288  C 4.096151 -0.719680 0.252700 
H -4.452484 -1.349926 -1.687130  H 5.165593 1.090374 -0.347908 
H -5.623610 -0.001840 0.070228  H 4.897253 -1.419405 0.494677 
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